,Name_VH,Name_VL,Genbank_protein_id_vh,Genbank_protein_id_vl,Binds_to,Origin,VH,VL,Reference,Description_VH,Description_VL,Date_added,Description_VB,Description_VA
0,NaN,NaN,UGO91527,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycardirdssgwanwfdpwgqgtlvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1,NaN,NaN,UGO91525,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsmssyywswirqppgkglewigyiynsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarlegegqlvdyygmdvwgqgttvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2,NaN,NaN,UGO91523,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqsgrslrlscaasgftfssyamhwvrqapgkglewvavishdgsntyyedsvkgrftisrdnskntlhlqvnslrvedtavyycarakgevryfdwaeqggdywgqgtlvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
3,NaN,NaN,UGO91521,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfstyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymglsslrsedtavyycarwvtaygdyvpfdpwgqgtlvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
4,NaN,NaN,UGO91519,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipifgianyaqkfqgrvtitadkststaymelsslrsedtavyycardivgateidywgqgtlvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
5,NaN,NaN,UGO91517,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsryaiswvrqapgqglewmgriipifgianyaqkfqgrvtitadkststaymevsslrsedtavyycarktyyydssgypeafdiwgqgtmvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
6,NaN,NaN,UGO91515,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslhlqmnslraedtalyycanlltpprrysgydlredyfeywgqgtlvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
7,NaN,NaN,UGO91513,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfspysmnwvrqapgkglewvssisvsniytyyadsvkgrftisrdnaknslylqmnslraedtaiyycardlkkggiqydafdiwgqgtvvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
8,NaN,NaN,UGO91511,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfgiswvrqapgqglewmgriipilgtanhaqkfqgrvtitadkstgtvymelsslrsedtavyycardgdsgsyyetlgfdywgqgtlvtvss,NaN,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
9,NaN,NaN,NaN,UGO91528,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdserpsgiperfsgsssgtivtltisgvqaedeadyycqsadssatyvvfgggtkltvl,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
10,NaN,NaN,NaN,UGO91526,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqrpgqspvmviyqdskrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstvvfgggtkltvl,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
11,NaN,NaN,NaN,UGO91524,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkkyaywyqqksgqapvlviyedskrpsgiperfsgsssgtmatltisgaqvedeadyycystdnsgdhgvfgggtkltvl,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
12,NaN,NaN,NaN,UGO91522,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssppwtfgqgtkveik,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
13,NaN,NaN,NaN,UGO91520,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqsplslpvtlgqpasiscrssqslvysdgntylnwfqqrpgqsprrliykvsnrdsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqgthwprtfgqgtkleik,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
14,NaN,NaN,NaN,UGO91518,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspwtfgqgtkveik,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
15,NaN,NaN,NaN,UGO91516,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqapvlviydrnnrpsgipdrfsgsssgntasltitgaqaedeadyychsrdssgnplhvvfgggtkltvl,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
16,NaN,NaN,NaN,UGO91514,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvndylawyqqkpgqaprlliydasnratgfparfsgsgsgtdftltisslepedfavyycqqrsnwpptfgqgtrleik,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
17,NaN,NaN,NaN,UGO91512,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsasgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiyevnkrpsgvpdrfsgsksgntasltvsglqaedeadyycssyagsnnlvfgggtkltvl,"Cho,H. et al.; Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern; Sci Transl Med 13 (616), eabj5413 (2021); 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
18,NaN,NaN,ULE72511,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgesltisckasgyrftsnwitwvrqmpgkglewmgridpddpysnsspsfqghatlsldkaintaylhwsslkasdtamyycarvnrvgdgpdfwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
19,NaN,NaN,ULE72510,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfndygvswvrqapgqglewmggiiaifgtanyaqkfqgrvaitadeststaymelsglrsedtavyfcaslggdsyisgthydrsgydpwgqgtlvivss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
20,NaN,NaN,ULE72509,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewltlisydginkyygdsvkgrftisrdnskntlyiqmnslrpedtavyycarayggnyyygmdvwghgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
21,NaN,NaN,ULE72508,NaN,SARS-CoV-2,Homo sapiens (human),evqlvgsggglvqpggslrlscaasgftfstywmswvrqapgkglewvadikqdgsekyyvdsvkgrftisrdnaknslylqmnslrvedtalyycargglwgtfdywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
22,NaN,NaN,ULE72507,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsgasissssyywgwirqppgkglewigtmyyrgstdynpslksrvtisvdtsknqfslrlssvtaadtavyycarrvpgdyycldvwgkgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
23,NaN,NaN,ULE72506,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssypitwvrqapgqgfewmgkiipilgiadyaqsfqgrvtitadkstttaymelsslrsedtavyycarekgysssssatyyldfwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
24,NaN,NaN,ULE72505,NaN,SARS-CoV-2,Homo sapiens (human),qvqlrlwgagllkpsetlsltcavsggsfidyywtwirqppgkglewigeinhfggsgynpslksrvsisvdtsknqfslrlnsvtaadtaiyycarkpllhssvnpgafdiwgqgtmltvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
25,NaN,NaN,ULE72504,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscsasgftfssypmywvrqapgigleyvsgitdnggstyygdsvkgrftisrdnskntlnlqmnnlrtedtavyycvkgkiqlwlgadywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
26,NaN,NaN,ULE72503,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckvsggtfssytiiwvrqapgqglewmgrvipvvhithyaqrfrgrvtisadkststaymelsslrsedtavyycarglwfgdsetvwfdpwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
27,NaN,NaN,ULE72502,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfstsvvqwvrqprgqrlewiggivvgrgntkyaqnfqervtitrdmststaymelsnlrsedtavyycaadpfadywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
28,NaN,NaN,ULE72490,NaN,SARS-CoV-2,Homo sapiens (human),evqlvefggglvqpgrslrlscatsgftfedfdmhwvrqapgkglewvsgstwnsgiigyadsvkgrfttsrdnaknslymqmnnlreedtalyycakdigrydhynifgrvggafdiwgqgtmvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
29,NaN,NaN,ULE72489,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywdgdkryspslknrltitedtsknqvvltmtnmdpvdtatyycahhtvptiydywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
30,NaN,NaN,ULE72488,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglilpggslrlscaasgvtvssnymnwvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycarggwpsgdtfdiwgqgtmvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
31,NaN,NaN,ULE72487,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsktqfslklssvtaadtavyycardrrgggwtasfdfwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
32,NaN,NaN,ULE72486,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftlssyamnwvrqapgkglewvsaisgsggstyyadsvkgrvtisrdnskntlylqmnslrvedtavyycakdafyygsgshfyyyyymdvwgkgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
33,NaN,NaN,ULE72485,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvsdnymswvrqapgkglqwvsviysggntyyadfvkgrfnitrddsknmlylqmnslrredtavyycvrdrrivgyyfgldvwgqgttvtvfs,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
34,NaN,NaN,ULE72484,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsctasggdftyyplswmrqapgrglewlggiipgyggahvarrfqdrvtitadestttvnmelrslrsddsavyycareegsgwwkhdywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
35,NaN,NaN,ULE72483,NaN,SARS-CoV-2,Homo sapiens (human),qitleesgptlvtptqtltltcsfsgfsldtigvavawirqppgkalewlgtvfwdydkryspplssrltvikdtsqqyvvlrltdvgpgdtatyycarlliehdafdiwgqgavvivss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
36,NaN,NaN,ULE72482,NaN,SARS-CoV-2,Homo sapiens (human),evhlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggntyyadsvkgrftisrdnskntlylqmnslraedtavyycardrriigyyfgmdvwgrgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
37,NaN,NaN,ULE72481,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfnsysmnwvrqapgkglewvsyistssstmyyadsvkgrftisrdnaknslylqmnslraedtavyycareggwysvgwvdpwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
38,NaN,NaN,ULE72480,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlsctasgitvstnymtwvrqapgkglewvsiiysggstyyadsvkgrftisrdnskntlylqmnslraddtavyyctrggwpsgdtfdiwglgtmvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
39,NaN,NaN,ULE72470,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgitfkdygmhwvrqapgrglewvafisydgsvqhygdsvkgrftisrddlkstlflqmnslrgddtavyycvkgatkidywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
40,NaN,NaN,ULE72469,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsdhymdwvrqapgkglewvgrtrnkansyiteyaasvkgrftisrddsknslylqmnslktedtavyycarvrggewvgdlgwyyyygmdvwgqgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
41,NaN,NaN,ULE72468,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscvdseftfityamswvrqapgkglewvstisgsgdstsyadsvkgrftisrdsskntlflqmhslraedtalyycaksativlmvsaiywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
42,NaN,NaN,ULE72467,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyswswirqspgtglewvgdiystgstnynpslksrltmsldtskshfslklssvaaadtavyycargageqrlvgglfgvshfyyymdvwgkgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
43,NaN,NaN,ULE72466,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqvsgpgllkpsetlsltcivsggsisshywswfrqppgkglewigyiyysgstnynpslksrvaisvdtsknhfslnltsvtaadtavyycargfdywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
44,NaN,NaN,ULE72465,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfsfssygmhwvrqapgkglewvtliwfdgsnqyyadsvkgrftisrdnskntlylqmnslrgedtavyycaregavgatsgldywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
45,NaN,NaN,ULE72464,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggsfssyafswvrqapgqglewmggivgmfgttsysqkfqgrliitadeltstaymelsslrsedtavyfcarsggyrlwfgelwgpgtqvivss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
46,NaN,NaN,ULE72463,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsysinwvrqapgqglewmgwisayngstnyaqklqgrvtmttdtststaymelrslrsddtavyycardpasyydlwsgyvdyyyygmdvwgqgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
47,NaN,NaN,ULE72462,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftnyvltwvrqapgqglewmgwisayngstnyaqnlqgrvtmttdtststaymelrslrsddtavyycardpasyydfwsgyvdyyyygmdvwgqgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
48,NaN,NaN,UKY18853,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcivsddsinsyywswirqppgrglewigyiyysgstnydpslksratisldtsknqlslkltsvtaadtavyycarsgsygdrtfdhwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
49,NaN,NaN,UKY18852,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsgfntnyadsvkgrftisrdnskntlylqmnslraedtavyycakygwgllaaagdafdiwgqgtmvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
50,NaN,NaN,UKY18851,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkisckpsgytftnyliqwvrqapgqslewmgwinagdgysknslsfrgrvtftrdtsastasmelsslnsedtavyycarggfnyghgldywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
51,NaN,NaN,UKY18850,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasryafttyaihwvrqapgqglewmgwintntgdpmyahgftgrfvfslatsvstayleisslkaedtavyycaredtfyfdywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
52,NaN,NaN,UKY18849,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyamhwvrqapgqrlewmgwinagngdtkysqkfqgrvtitrdtsastaymelrslrsedtavyycarpprgyydrsgyynvllyfqhwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
53,NaN,NaN,UKY18848,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftsydlhwvrqapgqrlewmgwinvgngntkysqkflgrvtftrdtsastvymelsslrsedtamyycarpprgyydrtgyynvvhyfqhwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
54,NaN,NaN,UKY18847,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsasywswirqppgkglewigeihhsgstnynpslesrvtisvdtsknqfslklssvtatdtavyycareysstvwdnwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
55,NaN,NaN,UKY18846,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqslsltcnvsggsissnnyywnwirqpagkglewigrgyssgstnynpslksrltisldtsknqfslklssvtaadtavyycarstyyydrsgystsdgmdvwgqgttvivss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
56,NaN,NaN,UKY18845,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgggvvqpgrslrlscavsgftfssygmhwvrqapgkglewvtfisydgsneyyadsvkgrftisrdsskntlylqmnslrpedtavyycakseysyaykvhfldywgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
57,NaN,NaN,UKY18844,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcsvsnysissgyywgwirqppgkglewigsifhsgstyynpslkgrvtisvdrsknqfslkltsvtaadtavylcakegargrgattsfyyyymdvwgkgttvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
58,NaN,NaN,UKY18843,NaN,SARS-CoV-2,Homo sapiens (human),evqlvdsggglvqpggslrvscaasgftvssnhmswvrqapgkglewvsliygdgsthyadsvkgrftmsrdkskntlylqmnslraedtavyycardvthafdlwgqgtmvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
59,NaN,NaN,UKY18842,NaN,SARS-CoV-2,Homo sapiens (human),evllvesggglvkpggslrlscaasgfsfssynmnwvrqapgkglewvssissssnyiyyadsvkgrftisrdnaknslylqmnslraedtavyycanmrtnydiftgyypdafdiwgqgtmvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
60,NaN,NaN,UKY18841,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpgvvkpsetlsltcsvsggsisstnyywawirqppgkglewigsifytgstyynpslksrviisvdtsknqfslrltsvtaadtavyycarytsyydrsgfrrveyfqhwgqgtlvtvss,NaN,"Shiakolas,A.R. et al.; Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking; Unpublished; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
61,N3113.1,NaN,7VNE_V,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdssfydyemswvrqapgkaqewigsmypsgrtyinpslkslvtisrdnskntlylqlnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain V, n3113.1",NaN,2022-03-14,NaN,NaN
62,N3113.1,NaN,7VNE_U,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdssfydyemswvrqapgkaqewigsmypsgrtyinpslkslvtisrdnskntlylqlnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain U, n3113.1",NaN,2022-03-14,NaN,NaN
63,N3113.1,NaN,7VNE_W,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdssfydyemswvrqapgkaqewigsmypsgrtyinpslkslvtisrdnskntlylqlnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain W, n3113.1",NaN,2022-03-14,NaN,NaN
64,N3113,NaN,7VND_D,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdfsfydyemswvrqapgkalewigsmyhsgrtyinpslkslvtisrdnskntlylqmnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain D, n3113",NaN,2022-03-14,NaN,NaN
65,N3113,NaN,7VND_V,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdfsfydyemswvrqapgkalewigsmyhsgrtyinpslkslvtisrdnskntlylqmnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain V, n3113",NaN,2022-03-14,NaN,NaN
66,N3113,NaN,7VNC_V,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdfsfydyemswvrqapgkalewigsmyhsgrtyinpslkslvtisrdnskntlylqmnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain V, n3113",NaN,2022-03-14,NaN,NaN
67,N3113,NaN,7VNB_A,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasdfsfydyemswvrqapgkalewigsmyhsgrtyinpslkslvtisrdnskntlylqmnslraedtamyycvsnwasgstgdywgqgtlvtvss,NaN,"Yang,Z. et al.; A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants; Signal Transduct Target Ther 6 (1), 378 (2021); 2021.","Chain A, n3113",NaN,2022-03-14,NaN,NaN
68,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Szeto,C. et al.; Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR; Cells 10 (10), 2646 (2021); 2021.",NaN,NaN,2022-03-14,"Chain E, YLQ-SG3 TCR beta chain (TRBV7-9)",NaN
69,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Szeto,C. et al.; Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR; Cells 10 (10), 2646 (2021); 2021.",NaN,NaN,2022-03-14,NaN,"Chain D, YLQ-SG3 TCR alpha chain (TRAV12-2)"
70,NB_RBD,NaN,7RXD_N,NaN,not determined,Vicugna pacos (alpaca),qvqlvesggglvqaggslrlscaasgfpvyrdrmawyrqapgkerewvaaiysagqqtryadsvkgrftisrdnakntvylqmnslkpedtavyycnvkdvghhyeyydywgqgtqvtvsslehhhhhh,NaN,"Wu,X. et al.; Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies); Proc Natl Acad Sci U S A 118 (41) (2021); 2021.","Chain N, Nb_RBD",NaN,2022-03-14,NaN,NaN
71,NB_KR,NaN,7RXC_N,NaN,not determined,Vicugna pacos (alpaca),qvqlvesggglvqaggslrlscaasgfpvkrwsmtwyrqapgkerewvaairsaghwthyadsvkgrftisrdnakntvylqmnslkpedtavyycnvkdegdfsywydywgqgtqvtvsslehhhhhh,NaN,"Wu,X. et al.; Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies); Proc Natl Acad Sci U S A 118 (41) (2021); 2021.","Chain N, Nb_KR",NaN,2022-03-14,NaN,NaN
72,C5,NaN,7OAU_FFF,NaN,SARS-CoV-2,Lama glama (llama),maqvqlvesgggsvqaggsltlscvasgvtlgrhaigwfrqapgkerervscirtfdgitsyvestkgrftissnnamntvylqmnslkpedtavyfcalgvtaacsdnpyfwgqgtqvtvsshhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain FFF, C5",NaN,2022-03-14,NaN,NaN
73,C5,NaN,7OAU_BBB,NaN,SARS-CoV-2,Lama glama (llama),maqvqlvesgggsvqaggsltlscvasgvtlgrhaigwfrqapgkerervscirtfdgitsyvestkgrftissnnamntvylqmnslkpedtavyfcalgvtaacsdnpyfwgqgtqvtvsshhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain BBB, C5",NaN,2022-03-14,NaN,NaN
74,H3,NaN,7OAQ_FFF,NaN,SARS-CoV-2,Lama glama (llama),maqvqlvesggglvktggslrlscaasgrtfstysmgwfrqapgkerefvagmrwtgsstfysdsvkgrftvsrnnakdtvylhmnslkpedtavyycaittivrayyteyteadfgswgqgtqvtvsskhhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain FFF, H3",NaN,2022-03-14,NaN,NaN
75,H3,NaN,7OAQ_AAA,NaN,SARS-CoV-2,Lama glama (llama),qvqlvesggglvqpggslrlscaasgftndfysiawfrqapgkeregvswlsvsdntptyvdsvkdrftisrhnanntvylqmnmlkpedtaiyycaagrfagrdtwpssydywgqgtqvtvsskhhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain AAA, H3",NaN,2022-03-14,NaN,NaN
76,NaN,NaN,7OAN_H,NaN,SARS-CoV-2,Vicugna pacos (alpaca),maqvqlvesgggsvqaggsltlscvasgvtlgrhaigwfrqapgkerervscirtfdgitsyvestkgrftissnnamntvylqmnslkpedtavyfcalgvtaacsdnpyfwgqgtqvtvsshhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain H, immunoglobulin mu heavy chain",NaN,2022-03-14,NaN,NaN
77,NaN,NaN,7OAN_G,NaN,SARS-CoV-2,Vicugna pacos (alpaca),maqvqlvesgggsvqaggsltlscvasgvtlgrhaigwfrqapgkerervscirtfdgitsyvestkgrftissnnamntvylqmnslkpedtavyfcalgvtaacsdnpyfwgqgtqvtvsshhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain G, immunoglobulin mu heavy chain",NaN,2022-03-14,NaN,NaN
78,NaN,NaN,7OAN_F,NaN,SARS-CoV-2,Vicugna pacos (alpaca),maqvqlvesgggsvqaggsltlscvasgvtlgrhaigwfrqapgkerervscirtfdgitsyvestkgrftissnnamntvylqmnslkpedtavyfcalgvtaacsdnpyfwgqgtqvtvsshhhhhh,NaN,"Huo,J. et al.; A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19; Res Sq (2021); 2021.","Chain F, immunoglobulin mu heavy chain",NaN,2022-03-14,NaN,NaN
79,NB21,NaN,7MDW_A,NaN,SARS-CoV-2,Lama glama (llama),qvqlvesggglvqaggslrlscavsglgahrvgwfrrapgkerefvaaiganggntnyldsvkgrftisrdnakntiylqmnslkpqdtavyycaardietaeytywgqgtqvtvss,NaN,"Sun,D. et al.; Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes; Nat Commun 12 (1), 4676 (2021); 2021.","Chain A, nonobody Nb21",NaN,2022-03-14,NaN,NaN
80,SR31,NaN,7D2Z_A,NaN,"SARS-CoV-2, Spike protein RBD",synthetic construct,gsssqvqlvesggglvqaggslrlscaasgfpvwqgemawyrqapgkerewvaaissmgyktyyadsvkgrftisrdnakntvylqmnslkpedtavyycavmvgfwyagqgtqvtvsagrageqkliseedlnsavdhhhhhh,NaN,"Yao,H. et al.; A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2; PLoS Pathog 17 (3), e1009328 (2021); 2021.","Chain A, SR31 against SARS-CoV-2 RBD, non neutralizing",NaN,2022-03-14,NaN,NaN
81,NaN,NaN,UIK23909,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyaihwvrqapgkglewvaiisydgsnkyyadsvkgrftisrdnsnntvylqinslrtedtavyycaksragsyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
82,NaN,NaN,UIK23908,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisctgsgysfttywigwvrqmpgkglewmgviypgdsdtryspsfqgqvtfsadksistaylqwsslkasdtaiyycarhgnryssgwyqptgvdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
83,NaN,NaN,UIK23907,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgasigsyywswirqppgkgleyigyiyysgstdynpslksrvtisidtsknlfslnltsvtaadtavyycargfdswgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
84,NaN,NaN,UIK23906,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggdvvqpgrslrlscaasgftfstyamhwvrqapgkglewvslisydginkyyagsvkgrfsisrdnskntlylqmnslrvedtavyycarslsggyyygmgvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
85,NaN,NaN,UIK23905,NaN,SARS-CoV-2,Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwyhgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardretstnyvghyyngmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
86,NaN,NaN,UIK23904,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftgyyihwvrqapgqglewmgwvnpnsgatncaqkfqgrvtmtrdtsittvymelsrlkfddtavyycargvdfsifgaaisddwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
87,NaN,NaN,UIK23903,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsenlsltcnvagdsisgyywswirqtpgkglefigymyyggstiynpslrtrvtisidtsknqfslnlnsvtaadtaiyycargfdlwgrgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
88,NaN,NaN,UIK23902,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsgyamhwvrqapgkglewvavisydgdnkyyadsvrgrftisrdnskntlylqmnslrvedtavyycarsssgsyfaafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
89,NaN,NaN,UIK23901,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgdyfwtwirqppgkglewighifysgstyynpslksrvtisldtsknqfslklssvtaadtavyycarvvlaknyydrsgyfhgdwyfygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
90,NaN,NaN,UIK23900,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvssvsgsgdrtyyadsvkghfiisrdnskntlylqmnslraedtavyycatdsyyhdrdgfvnyafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
91,NaN,NaN,UIK23899,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgfnfnnvwmswvrqapgkglewvgliksksdggtkdyaapvrgrftisrddprnnlylqmnslktedtavyycstapyyydysaypqihfeywgrgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
92,NaN,NaN,UIK23898,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglecvsviygggptyyadsvkgrftisrdnskntlylqmnslraedtavyycardkripyyfygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
93,NaN,NaN,UIK23897,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasrfpfstygmhwarrapgkglewvslisddgknkyyadsvkgrftisrdnyentlylemnslrpedtavyycakailrgvkyylygvdiwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
94,NaN,NaN,UIK23896,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpgvvkpsetlsltctvsgdsissyywswirqspgkglewigyiyssgstnynpslksrvamsvdtsknhfslkmtsvtaadtavyycargfdfwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
95,NaN,NaN,UIK23895,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvsnrymswvrqtpgkglewvsiiysagstyyadsvkgrftisrdnskntlylqmnslrvedtavyycaragsplslrwrphidywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
96,NaN,NaN,UIK23894,NaN,SARS-CoV-2,Homo sapiens (human),qvqvqqwgagllkpsetlsltcavyggsfsdyswtwirqspgkglewigeindsgitnydptlksriimsvdrsknqfslrltsvtaadtavyfcargstvlglsslryyssldvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
97,NaN,NaN,UIK23893,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsggevkkpgasvkvsckasgytftnyglswvrqapgqglewmgwisgnngntnyaqkfqgrvtmttdtststgymelrslrsddtavyycardqstvvtfgtfdywgqgtlltvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
98,NaN,NaN,UIK23892,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpggslrlscaasgftfssygmhwvrqapgkglewvafirydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaspsryydssgyylaeyfqhwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
99,NaN,NaN,UIK23891,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpgpvkpsgtlsltcavsgdsitntnwwswvrqspggglewigeihhsgttnyksslksrviisidksknqfslkmrsvtaadtalyycargrynwnggyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
100,NaN,NaN,UIK23890,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvnvsckasggtfssyaiswvrqapgqglewmggifplygttkyaqqfqgrvtfsadestrtaymdlrslrsedtavyycarsadgdyvvgyyhymdvwgkgttvivss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
101,NaN,NaN,UIK23889,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsggtfssytfswvrqapgqglewmgvfipifgttsyaqkfqgrvtitadestytsymelssltsedtamyycasrlgcpngachepdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
102,NaN,NaN,UIK23888,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlsctasgftfntyaihwvrqapgkglesvalisydginkyyadsvkgrftisrdnskntlylqmnslraedtavyycargtggnyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
103,NaN,NaN,UIK23887,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmagimpifgrpnyaqkfqgrvtitadeststaymelsslrsedtavyycasrhsgyryshfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
104,NaN,NaN,UIK23886,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggwvqpggslrlscaasefsvstnymtwvrqapgkglewvsiiysdgrtfyadsvkgrftisrdnskntvylqmnnlrpedtavyfcararvtiivvvvdyffdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
105,NaN,NaN,UIK23885,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvkpggslrlscaasgftfynawmswvrqapgkglewvghikgntnggttdyaapvkgrftisrddskntlylqmnslrtedtgvyycttetllwfgespfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
106,NaN,NaN,UIK23884,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgvtvssnymtwvrqapgkglewvsviysggstfyadsvkgrftisrddsmntlylqmsnvraedtavyycardlyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
107,NaN,NaN,UIK23883,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfnsyaftwvrqapgqglewmgaiipilgianheqkfqdratitadkststaymelrslrsddtavyycasgvvvpatdyyyamdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
108,NaN,NaN,UIK23882,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgfifsssamswvrqapgkglewvsgisdsglrtyygdsvkgrftisrdnskntvsllmnslraedtavyycaygyspdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
109,NaN,NaN,UIK23881,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymnwvrqapgkglewvsviysggttyyadsvkgrftisrdnskntlylqmnnlrdedtamyycardlivygmdvwgqgtpvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
110,NaN,NaN,UIK23880,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasglivssnymswvrqapgkglewvsiiyaggstfyadsvkgrftisrdnskntlylqmnslraedtavyyctrdlvyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
111,NaN,NaN,UIK23879,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglaqpggslrlscaasgitvssnymswvrqapgkglewvsvmyaggstfysdsvkgrftisrdgpkntlylhmhslraedtavyycardlvhygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
112,NaN,NaN,UIK23878,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwirqapgkglewvaviwsdginkyyvdsvkgrftisrdnskntlylqmnslraddtavyycarapqdpdsssyyyfyygldvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
113,NaN,NaN,UIK23877,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftayyihwvrqapgqglewmawinpmsgatnytqkfqgrvtmtrdtsittvymelsrlrsadtavyycarvspptifgvtvdhwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
114,NaN,NaN,UIK23876,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymnwirqapgkglewvssisttgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycarddssgyyygsaldwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
115,NaN,NaN,UIK23875,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgitvssnymswvrqapgkglewvsviysggstfytdsvkgrftisrdnskntlylqmnslraedtavyycardlvvlygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
116,NaN,NaN,UIK23874,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaapgvtvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardldyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
117,NaN,NaN,UIK23873,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfnnyainwvrqapgqglewmgriipmlgvvnhaqkfqgrvtitadkststaymelsslrsedtavyycatrvsvttmgvnfdgmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
118,NaN,NaN,UIK23872,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasglivssnymtwvrqapgkglewvsvlyaggssfyadsvkgrftisrdnskntlflqmnslraedtavyycardlvaygmdvwgqgttvsvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
119,NaN,NaN,UIK23871,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpessvkvsckvsggtfssygiswvrqapgqglewmgriipslgvvnyaqrfqgrvtftadkststaymdlsslksedtavyycakttvvtpglgkdafdvwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
120,NaN,NaN,UIK23870,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgyiftnfwiawvrqmpgkglewmgiiypddsdvrysppfqgqvtisadksintaylqwsslkasdtamyycarlsflpsgfshyyaldvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
121,NaN,NaN,UIK23869,NaN,SARS-CoV-2,Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvalisydgsneyyadsvrgrftisrdnskntlylqmsslraedttmyycaranrgnyyygmdvwgpgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
122,NaN,NaN,UIK23868,NaN,SARS-CoV-2,Homo sapiens (human),qvqleqsgaevkkpgssvkvsckasgssfssyaitwvrqapgqglewmggiipifgtanyaqifqgrvtltaeestgaaymelsslrsedtalyyctiigmfdssgsythywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
123,NaN,NaN,UIK23867,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfifntyamhwvrqapgkglewvavisydgdnkyyadsvkgrftisrdnskstlylqmnslriedtavyycarsrsgsyfsafdiwgqgtkvtvsp,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
124,NaN,NaN,UIK23866,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvrpgrslrlscaasgftfssygmhwvrqapgkglewvalisydginkyypdsvkgrftisrdnsnntlylqmnslraedtavyycanaktgnyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
125,NaN,NaN,UIK23865,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsistyywswirqppgkrlewigyiyysgstnynpslksrvtisvdtsknqfslklnsvtaadtaiyycargfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
126,NaN,NaN,UIK23864,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvaiisydgdkkyytdsvkgrftisrdnskntlflqmnslraedtavyycararegtyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
127,NaN,NaN,UIK23863,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarlsfgyssssnyyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
128,NaN,NaN,UIK23862,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscavsgftfrsyamswvrqapgkglewvstisgsggrtdyadsvkgrftisrdnskntlyvqmsslraedtavyycalpylgwlrsfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
129,NaN,NaN,UIK23861,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqisgpglekpsgtlsltctvsggsvsrsdfywgwvrqppgkglewigsihysgstyynpslksrvtisvdtsenqlslrlssvtaadtavyycarsggysygravwfdnwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
130,NaN,NaN,UIK23860,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsisaihwvrqapgkglewvavisydgfnkyyedsvkgrfiisrdnskntlylqmnslrvedtavyycakgggsyyhpfdnwgqgtlvsvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
131,NaN,NaN,UIK23859,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptvvkptqtltltctfsgfslsisgegvgwirqppgkalewlaliywnderrytpslksrlsitkdtsknqvvltmtnmdpvdtatyycahtyyydsrgyafdnwgqgtlvpvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
132,NaN,NaN,UIK23858,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavfggsfsayywnwirqppgkglewigeinhsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargsreqwlvrrawyfdlwgrgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
133,NaN,NaN,UIK23857,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcavsggsisiyywswirqppgkglewigyishsgdtnynpslksrvtisvdtsknqfslrlssvtaadtalyycargdimwtqwltsggrfldywgqgalvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
134,NaN,NaN,UIK23856,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsisgyywswirqspgkglewmgylyysgsinynpslksrvtisidtsknqfslkmrsvtaadtavyycargfeswgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
135,NaN,NaN,UIK23855,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgntfidsymhwvrqapgqglewmglidpsgknryypqnfqgrltltrdaststtymqlsslrsqdtavyycarmteagswdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
136,NaN,NaN,UIK23854,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyaiywvrqapgkglewvavisydginkyyadsvkgrftisrdnskntlslqlnslraedtavyycarmhsgsyigyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
137,NaN,NaN,UIK23853,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfitysfhwvrqapgkglewvavisydggnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarqksqwellfrgdafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
138,NaN,NaN,UIK23852,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyaihwvrqapgkglewvaliaydgdkkyyadsvrgrftlsrdnskntlylemnslraedtavyycarpysgsyygafeiwgqgtmvtvsa,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
139,NaN,NaN,UIK23851,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyvmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnsnstlylqmnslraedtalyycarggyhyfrhfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
140,NaN,NaN,UIK23850,NaN,SARS-CoV-2,Homo sapiens (human),dvllvesggglvqpggslrlscsasgfpfitywmswvrqapgkglewvanikedgsekyyvdsvrgrftisrdnaenslslqmnslraddtavyycartggrgsldrgrfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
141,NaN,NaN,UIK23849,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscvvsgftfntyamhwvrqapgkglewvavisydgnnhysadsvrgrfsvsrdnskktlflqmnslraedtavyycarsyggnylgyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
142,NaN,NaN,UIK23848,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsmyysgstnynpslksrvtisldtsknqfslkltsvtaadtavyycarrrrgysyghptyhafdmwgqgtmvtvsa,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
143,NaN,NaN,UIK23847,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycarhslrggtrggyyyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
144,NaN,NaN,UIK23846,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggavvqpgrslrlsceasgftfstyamhwvrqapgkglewvalvsydgsnkyyadsvkgrftisrdnskntlylqmdslraedsavyycaralsgsyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
145,NaN,NaN,UIK23845,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscavsgftfgsywmswvrqapgrglewvanirqdgsekyyvdsvkgrftisrdnaknsmylqmnslraedtavyycakenivavpaargydyyyymdvwgkgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
146,NaN,NaN,UIK23844,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlsceasgltfinawmswvrqapgkglewvgriksktdggttdfaapvkgrftisrddskntvflqmnslktedtavyycatdllfprdpgdnwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
147,NaN,NaN,UIK23843,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevqkpgeslkiscrasgytftdqwigwvrqmpgkglewvgviypgdsdtryspsfqgqvtisvdksistaylqwsslkasdtamyycarqsafwtgylyyyafdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
148,NaN,NaN,UIK23842,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaaseftfstytmhwvrqapgkglewvalisydgshkyyadsvkgrftisrdnskntlslqmnslraddtavyycararggnyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
149,NaN,NaN,UIK23841,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggmvqpgrslrlscaasgftfstyaihwvrqapgkglewvavvsydglnkyyadsvrgrftisrdnskntlylqmnnlraedtalyycarsasggywselpywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
150,NaN,NaN,UIK23840,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrtnyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslkltsvtaadtavyycarlppwynsgwagldsltyqyymdvwgkgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
151,NaN,NaN,UIK23839,NaN,SARS-CoV-2,Homo sapiens (human),qvqlmesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglqwvavisydgnnkyyadsvkgrftisrdnskntlylqintlraedtavyycargyggnyhyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
152,NaN,NaN,UIK23838,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpseilsltctvsggsisshywswirqppgkglewigyisysgstnynpslksrvtisvdtsknqfslkltsvtaadtavyycargfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
153,NaN,NaN,UIK23837,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaelkkpgeslrisckgsgysftsywiiwvrqmpgkglewmgridpsdsytkyspsfqghvtissdksistaylqwnslktsdtavyycarqfatlenvigpaaldwfdpwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
154,NaN,NaN,UIK23836,NaN,SARS-CoV-2,Homo sapiens (human),qmhlvqsgpevkkpgtsvkvsckasgftfsssavqwvrqargqhlewigwivvgsgntnygqkfqervtitrdlststvymelislrsedtavyfcaapyctggscfdafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
155,NaN,NaN,UIK23835,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfifstyamhwvrqapgkglewmavisydgsnkyyadsmkarfsisrdnskntlylhmnslrpedtavyycaraaggnyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
156,NaN,NaN,UIK23834,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvrvscraseyaftdyyihwvrqapgqtlewmgiinpsggsaryaqkfqgrvtmtrdtststvymevsslrfedtavyycardpsggssvttqnyfdswgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
157,NaN,NaN,UIK23833,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasglivssnymnwvrqapgkglewvsvlysggstfyadsvkgrftisrdnskntlhlqmnslrvedtavyycardlvaygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
158,NaN,NaN,UIK23832,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsnlgfswvrqapgqglewmggiipivalanyaekfqgrvtitadkststvymelsslrsedtavyycatkgdghnyfyyygvdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
159,NaN,NaN,UIK23831,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasglivssnymnwvrqapgmglewvsviypggttyyadsvkgrftisrdnskntlflqmnslriddtalyycardlvyrgmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
160,NaN,NaN,UIK23830,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgiivssnymtwvrqapgkglewvsvifpggstfsadsvkgrftisrdnsnntlylqmnslraedtavyycargegwdlpfdywgqgilvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
161,NaN,NaN,UIK23829,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscktsgytftsydinwvrqatgqglewmgwmnpnsgnrgyaqmfqgrvtmtsnpsigtaymeltslrsedtavyycargtkfgsnwfwfdhwgqgtlltvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
162,NaN,NaN,UIK23828,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasefivsrnymswvrqapgkglewvsiiypggstfyaesvkgrftisrdnskntlflqmnnlraedtaiyycardygdyyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
163,NaN,NaN,UIK23827,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltcsvsgdsitnimsywgwirqspgkalewigsaynsgnsyynpslksrvtisvdtsknqfslklrsvtaadtsvyfcarhryyydgspgyffdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
164,NaN,NaN,UIK23826,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyafswvrqapgqglewmggiipilhipnyaqkfqarltitadrststaymelsslksedtavyycagtaaehdylwgtyreiygldvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
165,NaN,NaN,UIK23825,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyifisygiswlrqapgqglewmgwispynsntnyaqkfqgrvtmttdtststaymelrslrsddtavyycardgewggwfdpwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
166,NaN,NaN,UIK23824,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscvasgltvssnymtwvrqapgkglewvsvlyvggstfyadsvkgrftisrdkskntlylqmnnlraedtavyycardryvlgmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
167,NaN,NaN,UIK23823,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfgsyainwvrqapgqglewmgrifpmldkatyaqnfqgrvtftadkstntasmelsslssedtafyycargivgptpfyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
168,NaN,NaN,UIK23822,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssfvinwvrqapgqglewmggiipisatanyaqkfqgrvtitadestrtaymelsslrsedtavyycargsrkpfstdiyghvdyyyygmdvwgqgtavtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
169,NaN,NaN,UIK23821,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesaggvvqpgrslrlscaasgftfsdygmkwvrqapgkglewvaviwhdgsnkyyedsvkgrftisrdnsqntlylhmnslrvedtaiyfcargsgssdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
170,NaN,NaN,UIK23820,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsssamywvrqapgkglewvavisndgsnkyyadtvkgrftisrdiskntlyllmnslrvedtgiyycardslpgyngydapdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
171,NaN,NaN,UIK23819,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfssyaiswvrqapgqglewmggiipifgttnyaqkfqgrvtitadkststasmelsslelsslrsedtavyycarthsydssgyyvdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
172,NaN,NaN,UIK23818,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvdsgggvvqpgrslrlscaasgfifssfamhwvrqtpgkglewvavisydginkyyadsvkgrftvsrdnskntlslqmnslrgedtavyycargqgayktafdswgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
173,NaN,NaN,UIK23817,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakssyggyvgyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
174,NaN,NaN,UIK23816,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsgasissggyywswirqhpgkglewigyiyytgstyyspslkgrvtisvdtsknqfslklssltaadtavyycargsgpevvvirpyyldnwgpgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
175,NaN,NaN,UIK23815,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfifskysmdwvrqapgkglewvsyidsggssryyadsvkgrftisrdnaknslylqmnslraedtavyycvrdardghsnndfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
176,NaN,NaN,UIK23814,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfnnyamhwvrqapgkglewvavisydgsnkhyvdsvrgrftisrdnskntlylqmislitedtavyycardwsakmatignfdywgqgslvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
177,NaN,NaN,UIK23813,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfdssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdvstntaymelrslgsedtavyfcaaphcnrttcydafdlwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
178,NaN,NaN,UIK23812,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsistgayywswirqhpgkgleligyiyysettyynpslksrvtmsvdtsenqfslklnsvtaadtavyycarvvhcsgggcsrhnyfdpwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
179,NaN,NaN,UIK23811,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssfaihwvrqapgkglewvtvisfdgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarglsgnyyyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
180,NaN,NaN,UIK23810,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfifssfaihwvrqapgkglewvavisydgsnkyyadsvkgrfsisrdnskntlylqmnslrsedtaiyycarplggnyggafdiwgqgalvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
181,NaN,NaN,UIK23809,NaN,SARS-CoV-2,Homo sapiens (human),qvqleesgpglvkpsetlsltcsvsadsisnyywswirqppgkglewigyiyysgstsynpslksrvtmsvdtsknqfslklssvtaadtavyycargfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
182,NaN,NaN,UIK23808,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsiastyyywgwirqspgkglewianihyngstynkpslknrvtlsvdtsknqfslklssvtaadtavyycarygpyyydrsgsllsdpfdnwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
183,NaN,NaN,UIK23807,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgpglvkpsetlslsctvsggsissyfwswlrqppgkglewigyisyigstnhnpslksrvtmsvdtskkqfslrlssvtdadtavyycarrfphhydstglssdafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
184,NaN,NaN,UIK23806,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvnsgsyywswirqppgkglewigyiyytgstnynpslksrvtisvdtsknqfslklnsvtaadtavyycarvrfcsgsscrshnwfdpwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
185,NaN,NaN,UIK23805,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvhpgrslrlscaasgftfstyamhwvrqapgkglewvavisydgnnkysadsvkgrftisrdnskntlylqmnslrpedsavyycarglggnyyaadywgqgslvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
186,NaN,NaN,UIK23804,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvaiisydgynkyyadsvkgrftisrdnskntlylqmnslrvedtamyycaralggnyyygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
187,NaN,NaN,UIK23803,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvtvsckasgytftsyyihwvrqapgqglewmgiinpgagstsnaqkfqgrvtmtsdtststvymelsslrsedtavyycasgmdtlipaaqrafdiwgqgtvvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
188,NaN,NaN,UIK23802,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcsvsggsissgsvfwtwirqhpgkglewighiyyrgttnynpslksrisisvdtsknqfslnltsvtaadtaiyycarkaggcggdcyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
189,NaN,NaN,UIK23801,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqperslrlscaasgftfsrdgmhwvrrapgkglewvavisydgsnkvyaesvkgrftvsrdsskntvylqmnslraedtavyycakdgpqafgtyfdywgqgtlvivss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
190,NaN,NaN,UIK23800,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaeviqpgaslkvsckasgytftayylfwvrqapgrglewmgwinpnnggtnyaqnfqgrvtmtrdtsmstaymelsrlssddtavyfcarwmvavagmgdrgynyhyymdvwgkgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
191,NaN,NaN,UIK23799,NaN,SARS-CoV-2,Homo sapiens (human),evqveesggglvkpggslrlscaasgfnfssygmnwvrqapgkglewvssisrssdfiyyadsvkgrftisrdnaknavflqmnrlrvedtavyycarnlkirssgdlfrgyyyhgmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
192,NaN,NaN,UIK23798,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvdsgggvvqpgrslrlscaasgftfssyamywvrqapgkglewvavisydgdnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarpgsgnylgyfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
193,NaN,NaN,UIK23797,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvlsgaevkkpgasvkvsckasgyiftgyyihwvrqapgqglewmgwinpmsgatnfarkfqgrvtltrdtsittaymelsrlrsddtavyycarvppfyengahfdnwgqgslvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
194,NaN,NaN,UIK23796,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycargfwvpaaipgvwfdpwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
195,NaN,NaN,UIK23795,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvssnymrwvrqapgkglewvsliyaggstfyadsvkgrfiisrhnsknilylqmnslraedtavyfcardlyvfgmdvwgqgtavtvsa,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
196,NaN,NaN,UIK23794,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgsslrlscaasgfsfisygmhwlrqapgeglewvaiiwfdgrnkyyadsvkgrftisrdnsksmlylqmnslraedtavyycardlpaqkrgdafdiwglgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
197,NaN,NaN,UIK23793,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyythwvrqapgqglewmgwinpnsggtiyaqrfqgrvtmtrdtsistaymelsrlrsddtavyycarwvpprgygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
198,NaN,NaN,UIK23792,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsrygmnwvrqapgkglewvaviwydgnnkyyadsvkgrftisrdnskttlylqmkslraedtavyycaralqyydiltgdysvvrsdafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
199,NaN,NaN,UIK23791,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycardrafgvvtvdfdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
200,NaN,NaN,UIK23790,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggtlvkpggslrlscaasgftfsdyamswvrqapgrglewvsalsdsggstffadsvkgrftisrdnskntlylqmsslraedtakyycargevqpfllafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
201,NaN,NaN,UIK23789,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgvtvsrnymswvrqapgkglewvsviyaggstfyadsvkgrftisrhnskntlylqmnslrvedtavyycvrdlvdygmdvwgqgttvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
202,NaN,NaN,UIK23788,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmsvnwirqppgkalewlaridwdddkyystslmtrltiskdtsknqvvltmtnmdsvdtatyycarsvpttaldywgqgtlvivss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
203,NaN,NaN,UIK23787,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftdyymhwvrqapgqglewmgwinpksggtdfaqiflgrvtmtrdtsistaymelrglrsddtavyycargsyprdvvvvpaaapfnwldpwgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
204,NaN,NaN,UIK23786,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvavlshdgsesyyadsvkgrftisrdnsknslyvqmnslraedtavyycasacnsfncqlgdafdiwgqgtmvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
205,NaN,NaN,UIK23785,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggrvvqpggslrlscaasgftfhdyamhwvrqapgkglewvslingdgrgryyadsvkgrftisrdnsknslylqmnslrtedtalyycakdmesnwnesdfvdywgqgtlvtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
206,NaN,NaN,UIK23784,NaN,SARS-CoV-2,Homo sapiens (human),qahlvqsgpevkkpgasvkvsckasgyafttfaiswvrqapghglewmgrinpyngktyyaqkvqgrvtmttetststaymevrslrsddtavyycarqypmprgphynymdvwgkgtavtvss,NaN,"Vanshylla,K. et al.; Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers; Cell Host Microbe (2021) In press; 2022.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
207,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,"Chain E, pYLQ7 T cell receptor beta chain",NaN
208,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,NaN,"Chain D, pYLQ7 T cell receptor alpha chain"
209,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,"Chain E, pRLQ3 T cell receptor beta chain",NaN
210,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,NaN,"Chain D, pRLQ3 T cell receptor alpha chain"
211,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,"Chain B, pYLQ7 T cell receptor beta chain",NaN
212,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,NaN,"Chain A, pYLQ7 T cell receptor alpha chain"
213,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,"Chain E, pRLQ3 T cell receptor beta chain",NaN
214,NaN,NaN,NaN,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,NaN,"Wu,D. et al.; Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors; Biorxiv (2021); 2021.",NaN,NaN,2022-03-14,NaN,"Chain D, pRLQ3 T cell receptor alpha chain"
215,AB8,NaN,7MJI_E,NaN,"SARS-CoV-2, Spike protein",synthetic construct,evqlvesggglvqpggslrlscaasgftfddyamswvrqapgkglewigrmynngrtsynpslkslvtisrdnskntlylqmnslraedtatyycardnlgyrpsenlygmdvwgqgttvtvsssgqaghhhhhhgdykddddkg,NaN,"Zhu,X. et al.; Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies; PLoS Biol 19 (4), e3001237 (2021); 2021.","Chain E, VH ab8",NaN,2022-03-14,NaN,NaN
216,AB8,NaN,7MJH_F,NaN,"SARS-CoV-2, Spike protein",synthetic construct,evqlvesggglvqpggslrlscaasgftfddyamswvrqapgkglewigrmynngrtsynpslkslvtisrdnskntlylqmnslraedtatyycardnlgyrpsenlygmdvwgqgttvtvsssgqaghhhhhhgdykddddkg,NaN,"Zhu,X. et al.; Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies; PLoS Biol 19 (4), e3001237 (2021); 2021.","Chain F, VH ab8",NaN,2022-03-14,NaN,NaN
217,AB8,NaN,7MJH_E,NaN,"SARS-CoV-2, Spike protein",synthetic construct,evqlvesggglvqpggslrlscaasgftfddyamswvrqapgkglewigrmynngrtsynpslkslvtisrdnskntlylqmnslraedtatyycardnlgyrpsenlygmdvwgqgttvtvsssgqaghhhhhhgdykddddkg,NaN,"Zhu,X. et al.; Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies; PLoS Biol 19 (4), e3001237 (2021); 2021.","Chain E, VH ab8",NaN,2022-03-14,NaN,NaN
218,AB8,NaN,7MJH_D,NaN,"SARS-CoV-2, Spike protein",synthetic construct,evqlvesggglvqpggslrlscaasgftfddyamswvrqapgkglewigrmynngrtsynpslkslvtisrdnskntlylqmnslraedtatyycardnlgyrpsenlygmdvwgqgttvtvsssgqaghhhhhhgdykddddkg,NaN,"Zhu,X. et al.; Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies; PLoS Biol 19 (4), e3001237 (2021); 2021.","Chain D, VH ab8",NaN,2022-03-14,NaN,NaN
219,NaN,NaN,7LX5_A,NaN,SARS-CoV-2,Vicugna pacos (alpaca),qvqlqesggglvqpggslrlscaasgftfrrylmgwarqvpgkglewvsgiysdgstyyadsvkgrftisrdnakntvylqmnslkpedtavyycakdrmdgstwperdfgswgqgtqvtvss,NaN,"Pymm,P. et al.; Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice; Proc Natl Acad Sci U S A 118 (19) (2021); 2021.","Chain A, WNb 10",NaN,2022-03-14,NaN,NaN
220,NaN,NaN,7LX5_C,NaN,SARS-CoV-2,Vicugna pacos (alpaca),qvqlqesggglvqpggslrlscavsgftldyyaigwfrqapgkeregvscisssggntkyadsvkgrftasrdnakntfylqmnslkpedtavyycaaiaatyysgsyyfqcphdgmdywgkgtqvtvss,NaN,"Pymm,P. et al.; Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice; Proc Natl Acad Sci U S A 118 (19) (2021); 2021.","Chain C, WNb 2",NaN,2022-03-14,NaN,NaN
221,NaN,NaN,7JWB_D,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgfriysyysyigwvrrapgkgeelvariypssgytyyadsvkgrftisadtskntaylqmnslraedtavyycarwdfaspyypgssgldywgqgtlvtvssggggtggggsggggsggggsevqlvesggglvqpggslrlscaasgfriysyysyigwvrrapgkgeelvariypssgytyyadsvkgrftisadtskntaylqmnslraedtavyycarwdfaspyypgssgldywgqgtlvtvssggggsggggsggggsggggsevqlvesggglvqpggslrlscaasgfriysyysyigwvrrapgkgeelvariypssgytyyadsvkgrftisadtskntaylqmnslraedtavyycarwdfaspyypgssgldywgqgtlvtvss,NaN,"Bracken,C.J. et al.; Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike; bioRxiv (2020); 2020.","Chain D, autonomous human heavy chain variable domain",NaN,2022-03-14,NaN,NaN
222,NaN,NaN,UBT83456,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycarqaeedisaesrrrgvyyyyygmdvwgqgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
223,NaN,NaN,UBT83454,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycarsgtyyydssgyyqashfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
224,NaN,NaN,UBT83452,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycargykshywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
225,NaN,NaN,UBT83450,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardfrgglvgggscldywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
226,NaN,NaN,UBT83448,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdslfcpqcspayyfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
227,NaN,NaN,UBT83446,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycamgamssswptnwfdpwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
228,NaN,NaN,UBT83444,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipilgianyaqkfqgrvtitadkststaymelsslrsedtavyycarvvsnwfdpwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
229,NaN,NaN,UBT83442,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycardfldssgywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
230,NaN,NaN,UBT83440,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycaralggykldafdiwgqgtmvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
231,NaN,NaN,UBT83438,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlrgitwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
232,NaN,NaN,UBT83436,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlrgitwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
233,NaN,NaN,UBT83434,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlrgitwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
234,NaN,NaN,UBT83432,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvkpgrslrlsctasgftfgdyamswfrqapgkglewvgfirskayggtteyaasvkgrftisrddsksiaylqmnslktedtavyyctrvgitfggvivhpfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
235,NaN,NaN,UBT83430,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardvssgwspgdfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
236,NaN,NaN,UBT83428,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardqeyydiltgasggfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
237,NaN,NaN,UBT83426,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycaragatrlyyyyymdvwgkgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
238,NaN,NaN,UBT83424,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgrinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycarhygdygedafdiwgqgtmvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
239,NaN,NaN,UBT83422,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslkltsvtaadtavyycarrtlsydiltgdyrnynwfdpwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
240,NaN,NaN,UBT83420,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarvirqlwlrfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
241,NaN,NaN,UBT83418,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakaghssgweggpdafdiwgqgtmvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
242,NaN,NaN,UBT83416,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakdrghdygdyvqldwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
243,NaN,NaN,UBT83414,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakpprgyydssgyyyegwyfdlwgrgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
244,NaN,NaN,UBT83412,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarqgkrtyydiltgspagafdiwgqgtmvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
245,NaN,NaN,UBT83410,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycargsryygsgsyynvfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
246,NaN,NaN,UBT83408,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargryyydssgyfgyyymdvwgkgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
247,NaN,NaN,UBT83406,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycargrrtpghyyyymdvwgkgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
248,NaN,NaN,UBT83404,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarglllrflewrhssygwfdpwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
249,NaN,NaN,UBT83402,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycarggvpaarrywyfdlwgrgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
250,NaN,NaN,UBT83400,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadkststaymelsslrsedtavyycaractewepfdafdiwgqgtmvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
251,NaN,NaN,UBT83398,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvhgyyydssgyprgrwfdpwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
252,NaN,NaN,UBT83396,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfpsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarsdgysygyywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
253,NaN,NaN,UBT83394,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargrriwskghyyyymdvwgkgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
254,NaN,NaN,UBT83392,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakdsgaayyyyymdvwgkgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
255,NaN,NaN,UBT83390,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardsdygdsyndywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
256,NaN,NaN,UBT83388,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardqcsgchvfdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
257,NaN,NaN,UBT83386,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlalidwdddkyystslktrltiskdtsknqvvltmtnmdpvdtatyycariratsgwyffdywgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
258,NaN,NaN,UBT83384,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycartsyasfaglgwfdpwgqgtlvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
259,NaN,NaN,UBT83382,NaN,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycasphcsstsclyhyyyygmdvwgqgttvtvss,NaN,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
260,NaN,NaN,NaN,UBT83457,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qseltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsayvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
261,NaN,NaN,NaN,UBT83455,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctrssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsyhssnrvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
262,NaN,NaN,NaN,UBT83453,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnlpqtfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
263,NaN,NaN,NaN,UBT83451,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsksvhwyqqkpgqapvlviyydsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhyvfgtgtkvtvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
264,NaN,NaN,NaN,UBT83449,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstlvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
265,NaN,NaN,NaN,UBT83447,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlwvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
266,NaN,NaN,NaN,UBT83445,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qseltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgpvfgtgtkvtvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
267,NaN,NaN,NaN,UBT83443,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystpytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
268,NaN,NaN,NaN,UBT83441,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,dvvmtqsplslpvtlgqpasiscrssqslvysdgntylnwfqqrpgqsprrliykvsnrdsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqgthwpytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
269,NaN,NaN,NaN,UBT83439,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiyevsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsstvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
270,NaN,NaN,NaN,UBT83437,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
271,NaN,NaN,NaN,UBT83435,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnlppafgggtkveik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
272,NaN,NaN,NaN,UBT83433,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhpvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
273,NaN,NaN,NaN,UBT83431,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiyevsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstyvfgtgtkvtvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
274,NaN,NaN,NaN,UBT83429,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
275,NaN,NaN,NaN,UBT83427,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliydasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsylwtfgqgtkveik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
276,NaN,NaN,NaN,UBT83425,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwpltfgggtkveik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
277,NaN,NaN,NaN,UBT83423,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
278,NaN,NaN,NaN,UBT83421,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
279,NaN,NaN,NaN,UBT83419,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqygtfgqgtkveik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
280,NaN,NaN,NaN,UBT83417,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdivvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
281,NaN,NaN,NaN,UBT83415,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlvvfgtgtkvtvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
282,NaN,NaN,NaN,UBT83413,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystplitfgpgtkvdik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
283,NaN,NaN,NaN,UBT83411,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdqevfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
284,NaN,NaN,NaN,UBT83409,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhpvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
285,NaN,NaN,NaN,UBT83407,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgsmvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
286,NaN,NaN,NaN,UBT83405,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,aivmtqspsslsasvgdrvtitcrasqgissalawyqqkpgkapklliydasslesgvpsrfsgsgsgtdftltisslqpedfatyycqqfnsypytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
287,NaN,NaN,NaN,UBT83403,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslnglvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
288,NaN,NaN,NaN,UBT83401,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,aivmtqspsslsasvgdrvtitcrasqgissalawyqqkpgkapklliydasslesgvpsrfsgsgsgtdftltisslqpedfatyycqqfnsypytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
289,NaN,NaN,NaN,UBT83399,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,aivmtqspsslsasvgdrvtitcrasqgissalawyqqkpgkapklliydasslesgvpsrfsgsgsgtdftltisslqpedfatyycqqfnsypytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
290,NaN,NaN,NaN,UBT83397,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedgadyycssytssrtpwvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
291,NaN,NaN,NaN,UBT83395,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,syvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
292,NaN,NaN,NaN,UBT83393,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwppltfgggtkveik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
293,NaN,NaN,NaN,UBT83391,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspgytfgqgtkleik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
294,NaN,NaN,NaN,UBT83389,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssssvvfgggtkltvl,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
295,NaN,NaN,NaN,UBT83387,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystgqftfgpgtkvdik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
296,NaN,NaN,NaN,UBT83385,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspgltfgggtkveik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
297,NaN,NaN,NaN,UBT83383,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynyldwylqkpgqspqlliylgsnrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqalqtpwlftfgpgtkvdik,"Altomare,C.G. et al.; Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
298,NaN,NaN,QZB58915,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgfifddyamhwvrqvpgkglewvsgvdwnsgtigyadsvkgrfiisrdnaknslylhmrslrvedtafyycakdrlktgpgyfdlwgrgtlvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
299,NaN,NaN,QZB58914,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscsasgftfsnygmhwvrqapgkglewvaviwfdgnnkyyansvkgrftisrdnskntlylqmktlraedtavyycakdtwdvpaanppysfyymdvwgmgttvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
300,NaN,NaN,QZB58913,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgvnvssnymswvrqapgkglewvsliysggstfyadsvkgrftisrdnskntlylqmislraddtavyycardlvyygmdvwgqgttvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
301,NaN,NaN,QZB58912,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasglivsrnymtwvrqapgrglewvstiyaggsafyadsvkgrftisrdnskntlylqmnslraedtavyycardlnvrggldvwgqgttvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
302,NaN,NaN,QZB58911,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggdlvqpgrslrlscaasgftfeyyamhwvrqppgkglewvsgigwnrgslgyadsvkgrftisrddaksslylqmnslrtedtafyycvrgfreflktsgpndywgqgtlvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
303,NaN,NaN,QZB58910,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslsthgmsvswirqppgkalqwlaridwdddkfystslktrltiskdtsknqvvltmtnldpvdtatyycarvrlggfdyymdvwgkgttvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
304,NaN,NaN,QZB58909,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstigvgvswirqppgkaldwlaliywdddkryspslksrltvtmdtsknqvvltltnmdpvdtatyfcahglfsssdwggldvwgqgttvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
305,NaN,NaN,QZB58908,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvsskymswvrqapgkglvcvsliyggdstyyadsvrgrftisrdsskntlylqmnslraedtavyycarvhfryyddsgyyeanpwffdlwgrgtpvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
306,NaN,NaN,QZB58907,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfafsnyamhwvrqapgkglewvavaphnrtdkyyadsvrgrftisrdtskntlyllmnsltvedtglyycakddgyclgrgcyyapgphwgqgtlvtvss,NaN,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
307,NaN,NaN,NaN,QZB58906,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvsnylawyqqrpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfalyycqqrsdwltfgggtnveik,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
308,NaN,NaN,NaN,QZB58905,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,etvltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrstlitfgqgtrleik,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
309,NaN,NaN,NaN,QZB58904,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,aiqltqspsslsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqvdsyspftfgpgtkvdik,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
310,NaN,NaN,NaN,QZB58903,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqginnylawyqqkpgkapkllifaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsdpaltfgggtkveik,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
311,NaN,NaN,NaN,QZB58902,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsaapgqkvtiscsgsssnignnyvswyqqvpgtapklliydnhsrpsgipdrfsgsksgtsatlgitglqtgdeadyycgtwdgslsvyvfgsgtkvtvl,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
312,NaN,NaN,NaN,QZB58901,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsaapgqkvtiscsgtrsnignnyvswyqqlpgtapklliydntkrpsgipdrfsgsrsgtsatlgitglqtgdeadyycgtwdnnlntgvfgggtkltvl,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
313,NaN,NaN,NaN,QZB58900,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dmqmtqspsslsasvgdrvtitcrasqsvftylnwyqqkpgkapklliyaasrlqsgvpsrfrgsgsgtdftltisslqpedfatyycqqshstpfifgpgtkvdik,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
314,NaN,NaN,NaN,QZB58899,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtiscagsssniganydvhwyqvlpgaapkllifrnnnrpsgvpdrfsgsksvtsaslaitglqaedeadyycqsydsslsawvfgggtkltvl,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
315,NaN,NaN,NaN,QZB58898,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqaaritcsgdalpekyaywyqqksgqapvlliyedfkrpseiperfsgsssgtvatltisgaqvddegdyycystdssgnqnyvfgtgtkvtvl,"Kramer,K.J. et al.; Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition; Unpublished; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
316,NaN,NaN,QXI90084,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mdctwrilllvaaatgthaqvqlvqsgaevkkpgasvkvsckvsgyslievsvhwvrqapgkglewmggfdpenaetiyaqkfqgrvtmtedtstdtaymelsslkyedtavyfcatapavagpfyyyyygmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
317,NaN,NaN,QXI90082,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mdctwrilllvaaatgthaqvhlvqsgaevkkpgasvkvsckvsgytlvevsvhwvrqapgkgfewmggfdpenaatiyaqkfqgrvtmtedtstdtaymelsslryedtavyfcatapavagplyyyyygmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
318,NaN,NaN,QXI90080,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mdctwrilllvaaatgthaqvqlvqsgaevkkpgasvkvsckvsgytltevsvhwvrqapgkglewmggfdpedaetiyaqkfqgrvtmtedtstdtaymelsslryedtavyfcatapavagpfyyyyygmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
319,NaN,NaN,QXI90078,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mdctwrilllvaaatgthaqvqlvqsgaevkkpgasvkvsckvsgytltevsvhwvrqapgkglewmggfdpedaktiyaqkfqgrvtmtedtstdtaymelsslssedtavyfcatapavagpfyyyyygmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
320,NaN,NaN,QXI90076,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mdctwrilllvaaatgthaqvqlvqsgaevkkpgasvkvsckvsgytltevsvhwvrqapekglewmggfdpedaetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyfcatapavagpfyyyyygmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
321,NaN,NaN,QXI90074,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mdctwrilllvaaatgthaqvqlvqsgaevkkpgasvkvsckvsgytltevsvhwvrqapgkglewmggfdpedaetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyfcatapavagpfynfyygidvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
322,NaN,NaN,QXI90072,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mefglswvflvallrgvqcqvqvvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslrvedtavyycvretvdgmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
323,NaN,NaN,QXI90070,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mefglswvflvallrgvqcqvqvvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslrvedtavyycvretvdgmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
324,NaN,NaN,QXI90068,NaN,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),mefglswvflvallrgvqcqvqvvesgggvvqpgrslrlscaasgftfsgygmhwvrqapgkglewvaviwydgsnqyyadsvkgrftisrdnskntlylqmnslrvedtavyhcvretvdgmdvwgqgttvtvss,NaN,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.","anti-SARS-CoV-2 spike immunoglobulin heavy chain, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
325,NaN,NaN,NaN,QXI90085,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrllaqllgllmlwvpgssgdivmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprlliykvsnrfsgvpdrfsgsgagteftlkisrveaedvgvyyctqatqfphtfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
326,NaN,NaN,NaN,QXI90083,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrllaqllgllmlwvpgssgdivmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprlliykvsnrfsgvpdrfsgsgagteftlkisrveaedvgvyyctqatqfphtfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
327,NaN,NaN,NaN,QXI90081,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrllaqllgllmlwvpgssgdivmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprlliykvsnrfsgvpdrfsgsgagteftlkisrveaedvgvyyctqatqfphtfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
328,NaN,NaN,NaN,QXI90079,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mvsplqligflllwvpgssgdivmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprlliykvsnrfsgvpdrfsgsgagtdftlkisrveaedvgvyyctqatqfphtfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
329,NaN,NaN,NaN,QXI90077,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrlrdqlmglimlwvpgssgdivmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprliiykvsnrfcgvpdrfsgsgagtdftlkisrveaedvgvyyctqatqfphtfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
330,NaN,NaN,NaN,QXI90075,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mvsplqligflllwvpgssgdivmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprlliykvsnrfsgvpdrfsgsgagtdftlkisrveaedvgvyyctqatqfphtfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
331,NaN,NaN,NaN,QXI90073,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrvpaqllgllllwfpgarcniqmtqspsamsasvgdsvtitcrarqdinnylawfqqkpgkvpkhliyaassllsgvpsrfsgsgsgteftltisslqpedfatyyclqhnsypytfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
332,NaN,NaN,NaN,QXI90071,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrvpaqllgllllwfpgarcniqmtqspsamsasvgdsvtitcrarqdinnylawfqqkpgkvpkhliyaassllsgvpsrfsgsgsgteftltisslqpedfatyyclqhnsypytfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
333,NaN,NaN,NaN,QXI90069,"SARS-CoV-2, Spike protein",Mus musculus (house mouse),NaN,mdmrvpaqllgllllwfpgarcniqmtqspsamsasvgdsvtitcrarqdinnylawfqqkpgkvpkhliyaassllsgvpsrfsgsgsgteftltisslqpedfatyyclqhnsypytfgqgtkleik,"Peter,A.S. et al.; A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model; Eur J Immunol (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 spike immunoglobulin light chain, partial [Mus musculus]",2022-03-14,NaN,NaN
334,NaN,NaN,QYF06251,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrfiisrdnaknslylqmnslraedtavyycardqrrflewlsyyyymdvwgkgttvtvss,NaN,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
335,NaN,NaN,NaN,QYF06508,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstwvfgggtkltvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
336,NaN,NaN,NaN,QYF06454,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlvvfgggtkltvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
337,NaN,NaN,NaN,QYF06418,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstyvfgtgtkvtvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
338,NaN,NaN,NaN,QYF06417,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstwvfgggtkltvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
339,NaN,NaN,NaN,QYF06416,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstwvfgggtkltvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
340,NaN,NaN,NaN,QYF06405,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiyevsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstrvfgggtkltvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
341,NaN,NaN,NaN,QYF06404,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsnyvywyqqlpgtapklliyrnnqrpsgvpdrfsgsksgtsaslaisglrsedeadyycaawddslsgyvfgtgtkvtvl,"Tong,P. et al.; Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike; Cell (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
342,NaN,NaN,QXV87644,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgitvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardleeaggmdvwgqgttvtvss,NaN,"Kaku,Y. et al.; Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19; Cell Rep 36 (2), 109385 (2021); 2021.","anti SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
343,NaN,NaN,QXV87643,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaaseitvsrnymswvrqapgkglewvsviysggsryyadsvkgrftisrdnskntlylqmnslraedtavyycardknegamdvwgqgttvtvss,NaN,"Kaku,Y. et al.; Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19; Cell Rep 36 (2), 109385 (2021); 2021.","anti SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
344,NaN,NaN,QXV87642,NaN,SARS-CoV-2,Homo sapiens (human),evqllesgggliqpggslrlscaasgftvssnymnwvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraddtavyycarsygdyfidywgqgtlvtvss,NaN,"Kaku,Y. et al.; Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19; Cell Rep 36 (2), 109385 (2021); 2021.","anti SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
345,NaN,NaN,QXV87641,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarvhihapnydiltgyygttpgyyygmdvwgqgttvtvss,NaN,"Kaku,Y. et al.; Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19; Cell Rep 36 (2), 109385 (2021); 2021.","anti SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
346,NaN,NaN,QXV87640,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvsrnymswvrqapgrglewvsliysggstyyadsvkgrftisrdsskntlylqmnslraedtavyycarpivgaragmdvwgqgttvtvss,NaN,"Kaku,Y. et al.; Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19; Cell Rep 36 (2), 109385 (2021); 2021.","anti SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
347,NaN,NaN,QXP08760,NaN,SARS-CoV-2,synthetic construct,evqlvesggglvqpggslrlscaasgftfidyymnwvrqapgkglewvgfirnkandytteystsvkgrftisrdnskntlylqmnslraedtavyycarhmyddgfdfwgqgtlvtvssastkgpsvfplapcsrstsestaalgclvkdyfpepvtvswnsgaltsgvhtfpavlqssglyslssvvtvpssslgtktytcnvdhkpsntkvdkrveskygppcppcpapefeggpsvflfppkpkdtlmisrtpevtcvvvdvsqedpevqfnwyvdgvevhnaktkpreeqfnstyrvvsvltvlhqdwlngkeykckvsnkglpssiektiskakgqprepqvytlppsqeemtknqvsltclvkgfypsdiavewesngqpennykttppvldsdgsfflysrltvdksrwqegnvfscsvmhealhnhytqkslslspgk,NaN,"Shi,R. et al.; A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants; Unpublished; 2021.","humanized ACE2-targeting immunoglobulin heavy chain, partial [synthetic construct]",NaN,2022-03-14,NaN,NaN
348,NaN,NaN,QXE98516,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpfkgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitertygldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
349,NaN,NaN,QXE98515,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssisedgystyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtawagtgfeywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
350,NaN,NaN,QXE98514,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdskyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
351,NaN,NaN,QXE98513,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvsdtpfywgwirqppgkglewigsmyytgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarhpssifrgtvftpyyfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
352,NaN,NaN,QXE98512,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvnpggslrlscagsgftfsdyymgwirqapgkglevvsyisttgsyikdadsvkgrftisrdnaknsvylqmnslraedtavyycarmgpygsgsfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
353,NaN,NaN,QXE98511,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglsqpggslrlscatsgfavrnncmnwvrqapgkglewvslicgdgityhsdsvkgrfiisrddsenalhlqmnslrvedtavyycvkasppggntgwpffhywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
354,NaN,NaN,QXE98510,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymiwirqapgkglewlsyishtastiyyadsvkgrftisrdnaknslflqmnsltaedtavyycardrgsgvidpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
355,NaN,NaN,QXE98509,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrepgssvklscktsggpfsthafswvrqapgqrpewmggimpvfgeskdtqkfkgrvtftadasttttymelrslksddtaiyycvrdsdpytatsshnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
356,NaN,NaN,QXE98508,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsthaiswvrqapghgpewlggiiplfgtsesaqrfqarvkitadeststaymelssltsedtavyycvrdsdpytatsrnnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
357,NaN,NaN,QXE98507,NaN,SARS-CoV,Homo sapiens (human),evqlvqwgagllkpsetlslrcavyggsfngfywtwirqapgqglewiaeinhsgttnynpslksrvtisidtskkqfslslksvtaadtamyfcargtispivgvptpvvprrgrswfdpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
358,NaN,NaN,QXE98506,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgggvvqpgtslrlscaatgftfttypmhwvrqapgkglewvavisydgmnqyyadflkgrftisrdnskntlylqmnslraddtavyycarayggnyqnhfdhwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
359,NaN,NaN,QXE98505,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggvvqpggslrlscadsgnafianpmhwvrqapgkglewlalistdgnnrhyadsvkgrftfsrdnsknslylqmdslrpedtgvyycaresrssgragcfdswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
360,NaN,NaN,QXE98504,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscsasgftfsryamhwvrqapgkgleyvsainlngdstyytdsvrgrftisrdnskntlflqmsnvrpedtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
361,NaN,NaN,QXE98503,NaN,SARS-CoV,Homo sapiens (human),evqllesgpglvkpsetlsltctvsggsissnnlywgwirqppgkglewigsiyysgstyynpslksrviipvdtskdqfslrlssvtaadtavyycarhsqkdivlipaaqspifdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
362,NaN,NaN,QXE98502,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckvsggtfsshaiswvrqapgqrpewmggimpifgeskdtqkfqgrvtftvdestntaymeltslksedtaiyycvrdpdpytatvrhnhywhgmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
363,NaN,NaN,QXE98501,NaN,SARS-CoV,Homo sapiens (human),evqllesgpglvkpsetlsltctvsggsinsqywnwirqspgkglewigyvyysgstnynpslksrvtmsvdtsknhfslnlrsvtaadtavyycarglvvryfdgfpsgpiigafdiwnqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
364,NaN,NaN,QXE98500,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkisckisgdtfstnaiswlrqapgrepewmggivplvgpasyaqrpqgrltitadeftntaylelnslrsedtatyycardsdpytatrrhnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
365,NaN,NaN,QXE98499,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlsltcgvyggsfsgyfwswirqspgkglewigeinhsrsmsynpslksritmsvdtsknqfslnlnsvtaadtavyfcargkahrndfwsgyyphwfdpwgqgilvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
366,NaN,NaN,QXE98498,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgfywtwirqppgkglewigeinhsgssnydlslksrvtmsvdtsknqfslklssvtaadtavyycargmispriprttrqrwfdtwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
367,NaN,NaN,QXE98497,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckvsggtfsnyaiswlrqapgqgpewmggiipalsrvgyvrkfqarltisadeltttaymdlssltsedtavyycardpsflntgnhfwydfdlwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
368,NaN,NaN,QXE98496,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsthaiswvrqapghgpewlggilplfgtsesaqrfqarvkitadeststaymelssltsedtavyycvrdsdpytatsrnnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
369,NaN,NaN,QXE98495,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkmpgssvkvsckvsggrfsdyaiswlrqapleglewmggivphlnrkgysqkfqdrltftaddststaymelsgltsedtavyycardptflntgnhfwyavdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
370,NaN,NaN,QXE98494,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmlsdyaiswvrqapgqrlewmggimpafgspgyaqifrgratisadvststayleltslkpedtavyycardpsilntgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
371,NaN,NaN,QXE98493,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscaaseftfstyamhwvrqapgkglewvalisydginkyyadsvkgrfaisrdnskntlylqvnslraddtavyycvrpysgsytnwfdlwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
372,NaN,NaN,QXE98492,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscvasgftfsdfymswirqapgkglewvsyisgsgdtiyyadsvkgrftvsrdnaknslflqmsslgaedtamyycarematsfgyyfvldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
373,NaN,NaN,QXE98491,NaN,SARS-CoV,Homo sapiens (human),evqllesgggvvqpgtslrlscavsgfmfknyaihwvrqapgkglewvavisfdgsdisytesvqgrftisrdnsenmlylqmnslraedtamyycarepdgigaagisgywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
374,NaN,NaN,QXE98490,NaN,SARS-CoV,Homo sapiens (human),evqllesgaevkkpgssvkvscktsggtfsthaiswvrqapgqgpewmggiiplfgtsehaqrfqarvkftadeststaymelssltpedtavyycvrdsdpytatsrnnhywygmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
375,NaN,NaN,QXE98489,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsckaaggtltnyaiswvrqapgqgfewmggimpvshtagyaqkfqgrvtftadesattaymdltslrpedtaiyycardpsihytgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
376,NaN,NaN,QXE98488,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggevkkpgasvkvsckasgytlssypiswvrqapghglewmgwintyngrtnyeqmlqgrvtmttdtststaymelrslrsddtavyycarvvfrhgqyddssgrlafdiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
377,NaN,NaN,QXE98487,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlsceasgfnfnsysmswvrqapgkglewlsyissrsstikyassvqgrftvsrdnakksvylqmnslrdedtavyfcareldsetyynynsldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
378,NaN,NaN,QXE98486,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkgpgasvkvsckvsgysfityditwvrqapgqglewmgwistksgdtryaqnvqgrvtmttdtstntaymelrnlksddtalyycarttprgweqwpvleywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
379,NaN,NaN,QXE98485,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgrglvkpsetlsltctvsggsitssryywgwirqppgrnlewigsihysgttsynpslwsrvaisvdtaqnqfslrlnsvtaadtavyycaapapsnheswsgtdwfdpwgqgilvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
380,NaN,NaN,QXE98484,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgssvkvsckvsggrfsdyaiswlrqapvkglewmggiiprlnrkgysqdfqgrltftadeststaymelsgltsedtavyycardptflnsgnhfwyavdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
381,NaN,NaN,QXE98483,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrepgssvklscktsggtfsthaiswvrqapgqrpewmggimpifgeskdtqkfqgrvtftadestttaymelrslksddtaiyycvrdsdpytatvrsnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
382,NaN,NaN,QXE98482,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlsceasgftfadypmhwvrqapgkglewvavisshgrsqgyaasvkgrftfsrdnsqsslflqlnslrvedtavyfcareaqssgragcldawgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
383,NaN,NaN,QXE98481,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscgasgftfsdyamswvrqapgkglewvstisgsgdktyyadslkgrftnsrdnskstlylqmtslraedtavyfcakdrycsggscfydafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
384,NaN,NaN,QXE98480,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpfsgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
385,NaN,NaN,QXE98479,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkagssvkvsckasggpfssfaiswvrqapgqglewlggimtvfgpahyaqksrdrisitadeststsylelssltsddtavyycaaeersgtnhnyygldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
386,NaN,NaN,QXE98478,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggdsvnpggslrlscagsgfsvrdvwmswvrqapgkglewigrikseadggssdyraslkdrfsiwrdaskntlylqvnglqtedtaiyfcswndvgwaftfwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
387,NaN,NaN,QXE98477,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvalisydgdkkyypdsvrgrftisrdnskntlhlqmnslrledtavyycarsyggsystvgywgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
388,NaN,NaN,QXE98476,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavnggsfnnyywswirqppgkgpewigevvhsgsttynpslksrvtisidmsknqfalklnsvtaadtavyycargftftysdfltgqrtfeywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
389,NaN,NaN,QXE98475,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpggslrlscvasgfpfgryamhwvrqapgqglewltlisfdssnieysdsvqgrftisrdnsrntlflqmtslrpedtavyfcardlppldywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
390,NaN,NaN,QXE98474,NaN,SARS-CoV,Homo sapiens (human),evqlvesgptlvkptqtltltctfsgfslntrelgvgwirqppgkalewlaliywdddkryspslksrlsitkdtsknqvvltltnmdpgdtatyycahtselpprrpyaafdfwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
391,NaN,NaN,QXE98473,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvkpggslrvscvgsgftfsdhymswirqapgkgleiisyistdgsyindadsvkgrfinsrdnaknsvylqlnslraedtavyycarmgpsgsgsldywgqgslvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
392,NaN,NaN,QXE98472,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckvsggrfsdyaiswlrqapvkglewmggiiprlnrkgysqdfqgrltftadeststaymelsgltsedtavyycardptflnsgnhfwyavdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
393,NaN,NaN,QXE98471,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsthaiswvrqapghgpewmggiiplfgtsesaqrfqarvrftadeststaymelssltsedtavyycvrdsdpytatsrnnhywydmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
394,NaN,NaN,QXE98470,NaN,SARS-CoV,Homo sapiens (human),evqlvqsggglvqpggslrlscaasgftfssysmswvrqapgkglewvsyitrssdniyyaesvkgrftisrdsaknslylhmnslrdedtavyycardpgleysgnyfsyyyyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
395,NaN,NaN,QXE98469,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvtdnymswvrqapgkglewvsvlysggstyyadavqgrfsisrdnsknalylqmnslraedtavyycargfgngwsyyfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
396,NaN,NaN,QXE98468,NaN,SARS-CoV,Homo sapiens (human),evqllesggglvkpggslrlsceasgftfsnynmnwvrqapgkglewvssisgsssyisyadsvkgrftisrdnaknslylqmnslrvedtavyycaradrdydfwsdpplidhwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
397,NaN,NaN,QXE98467,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgaevkrpgasvkvsckasgyafsdyymhwvrqapgqgpewmgwinpnsgdtgypqkfrgwvtmtrdtsvstaymelkrlksddtavyycasgpnyfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
398,NaN,NaN,QXE98466,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtlshyaiswvrqapgqglewmggimpvsgtvgyaqkfqgrvkftadeyastaymeltnlrsedsavyfcardpsivdsgphhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
399,NaN,NaN,QXE98465,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsckaaggtltnyaiswvrqapgqgfewmggimpvshtagyaqkfqgrvtftadesattaymdltslrpedtaiyycardpsihytgnhhwydldiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
400,NaN,NaN,QXE98464,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssmrvscrvsggtfithamswvrqapgqgpewmggivplfgrasyaqpsqtrvqitadeststvylevpsltsedtavyycvrdsepytatrsqnhywydmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
401,NaN,NaN,QXE98463,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsckaaggtltnyaiswvrqapgqgfewmggimpvshtagyaqkfqgrvtftadesattaymdltslrpedtaiyycardpsihytgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
402,NaN,NaN,QXE98462,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmftdyaiswvrqapgqrlewmggilpafaasgspgyapifrgratfsadvststayleltnlkpedtavyycardpsilntgnhhwydldlwgqgtevtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
403,NaN,NaN,QXE98461,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfskfamhwvrqapgkglewvaiisydgshknyadsvkgrftisrdnskntvylqvdslraedtavyycallygsgsyynfvffgwkdgsdawgpgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
404,NaN,NaN,QXE98460,NaN,SARS-CoV,Homo sapiens (human),evqllesgghvvlpgkslrlscagsgfgfplyamqwvrrapgkglewvalvsydssniryadsvkgrftisrdnsqntlylqmdslrpedtamyycardnalqdgrpgyfdswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
405,NaN,NaN,QXE98459,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgfifsdyymswirqapgkglewvsyitgsgrtihyadsvkgrftisrdnaknsvylqmnslraedtavyycarghrflefplnyfdpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
406,NaN,NaN,QXE98458,NaN,SARS-CoV,Homo sapiens (human),evqlvesgghvvlpgkslrlscagsgfgfplyamqwvrrapgkglewvalvsydssniryadsvkgrftisrdnsqntlylqmdslrpedtamyycardnalqdgrpgyfdswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
407,NaN,NaN,QXE98457,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvkvsckasggtfynsafswlrhapgqgpewmggitpslgrvgyserflarltitadeststvymeltslasedtavyycardasivgtgnhlwygldfwghgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
408,NaN,NaN,QXE98456,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtladyaiswvrqapgqglewmggikplhgaagysqhfrgrlsitadesastaymeltglrsedtamyycardpsilntgnhhwydldlwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
409,NaN,NaN,QXE98455,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscsaseftlrshamhwvrqapgkgleyvsgistdgsgrfyadsvkgrftisrdnsknklflqmsslrpedtavyycvrdwgssthydvfdlwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
410,NaN,NaN,QXE98454,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsgatyknsafswarqapgqgfqwmggiiplfgvphyvqmfqgrvtitadestsavymelsgltsddtavyycareeysgtvhnffgmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
411,NaN,NaN,QXE98453,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgaevkkpgssvkvsckasggtlsdyaiswvrqapgqglewmggimpifgspgyaeifqgrvtitadeskstvymeltslrsedtavyycardpsildtgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
412,NaN,NaN,QXE98452,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggglvqpggslrlscaasgfifsghwmswvrqapgkglewvanikqdgrekhyvdsvkgrftisrdnaknsvslqmnslraedtavyycvrqnvaiqyyyyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
413,NaN,NaN,QXE98451,NaN,SARS-CoV,Homo sapiens (human),evqllesgggvvqpgrslrlscaasgftfnsyalfwvrqapgkglewvavvsydgnnkyyadsvkgrftisrdnskntlylqmnslktedtsvyycarprsgsyrqaidywglgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
414,NaN,NaN,QXE98450,NaN,SARS-CoV,Homo sapiens (human),evqlvesgaevknpgssvkisckssggtlgdyaiswvrqapglglewlggimplhgttgysqrfrprltitadesartaymeltalssedsaiyycardpsilntgnhhwydldlwgqgtevtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
415,NaN,NaN,QXE98449,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggglvqpgeslrlscaasgfnfspygmnwvrqapgkglewiayiisgsgtiyyadsvkgrftisrdnaqsslylqmnslraedtavyycarglldylhdafdiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
416,NaN,NaN,QXE98448,NaN,SARS-CoV,Homo sapiens (human),evqlvesgpglvkpsetlslactvsggsisnyywnwvrqppgkglewigniyysgsttfnpslksrvtisvdtsrnqfslklssvtaadtavyycarqssswynpyyfdqwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
417,NaN,NaN,QXE98447,NaN,SARS-CoV,Homo sapiens (human),evqllesgaevkkpgssvkvscktsggtfnsytiswvrqapgqglewmggiipildtphyaqkfrgrvtitadkststafmdlssltsedtavyycairrdysdyrdfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
418,NaN,NaN,QXE98446,NaN,SARS-CoV,Homo sapiens (human),qvqllesggglvqpgrslrlsctasgfrfgdytmtwfrqapgkglewvgfirsiayggttehaasvegrfiisrddsksiaylqmnslkaedtgvyfctrgsgmfygsssgmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
419,NaN,NaN,QXE98445,NaN,SARS-CoV,Homo sapiens (human),evqlqesgpglvkpsetlsltcavsggsvssdtdywgwirqppgkglewigsihdsertyydpslksrvtisvdtsknqfslrlssvtaadtalyfcasrhldllpigsfdvwgrgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
420,NaN,NaN,QXE98444,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpgeslrlscaasgfnfspygmnwvrqapgkglewiayiisgsgtiyyadsvkgrftisrdnaqsslylqmnslraedtavyycarglldylhdafdiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
421,NaN,NaN,QXE98443,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqvpgrglewvsgiswnsgtinyadsvmgrftisrdnaknslylqmnslraedtalyycakdgrycsgiscrtgmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
422,NaN,NaN,QXE98442,NaN,SARS-CoV,Homo sapiens (human),evqllesgpglvkpsqtlsltctvsngfissgeyywswirqspgkglewigyishsgstyynrslksrvtisldtsrnqfslnlssvtaadtavyycardlakwsygyyysgmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
423,NaN,NaN,QXE98441,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgysstnygfswvrqapgqglewmgwisvhsgnanfaqkfqgritmttdtstttaymelrnlrsddtatyycatsassysryyfgldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
424,NaN,NaN,QXE98440,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfsnynmvwvrqapgkglewisyissssstiyyadsvkgrfiisrdnaknslhlqmnslrdedtavyycvrdycnsvscytyyyigmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
425,NaN,NaN,QXE98439,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsggsftsyvlswvrqapgqglewmgrivpnlgvanyaqkfqdrvtitadkstttaylelrslrsedtavyycardlyydnggynyldywgpgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
426,NaN,NaN,QXE98438,NaN,SARS-CoV,Homo sapiens (human),evqlvesgaevrkpgssvkvsckatggtfssygitwvrqapgqglewmgriiptlgrtnyaqkfqgrvtitadkststahmelsslrsedtavyycardlstlqpdaivnfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
427,NaN,NaN,QXE98437,NaN,SARS-CoV,Homo sapiens (human),evqllesgggvvnpggsmrlscagsgftfsdhymgwirqapgkglevisyisssgsfirdadsvkgrftisrdnaknsvylqmnslraedtavyycarmgpygsgtfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
428,NaN,NaN,QXE98436,NaN,SARS-CoV,Homo sapiens (human),evqllesgaevkkpgssvkvsckasggtfssdaiswvrqapgqglewmggiipifgttnyaqkfqgrvtitadestntaymelsslrsedtavyycardgpydsggyhlnhwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
429,NaN,NaN,QXE98435,NaN,SARS-CoV,Homo sapiens (human),evqlvesgaevkkpgasvilsckasgytvtnyyihwvrqapgqglewmgwidpdsgvtnfaekfqgrvtmtrdtsistaymelrwlesddtavyycakdlitvirglgggmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
430,NaN,NaN,QXE98434,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyyihwvrqapgqglewlgvihpsggsttfaqkfqgrvtmtrdtststvymelgslrsddtavyycarvlagsshewqlthdafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
431,NaN,NaN,QXE98433,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagvlkpsetlsltcavyggsfrgffwswirqppgkglewigqithsgstnynsslksrltisvdtsknqfslnlssvtaadtaiyycargqggydlrrvgygltswfdpwgqgilvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
432,NaN,NaN,QXE98432,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsgasvssdhwwswvrqspgkglewigevyhsgstnynpslksrvtisldqsnnqfslkltsvtaadtaiyycatmwgglctasncygnpmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
433,NaN,NaN,QXE98431,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggvvqpgkslrlscvasgfsfgtygmhwvrqapgkgpewlavmwydgitqyyadsvkgrftisrdnsketlylqmnsltaddtgvyycvkdqssgdrllylgyfdlwgpgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
434,NaN,NaN,QXE98430,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgkslrlscvpsgfsfgtygmhwvrqapgkgpewlavmwydgitqyyadsvkgrftisrdnsketlylqmnsltaddtgiyycvkdqssgdrllylgyfdlwgpgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
435,NaN,NaN,QXE98429,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscktsgytftghyihwvrqapgqglewmgwinpasgdtnyaqkfqgrvtktrdtsittaymelnrlrsddtavyycarggplpwsdldivgtfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
436,NaN,NaN,QXE98428,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyyvhwvrqvpgqglewmgwispdsgdtiraqnfqgrvtmtrdtsmntaymevnrlrtddtaiyycardlisvirglgggmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
437,NaN,NaN,QXE98427,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfsnyamtwvrqapgkglkwvsginpsgdatfytdsvkgqftisrdnsknilylqmnrlraddtaiyycakglsfygsgsdafdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
438,NaN,NaN,QXE98426,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssmkvsckasgvnfrsysfswvrqapgqglewmggvipyfptanyadkfrdrvtitadestgtvyldmsslrsedtavyfcaseyfdgrsyhsfcgldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
439,NaN,NaN,QXE98425,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgeslkisckasgysftnywvgwvrqmpakglewmgiiwpddsdtryrpsfqgqvtisvdksistaylhwnslkasdngmyfcaraplascsggrcptynrfdlwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
440,NaN,NaN,QXE98424,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgpglvrpsgtlsvtcavsgdsissdywctwvrqspgkglewigkishsgslnynpslksrvtmsvdksknhfslklasvtaadtavyycarvrigashhnfwsgyytdafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
441,NaN,NaN,QXE98423,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarvgsgrvywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
442,NaN,NaN,QXE98422,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgaevkkpgssvrvsckasggtfrksaiswvrqapgqgfewmggiiptldrrgfaqkfqdrltmtadeftstaymdlsdlrsddtavyycardasfpntgnhfwydfdlwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
443,NaN,NaN,QXE98421,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvscrvsggrfsdyafswlrqapvkglewmggiiprldrkgyshifqdrltftadeststtymelsgltsddtavyycardptflnsgnhfwydvdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
444,NaN,NaN,QXE98420,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvevsckvsggtfrdyaiswvrqapgqrlewmggimpglgspayaqifgdrvtisadtststaylqvtnlrpedtavyycardpsilntgnhhwydldmwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
445,NaN,NaN,QXE98419,NaN,SARS-CoV,Homo sapiens (human),evqllesgggvvqpgrslrlscvtsgfdfrpyamqwvrqapgkglewvavishdgvhtgyadslkgrftisrdnskntlylqvdslrpddsalyycardnalqnaqigyldywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
446,NaN,NaN,QXE98418,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpgllkpsetlsltctvsnspissnywswirqpagkglewigriditgntnynpslksrvimsvdtsksqfslkmtsvtaadtavyycarsfisfdssghpyyyyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
447,NaN,NaN,QXE98417,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlslicdvyggsfngfywswirqppgkglewigeishdgstnyspslksrvsisidtskkqfslklrsvtaadtamyycargmtspvvhlyssgrpsrwfdfwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
448,NaN,NaN,QXE98416,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytfsnyamnwvrqapgqgpewmgwidtntgnptyaqgfigrfvfsldtsvntaylligsleaedtavyycareehydfssgyfrpaywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
449,NaN,NaN,QXE98415,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsckaaggtltnyaiswvrqapgqgfewmggimpvshtagyaqkfqgrvtftadesattaymdltslrpedtaiyycardpsihytgnhhwydldiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
450,NaN,NaN,QXE98414,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrkpgssvklsckasggifsthaiswvrqapgqrpewmggiipifgeskdtrkfqgrvtftadestttaymelrslksddtaiyycvldsdpytatfshnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
451,NaN,NaN,QXE98413,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscvtsgfdfrpyamqwvrqapgkglewvavishdgvhtgyadslkgrftisrdnskntlylqvdslrpddsalyycardnalqnaqigyldywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
452,NaN,NaN,QXE98412,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsgasvssdhwwswvrqspgkglewigevyhsgstnynpslksrvtisldqsnnqfslkltsvtaadtaiyycatmwgglctasncygnpmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
453,NaN,NaN,QXE98411,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggsvvqpgtslklscagsagltitryamhwvrqapgkglewvalvshdgihigysdsvrgrftisrdnsrntlylqmdglrpedtavyycvrddvlqhsrpsgpgyfvswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
454,NaN,NaN,QXE98410,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmisdyaiswvrqapgqrlewmggimpafgspgyaqifrgratisadvstntayleltslnpddtavyycardpsilntgnhhwydldmwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
455,NaN,NaN,QXE98409,NaN,SARS-CoV,Homo sapiens (human),qvtlkesggglvqpggslrlscaasgftvnsygmswvrqapgkglewvsgfksrsdrpdyaesvkgrftisrdtskntvylemiglraedtatyycvrmdwmewmkyyfdswgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
456,NaN,NaN,QXE98408,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmftdyaiswvrqapgqrpewmggimpglgspayaqifrgratisadlststayleltslkpedtavyycardpsilntgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
457,NaN,NaN,QXE98407,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmftdyaiswvrqapgqrlewmggimpglgspayaqifrdratisadvststayleltslkpedtavyycardpsilntgnhhwydldiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
458,NaN,NaN,QXE98406,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgdemkkpgssvkvsckasgdtfsthaiswvrqapgqgpewmggiiplfgtasyaqtsqsrvkitadeststaymelssltsedtavyycvrdsdpytatsrnnhywygmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
459,NaN,NaN,QXE98405,NaN,SARS-CoV,Homo sapiens (human),evqllesgpgllkpsetlsltctvsgdsvssgnfywswvrrppgkalewiayshytggtnsdpsfmgrvtmsidpsrnqfslrltsvaaadtavyycarttspltysghwplfdywgqgslvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
460,NaN,NaN,QXE98404,NaN,SARS-CoV,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsgidggggssyyadsvrgrftvsrdnsknmlhlqmnslraddtavyfcakgdwiryfdwslpisffdywgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
461,NaN,NaN,QXE98403,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgadvkkpgasvkvsckasgytftsyymhwvrqapgqglewlgvihpsggsttfaqkfqgrvtmtrdtststvymelsslrsedtavyycarvlagsshewqlthdafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
462,NaN,NaN,QXE98402,NaN,SARS-CoV,Homo sapiens (human),evqllesggglvqpggslrlscaasgfifknepmnwirqfpgkglewisnirdngndvyyadsvkgrftvsrdnaknslylqmnslrdddtalyycvrdtdwafdswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
463,NaN,NaN,QXE98401,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgaevkkpgssvkisckisgdtfstnaiswlrqapgrepewmggivplvgpasyaqrpqgrltitadeftntaylelnslrsedtatyycardsdpytatrrhnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
464,NaN,NaN,QXE98400,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsmnhyywswirqppgkglegigytyysgstnynpslksrvtisvdasknqfslrlssvtaadtavyycargsqidlrgglgatffdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
465,NaN,NaN,QXE98399,NaN,SARS-CoV,Homo sapiens (human),evqlvesggsvvqpgtslklscagsagltitryamhwvrqapgkglewvalvshdgihigysdsvrgrftisrdnsrntlylqmdglrpedtavyycvrddvlqhsrpsgpgyfvswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
466,NaN,NaN,QXE98398,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsitsrdwwswvrqppgkglewigevyhsgstsynpslksrvtisvdksknefslklssvtaadtavyycaragnivvmpaaqyyfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
467,NaN,NaN,QXE98397,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgssvkvsckvsggtfsnyaiswlrqapgqgpewmggiipalskvgyagkfqarltfsadelkttvymdlssltsedtavyycardpsflnagnhfyydfdvwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
468,NaN,NaN,QXE98396,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsafamhwvrqapgkglewvtiisydgsneyyadsvqgrfsisrdnskntlflqmsslrtedtaiyycaraggylsafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
469,NaN,NaN,QXE98395,NaN,SARS-CoV,Homo sapiens (human),evqlvesgpglvkpsatlsltctvsggsinnyywtwvrqsagkglewigrintsgstnynaslksrvtmsidtsknefslrlssvtaadtavyycarefgvrfldrslfgamdvwghgatvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
470,NaN,NaN,QXE98394,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgssmrvscrvsggtfithamswvrqapgqgpewmggivplfgrasyaqpsqtrvqitadeststvylevpsltsedtavyycvrdsepytatrsqnhywydmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
471,NaN,NaN,QXE98393,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtlsdyaiswvrqapgqglewmggimpvfgspgyaeifqgrltitadesrstaymeltslrsedtavyycardpsilntgphhwydldiwgpgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
472,NaN,NaN,QXE98392,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgpevkkpgssvrvsckvsggpfssygvswarqapekglewmggvlpifgtvgyvhkfqgrvtitadeststvymalsslrsedtavyycvldttmshphnwygmdvwghgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
473,NaN,NaN,QXE98391,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftndgfvwvrqapgqvpewmgwisvhtgdtiyaqrfqgrvtmttdtstrtsymelmslrsddtavyycardygdgppdhwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
474,NaN,NaN,QXE98390,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggslrdyaiswvrqapgqgpewmggimpifgtagyaqkfqgrvkftadesattaymeltglrsedsavyfcardpsilntgnhhwydldiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
475,NaN,NaN,QXE98389,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlsltcgvygvsfsdyywswirqppgkglewigeinhsgitnynpslksrvtisvdtsknqfslklssvtaadtavyycarglisytlwlresyfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
476,NaN,NaN,QXE98388,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgasvkisckasgyafrnnyinwirqapgqglewmgiinpsagtstyaqkfqgrvtmtrdtstntvymeitslrsedtatyfcarearrqvtqwfgefwgpynwfdpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
477,NaN,NaN,QXE98387,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvrpsetlsltctvsrgsisssywswirqppgkglewigfmyysgstnynpslksrvtisldtsknqfslklssvtaadtavyycakaqgiyyrgwsywfdpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
478,NaN,NaN,QXE98386,NaN,SARS-CoV,Homo sapiens (human),qvqlqqsggglvqpggslrlsceasgfnfnsysmswvrqapgkglewlsyissrsstikyassvqgrftvsrdnakksvflqmnslrdedtavyycareldsetyynynsldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
479,NaN,NaN,QXE98385,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggglvqpggslrlscsasgftfntytmhwvrqapgkgleyvsaissngvvtyyadsvkgrftisrdnskntlylqmsslraedtavyycvkalyssswcpfdywgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
480,NaN,NaN,QXE98384,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgfilddyavhwvrlapgkglewvsgitwnsgylgyadsvkgrftisrdnaknslylqmnslrpedtalyycaklgtdhpigvdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
481,NaN,NaN,QXE98383,NaN,SARS-CoV,Homo sapiens (human),evqllesggglvqpggslrlscaasgfpfstdamnwvrqapgeglewvstisdtgrdtyyaasvkgrftisrdnskntvylqmnslraedtavyycantnfldywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
482,NaN,NaN,QXE98382,NaN,SARS-CoV,Homo sapiens (human),qvqlqesggglvqpggslrlsceasgfsfsdfvmhwvrqvpgkglewvsrishdgsitsyvdsvkgrftvsrdngkktlylqmnsprtedtavyycardlawtffdywghgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
483,NaN,NaN,QXE98381,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsgasvssdhwwswvrqspgkglewigevyhsgstnynpslksrvtisldqsnnqfslkltsvtaadtaiyycatmwgglctasncygnpmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
484,NaN,NaN,QXE98380,NaN,SARS-CoV,Homo sapiens (human),evqlvesgpglvkpsgtlsltcavtgasvssdhwwswvrqspgkglewigevyhsgstnynpslksrvtisldqsnnqfslkltsvtaadtaiyycatmwgglctasncygnpmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
485,NaN,NaN,QXE98379,NaN,SARS-CoV,Homo sapiens (human),evqlvesgpglvkpsgtlsltcavsgasvssdhwwswvrqspgkglewigevyhsgstnynpslksrvtisldqsnnqfslkltsvtaadtaiyycatmwgglctasncygnpmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
486,NaN,NaN,QXE98378,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrkpgssvklscrasggtfhtytvnwvrqapgqglewlggiipifgtptyaqrfqgkvsitadsstntvfmeltsltsedtavyyctretgtdefdfwgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
487,NaN,NaN,QXE98377,NaN,SARS-CoV,Homo sapiens (human),evqlqesgpgllkpsetlsltctvsgspiasnywswvrqpagkglewigridtspttdynpslksrvimsvdtstsqfslkmssvtaadtavyyctrsfisfdssghpyyyyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
488,NaN,NaN,QXE98376,NaN,SARS-CoV,Homo sapiens (human),evqllesggglvqpggslrlscaasgfpfstdamnwvrqapgeglewvstisdsgrdtyyaasvrgrftisrdnskntvylqmnslrvedtavyycantnfldywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
489,NaN,NaN,QXE98375,NaN,SARS-CoV,Homo sapiens (human),evqlvesgptlvkptqtltltctfsgfslttrrqgvgwlrrppgkalewlaliywdddkryspslksrltitkdtsknhvvlsltnvgpadtatyycahtselpprrpyaafdfwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
490,NaN,NaN,QXE98374,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfifknepmnwirqfpgkglewisnirdngndvyyadsvkgrftvsrdnaknslylqmnslrdddtalyycvrdtdwafdswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
491,NaN,NaN,QXE98373,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaemkkpgeslkisckgsgysfpnywigwvrqmpgkglewmaimwpsdsdtryspsfqgqvtisadtststvylqwgslkasdtamyycvrqrycsggscflfedafeiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
492,NaN,NaN,QXE98372,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggglvqpggslrlscsasgftfntyamhwvrqapgkrleyvssitrdgagkfyadsvkgrftisrdnskntlyqqmsslrpedtavyycvregqqwlglyfdhwgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
493,NaN,NaN,QXE98371,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggnvvqpggslrlscvgsefsitffamqwvrrtpgkglewvalvshdgsnirysdsvkgrfiisrdnakntlylqldsltpedtgiyycardhalqngrpgyfdswgqgsqvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
494,NaN,NaN,QXE98370,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggvvnpggsmrlscagsgftfsdhymgwirqapgkglevisyisssgsfirdadsvkgrftisrdnaknsvylqmnslraedtavyycarmgpygsgtfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
495,NaN,NaN,QXE98369,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfrgfywtwirqppgkglewigevshsgetnynpslksrvtisvdtsknqfslnlisvtaadtsvyycargytapiirevpitfrprwfdpwgqgtpvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
496,NaN,NaN,QXE98368,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmswvrqapgkglewvsghdggtthyadsvkgrftisrddsmntlslqmnslraedtavyycakerdlpgrggyfdhwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
497,NaN,NaN,QXE98367,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscsasgftfsnyamywvrqapgkrpeyvsgissnggityyadsvegrftvsrdnskkslylqmsslrpedtavyycvkdlgatvtydvfdvwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
498,NaN,NaN,QXE98366,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmfsdyaiswvrqapgqrlewmggimpglgspayaqsfggrvtisadiststaylevtslrpedtavyycardpsilntgnhhwydldmwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
499,NaN,NaN,QXE98365,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgdemkkpgssvkvsckasgdtfsthaiswvrqapgqgpewmggiiplfgtasyaqtsqsrvkitadeststaymelssltsedtavyycvrdsdpytatsrnnhywygmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
500,NaN,NaN,QXE98364,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscltsgfsfssywmiwvrqapgkglewvaniepdgneeyyvdsvkgrftisrdnaknslylqmnslraedtavyycargpirhfgldafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
501,NaN,NaN,QXE98363,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmfsdyaiswvrqapgqrlewmggimpglgspayaqifrgrvtisadiststaylevtslrpedtavyycardpsilntgnhhwydldmwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
502,NaN,NaN,QXE98362,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmfsdyaiswvrqapgqrlewmggimpglgspayaqsfggrvtisadiststaylevtslrpedtavyycardpsilntgnhhwydldmwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
503,NaN,NaN,QXE98361,NaN,SARS-CoV,Homo sapiens (human),qvtlkesgaevkkpgssvkvscktsggtfsthaiswvrqapgqgpewmggiiplfgtsqhaqrfqarvkftadestntaymelssltpedtavyycvrdsdpytatsrnnhywygmdvwghgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
504,NaN,NaN,QXE98360,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggmfrdyaiswlrqapgqrlewmggimpafgapgyaqifrgratisadvstttayleltslmpddtavyycardpsilntgnhhwydldlwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
505,NaN,NaN,QXE98359,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscvasgftlapygmqwvrqapgkglewvaflshdgshlgyvdsvkgrftisrdnskntlylemnslraedtatyycardnvvqqnadnvgyfdfwgqgslvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
506,NaN,NaN,QXE98358,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckvsggmfsdyaiswvrqapgqrlewmggimpglgspayaqifrgrvtisadiststaylevtslrpedtavyycardpsilntgnhhwydldmwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
507,NaN,NaN,QXE98357,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggglvqpggslrvscsasgftfssfamhwvrqapgkgleyvagisdnghttmyadsvkgrftisrdnskntlylqlsslrpedtavyfcvkdnvilpgaivrpqfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
508,NaN,NaN,QXE98356,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrkpgssvklsckasggtfsthaiswvrqapgqrpewmggiipifgeskdtqkfqgrvtftadestttaymelrslrsddtaiyycvrdsdpytttfshnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
509,NaN,NaN,QXE98355,NaN,SARS-CoV,Homo sapiens (human),evqllesgggvvqpgtslrlscvasgftfstfamhwvrqapgkglewvalisfdstniryansvrgrftisrdnskntlylevdslriedtgvyycardlppldywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
510,NaN,NaN,QXE98354,NaN,SARS-CoV,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsrygmhwvrqapgkglewvaviysdgrneyyadsvkgrftisrdnskntlhlqmnslgaadtavyycardpgpitffdwspdksrksyydyngmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
511,NaN,NaN,QXE98353,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggdlvkpgrslrlsctasgftigdyamtwfrqapgkglecvavirsrafggtteyaasvkgrfivsrddsnsvaflqmnslktedtavyycsrdlrrgyydsnghqqfdlwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
512,NaN,NaN,QXE98352,NaN,SARS-CoV,Homo sapiens (human),evqlqqsgaevkkpgssvkvsckasggtssthaiswvrqapgqglewmggiipifgttnyaqkfqdrvtitadeststaymelsslrsedtavyfcvrdgaydssgyystqwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
513,NaN,NaN,QXE98351,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckvsggtfsnyaiswlrqapgqgpewmggiipalsrvgyarkfqarltisadeltttaymdlssltsedtavyycardpsflntgnhfwydfdmwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
514,NaN,NaN,QXE98350,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgpglvrpsgtlsltcavsgdsisgdywctwvrqtpgkglewigkishsgsinynpslksritmsvdksknqfslklnsvtaadtamyycarvrvgashhnfwsgyytdafdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
515,NaN,NaN,QXE98349,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgpelkkpgssvrvsckasggsissyaiswvrqapgqrlewmggvlpmmgrespvqkfkdrvtiaadeststaymelrslsaedtavyycvvdttmadphnwygldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
516,NaN,NaN,QXE98348,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtladyaiswvrqapgqglewmggikplhgaagysqlfrgrlsitadesastaymeltgltsddtamyycardpsilntgnhhwydldlwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
517,NaN,NaN,QXE98347,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfslfhvhwvrqapgqglewmgwinphngdttfaerfqgrvaltrdtsintaymelsrltsddtavyfcardfgvryddsrqlmkycdswgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
518,NaN,NaN,QXE98346,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvtvsckvsggrfsdyaiswlrqapveglewmggiiphlnkkgysqkfqdritftadeststaymelsgltsedtaiyycardptflntgnhfwyavdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
519,NaN,NaN,QXE98345,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgssvkvsckvsggrfsdyaiswlrqapvkglewmggiiprlnrkgysqdfqgrltftadeststaymelsgltsedtavyycardptflnsgnhfwyavdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
520,NaN,NaN,QXE98344,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtssthaiswvrqapgqglewmggiipifgttnyaqkfqdrvtitadeststaymelsslrsedtavyfcvrdgaydssgyystqwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
521,NaN,NaN,QXE98343,NaN,SARS-CoV,Homo sapiens (human),pgpactvwaevkkpgssvkvsckasggmfsdyaiswvrqapgqrlewmggimpglgspgyaqifrgratisadvststayleltslkpedtavyycardpsilntgnhhwydldiwgqgtqvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
522,NaN,NaN,QXE98342,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggvvnpggslrlscvgsgftfsdyymgwirqapgkglevisyisstgsyirdadsvkgrftisrdnaensvylqmnslrgedtavyycarmgpygsgsfdywglgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
523,NaN,NaN,QXE98341,NaN,SARS-CoV,Homo sapiens (human),evqlvesgpelkkpgssvrvsckasggsfsnfavswvrqapgqrlewmggviprfgrseyvqkfqgrvtitvdeaastaymelsslrsedtaiyycvldttsanphnwygmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
524,NaN,NaN,QXE98340,NaN,SARS-CoV,Homo sapiens (human),qvqlvqwgagllkpsetlsltcavyggsfsgfhwswirqppgkglewigeinhsgstkynpslksrvtisvdtsknqfslrlrsvtaadtaiyycargslsreydfltapqngpwfdswgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
525,NaN,NaN,QXE98339,NaN,SARS-CoV,Homo sapiens (human),evqlqesgpglvkpsgtlsltcgvsgvsisssswwswvrqppgrglewigeispsgstsynpsfrsrltmsvdksrnqlslklssvtaadtavyycartqsndfwsgyytaafdlwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
526,NaN,NaN,QXE98338,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssdwcswvrqppgkgpewiaeishsgstnynpslksrvtmsvdrsknqfslnlnsvtaadtavyycaarirgathydfwsgfwagpfdiwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
527,NaN,NaN,QXE98337,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaemrkpgssvkvsckasggtfsrycfswvrqapgqrlewmggimsilgahyaqkfqgrvtftadestntaymelisltsedtavyycareepsgtyhnyygldvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
528,NaN,NaN,QXE98336,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglsqpggslrlscaasgftvrtycmnwvrqapgkglewvslvcgdnidyypdsvkgrfsisrddskntlllhmdslrvedtavyycaratppgggtgwpyfdfwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
529,NaN,NaN,QXE98335,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrkpgssvklsckasggtfsthaiswvrqapgqrpewmggimpifgeskdtqkfqgrvtftadestttaymelrslksddtaiyycvrdsdpytatvrnnhywyaldvwgpgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
530,NaN,NaN,QXE98334,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfstsamswvrqapgkglewvsrigggggrtkyadsvkgrftisrdnskntlylqmnslraddtavyycakcdlvryfdwlgeennwfdpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
531,NaN,NaN,QXE98333,NaN,SARS-CoV,Homo sapiens (human),evqlvesgpglvkpsetlsltctvsgasvtagssywgwirqppgkglewigymfssgntkynpslksrvtisadtsknqfslrlssvtaadtavyfcarvgwvryfdwskpyyyfdlwgrgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
532,NaN,NaN,QXE98332,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgfhwswirqppgkglewigevnhsgstkynpslksrvtvsvdtsknqfslrlssvtaadtaiyycargslsreydfltapqngpwfdswgqgalvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
533,NaN,NaN,QXE98331,NaN,SARS-CoV,Homo sapiens (human),qvqlqqwgagllkpsetlslscavyggsfsgfywswirqppgkglewigeinhsgsanynpslmsrvtismdtskkqfslqlrsvtaadtavyycargqespivgvtgrwfdpwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
534,NaN,NaN,QXE98330,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsckaaggtltnyaiswvrqapgqgfewmggimpvshtagyaqkfqgrvtftadesattaymdltslrpedtaiyycardpsihytgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
535,NaN,NaN,QXE98329,NaN,SARS-CoV,Homo sapiens (human),evqlvesgaevrtpgssvklsckasggtfsthafswvrqapgqrpewmggiipifgeskdtqkfqgrvtftadestttvymelrslksddtaiyycvrdsdpytatyrnnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
536,NaN,NaN,QXE98328,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaelkkpgssvrvsckaaggtltnyaiswvrqapgqgfewmggimpvshtagyaqkfqgrvtftadesattaymdltslrpedtaiyycardpsihytgnhhwydldiwgqgtmvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
537,NaN,NaN,QXE98327,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsgypmhwvrqapgkglewvalisfdgdskyytdsvkarfaisrdnskntlflqmnslrvadtalyycarakggsysnafdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
538,NaN,NaN,QXE98326,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckisggtfknsafswarqvpgqgfqwmggiipmfgvphsvqmfqgrvtltadestsavymelsgltsddtavyycareeysgtvhnffgmdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
539,NaN,NaN,QXE98325,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevrkpgssvklsckasggtfsthaiswvrqapgqrpewmggimpifgeskdtqkfqgrvtftadestttaymelrslrsddtaiyycvrdsdpytatvtsnhywyamdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
540,NaN,NaN,QXE98324,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggvvqpgrslklscvvsgfsfshygmnwvrqapgkglewvavmsydgsdkyyadsvkgrftisrdiskntlylemnslrtedtavyycakkgspycgvdcykgyfdywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
541,NaN,NaN,QXE98323,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglsqpggslrlscaasgfvvknncmnwvrqapgkglewvalicadgityhsdsvtgrftiyrdesdntlhlqmdslriedtavyycvrasppggntgwpffedwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
542,NaN,NaN,QXE98322,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfssydinwvrqatgqglewmgwmspntgdtgyahkfqgrvrmtsntsistaymelnsltsedtavyycarrgnnfgyyyyytvdvwgqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
543,NaN,NaN,QXE98321,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgssmklsckasginfrsysfswvrqapgqglewmggvipyfptanyaekfrgrvtatadestgtvylemsslrsedtavyycaseyfdgrsyhsfcgldvwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
544,NaN,NaN,QXE98320,NaN,SARS-CoV,Homo sapiens (human),evqllesggglsrpggslrlscaasgfiasrncmqwvrqapgkglewvsiicgdeityirdsvkgrftisrddskntlhlemnslraddtavyycaratppggttgwpyidlwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
545,NaN,NaN,QXE98319,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscrasgytfsgydinwvrqatgqglewmgwmnpnsgdtgyahkfqgrvtmtrnssistaymelssltsedtavyfcarekksfgpqyyygsgedwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
546,NaN,NaN,QXE98318,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpgrslrlscsasgfsfgdyamswfrqapgkglqwvgliktraygaatdyaasvqgrfiisrddsksiaylqmnslktedtavyfcaregtslgyyyyyamdvwghgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
547,NaN,NaN,QXE98317,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsdyymnwvrqapgkglewvssissssymyyadsmkgrftisrdnaqnslylqmsslraedtavyycardfpgdtavagtgfnywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
548,NaN,NaN,QXE98316,NaN,SARS-CoV,Homo sapiens (human),qvqlqesgpglvrpsetlsltctvsgdsvsssdyhwgwirqppgkglewigsiyyggrshfnpslksrvaifvdtsnnqfslrlnsvtasdtavyfcagrhqellpmgsfdmwaqgttvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
549,NaN,NaN,QXE98315,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdstyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
550,NaN,NaN,QXE98314,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssissdgyntyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtavagtgfeywgqgtlvtvss,NaN,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
551,NaN,NaN,QXE98038,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycsggscfdgfdiwgqgtmvtvss,NaN,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
552,NaN,NaN,QXE98037,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapncsnvvcydgfdiwgqgtmvtvss,NaN,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
553,NaN,NaN,QXE98036,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyafhwvrqapgkglewvavisydgsnqyyadsvkgrftisrdnskntlylqmnslraddtavyycardlaiavagtwhyyngmdvwgqgttvtvss,NaN,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
554,NaN,NaN,QXE98035,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftlssygmhwvrqapgkglewvavisydgsnkyyvdsvkgrftisrdnskntlylqmnslraedtavyycargwaywellpdyyygmdvwgqgttvtvss,NaN,"Wang,L. et al.; Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants; bioRxiv (2021); 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
555,NaN,NaN,QQP23469,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgfdfsrfamhwvrqapgkgleyvsainlhgdsryytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
556,NaN,NaN,QQP23468,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlygdstyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
557,NaN,NaN,QQP23467,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlygdstyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
558,NaN,NaN,QQP23466,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdsryytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
559,NaN,NaN,QQP23465,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgfdfsrfamhwvrqapgkgleyvsainlwgdstyytdsvrgrftisrdnskntlylqmrsvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
560,NaN,NaN,QQP23464,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlhgdskyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
561,NaN,NaN,QQP23463,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlygdstyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
562,NaN,NaN,QQP23462,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlygdskyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
563,NaN,NaN,QQP23461,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdsryytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
564,NaN,NaN,QQP23460,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdsryytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
565,NaN,NaN,QQP23459,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdskyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
566,NaN,NaN,QQP23458,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdsryytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
567,NaN,NaN,QQP23457,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssisedgyntyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtavagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
568,NaN,NaN,QQP23456,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssisedgyntyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtavagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
569,NaN,NaN,QQP23455,NaN,SARS-CoV,Homo sapiens (human),evqlvesggdlvkpggslrlscaasgftfssyymnwvrqapgkglewvssisedgyntyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtasagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
570,NaN,NaN,QQP23454,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssisedgystyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtawagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
571,NaN,NaN,QQP23453,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssisedgyntyypdslkgrftisrdsaknslylqmnslgaddtavyycardfsghtawagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
572,NaN,NaN,QQP23452,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsdyymnwvrqapgkglewvssisedgynpyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtawagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
573,NaN,NaN,QQP23451,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpflgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrddskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
574,NaN,NaN,QQP23450,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpflgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrddskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
575,NaN,NaN,QQP23449,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpflgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrddskntlflqmnnlrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
576,NaN,NaN,QQP23448,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlwgdstyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
577,NaN,NaN,QQP23447,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdskyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
578,NaN,NaN,QQP23446,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssissdgyttyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtasagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
579,NaN,NaN,QQP23445,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsayymnwvrqapgkglewvssissdgystyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtawagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
580,NaN,NaN,QQP23444,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpfkgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitertygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
581,NaN,NaN,QQP23443,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfplrgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
582,NaN,NaN,QQP23442,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpflgtymtwvrqapgkglewvsiiysdgdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
583,NaN,NaN,QQP23441,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpfkgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
584,NaN,NaN,QQP23440,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfpfsgtymtwvrqapgkglewvsiiysggdtyyadsvkgrftisrdnskntlflqmnslrvedtamyycardremaiitersygldvwgqgtmvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
585,NaN,NaN,QQP23439,NaN,SARS-CoV,Homo sapiens (human),qvqlvesggglvqpggslrlscsasgftfsrfamhwvrqapgkgleyvsainlngdstyytdsvrgrftisrdnskntlylqmssvrpddtafyycvkdggyydssgpghwgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
586,NaN,NaN,QQP23438,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyymnwvrqapgkglewvssissdgyntyypdslkgrftisrdsaknslylqmnslraddtavyycardfsghtavagtgfeywgqgtlvtvss,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
587,NaN,NaN,NaN,QVN48245,"SARS-CoV-2, Spike protein RBD",Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlvvfgggtkltvl,"Voss,W.N. et al.; Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes; Science (2021) In press; 2021.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
588,NaN,NaN,QVL61760,NaN,SARS-CoV-2,Homo sapiens (human),evqlqqwgagllkpsetlsltcavyggsfsgyywswirqppgkglewigevnhsgstnynpslksrvtisvdtsknqlslklnsvtaadtavyycargntmvrgviipfeywdkgtlvtvssastkgpsvfplapcsrstsestaalgclvkdyfpepvtvswnsgaltsgvhtfpavlqssglyslssvvtvpssslgtktytcnvdhkpsntkvdkrveskygppcppcpapeaaggpsvflfppkpkdtlmisrtpevtcvvvdvsqedpevqfnwyvdgvevhnaktkpreeqfnstyrvvsvltvlhqdwlngkeykckvsnkglpssiektiskakgqprepqvytlppsqeemtknqvsltclvkgfypsdiavewesngqpennykttppvldsdgsfflysrltvdksrwqegnvfscsvmhealhnhytqkslslslg,NaN,"Song,D. et al.; Structure and function analysis of a potent human neutralizing antibody CA521LALA against SARS-CoV-2; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
589,NaN,NaN,QVG73945,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcsvsggsisshywswirqppgkglewigyiyysgstnhnpslksrvtisvdtsknqfslklssvtaadtavyycargvllwfgepifeiwgqgtmvtvss,NaN,"Fedry,J. et al.; Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11; Sci Adv (2021) In press; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
590,NaN,NaN,QUX33762,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvassgnrreidywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
591,NaN,NaN,QUX33761,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarqdntamsyyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
592,NaN,NaN,QUX33760,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarrtgtteyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
593,NaN,NaN,QUX33759,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarrtgtteyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
594,NaN,NaN,QUX33758,NaN,SARS-CoV-2,Homo sapiens (human),ecrllesggglvqpggslrlscaasgftfsiypmtwvrqapgkglewvsaitagggstyytdsvkgrftisrdnskntlylqmnslraedtaiyycakngdcdstscppdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
595,NaN,NaN,QUX33757,NaN,SARS-CoV-2,Homo sapiens (human),eaqllesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycardivvatartagdyyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
596,NaN,NaN,QUX33756,NaN,SARS-CoV-2,Homo sapiens (human),qcrlvesggglvkpggslrlscaasgftfsdfymswirqapgkglewisyisrsggtiyyadsvkgrftisrdnaknslylqmnslraedtavyycargvsgydygsrfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
597,NaN,NaN,QUX33755,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqexgpglvkpsqtlsltctvxggsissgdxywswxrqppgkglewigyiyysgstyynpslksrvtisvdtsknqfslkxssvtaadtavyycarvdcggdcypdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
598,NaN,NaN,QUX33754,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvkpggslrlscaasgfrfsntwmnwvrqapgrglewvgriktlgeggitdyaapvkgrftisrddskqtlylqmnslkiedtavyycttdlptafdsyygmaawgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
599,NaN,NaN,QUX33753,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvkpggslrlscaasgftftnarmtwvrqapgkglewvgriktktqggtidygapvrgrftisrddlkntldlqmnslktedtavyycaaiddgldhwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
600,NaN,NaN,QUX33752,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgridpsdfyanyspsfqghvtisadksistaylqwsslkasdtamyycarqtgycsstscyaggpfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
601,NaN,NaN,QUX33751,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgsglvkpsqtlsltcavsggsissggyswswirqppgkglewigyiyhsgstyynpslksrvtisvdrsknqfslklssvtaadtavyycarspydssgaidywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
602,NaN,NaN,QUX33750,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarhtdcsggscylggafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
603,NaN,NaN,QUX33749,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyyccffdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
604,NaN,NaN,QUX33748,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsvisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakgggetyvryyfdfwgqgglvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
605,NaN,NaN,QUX33747,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakdmtpyydilteaygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
606,NaN,NaN,QUX33746,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftftnawmnwvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylemnslktedtavyycttrrycsstrcylgewsyfdcwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
607,NaN,NaN,QUX33745,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycasgwylswfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
608,NaN,NaN,QUX33744,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvsdyglfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
609,NaN,NaN,QUX33743,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvgpyydssgyfdafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
610,NaN,NaN,QUX33742,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarggdlfgellgatgyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
611,NaN,NaN,QUX33741,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycatcsggschpyyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
612,NaN,NaN,QUX33740,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycardfsrggydspsgyyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
613,NaN,NaN,QUX33739,NaN,SARS-CoV-2,Homo sapiens (human),evqlvefggglvqpgrslrlscaafgftfddyamhwvrqapgkglewvsgiswnsgsigyadfvkgrftisrdnaknslylqmnslraedtalyycaksriaaavfyyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
614,NaN,NaN,QUX33738,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssytmnwvrqapgkglewvsyitsdsstiyyadsvkgrftisrdnaknslylqmnslraedtavyycarnkamddywgrgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
615,NaN,NaN,QUX33737,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscavsgftfssswmfwvrqapgkglvwvsrisadgytatyaesvegrftisrdnakntlylqmnslraedtalyycarglthdywgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
616,NaN,NaN,QUX33736,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycardldivvvpaadlnyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
617,NaN,NaN,QUX33735,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvkpggslrlscaasgftfsnawmnwvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdlgrfrayyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
618,NaN,NaN,QUX33734,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvkpggslrlscaasgftfsnawmnwvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdlgrfrayyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
619,NaN,NaN,QUX33733,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaktmmgyyyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
620,NaN,NaN,QUX33732,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyalswvrqapgkglewvsaisgsggttyyadsvkgrftisrdnskntlylqmnslraedtavyycarangdydlpyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
621,NaN,NaN,QUX33731,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslraedtavyycatdadniatgfwsgyyseyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
622,NaN,NaN,QUX33730,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycareardpfyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
623,NaN,NaN,QUX33729,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsshwmhwvrqapgkglvwvsriigdgseityadsvkgrftisrdnvkntlyleinslraedtavyyclrghvsgstrhfdywgqgtlltvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
624,NaN,NaN,QUX33728,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssssytnyadsvkgrftisrdnaknslylqmnslraedtavyycardlfpeyssswyrplyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
625,NaN,NaN,QUX33727,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdrssswhyyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
626,NaN,NaN,QSI99137,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyvyysgstnynpslksrvtisvdtsknefslklssvtaadtavyycassqrpdgnlyyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
627,NaN,NaN,QSI99136,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaslqwsslkasdtamyycarqkrdgttwafdywgqgtlvtass,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
628,NaN,NaN,QSI99135,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssgsyywswirqppgkglewigyiyysgstnykyslksrvtisvdtsknqfslklssvtaadtavyycarekggtewefndafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
629,NaN,NaN,QSI99134,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvstnymswvrqapgkglewvsviysggstyyvdsvkgrftisrdnskntlylqmnslraedtavyycastnsgsyshvfdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
630,NaN,NaN,QSI99133,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglgqpggslrlscaasgftfsnyamswvrqapgkglewvsvisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakagavgyydsngyyydvdyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
631,NaN,NaN,QSI99132,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaitwvrqapgqglewmggiipifgtanyaqkfqgrltitaddststaymelsslksedtavyycarfraydssgygpdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
632,NaN,NaN,QSI99131,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslklscaasgftfnsyamtwvrqapgkglewlstisgsggrtyyadsvkgrfaisrdnskntvflqmstlraedtavyfcardfyglesfypgidswgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
633,NaN,NaN,QSI99130,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarhiaglewlfraaavlnwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
634,NaN,NaN,QSI99129,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycagtyydfwsgstnyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
635,NaN,NaN,QSI99128,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlsctasgftfgdyamswfrqapgkglewvgfirskayggtteyaasvkgrftisrddsksiaylqmnslktedtavyyctrvhhcsggscygyyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
636,NaN,NaN,QSI99127,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqpagkglewigriytsgstnynpslksrvtmsvdtsknqfslklssvtaadtavyycaredsygsgstgafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
637,NaN,NaN,QSI99126,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarlsgifgvviipgffdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
638,NaN,NaN,QSI99125,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgdnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardptavtgpfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
639,NaN,NaN,QSI99124,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyemnwvrqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycarvprppwddfwsgylyyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
640,NaN,NaN,QSI99123,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpseslslaffvyggsfsgyywswirqppgkglewigeinhsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargggysygaidywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
641,NaN,NaN,QSI99122,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgynfisygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvrifgvviivdtamvldywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
642,NaN,NaN,QSI99121,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatgptvttvtnwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
643,NaN,NaN,QSI99120,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipilditnyaqkfqgrvtitadkststaymelsslrsedtavyycarglwrssiaglhvpygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
644,NaN,NaN,QSI99119,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgynfisygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvrifgvviivdtamvldywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
645,NaN,NaN,QSI99118,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgnslrlscvasgfkfsssamhwvrqapgkglewvaiiwfhgntkfygdfvkgrftvsrdnsnntlhlqmnslraedtavyhcarassdyggafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
646,NaN,NaN,QSI99117,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaraltgnyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
647,NaN,NaN,QSI99116,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssytiswvrqapgqglewmggiipifgtanyaqnfqgrvtitadeststaymelsslrsedtavyycarvsyydssgyytdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
648,NaN,NaN,QSI99115,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtftsyaitwvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvgaydssgyyqdlwgrgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
649,NaN,NaN,QSI99114,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydginkyyadsvkgrftisrdsskntlylqmnslraedtavyycarggvgyqllfgndwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
650,NaN,NaN,QSI99113,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnqyyadsvkgrftisrdnskntlylqmnslraedtavyycakdptifgvvlqiprfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
651,NaN,NaN,QSI99112,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpelvkpsetlsltcsvsggsissyywswirqppgkglewigyiyysgstnynpslsgstnynpslksrvtvsvdtsknqfslkvssvtaadtavyycargfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
652,NaN,NaN,QSI99111,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigniyysgityynpslksrvtisvdtsknqfslklssvtaadtavyycarqlwgyydssgyyafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
653,NaN,NaN,QSI99110,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsggtfsnyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtftadeststaymelsslrsedtavfycvsriaaaadfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
654,NaN,NaN,QSI99109,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdrlydyvwgsyrfghtwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
655,NaN,NaN,QSI99108,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntldlqmnslraedtavyycarayggnyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
656,NaN,NaN,QSI99107,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfisygiswvrqapgqglewmgwisgyngntnyaqkfqgrvtmttdtststaymelrslrsddtavyycarvrifgvviivdtamvldywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
657,NaN,NaN,QSI99106,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycaraysydssgyspdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
658,NaN,NaN,QSI99105,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardrrgsgwswdyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
659,NaN,NaN,QSI99104,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgyywswirqppgkglewigeinhsgstnynpslksrvtisvdtstnqfslklssvtaadtavyycarrvhydiltgfyggalitrafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
660,NaN,NaN,QSI99103,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyissrssytnyadsvkgrftisrdnaknslylqmnslraedtavyycargydssgyhyslwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
661,NaN,NaN,QSI99102,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscsasgftfssyamhwvrqapgkgleyvsgissnggstyyadsvkgritisrdnskktlylqmsslraedtavyycvksssrgyywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
662,NaN,NaN,QSI99101,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycasarfitmvrgviniyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
663,NaN,NaN,QSI99100,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscrasgytftnfgiswvrqapglglewmgwistyngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarasgpyllglywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
664,NaN,NaN,QSI99099,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycatnsnypywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
665,NaN,NaN,QSI99098,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsncwmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarmgntawyfdlwgrgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
666,NaN,NaN,QSI99097,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasrftfstyamhwvrqapgkglewvtvisydgdnkyyadsvkgrftisrdnskntlylqmnslrtedtavyyctragsgsylsyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
667,NaN,NaN,QSI99096,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarissydssgysmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
668,NaN,NaN,QSI99095,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlsctasgftfgdyamswfrqapgkglewvgfirskayggtteyaasvkgrftisrddsksiaylqmnslktedtavyyctmvwqqlhdafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
669,NaN,NaN,QSI99094,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaitwvrqapgqglewmggiipifgtanyaqkfqgrvtitadestntaymelssltsedtavyycakigdydssgyyfdywaqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
670,NaN,NaN,QSI99093,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarayggsyfygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
671,NaN,NaN,QSI99092,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsvssnayywgwirqppgkglewigsvnyrgstyyiptlksritisvntsknqfslkltsvtaadtavyycarrgvalvtityfdfwgqgalvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
672,NaN,NaN,QSI99091,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglefigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycatqevvlvrpynyngmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
673,NaN,NaN,QSI99090,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaaagfifssyamnwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlnlqmnslraedtavyycargngyiiidywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
674,NaN,NaN,QSI99089,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgkidpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycarqfggellgwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
675,NaN,NaN,QSI99088,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisstsnyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarvspnydfwsgyypdafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
676,NaN,NaN,QSI99087,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfnsfamhwvrqapgkglewvavisydgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardrsggyscfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
677,NaN,NaN,QSI99086,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtalyycaseivsfigssedywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
678,NaN,NaN,QSI99085,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckafgytftknginwvrqapgqglewmgwispnngytnfaqkfqgratmtsdtststaymelrslrsddtavyycarvrvdydssgydayyyhldvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
679,NaN,NaN,QSI99084,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmardtsistaymelsrlrsddtavyycardqvspycggdcpdafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
680,NaN,NaN,QSI99083,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvaiisydginkyyadsvkgrftisrdnskntlylqmnslrvedtavyycarpgggsyygpfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
681,NaN,NaN,QSI99082,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvgaydssgyyqdlwgrgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
682,NaN,NaN,QSI99081,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscsasgftfssyamhwvrqapgkgleyvstistnggstyyadsvkgrftisrdnskntlylqmsslraedtavyycvlgycsstscqhfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
683,NaN,NaN,QSI99080,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssfafiwvrqapgqglewmggiipifgtakytqkfqgrvtitadeststaymelsslrsedtavyycarvsyydssgfytdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
684,NaN,NaN,QSI99079,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsggifssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycasysgfddyghyrnywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
685,NaN,NaN,QSI99078,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssfalhwvrqapgkglewvavvsydgsnkyyadsvkgrftisrdnskntlylqmnslraedtaayycarsmggnyadyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
686,NaN,NaN,QSI99077,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyemnwvrqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylemnslraedtavyycastsdsgsyyihwyfdlwgrgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
687,NaN,NaN,QSI99076,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygihwvrqapgkglewvavisydginkyyadsvkgrftisrdnskntlylhmnslraedtavyycarpnsgsyhsyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
688,NaN,NaN,QSI99075,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssrsyiyyadsvkgrftisrdnaknslylqmnslraedtavyycasnpaadpntyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
689,NaN,NaN,QSI99074,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsissstwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycarsasnyfgyyyygmdvwgqgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
690,NaN,NaN,QSI99073,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymtwvrqapgkglewvsiiysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaagyydsinwgqgtlvtvps,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
691,NaN,NaN,QSI99072,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscgasgfifssyamhwvrqapgkglewvavisydgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarpysgtyfsafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
692,NaN,NaN,QSI99071,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgnsftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarhrnydiltgyryyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
693,NaN,NaN,QSI99070,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiyaihwvrqapgkglewvavisydginkyyadavkgrftisrdnskntlflqmnslrtedtavyycaramggnyfhafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
694,NaN,NaN,QSI99069,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgttnnaqkfqgrvtltadestsaaymelsslrsedtavyycariepyastgytfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
695,NaN,NaN,QSI99068,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaitwvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycvrvalydssgyspdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
696,NaN,NaN,QSI99067,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissstyywgwirqppgkglewigniyytgstyynpslksrvtisvdtsknhfslrlssvtaadtavyycarhnrfwsedtpfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
697,NaN,NaN,QSI99066,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglaqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggntyyadslkgrftisrdnskstlylqmnslraedtavyycakgpmwqwlvrlslvgdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
698,NaN,NaN,QSI99065,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtaiyycarpysgsyyayfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
699,NaN,NaN,QSI99036,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssdnyywswirqppgkglewigyiyysgstnynpslksrvtmsvdtsknqfslklssvtaadtavyycargfvatyyyymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
700,NaN,NaN,QSI99035,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfsvssnymnwvrqaprkglewvsviysggstyyadsvkgrftisrdnskntlylqmntlraedtavyycargygdsqrwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
701,NaN,NaN,QSI99034,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpgqvkpsetlsltctvsgysissgyfwgwvrqppgkglewigsiyhsgstyynpslksrvtisvdtsknqfslnlssvtaadtavyycardhgsydfwsgysrdafdiwgqgtmvtfss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
702,NaN,NaN,QSI99033,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgasvkvscktsgyiftdyfmhwvrqapgqglewmgwinpnsgganyaqkfqgrvtmtrdtsittvymelsrlriddtamyycareaslnrsryyssggtvyyyyyymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
703,NaN,NaN,QSI99032,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarvglsswyfeywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
704,NaN,NaN,QSI99031,NaN,SARS-CoV-2,Homo sapiens (human),evqllesgpglvkpsetlsltctvsggsirsyshywgwirqppgkglewigtiyysgstyynpslksritisvdtsksqfslklssvtaadtavyfcastiptyddiltgyqfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
705,NaN,NaN,QSI99030,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssyaiywvrqapgkglewvavisydgsnkyyadsvrgrftisrdnskntlylqmnslraedtavyycarggggyntffdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
706,NaN,NaN,QSI99029,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvstisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyfcakdgavatgpgyfyfymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
707,NaN,NaN,QSI99028,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpggslrlscaasgfpfrnyamhwvrqapgkglehisvissrgdttyyansvkgrftisrdnsqntlylqmdslraddmavyycarvqsgfsygygfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
708,NaN,NaN,QSI99027,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisadtsknqfslklssvtaadtavyycarapgatyssgwyyyyyymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
709,NaN,NaN,QSI99026,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgeslkisckgsgytftrywigwvrqmpgkglewmgiiypgdsdtryspsfqghvtisadksistaylqwnslkasdtamyycarlpqycsngvcqrwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
710,NaN,NaN,QSI99025,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgggvvqpgrslrlscaasgftfssyaihwvrqapgkglewvavisydginkyyadsvkgrftssrdnskntlylqmnslraedtavyfcarmysgsylgyfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
711,NaN,NaN,QSI99024,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsetlsltctvsgdsissyywswirqppgkglewigyiyytgstnynpslksrvtisvdtsknqfslklssvtaadtavyycanlgynsgwyggyfeywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
712,NaN,NaN,QSI99023,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgfifsrysmnwvrqapgkglewvssissstsfiyyadsvrgrftisrdnaknslylqmnslraedtavyycarwiggdssgyypdafdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
713,NaN,NaN,QSI99022,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgpglvkpsetlsltctvsgdsisnyywswirqppekglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtamyycardfslwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
714,NaN,NaN,QSI99021,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscavsgftfsnygmhwvrqapgkglewvavilydgsnryyadsvkgrftvsrdnskntlylqmnslraedtavyycakgggpycgggscwahyfdywgqgtlvsvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
715,NaN,NaN,QSI99020,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltctvaggsissgtyywswirqpagkglewigriytsgsanynpslksrvtisvdtsknqfslrlssvtaedtavyycareysssyyyfyymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
716,NaN,NaN,QSI99019,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpglvkpsqtlsltctvsggsissgnyywswirqpagkglewigriytsgstnynpslksrvtisvdtsknqfslklssvtaadtalyycardayydflsgyiptynwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
717,NaN,NaN,QSI99018,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpgrslrlsctasgftfgdyamiwfrqapgkglewvgfirskayggtteyaasmkgrftisrddsksiaylqmnslktedtavyyctrdldyydssgyyptyidywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
718,NaN,NaN,QSI99017,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfsyyalswvrqapgkglewvsatygsgsntyyadsvkgrftisrdnskntlylqmsnlraddtavyycakdqrnaydsfdfwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
719,NaN,NaN,QSI99016,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsiyaihwvrqapgqglewvavisydgsnkyyadsvrgrftisrdnskntlylqmntlraedtavyycargptysymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
720,NaN,NaN,QSI99015,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsrygmhwvrqapgkglewvalisydgsnkyyadsvkgrftisrdksknmvylqmnslraedtalyycakdleyytsgsyslfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
721,NaN,NaN,QSI99014,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcgfyggslnnyfwswirqppgkglewigdinhsgstnynpslksrvtvsvdtsknqfslnlnsvtaadtavyycarglflvyygsglggfdywgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
722,NaN,NaN,QSI99013,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssygmswvrqapgkglewvsginnhggstyygdsvkgrftisrdnskntlylqmnslraedtavyycaksdtamvpynwfdpwgqgtlvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
723,NaN,NaN,QSI99012,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqgsgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslkltsvtaadtavyycarhptfsgyeyyfdhwgqgtlitvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
724,NaN,NaN,QSI99011,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlsceasgftfssyalswvrqapgkglewvsaisgsggsiyyadsvkgrftisrdnskstlylqmnslkaedtavyycakddstsayyyyyymdvwgkgttvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
725,NaN,NaN,QSI99010,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyigssgssihyadsvkgrftisrdnaknslylqmnslraedtavyycardgsygdyvrgywgqgalvivss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
726,NaN,NaN,QSI99009,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpevkkpgtsvkvpckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapscsggrcydgfdiwgqgtmvtvss,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
727,NaN,NaN,QTX15864,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqptgqdlewvsaigtagdtyypdsvkgrftisrenaknssylqmnslragdtavyycarasfdssgylnyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
728,NaN,NaN,QTX15863,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsnnqfslklssvtaadtavyycarhvqwlvlyyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
729,NaN,NaN,QTX15862,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvalisydggnkyyadsvkgrftisrdnskntlylqmnslraedtavyycartrggsyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
730,NaN,NaN,QTX15861,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaemkepgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqdrvtitadeststaylelsslrsedtavyycaresttifgvviltsygmdvwgqgttitiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
731,NaN,NaN,QTX15860,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgggliqpggslrlscaasvfivssnymswvrqapgkglewvsviysggstfyadsvkgrftisrddskntlylqmnslraedtavyycarsrggpldywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
732,NaN,NaN,QTX15859,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkepgasvkvsckasgytftsygiswvrqapgqglewmgwisaydgntnyaqklqgrvtmttdtststaymelrslrsddtavyycaregsdyydssgfhdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
733,NaN,NaN,QTX15858,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgdyywswirqppgkgltwighisysgstyynpslksrltisvdtsknqfslklssvtaadtavyycarqlwlrapfdywgqgalvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
734,NaN,NaN,QTX15857,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpgrslrltcaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslrpedtalyycakddssswyfysraklgqyyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
735,NaN,NaN,QTX15856,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgsglvkpsqtlsltcavsggsidsggdswswirqppgkglewigyiyhsgstyynpslksrvtisvdrsnnqfslklssvtaadtavyycarhsgydlggafdiwgqgtmvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
736,NaN,NaN,QTX15855,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewlggfdpedaetiyaqkfqgrvtmtedtstdtaymglssltsedtavyycatgvavagtqknysyyygldvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
737,NaN,NaN,QTX15854,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvasgggvvqpgrslrlscaasgfiitsygmhwvrqapgkglewvaaiwydgsnkyyadsvkgrftisrdnskntlylqmnspraedtavyycarddptpdgdafdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
738,NaN,NaN,QTX15853,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvkpggslrlscaasgftfstysmnwvrqapgkglewvssisssstdihyadsmkgrftisrdnaknslylqmnslraedtavyycardfhrgwydhsayifdfwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
739,NaN,NaN,QTX15852,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsviswhsgsidyadsvkgrftisrdnaknslylqmnslraedtalyhcakgtgysygyavdggfdywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
740,NaN,NaN,QTX15851,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyisssgstkyygdsvkgrftisrdnaknslylqlnslrdedtavyycartiysydssgyygteryfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
741,NaN,NaN,QTX15850,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgeslkisckgsgysftnswiawvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdsamyycarlgswyvyyyyyaldvwgqgplvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
742,NaN,NaN,QTX15849,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgfyihwvrqapgqglewmgwinpnsggsncaqkfqgrvtmtrdtsistaymevsrlrsddtavyycarysnyyyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
743,NaN,NaN,QTX15848,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavygesfsgyywswirqppgkglewigeiihsgstnynpplksrvtisvdtsksqfslklssvtaadtavyycaremsvavvdhwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
744,NaN,NaN,QTX15847,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgtevkkpgasvkvsctasgytftvcyihwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycarvarhyydrsgnlhsadyfqhwgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
745,NaN,NaN,QTX15846,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsggtdyvqkfqgrvtmtrdtsistaymelsrlrsddtavyycaslsaagplndvfdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
746,NaN,NaN,QTX15845,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyitspgsaiyyadsvkgrftisrdnaknslylqmnslraedtalyyctrdgvipprfdywgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
747,NaN,NaN,QTX15844,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasefivsrnymnwvrqapgkglewvsliysggttyyadavkgrftisrdnskntlylqmnslraedtavyycargfgdrrldywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
748,NaN,NaN,QTX15843,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygihwvrqapgkglewvavisydgstkyyadsvkgrftisrdnskntlylqmnslraedtavyfcakdrgtliegmdvwgkgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
749,NaN,NaN,QTX15842,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggvvqpggslrlscaasglifshygmhwvrqapgkglewvafirndgtnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdggyyyessgwfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
750,NaN,NaN,QTX15841,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsshamnwvrqapgkglewvsgisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaksmfgydssgyfygedfdywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
751,NaN,NaN,QTX15840,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggstsssfhywgwirqppgkglewigniyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarlgsgsyytadywgqgtrvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
752,NaN,NaN,QTX15839,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfisyamhwvrqapgkglewvavisydgnnkyysdsvkgrftisrdnskntlhlqmnslraedtavyycakdlsggysywdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
753,NaN,NaN,QTX15838,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgdtftsydvnwvrqatgqglewmgwmdpnsgntgyaqnfqgrvtmtrstsigtaymelsslrsedtavyycarskergyynrtgyyypgdwfdpwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
754,NaN,NaN,QTX15837,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgdsisnnyaywgwirqppgkglewignlyysgstyynpslksrvtisvdtsenqfslrlssvtaadtavyycarlpygydyveafdiwgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
755,NaN,NaN,QTX15836,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssnamhwvrqapgkglewvafisydgsnqystdpvkgrftfardnskdtlylqmnslrgddtavyycaksrggnyfdafdmwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
756,NaN,NaN,QTX15835,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvetgggliqpggslrlscaasgftvtanymswvrqapgkglewvstiysggstfyadsvkgrftisrdnsrntlylqmnslraedtavyycarergakafdpwgqgalvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
757,NaN,NaN,QTX15834,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsgygmhwvrqapgrglewvavisydgsnkyyadsvkgrftisrdnskntvylqmnslraedtavyycakpysgsywsyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
758,NaN,NaN,QTX15833,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissygkywswirqhpgkglewigyiyysgstqynpslksrvtisvdtsknqfslklnsvtaadtavyycardsaaghfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
759,NaN,NaN,QTX15832,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgpevkkpgtsvkvsckasgftftssamqwvrqargqrlewigwivvgsgnthyaqkfqervtitrdmststaymelsslrsedtavyycaapyctttrchdgfdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
760,NaN,NaN,QTX15831,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsdkyyadsvkgrltifrdnskntlylqmnslraedtavyycaregadrsgwwgsfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
761,NaN,NaN,QTX15830,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpggslrlscaasgitvnsnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmhslraedtavyycardrfgrindywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
762,NaN,NaN,QTX15829,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckafgysftsfnlnwvrqapgqglewmgwisayngntsyaqkfqgrvtmttdtstttvymelrslrsddtavyycaralenyydrngnyyvgafdywgqgslvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
763,NaN,NaN,QTX15828,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgpevkkpgtsvkvsckasgftftssamqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapncsrtscqdgfdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
764,NaN,NaN,QTX15827,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfsiywmhwvrqapgkglvwvsrinsdgsstsnadsvkgrftisrdnakntlylqmnslraedtavyycardhvvaatpgmdvwgqgttitvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
765,NaN,NaN,QTX15826,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfvaedgetiyaqkfqgrvsmtedtstdtaymelsslrsedtavyycatdrarldyfasgsyyghfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
766,NaN,NaN,QTX15825,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgfmfssynmnwvrqapgkglewvssisssssyiyyedsvkgrftisrdnaknslylqmislsaedtavyycarmayfdssgyypnafdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
767,NaN,NaN,QTX15824,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgfifssydmhwvrqatgkglewvsgignagdthypgavkgrftisrenaknslylqmnslragdtavyycarahrgyydrsgyyhnpdafdiwgqgttvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
768,NaN,NaN,QTX15823,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgysftsygiswvrqapgqglewmgwisafnnnanyvqkfqgrvtmttdtststaylelrslrsddaavyycardddnydttgyylywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
769,NaN,NaN,QTX15822,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsgdtfrsysiswvrqapgqglewmgriipilgipnyaqkfqgrvtitadkstntaymelsslrsedtavyycarespycssttclsdywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
770,NaN,NaN,QTX15821,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgpglvkpsetlsltctvsggsisstsyywgwirqppgkglewigsmyysgntyynpplqsrvtisvdtsknqvslslssvtaadtalyycarhpdicdfwsgypgwfdpwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
771,NaN,NaN,QTX15820,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgkslrlscaasgltfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegwgysygsyyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
772,NaN,NaN,QTX15819,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycastprgdsygggaywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
773,NaN,NaN,QTX15818,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggalvqpggslrlsceasefivsrnymnwvrqapgkglewvsviysggstfyadsvkgrfiisrdnskntlylqmnslraedtavyycarelvgyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
774,NaN,NaN,QTX15817,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyytdsvkgrftisrdnskntlylqmnslrpedravyycakdaadsritmfgvviishfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
775,NaN,NaN,QTX15816,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewassissnssciyyadsvkgrftisrdnaknslylqmnslraedtavyycasgehnyyyyygmdvwgqgttvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
776,NaN,NaN,QTX15815,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqqsgaevkkpgasvkdsckasgytftsygiswvrqapgqglewvgwisayngntnyglklqgrvtmttdtststaymelrslrsddtavyycarahpfydsggysdywgqgslvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
777,NaN,NaN,QTX15814,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrltcaasgfifssygmhwvrqapgkglewvavisydgsykyyadsvkgrftisrdnskntlylqmnslraedtavyyctkadyydfwsgyqktyyyymdvwgkgttvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
778,NaN,NaN,QTX15813,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvetgggliqpggslrlscaasgltvsanymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslrvedtavyycarniyddafdvwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
779,NaN,NaN,QTX15812,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgfsfssysmnwvrqapgkglewvssissnsnyiyyadsmkgrftisrdnaknslylqmnslraedtavyycasnrspydssnyyfdywgqgtrvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
780,NaN,NaN,QTX15811,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnggiidyadsvkgrftisrdnaknslylhmrslraedtafyycakdigpfeaarpggnyyyyamdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
781,NaN,NaN,QTX15810,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvtsnnyywgwirqppgeglewigsiyytgstfynpslksrvtisvdasknqfslklssvtaadtavyyctrqlvlvrgyfdywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
782,NaN,NaN,QTX15809,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgpglvkpsqtlsltctvsggsissgsyfwswirqpagkglewigriftsgstnynpslksrvtmsvdtsknqfslklssvtaadtavyycargpdivvvpaadprnwfdpwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
783,NaN,NaN,QTX15808,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvetgggliqpggslrlscatsgftvssnymtwvrqapgkglewvstiysggstyyadsvkgrfsisrdsskntlylqmnslraedtavyycargpyphfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
784,NaN,NaN,QTX15807,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsiayadsvkgrftisrdnaknslylqmnslraedtalyycakdiksfgifgvvtafdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
785,NaN,NaN,QTX15806,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisydgsneyyadsvkgrftisrdnskntlylqmnslrvedtavyycakkgysygyfdyyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
786,NaN,NaN,QTX15805,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgitvssnymnwvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttitvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
787,NaN,NaN,QTX15804,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpggslrlscaasgfifddyaihwvrqgpgkglewvsgiswnsgsigygdsvkgrftisrdnaknslylqmnslraedtafyycakggrraamllnyfdywgqgtlvtvsa,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
788,NaN,NaN,QTX15803,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvrgrftisrdnaknslflqmnslraedtalyycardpfsrwerpegwfdpwgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
789,NaN,NaN,QTX15802,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssytiswvrqapgqglewmgrifpilgianyaqkfqnrvtitadrststafmelsslrsedtavyycardqdsgyiwwfdpwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
790,NaN,NaN,QTX15801,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisydgsneyyadsvkgrftisrdnskntlylqmnslrvedtavyycakkgysygyfdyyfdywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
791,NaN,NaN,QTX15800,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytlteismhwvrqapgkglewmggfdpeegetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatsevvvpgairhkaayyynymdvwgkgttvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
792,NaN,NaN,QTX15799,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstnamhwvrqapgkglewvalisydgsnkyyavsakgrfiisrdnskntlhlqmsslraedtavyycvkglggnyyyfgfwgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
793,NaN,NaN,QTX15798,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakmvgqycsggncylgyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
794,NaN,NaN,QTX15797,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyissttsytnyadsakgrftisrdnaknslylqmnslraedtavyycardvayyydsgsyyyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
795,NaN,NaN,QTX15796,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakmmgqycsggdcysgyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
796,NaN,NaN,QTX15795,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsfiypggstyyvdsvkgrftisrdnskntlylqmnslraedtavyycarsygdyyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
797,NaN,NaN,QTX15794,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlslsctvsggsispyywswirqlpgkglewigyiyytgstnynpslkgrvtmsadmsknqfslnlssvtaadtamyycargydfwsrgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
798,NaN,NaN,QTX15793,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgitwnsgtigyadsvkgrftiskdnaknslylqmnrlraedtafyycakdltgwgltfggvitnwgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
799,NaN,NaN,QTX15792,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslksedtavyycateehpfagraklhhldywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
800,NaN,NaN,QTX15791,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftiyymhwvrqapgqglewmgiinpgggsrsyaqrfqgrvtmtrdtststvymelsslrsedtavyycargrycsssscyigldywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
801,NaN,NaN,QTX15790,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqprgslrlscaasgftfstywmtwvrqapgkglewvanigqdgseryfvdsvkgrftisrdnannslylqmnslraedsavyycardytddygdyggyfdlwgrgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
802,NaN,NaN,QTX15789,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsgdsissshwwswvrqppgkglewigeiyhsgstnynpslksrvtisveksknqfslklssvtaadtavyycarrrlgpssnnsgyfywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
803,NaN,NaN,QTX15788,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgfifsnyrmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslraedtavyycardsvpryyyhyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
804,NaN,NaN,QTX15787,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfniyvmhwvrqapgkglewvavisydgsneyyadsvkgrftisrdnskntlylqmnslraedtavyycakgrsgsyfnpldywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
805,NaN,NaN,QTX15786,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgtnkyyadsvngrftisrdnskntlylqmdslragdtavyycarpnsgsyssyldywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
806,NaN,NaN,QTX15785,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvhpggslrlscaasgftfssywmswvrqapgkglewvanikedgrekyyvdyvkgrftisrdnaknslylqmnslraedtavyycardsvhyyydssgyhysygmdvwgqgttvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
807,NaN,NaN,QTX15784,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcaahggsfsgynwswirqppgkglewigeinhsgstnynpslksrvtisvdtsknqlslklssvtaadtavyycarggtigttgiydiltgydpffdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
808,NaN,NaN,QTX15783,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakgnwndvlshyyyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
809,NaN,NaN,QTX15782,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlsctgsgftfgdyamswfrqapgkglewvgfirsedhggtteyaasvkgrftisrddsksiaylqmnslktedtavyycsrpltyyydssgyyypyyfdywgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
810,NaN,NaN,QTX15781,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakgwggynthfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
811,NaN,NaN,QTX15780,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftiywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarrtltttygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
812,NaN,NaN,QTX15779,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakshsgsyfssgdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
813,NaN,NaN,QTX15778,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarenydfwsgyfngwfdpwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
814,NaN,NaN,QTX15777,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvkpggslrlscaasgftfsnawmtwvrqapgkglewvgriksktdggttdyaapvkgrftisrhdskntlylqmnslktedtavyycttasnpdywgqgtrvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
815,NaN,NaN,QTX15776,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardtrgrgghdafdiwgqgtmvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
816,NaN,NaN,QTX15775,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygthwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarpdsgsywgafdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
817,NaN,NaN,QTX15774,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdladgetiyaqefqgrvtmtedtstdtaymalsslrsedtavyycatgpltiavagqwfdpwgqgtlvtiss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
818,NaN,NaN,QTX15773,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftiprdnskntlylqmnslraedtavyycakggsgyryyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
819,NaN,NaN,QTX15772,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaksafgsyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
820,NaN,NaN,QTX15771,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardgqvgatsgidywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
821,NaN,NaN,QTX15770,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycashpyydssgyypnygmdawgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
822,NaN,NaN,QTX15769,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnrlrdedtavyycardrcgdcygpyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
823,NaN,NaN,QTX15768,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycardldivvvpaarsyyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
824,NaN,NaN,QTX15767,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdptivvvavnptfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
825,NaN,NaN,QTX15766,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymnwvrqapgkglewvsviysggstyygdsvkgrftisrdnskntlylqmnslraedtavyycardfregafdiwgqgtmvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
826,NaN,NaN,QTX15765,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfssywmhwvrqapgkglvwvsriniygsstsyadsvkgrftisrdnakntlylqmnslraedtavyycardlhydssgwdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
827,NaN,NaN,QTX15764,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsgtlsltcavsggfisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycasrycsggscgyfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
828,NaN,NaN,QTX15763,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslraedtavyycaraqyssgwylrfdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
829,NaN,NaN,QTX15762,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycargaasvlrflewlldywgqgalvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
830,NaN,NaN,QTX15761,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevknpgasvkvsctasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycalvgatdywgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
831,NaN,NaN,QTX15760,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydginkyyadsvkgrftisrdnskntlylqmnslraedtavyycakafkgnyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
832,NaN,NaN,QTX15759,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycardrppivvvttyyyygmdvwgqgttvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
833,NaN,NaN,QTX15758,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgpglvkssqtlpltctvsgasinsnnyywnwirqpagkglewigrihssgntnyspslrsrltisvdtsknqfsleltsvtaadtavyycarddwttaldcwgqgtlvtvss,NaN,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
834,NaN,NaN,NaN,QTX15757,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspsslsasvgdrvtitcrasqsirnylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsygipdwtfgpgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
835,NaN,NaN,NaN,QTX15756,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqprsvsgspgqsvtisctgtssdvggynsvswyqhhpgkapklmiydvskrpsgvpdrfsgsksgntasltisglqaedeadyyccsyagrytlvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
836,NaN,NaN,NaN,QTX15755,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftptisslqpedfatyycqqsystppytfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
837,NaN,NaN,NaN,QTX15754,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsirswlawyqqkpgkapkvliydasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynyysvtfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
838,NaN,NaN,NaN,QTX15753,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspsslsasvgdrvtitcrasqsirnylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsygipxwtfgpgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
839,NaN,NaN,NaN,QTX15752,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapkvliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsyvtfgpgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
840,NaN,NaN,NaN,QTX15751,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgisgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydsskyvvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
841,NaN,NaN,NaN,QTX15750,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlslspgeratlscrasqsvnnylawyqqepgqaprlliydasnratgiparfsgsgsgtdftltisslepedlavyycqqcsnwppsltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
842,NaN,NaN,NaN,QTX15749,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsasgspgqsvtisctgtssdvggynyvswyqqhpgkapklmisevskrpsgvpdrfsgsksgntasltvsglqaedeadyycnsyagsnnwvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
843,NaN,NaN,NaN,QTX15748,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqtplsspvtlgqpasiscrssqslvhsdgntylswlqqrpgqpprlliykisnrfsgvpdrfsgsgagtdftlkisrveaedvgvyycmqatqfpitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
844,NaN,NaN,NaN,QTX15747,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qlvltqppsvsvapgqtaritcggnsigsktvhwyqqkpgqapvlvvyddsdrpsgiperfsgsksgntatltisrveagdeadyycqvwhissdhlwvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
845,NaN,NaN,NaN,QTX15746,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliydasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsysftfgpgtkkdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
846,NaN,NaN,NaN,QTX15745,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsasgtpgqrvtiscsgsssnigsytvnwyqhlpgtapklliysnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslngyvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
847,NaN,NaN,NaN,QTX15744,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspatlslspgeratlscrasqsvssylawyqhkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwptfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
848,NaN,NaN,NaN,QTX15743,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlsvspgeratlscrasqsvsrnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynngrgtfgpgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
849,NaN,NaN,NaN,QTX15742,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqtplslpvtpgepasiscrsgqslldsddgntyldwylqkpgqspqlliytlsyrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqriefpwtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
850,NaN,NaN,NaN,QTX15741,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdiggynyvswyqqhpgkapklmiydvtnrpsgvsnrfsgsksgntasltisglqaedeatyycnsytssstyvlfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
851,NaN,NaN,NaN,QTX15740,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspsslsasvgdrvtitcqasqdisnflnwyqekpgkapkllisdasnletgvpsrfsgsgsgtdftftitslqpediatyycqqydnllitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
852,NaN,NaN,NaN,QTX15739,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qlvltqpptvsvspgqtaritcsgdalpkkyaywyqqksgqapvlviyedskrpsgiperisgsssgtmatltisgaqvedgadyycysidssgnhyvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
853,NaN,NaN,NaN,QTX15738,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcqasqdiskylnwyqrkpgtaptlliydasnletgvpsrfsgsgsgtdftftisslqpedigtyycqqydnlptfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
854,NaN,NaN,NaN,QTX15737,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspsslsasvgdrvtitcqasqdinnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqfgewftfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
855,NaN,NaN,NaN,QTX15736,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qlvltqppsvseaprqrvtiscsgsssnignnpvnwyqqlpgkapkpliyyddllpsgvsdrfsgsrsatsaslaisglqsedeadyyctawdgslngyvfgsgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
856,NaN,NaN,NaN,QTX15735,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqksgqaprlliygassratgipdrfsgsgsgtdftltisrlqpedfavyycqqygsspmytfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
857,NaN,NaN,NaN,QTX15734,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqhkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsysipptfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
858,NaN,NaN,NaN,QTX15733,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgteftftitslqpediatyycqqydtlpptfgpgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
859,NaN,NaN,NaN,QTX15732,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydtsnratgiparfsgggsgtdftltisslepedfavyycqqrsnwrtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
860,NaN,NaN,NaN,QTX15731,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspatlslspgeratlscrasqsvssslawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslgpedfavyycqqrsnwpptwtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
861,NaN,NaN,NaN,QTX15730,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspsslsasvgdgvtitcrasqgirndlgwyqqkpgkapkrliyaasslqsgvpsrfsgggsgteftltisslqpedfatyyclqhnsypltfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
862,NaN,NaN,NaN,QTX15729,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsypwtfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
863,NaN,NaN,NaN,QTX15728,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspsslsasvgdrvtitcqasqdirnylnwyqqtpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyychqydnlpqsfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
864,NaN,NaN,NaN,QTX15727,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlhssnnknyvawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyhcqqyystpltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
865,NaN,NaN,NaN,QTX15726,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspsslsasvgdrvtitcqasqdinnylnwyqqkpgkapklliydasnletgvpsrfsgsgagtyftftisslqpediatyycqqydnlpplftfgpgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
866,NaN,NaN,NaN,QTX15725,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspgtlslspgeratlscrasqsvsrsylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsllftfgpgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
867,NaN,NaN,NaN,QTX15724,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspdslavslgeratinckssqsvlhnsknksylawyqqkpgqppnlliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyyggrwtfgqgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
868,NaN,NaN,NaN,QTX15723,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgrapklliydasnletgvpsrfsgsgsgtdftftisslqpedvatyycqqydnlpgtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
869,NaN,NaN,NaN,QTX15722,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspgtlslspgeratlscrashnissthlvwyqqkpgqaprlliygasnratgipdrfsgggsgtdftltisrlepedfavyfcqqfgsspqtfgqgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
870,NaN,NaN,NaN,QTX15721,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspgtlslspgeratlscrasqsvssshlawyqqksgqaprlfiygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssppwtfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
871,NaN,NaN,NaN,QTX15720,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspeqtasitcsgdklgdkyacwyqqkagqspvlviyedgkrpsgiperfsgsnsgntatltisgtqtmdeadyycqawdrttavfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
872,NaN,NaN,NaN,QTX15719,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgirsylawyqqkpgkapnlliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlntyaltfgggtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
873,NaN,NaN,NaN,QTX15718,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlsvspgervtlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqhyynwppwtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
874,NaN,NaN,NaN,QTX15717,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqpasvsgspgqsitisctgtssdvgvydyvswyqqhpgkapklmiyevsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlvlyvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
875,NaN,NaN,NaN,QTX15716,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspstlsasvgdrvtitcrasqsisrwlawyqqipgkapnlliyqtsslqsgvpsrfsgsgsgteftltisslqpddfatyycqqyysypltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
876,NaN,NaN,NaN,QTX15715,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsnsnigagydvhwyqqfpgtapklliydntnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydssridvvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
877,NaN,NaN,NaN,QTX15714,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qavvtqppsvsgapgqrvtisctgsssnigagydihwyqqlpgtapklliynnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgyvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
878,NaN,NaN,NaN,QTX15713,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyhqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnlpltfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
879,NaN,NaN,NaN,QTX15712,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qlvltqspsasaslgasvkltctlssghssnaiawhqqqpekgprylmklnidgshrkgdgipdrfsgsssgaeryltisslqsedeadyycqtwgtgpnwvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
880,NaN,NaN,NaN,QTX15711,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsflsasvgdrvtitcrasqgirndlgwyqqkpgkapkrliyaasslqsgvpsrfsgygsgteftltisslqpedfatyycqhlnsyprytfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
881,NaN,NaN,NaN,QTX15710,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsafvgdrvtiicrasqsisswlawyqqkpgkapklliykasslesgvpstfsgsgsgteftltisslqpddfatyfcqqynsypytfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
882,NaN,NaN,NaN,QTX15709,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslavtpgepasiscrssqsllhsdgynyldwylqkpgqspqlltylgsnrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqalqtsitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
883,NaN,NaN,NaN,QTX15708,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqgitnslawyqqqpgkapklllyaasrlasgvpsrfsgsgsgtdytltisslqpedfatyycqqyysapptfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
884,NaN,NaN,NaN,QTX15707,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygtssratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspqitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
885,NaN,NaN,NaN,QTX15706,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspsslsasvgdrvtitcrasqgvssylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsyppgtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
886,NaN,NaN,NaN,QTX15705,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqhhdslpltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
887,NaN,NaN,NaN,QTX15704,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qtvvtqapsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapklliysdnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslnvvvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
888,NaN,NaN,NaN,QTX15703,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qavvtqprsvsgspgqsvtisctgtssdvgaynfvswyqqhpgkapklmtydvtkrpsgvpdrfsgsksgntasltisglqaedeadyyccsyagsfyvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
889,NaN,NaN,NaN,QTX15702,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgegatlscrasqsvgrylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwppftfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
890,NaN,NaN,NaN,QTX15701,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspsslsasvgdrvtitcqasqdirnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqsediatyycqqydnlpitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
891,NaN,NaN,NaN,QTX15700,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqtplslsvtpgqpasisckssqsllhsdgktylywylqkpgqppqlliyevsnrfsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqsiqpwrltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
892,NaN,NaN,NaN,QTX15699,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqtplslsvtpgqpasisckssqsllhsdgktylywylqrpgqppqlliyevsdrfsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqsiqlpvtfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
893,NaN,NaN,NaN,QTX15698,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsisstylawyqqkpgqaprllihgassratgisdrisgsgsgtdfiltisrlepedfavyycqqygsspgtfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
894,NaN,NaN,NaN,QTX15697,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspatlsvslgeratlscrasqsvssnlawyqqkpgraprlliygastratgipvrfsgsgsgteftltisslqsedfavyycqqynnwppsitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
895,NaN,NaN,NaN,QTX15696,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspssvsasvgdrvtitcrasqgissglawyrqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqansfpytfgqgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
896,NaN,NaN,NaN,QTX15695,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qtvvtqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapkllifgnsnrpsgvpdrfsgsksdtsaslaitglqaedeadyycqsydssligsvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
897,NaN,NaN,NaN,QTX15694,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqtplslsvtpgqpasisckssqsllhsdgktylywylqrpgqppqlliyevsdrfsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqsiqlpvtfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
898,NaN,NaN,NaN,QTX15693,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgqapklliyaasnlqsgvpsrfsgsgsgtdftltisslqpadfatyycqqsysifrtsgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
899,NaN,NaN,NaN,QTX15692,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgegatlscrasqsvssylawyqrkpgqaprlliydssnratgiparfsgsgsgtdftltisslepedfavyycqersswppafgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
900,NaN,NaN,NaN,QTX15691,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsslsasegdrvtitcqasqdinnylnwyqqkpgkapklliydasnleagvpsrfsgsgsgtdftftisslqpediatyycqqydnlppafgpgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
901,NaN,NaN,NaN,QTX15690,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynkwprtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
902,NaN,NaN,NaN,QTX15689,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsrtdftftisslqpddiatyycqqydkppvtfgqgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
903,NaN,NaN,NaN,QTX15688,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlssspgeratlscrasqgvsssylawyqqklgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhsrtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
904,NaN,NaN,NaN,QTX15687,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvssiylawyqqkpgqaprlliyaassratgipdrfsgsgsgtdftltisrlepedfavyycqqygtspwtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
905,NaN,NaN,NaN,QTX15686,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvapgqtaritcggnniggksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhvvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
906,NaN,NaN,NaN,QTX15685,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapkfliydasnletgvpsrfsgsgsgtdftftisslqpedfatyfcqqyddlpytfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
907,NaN,NaN,NaN,QTX15684,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdinnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftistlqpediatyycqqydnllsltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
908,NaN,NaN,NaN,QTX15683,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsastgdrvtitcrasqgirtylvwyqqkpgqapnlliyaasslqsgvpsrfsgsgsgtdftltisglqsedfatyycqqyysypltfgggtkvevk,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
909,NaN,NaN,NaN,QTX15682,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsissnlawhqqkpgqaprllisdastratgiparfsgsgsgteftltidslqsediavyycqqynnwpptitfgqgtrleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
910,NaN,NaN,NaN,QTX15681,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,slsqlvltqgrlgpgqtaritcegnniggksvlwyqqkpgqapvlvvyddsdrpsgiperfsasnsgntatltisrveagdeadyycqvwdtssdhagvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
911,NaN,NaN,NaN,QTX15680,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspstvsasvgdrvtitcrasqsistwlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisrlqpddfatyycqqynsylfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
912,NaN,NaN,NaN,QTX15679,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsfsswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftlttsslqpddfatyycqqystyspltfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
913,NaN,NaN,NaN,QTX15678,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspstlsasvgdrvtitcrasqsfsswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsylktfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
914,NaN,NaN,NaN,QTX15677,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsvsgapgqrvtisctgsssnigadydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqssdsslsgsrvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
915,NaN,NaN,NaN,QTX15676,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhwvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
916,NaN,NaN,NaN,QTX15675,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsflsasvgdrvtitcrasqgisnylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnryplytfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
917,NaN,NaN,NaN,QTX15674,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyysppptfgpgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
918,NaN,NaN,NaN,QTX15673,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqspssvsasvgdrvtitcrasqgisswlawyqqkpgkapelpiyaastlqsgvpsrfsgsgsgtdftltisslqpedfatyycqqansfpwtfgqgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
919,NaN,NaN,NaN,QTX15672,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nivmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystwtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
920,NaN,NaN,NaN,QTX15671,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystprtfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
921,NaN,NaN,NaN,QTX15670,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspwtfgqgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
922,NaN,NaN,NaN,QTX15669,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhvvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
923,NaN,NaN,NaN,QTX15668,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssftfgpgtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
924,NaN,NaN,NaN,QTX15667,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynyldwylqkpgqspqlliymgsnrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqalqspynlgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
925,NaN,NaN,NaN,QTX15666,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssytfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
926,NaN,NaN,NaN,QTX15665,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqgisnylawyqqkpgkvpklliyaastlqsgvpsrfsgsgsgtdftltisslqpedvatyycqkynsaphtfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
927,NaN,NaN,NaN,QTX15664,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqppsvsvspgqtaritcsgdalpkkyaywyqqksgqapvlviyedskrpsgiperfsgsssgtmatltisgaqvedegdyycystdssgnkrvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
928,NaN,NaN,NaN,QTX15663,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqtplslsvtpgqpasisckssqsllhsdgktylywylqkpgqppqlliyevsnrfsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqsiqlarfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
929,NaN,NaN,NaN,QTX15662,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsistylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
930,NaN,NaN,NaN,QTX15661,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssgtyhvvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
931,NaN,NaN,NaN,QTX15660,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqprsvsgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiydvskrpsgvpdrfsgsksgntasltisglqaedeadyyccsyagsytfgyvfgtgtkvtvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
932,NaN,NaN,NaN,QTX15659,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsytltfgggtkvdik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
933,NaN,NaN,NaN,QTX15658,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystppwtfgqgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
934,NaN,NaN,NaN,QTX15657,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyevskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstwvfgggtkltvl,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
935,NaN,NaN,NaN,QTX15656,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsyssqytfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
936,NaN,NaN,NaN,QTX15655,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,airmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnlpltfgggtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
937,NaN,NaN,NaN,QTX15654,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwptfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
938,NaN,NaN,NaN,QTX15653,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsslsasvgdrvtitcrasqsissylnwyqqepgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpftfgpgtkleik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
939,NaN,NaN,NaN,QTX15652,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divltqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltissmqsedfavyycqqynnwppgdtfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
940,NaN,NaN,NaN,QTX15651,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvssnylawyqqkpgqaprlliyaassratgipdrfsgsgsgtdftltisrlepedfavyfcqqygssrntfgqgtkveik,"Graham,C. et al.; Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant; Immunity (2021) In press; 2021.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
941,NaN,NaN,QRW39016,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsfssywmswvrqapgkglewvgnikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycardlgvlwfgdpywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
942,NaN,NaN,QRW39015,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytftsyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsistaylqisslkaedtavyycarvgpssswpswgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
943,NaN,NaN,QRW39014,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakggwysskwyyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
944,NaN,NaN,QRW39013,NaN,SARS-CoV-2,Homo sapiens (human),qvhlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipifdianyaqkfqgrvtmtadkstttaymeltslrsedtamyycarteysydsgssraysmdvwgkgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
945,NaN,NaN,QRW39012,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsavgtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycargfdtttgfyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
946,NaN,NaN,QRW39011,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvalisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakaagggysyiywggdywgqgtlvtsph,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
947,NaN,NaN,QRW39010,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisssnyywgwirqppgrglewigsiyysgstyynpslksrvtisvdtsknqfslnlssvtaadtavyycariprhlgqdhyyyvmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
948,NaN,NaN,QRW39009,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkplewlaliywdddkryspslksrltitkdtsknqvvlrmtnmdpvdtatyycahspdhryfdvltgyfnserfyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
949,NaN,NaN,QRW39008,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsfstyywswirqppgkglewighisysgsthynpslkgrvtisldtsknqfslnlssvtaadtavyycarggyyygpprdfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
950,NaN,NaN,QRW39007,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycardlgvlwfgdllfssqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
951,NaN,NaN,QRW39006,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlaridwddakyystsletrltiskdtsnnqvvltltnmdpvdtatyycarevagavhldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
952,NaN,NaN,QRW39005,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssssytnyadsvkgrftisrdnaknslylqmnslraedtavyfcardgsavagpmsyfdywgqgtpvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
953,NaN,NaN,QRW39004,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasghtftsylihwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycardppsgnydnidewtrsenhynygmdawgqgttvtvlt,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
954,NaN,NaN,QRW39003,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpksvytgyaqkfqgrvtmtrntsirtaymelsslrsedtavyycarglwfgdltrtkynwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
955,NaN,NaN,QRW39002,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssgsyywswirqppgkglewigyiyysgstnynpsltsrvtlsvdtsknqfslklssvtaadtavyycareyfvslpaaqtlyyygidvwgqwttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
956,NaN,NaN,QRW39001,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsgisdsggspyyadsvkgrftisrdnskntlylqmnslrvedtavyycaesssltgnfnywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
957,NaN,NaN,QRW39000,NaN,SARS-CoV-2,Homo sapiens (human),qvrlvesgggvvqpgrslrlscaasgftfssfgmhwvrqapgkglewvallsydgtnkyyadsvkgrftisrdnskstlflqmhslraedtavyfcakgggyisawstryyamdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
958,NaN,NaN,QRW38999,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgysissgyywgwirqppgkglewigsiyqsgstyynlslksrvtilvdtsknqlslklssvtaadtavyycarvgvatilgvdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
959,NaN,NaN,QRW38998,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgdyywswirqhpgkglewigyifysgstyynpslksrviisvdtsknqfslklssvtaadtavyycarvsrytmvrgvifdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
960,NaN,NaN,QRW38997,NaN,SARS-CoV-2,Homo sapiens (human),qvqlmesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvaviwydgtnekyadsvkgrftisrdnskntlylqvnslraedtavyycakngysyayprqyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
961,NaN,NaN,QRW38996,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaaseiivssnymswvrqapgmglewvsvvysggstfyadsvkgrftisrhnskntlylqmnslrtedtavyycareapnsrgsgtnfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
962,NaN,NaN,QRW38995,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsrydmhwvrqttgkslewvsaigtagdtyypdsvkgrfiisrenansslylqmnslragdtavyycargsdtvttafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
963,NaN,NaN,QRW38994,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasrgtfssyaiswvrqapgqglewmggiipifttpnyaqnfqgrvtitadkststaymelnsltsedtavyycavlplhssynwyyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
964,NaN,NaN,QRW38993,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfsifamswvrqapgkglewvsgingsgdntyyadsvkgrftisrdnsrntlylqmnslrpedtavyycakqtdygvgwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
965,NaN,NaN,QRW38992,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckrsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycasqaaagyyyymdvwgkgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
966,NaN,NaN,QRW38991,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstyynpslksrvtisvdksknqfslklssvtaadtavyycarvqglidywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
967,NaN,NaN,QRW38990,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgvtvssnymnwvrqapgkglewvsviysggstfyadsvkgrftisrhnskntlylqmnslraedtavyycardlgplgmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
968,NaN,NaN,QRW38989,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgkslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgnigyadsvkgrftisrdnandslflqmnslraedtalyycakdirsgdyvgvfdywgqgalvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
969,NaN,NaN,QRW38988,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrvscaasgfavsnnymtwvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmkslraedtavyycardlvvagidywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
970,NaN,NaN,QRW38987,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvqpggslrlscaasgitvssnymnwvrqapgkglewisviysggstyyadsvkgrftisrdnskntlflqmnslraedtavyycardldiagafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
971,NaN,NaN,QRW38986,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaaagftfstydmhwvrqvtgkglewvsalgtsgdtyyadsvkgrftisrenaknslylqmnslragdtavyycvrgdhssgwygtyyyymdvwgkgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
972,NaN,NaN,QRW38985,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygitwvrqapgqglewmgwisvyngnthyaqklqgrvtmttgtststaymelrslrsddtavyycavldycsggssssgyynygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
973,NaN,NaN,QRW38984,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqnlqgrvtmttdtststaymelrslrsddtavyycaregagliiaydywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
974,NaN,NaN,QRW38983,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvtviwydgsnkyyadsvkgrftisrdnskntvylqmnslraedtavyycakggnygdylrgfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
975,NaN,NaN,QRW38982,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryrpsfqgqvtisadksistaylqwsslkasdtamyycalavgrgiptsyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
976,NaN,NaN,QRW38981,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgasissyfwswirqppgkgldwigyiyyngstnynpslksrvtisvdtsknqfslklssvtaadtavyfcastywdssgyyygvdywghgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
977,NaN,NaN,QRW38980,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarekirsiaaagtvyyygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
978,NaN,NaN,QRW38979,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdasekyyvdsvkgrftisrdnaknslylqmnslraedtavyycaglfwyggyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
979,NaN,NaN,QRW38978,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsgsstyyadsvkgrftisrdtskntlylqmnslraedtavyycarglqyyydtsgyykdsyyygvdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
980,NaN,NaN,QRW38977,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgpevkkpgasvkvsckasgytftsyyvhwvrqapghglewmaiinpdagstsfaqrfqgrltmttdtststvymglnslrsedtavyycargglvpavmpaldywgqgalvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
981,NaN,NaN,QRW38976,NaN,SARS-CoV-2,Homo sapiens (human),qvqliqsgaevkkpgasvkvscttsgytftsyflhwvrqapgqglewmgiinpsdgtttyaqkfqgrvtmtrdtstgtvsmelsslryedtavyycardgalysnsptefdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
982,NaN,NaN,QRW38975,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsintaymelsrltsddtavyycardslfsrvdwyfdlwgrgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
983,NaN,NaN,QRW38974,NaN,SARS-CoV-2,Homo sapiens (human),qvllqesgpglvkpsqtlsltctvsggsisngsyywswirqhpgkglewigyiyysgstyynpslrsrvtisldtsmnqfslklssvtaadtavyycariyrgtmvvvfsdlhwyfdlwgrgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
984,NaN,NaN,QRW38973,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevrkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpeansttyaqkfqgrvtmtsdtststvyldlsslrsedtavyycartgflipskgggmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
985,NaN,NaN,QRW38972,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgselkkpgasvkvsckasgysftdyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvstaylqistlkaedtavyycastvgrgsgtyyygnyysysmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
986,NaN,NaN,QRW38971,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckasgysfttywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksittaylqwsslkasdtaiyycarlpphfgsgsyygnafdiwglgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
987,NaN,NaN,QRW38970,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlaridwdddkyystslmtrltiskdtsknqvvltmtnmdpvdtatyycariqrgiaadywgqgilvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
988,NaN,NaN,QRW38969,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaaskftfsnyamnwvrqapgkglewvsaisgsggntyyadsvkgrftisrdnskntlylqmnslraedtavyycakgellwfgellenwfdpwgqgtrvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
989,NaN,NaN,QRW38968,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfssyainwvrqapgqglewmgriipilgianyaqkfqgrvtitadkststaymelsslrsedtavyycatgrytygygyyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
990,NaN,NaN,QRW38967,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywddddryspslksrltitkdtsknqvvltmtnmdpvdtatyycahslpskysysygsfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
991,NaN,NaN,QRW38966,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsiifsggttyyadsvkgrftisrdnsrntlylqmsslraedtavyycaetgwdgmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
992,NaN,NaN,QRW38965,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkgldwigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycardyggnsnyfhywgqgtlvtvsp,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
993,NaN,NaN,QRW38964,NaN,SARS-CoV-2,Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvatisydgsdkfyadsvkgrftisrdnsrntlyvqmnslrpedtalyycakggwygdirvdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
994,NaN,NaN,QRW38963,NaN,SARS-CoV-2,Homo sapiens (human),dvqlvesggglvqpggslrlscaasefivssnymswvrqapgrglewisviysggstfyadsvkgrftisrdsskntlylqmnslraedtavyycardlplhgdyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
995,NaN,NaN,QRW38962,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvssnymswvrqapgkgldwvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarelgpvggtdqwgqgtlvsvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
996,NaN,NaN,QRW38961,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkasetlsltctvsggsissssyywgwirqppgkglewigsihdsgstyynpslksrvtisvdtsknqfslrlssvtaadtavyycaryygpgtyydafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
997,NaN,NaN,QRW38960,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsfysihwvrqapgkglewvavisydgsykfyadsvkgrftisrdnskdtvylqmnslraedtavyycardwvhygsgsyppdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
998,NaN,NaN,QRW38959,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgdsfpsywiewvrqmpgkglewmgliypgdsdtryspsfqgqvtisadksistaylqlsslkasdtamyfcarhpvlrgnidywgqgtlvivss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
999,NaN,NaN,QRW38958,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasglivsrnymnwvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlenggldvwgqgttvtvfs,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1000,NaN,NaN,QRW38957,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggflqpggslrlscaasgftfssddmhwvrqvtgkglewvsaigtsgdtyysgsvkgrftisrenaknslylqmnslrvgdtavyycargslrggilsgyafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1001,NaN,NaN,QRW38956,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymiwirqapgkglewvsyisssgatiyyadsvkgrftisrdnaknslylqmtslraedtavyycaspllshnygsgsyynvywyfelwgrgtlvsvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1002,NaN,NaN,QRW38955,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsiityywswirqppgkglewigyidysgstnynpslksrvtisvdtsknqfslelssvtaadtavyycartlgayydiltgfrtpggwfapwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1003,NaN,NaN,QRW38954,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvstisasgdstyyadfvkgrftisrdnskntvylqmnslraedtaiyycakepsfglwfgelsgwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1004,NaN,NaN,QRW38953,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpksvytgyaqkfqgrvtmtrntsirtaymelsslrsedtavyycarglwfgdltrtkynwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1005,NaN,NaN,QRW38952,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgtevkkpgasvkvsckastytftnfglswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvqefwldpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1006,NaN,NaN,QRW38951,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaviywdddkryspslksrltitkdtsknqvvltmtnmdpvdtatyycahttwyyygsgwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1007,NaN,NaN,QRW38950,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfstywigwvrqmpgkglewmgiiypydsdtryspsfqgqvtisadksistaylqwsslkasdtaiyycarqesgwsfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1008,NaN,NaN,QRW38949,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlaridwdddkyystsletrltiskdtsknqvvltmtnmdpvdtatyycaritphlvydywsqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1009,NaN,NaN,QRW38948,NaN,SARS-CoV-2,Homo sapiens (human),qvqivqsgaevkkpgasvkvsckasgytftsyaihwvrqapgqrlewmgwintgngntkysqnfqdrvtitrdtsattaymelssltpedtavyycaragwelnywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1010,NaN,NaN,QRW38947,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasrftfsnyamtwvrqapgkglewvsaisgsagsiyyadsvkgrftisrdnskntlylqmnslraddtavyfcakgqrgspdffdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1011,NaN,NaN,QRW38946,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpksvytgyaqkfqgrvtmtrntsirtaymelsslrsedtavyycarglwfgdltrtkynwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1012,NaN,NaN,QRW38945,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftrywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarieyyndssgyyqfwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1013,NaN,NaN,QRW38944,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgfsfsnawmswvrqapgkglewvgrikfttdggtsdyaapvrgrftisrddskntlylqmnslrtedtavyycsttndygdysanywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1014,NaN,NaN,QRW38943,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfsfstyamhwvrqapgkglvwvafisydesnkyytdsvkgrftvsrdnskntlylqmnslraedtavyycagggvlvtsdpdafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1015,NaN,NaN,QRW38942,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissfywswirqpagkglewigrmsasgstnynpslksrvtmsvdtsenqislklgsvtaadtavyycageqhivttiidywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1016,NaN,NaN,QRW38941,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggdvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslrvedtavyycakdptslycsggscynnwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1017,NaN,NaN,QRW38940,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvqpggslrlscaasgftvssnymtwvrqapgkglewvsliysggstfyadsvkgrftisrlsskntlylqmnslrvedtavyycargpypssswawgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1018,NaN,NaN,QRW38939,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasmtvsckasgytfstyyihwvrqapgqglewmgiinpsagstsyaqkfqgrvtmttdtststvymelsslrsedtavyycardysritmirgagdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1019,NaN,NaN,QRW38938,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyvmhwvrqapgkglewvavisydgsskyyadsvkgrstisrdnskntlylqmnslraedtavyycakrggtycsggicyggyfdywgqgmlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1020,NaN,NaN,QRW38937,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfsfstyamhwvrqapgkglvwvafisydesnkyytdsvkgrftvsrdnskntlylqmnslraedtavyycagggvlvtsdpdafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1021,NaN,NaN,QRW38936,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlaridwdddkyystslktrltiskdtsknqvvltmtnmdpvdtatyycareeaagtkldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1022,NaN,NaN,QRW38935,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslntsgmcvswirqppgkalewlaridwddekyystslqtrltiskdtsknqvvltmtnmdpvdtatyycarmipipaldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1023,NaN,NaN,QRW38934,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslntsgmsvswirqppgkalewlaridwdddkyystslktrlsiskdtsknqvvltmtnvdpvdtatyyctrtatvvkdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1024,NaN,NaN,QRW38933,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssfamswvrqapgkglewvsvisssgdytsyadsvkgrftisrdnskntlylqmnslraedtavyycakdvgsrliydvfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1025,NaN,NaN,QRW38932,NaN,SARS-CoV-2,Homo sapiens (human),rgpgngvwaevkkpgssvkvscktsggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycasfgslwdlrdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1026,NaN,NaN,QRW38931,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlslictvsggsitsyywtwirqppgkglewigyiyyngssnynpslesrvtisvdasknqfslklssvtaadtavyycatdyydssgyrygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1027,NaN,NaN,QRW38930,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfnsygiswvrqapgqglewmgwissyngntnyaqklqgrvtmttdtststaymelrsltsddtavyycatddpdivlvpaamsldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1028,NaN,NaN,QRW38929,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnsnntlylqmnslraedtavyycardygdyyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1029,NaN,NaN,QRW38928,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaliwydgsnkyyadsvkgrftisrdnskntmylqmnslraedtavyycakdgsgsyynsgaldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1030,NaN,NaN,QRW38927,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscagsgftfshygmhwvrqapgkglewvavilydgsnnyyadsvkgrftvsrdnskntlylqmnslrtedtavyycgkgagpycgggscyptkvdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1031,NaN,NaN,QRW38926,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggalvqpggslrlscaasgftfssydmhwvrqatakglewvstigtagdtyypgsvkgrftisrenaknslylqmnnlragdtavyycarvgydssgyywyldlwgrgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1032,NaN,NaN,QRW38925,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvnwirqppgkalewlaridwdddkyystsletrltiskdtsknqvvltmtnmdpvdtatyycartrlgitafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1033,NaN,NaN,QRW38924,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgitvnsnymswvrqapgkglewvsviyngvttyyadsvkgrftisrdiskntvylqmnslraedtavyycaragwlrgrfdpwgqgtlvivss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1034,NaN,NaN,QRW38923,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslqisckgsgysfisnwigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylrwsslkasdtamyycarigdwigfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1035,NaN,NaN,QRW38922,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrhnskntlylqmnslraedtavyycardleergamdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1036,NaN,NaN,QRW38921,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfstywigwvrqmpgkglewmgiiypydsdtryspsfqgqvtisadksistaylqwsslkasdtaiyycarqesgwsfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1037,NaN,NaN,QRW38920,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslriscaasgftvssnymswvrqapgkglewvsliysggstfyadsvkgrftisrdnskntlylqmntlrvedtavyycardavgsyyygmevwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1038,NaN,NaN,QRW38919,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvrptqtltltctfagfslrthgmcvswirqppgkalewlaridwdgdkyystslktrltiskdtskdqvvltmtnmdpvdtatyycarflvggfkawfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1039,NaN,NaN,QRW38918,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysgdntyyadsvkgrftisrdnskntlylqmnslraedtavyycakmlwlrgwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1040,NaN,NaN,QRW38917,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckasgdtfsshyihwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtsdtststvylelsslrsedtavyycardqafivatlgpdywgqgilvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1041,NaN,NaN,QRW38916,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpggslrlscaasgftfddyamnwvrqapgkglewvslisgdgdspsysgsvkgrftisrdnsknslylqmislrtedtalyycarespkltgyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1042,NaN,NaN,QRW38915,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaaagftfsnydmhwvrqatgkglewvsvigtagdtyypdsvkgrftisrenaknslylqmnslragdtavyycarayydtsgyynyfdhwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1043,NaN,NaN,QRW38914,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymnwvrqapgkglewvsviysgdnthyadsvkgrftisrdnskntlylqmnslraedtavyycargygsgsygwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1044,NaN,NaN,QRW38913,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvaviwydgsdkyyadsvkgrftisrdnskntlylqmsslgvedtavyycakggfgyasgwyyldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1045,NaN,NaN,QRW38912,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgiivssnymswvrqapgkglewvsviysggstfyadsvkgrftisrhnskntlylqmnslraedtavyycareglvgttltfdywgqgslvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1046,NaN,NaN,QRW38911,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasagtfssyavswvrqapgqglewmgriipivsitkyaqkfqgrvtmtadkststaymelsslrsedtavyycargrytygtegyfdnwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1047,NaN,NaN,QRW38910,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgitvssnymnwvrqapgkglewvsviysggstfyadsvkgrftisrhnskntlylqmnslraedtavyycareglgmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1048,NaN,NaN,QRW38909,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnsnntlylqmnslraedtavyycardpmrpgmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1049,NaN,NaN,QRW38908,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssytlhwvrqapgkglewvavissdgsskyyadsvkgrftisrdnskntlylqmnslraedtavyycardpppgnmgsmaqhlvllvvfdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1050,NaN,NaN,QRW38907,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtftsyafswvrqapgqglewmggiipifgtsnyaqkfqgrvtisadessstaymelsslrsedtavyycargpayvsgtyywnafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1051,NaN,NaN,QRW38906,NaN,SARS-CoV-2,Homo sapiens (human),emqlvesggglvqpggslrlscaasgftfstyemnwvrqapgkglewvsyissstnsiyyagsvqgrftisrgnaknslylqmnslraedtavyycargrddygdyrggdfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1052,NaN,NaN,QRW38905,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkiscegsgysfisywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadrsistaylqwsslkasdtamyycvrsdgdyvighdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1053,NaN,NaN,QRW38904,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycatdggggsyyyahyyygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1054,NaN,NaN,QRW38903,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsdsigyadsvkgrftisrdnaknslylqmnslraedtalyycakdlssgwdlfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1055,NaN,NaN,QRW38902,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvisnymswvrqapgkglewvsviyrggstyfadsvkgrftisrdnskntlylqmnslraedtavyycarlasdgsgsyldyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1056,NaN,NaN,QRW38901,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckasgyrftnywtvwvrqmpgkglewmgiiypgdseirysppfqgqvtisadksistaylqwsslkasdtamyycarhpsnfydsggdyyamdvwgqgtpvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1057,NaN,NaN,QRW38900,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswssgsivyadsvkgrftvsrdnaknslylqmnslrvedtafyycakdmvagphyygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1058,NaN,NaN,QRW38899,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlaridwdddkyystslrtrltiskdtsknlvvltmtnmdpvdtatyycalgragtmdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1059,NaN,NaN,QRW38898,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsnydmhwvrqgtgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtalyycarvgyygsgsyplywyfdlwgrgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1060,NaN,NaN,QRW38897,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfssyainwvrqapgqglewmgriipilgianyaqkfqgrvtitadkststaymelsslrsedtavyycatgrytygygyyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1061,NaN,NaN,QRW38896,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywitwvrqmpgkglecmgridpsdsyskyspsfqghvtisadksistaflqwsslkasdtamyycarlpfcdsascgrahyyygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1062,NaN,NaN,QRW38895,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftlsrywmswvrqapgkglewvanikqdgsekkyvdsvkgrftisrdntknslylqmnslraedtavyycarlmyyygnfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1063,NaN,NaN,QRW38894,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasglivsrnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardlniaggfdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1064,NaN,NaN,QRW38893,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsavgvgwirqppgkalewlaliywnddkryspslknrltitkdpsknqvvltmtnmdpvdtatyycahrlapdydfltgyyngddafdvwgpgtmvtiss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1065,NaN,NaN,QRW38892,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvsvgwirqppgkalewlaliywdddkrynpslksrltitkdtsknqvvltmtnmdpvdtatyycahsmvrgvlfgadfdywgqgtlvavss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1066,NaN,NaN,QRW38891,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssysiswvrqapgqglewmgriipilgvaddaqkfqgrvtitadkststaymelsslrsedtavyycareagttdwyfdlwgrgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1067,NaN,NaN,QRW38890,NaN,SARS-CoV-2,Homo sapiens (human),rilltqsgaevkkpgasakvsckvsgyslsespmhwvrqapgkglewmggfdpedgeiinvqkfkgrvtmtedtssdtaymeltsltsedtavyfcaitslarglkgyfdswgqgtllivss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1068,NaN,NaN,QRW38889,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarrwdgvgfdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1069,NaN,NaN,QRW38888,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfnnywmtwvrqapgkglewvanikldgsekyyvdsvkgrftisrdnaknslylqvnslraedtavyycarsphyyggfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1070,NaN,NaN,QRW38887,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywtwirqapgkglewigyiynsgstnynpslrgrvtisvdtsknqfslnlssvtaadtavyycardqgyssgwndafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1071,NaN,NaN,QRW38886,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggfissyywswirqppgkglewigyiyysgttnynpslksrvtisvdtsknqfslklssvtaadtavyycarrsmgycsggncysgfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1072,NaN,NaN,QRW38885,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckasgytfttyglswvrqapgqglewmgwvsayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardygwfgelstegqfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1073,NaN,NaN,QRW38884,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsryglhwvrqapgkglewvgvilydgsdehyadsvkgrftisrdnskntldlqmnslrpedtavyycakqaspycsggscysgnfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1074,NaN,NaN,QRW38883,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissntfywgwirqppgkglewigsihytgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarfitdgyssgsdswgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1075,NaN,NaN,QRW38882,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssgiyywswirqppgkglewigyvfysgstnynpslksrvtisvdtsknqfslklrsvtaadtavyycamtyydyiwgrvdpqfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1076,NaN,NaN,QRW38881,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisstshywgwirqppgkglewigsihysgstyynpslksrvtisvdtskkqfslklrsvtaadtavyycarfitdgyssgsdswgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1077,NaN,NaN,QRW38880,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevknpgasvkvsckasgysfinygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrfddtavyycarvqwlrldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1078,NaN,NaN,QRW38879,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfttsavqwvrqargqrlewigwivvgsdntnyaqkfqervtitrdmstrtaymelsslrsedtavyycaadrmrivggkgyyygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1079,NaN,NaN,QRW38878,NaN,SARS-CoV-2,Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalqwlaridwdddkyystslktrltiskdtsknqvvltvtnvdpvdtgtyycarvqvaaagspydywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1080,NaN,NaN,QRW38877,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsgkhyadsvkgqftisrdnskntlylqmnslraedtavyycardgvdfgmvtlfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1081,NaN,NaN,QRW38876,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckasgytfttyglswvrqapgqglewmgwvsayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardygwfgelstegqfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1082,NaN,NaN,QRW38875,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamnwvrqapgkglewvsgiswnsgsfgyadsvkgrftisrdnaknslylqmnslrpedtalyycakdigcsstscsyyhyygmdvwglgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1083,NaN,NaN,QRW38874,NaN,SARS-CoV-2,Homo sapiens (human),evmlvesgggliqpggslrlscaasgfivssnymswvrqapgkglewvsliysggstfyadsvkgrftisrdnskntlylqmnslgaedtavyycarfrygdypdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1084,NaN,NaN,QRW38873,NaN,SARS-CoV-2,Homo sapiens (human),evqlvgsggglvqpggslrlscaasgftvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlflqmnslrpedtavyycardgravagtdwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1085,NaN,NaN,QRW38872,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgyywywswirqppgkglewigeinhsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycgvpycsssscyryygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1086,NaN,NaN,QRW38871,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywdddkryspslktrltitkdtsknqvvltltnmdpvdtatyycahrpagfwsahfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1087,NaN,NaN,QRW38870,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavygrsfsgnswswirqppgkglewigeidhsgstnynpslksrvtisvdtsknqfslklnsvtaadtavyycargwtvpplwvlnwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1088,NaN,NaN,QRW38869,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssysitwvrqapgqglewmgriipilgvanyaqkfqgrvtitadkststaymelsslrsedtavyycaregttiteyfqqwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1089,NaN,NaN,QRW38868,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywddnkryspslksrltitkdtsknqvvltmttmdpvdtatyycahrplfsgpfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1090,NaN,NaN,QRW38867,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvrpsetlsltctvsggsissssyfwgwirqppgkglewigsiyysgtthynpslksritisvdtsknqfslkltsvtaadtavyycatlewlrapfdnwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1091,NaN,NaN,QRW38866,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyyihwvrqapgqglewmgwinpnsggtnfvqkfqgrvtmtrdtsistaymelsrlksddtavyycargtppdsvvvpaaihpynwfdpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1092,NaN,NaN,QRW38865,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasevtvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardglvgatlafdfwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1093,NaN,NaN,QRW38864,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgtevkkpgasvkvsckastytftnfglswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvqefwldpwgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1094,NaN,NaN,QRW38863,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakd,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1095,NaN,NaN,QRW38862,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevknpgasvkvsckasgysfinygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrfddtavyycarvqwlrldywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1096,NaN,NaN,QRW38861,NaN,SARS-CoV-2,Homo sapiens (human),vqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsgiysggstyyadsvkgrftisrdkskntlylqmnslraedtavyycardggysaytlfysdfafdiwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1097,NaN,NaN,QRW38860,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyyihwvrqapgqglewmgifnpgagttnypqkfqgrvtmtrdtststvymelsslrsedtavyycardgspwgndydiygmdvwgqgttvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1098,NaN,NaN,QRW38859,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftlsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdkgplffwsgyytdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1099,NaN,NaN,QRW38858,NaN,SARS-CoV-2,Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywdddkryspslktrltitkdtsknqvvltltnmdpvdtatyycahrpagfwsahfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1100,NaN,NaN,QRW38857,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggfiryyywtwirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslnlssvtaadtavyycarrgkygsgspddafdvwgqgtmvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1101,NaN,NaN,QRW38856,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfnsyaihwvrqtpgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtalyycardgrifylsfyfdywgqgtlvtvss,NaN,"Li,H. et al.; Direct Submission; Submitted (09-FEB-2021) Chongqing Medical University, 1st Yixueyuan Road, Yuzhong District, Chongqing 400000, China; 2021.","anti-SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1102,NaN,NaN,QRN77147,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfnfsthwmhwvrqapgkglvwvsrinsdgsrrayatsvkgrftisrdnakntlylqmdslrdedtavyyctrddsswphffdnwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1103,NaN,NaN,QRN77146,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsskfyadsvkgrftisrdnskntlylqmnslraedtavyycardygsswyqvpdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1104,NaN,NaN,QRN77145,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscavsgftfsnvwmrwvrqapgkgrewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyyctsqvwlrgpgdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1105,NaN,NaN,QRN77144,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggvlvkpggslrlscaasgftfsnawmswvrqapgkglewvgrikskthgettdyaapvkgrftisrddsentlylqinslktedtavyfcathrseagdldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1106,NaN,NaN,QRN77143,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedmalyycakggvvpdlyyfdywgqgilvt,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1107,NaN,NaN,QRN77142,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaaiwydgsnkhyadsvkgrftisrdnskntlylqmnslraedtavyycardvgrvttwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1108,NaN,NaN,QRN77141,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgnyyltwirqpagkglewighiytsgstnynpslksrvtisvdtsmnqfslklssvtaadtavyycardipptwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1109,NaN,NaN,QRN77140,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgsyywswirqpagkglewighiytsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycareipstwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1110,NaN,NaN,QRN77139,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycatedyydssgsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1111,NaN,NaN,QRN77138,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftshwigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarlpsgrynwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1112,NaN,NaN,QRN77137,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrvscaasgfsfsyawmswvrqapgkglewvgriksktdggttdcaapvkgrftisrddskntlylqmnslktedtavyycttlsdygdlssvywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1113,NaN,NaN,QRN77136,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgyrftnywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksittaylqwsslkasdtamyycarlsdrwyspfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1114,NaN,NaN,QRN77135,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfisywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksintaylqwsslkasdtamyycarrvtipngwfdpwgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1115,NaN,NaN,QRN77134,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgttyynpslksrvtisvdtsknqfslklssvtaadtavyycassrydfwsgsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1116,NaN,NaN,QRN77133,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypdsvkgrftisrenaknslylqmnslragdtavyycargggetittvfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1117,NaN,NaN,QRN77132,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsnydmhwvrqatgrglewvstigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycarvkyggyvgyfdywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1118,NaN,NaN,QRN77131,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssawmswvrqapgkglewvgriktktdggtkdyaapvkgrftisrddskntlylqmnslktedtavyyctttndygdyspaywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1119,NaN,NaN,QRN77130,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlivaggmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1120,NaN,NaN,QRN77129,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvssisssgstiyyadsvkgrftisrdnaktslylqmnslraedtavyycargkwlrgsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1121,NaN,NaN,QRN77128,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglqwvsaigtagdtyypdsvkgrftisrenaknslylqmnslragdtavyycardrdsswsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1122,NaN,NaN,QRN77127,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmhwvrqapgkglvwvshingdgsstsyadsvkgrftisrdnakntlylqmnslraedtavyycasafwqrgnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1123,NaN,NaN,QRN77126,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlyssggtdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1124,NaN,NaN,QRN77125,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardlyssggtdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1125,NaN,NaN,QRN77124,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarvpsvgdcsstsclywyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1126,NaN,NaN,QRN77123,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckasgytftsydinwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtmtrntsistvymelsslrsedtavyycarfpkvpaaifpgdyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1127,NaN,NaN,QRN77122,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctfsggsissyswnwirqppgkglewigyiytsgstnynpslksrvtmsvdtsknqfslklnsvtaadaavyfcarglfynsggyyssnyyyyidvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1128,NaN,NaN,QRN77121,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyfmhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsittaymelsrlrsddtavyycarddtllrysdwlpttsfggmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1129,NaN,NaN,QRN77120,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscadsgftfstygmhwvrqapgkglewvalisydgsnkyyadsvkgrftisgdnskntlylqmnslraedtavyycaraewlrgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1130,NaN,NaN,QRN77119,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifytanyaqkfqgrvtitadkststaymelsslrsedtavyycardegycsggscygyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1131,NaN,NaN,QRN77118,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslrdedtavyycareahdgaltdygdylnwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1132,NaN,NaN,QRN77117,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllrpsetlsltcavyggsfsgsywtwirqppgkrlewigeishsgstnynpslksrftisidtsrnqfslkltsvtaadtavyycvrglpmnavvwfdpwgqgtqvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1133,NaN,NaN,QRN77116,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvlyyydssgypnleyfqhwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1134,NaN,NaN,QRN77115,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysrstnynpslksrvtisvdtsknqfslklssvtaadtavyycarhdtifgvgqyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1135,NaN,NaN,QRN77114,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarrprdyydrsgyyyvpgyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1136,NaN,NaN,QRN77113,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsynitwvrqapgqglewvgwisayngntnyaqkfqgrvtmttdtststaymelrslrsddtavyycarvprgyydrsgyyylphyldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1137,NaN,NaN,QRN77112,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycattegqqlphppyyyyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1138,NaN,NaN,QRN77111,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarggyyydssgyeyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1139,NaN,NaN,QRN77110,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvaviryngnniyyadfvkgrftisrdnskntlylqmnslrgedtavyycaregdgpdafdiwgqgtmv,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1140,NaN,NaN,QRN77109,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswgrqapgqglewmggiipilgtvnyaqkfqgrvtitadkststaymelsslrsedtavyycarvlgyydssgsndafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1141,NaN,NaN,QRN77108,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyycardstpgygdyisgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1142,NaN,NaN,QRN77107,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsiiswnsdnigyadsvkgrftisrdnarnslylqmnslrvedtalyycakdkgsgsgygmdvwgrgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1143,NaN,NaN,QRN77106,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwhdgsnkyyadsvkgrftisrdnskntlylqmnslraedtalyycardpsvvvtaidfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1144,NaN,NaN,QRN77105,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyylhwvrqapgqglewmgwinptsggtkyaqkfqgrvtmtrdtsittaymevnrlrsddtavyycardrplwfgveygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1145,NaN,NaN,QRN77104,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftshymhwvrqapgqglewmgiinpsgggtsyaqkfqgrvtmtrdtsmstvymelsslrsedtavyycasssstpdyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1146,NaN,NaN,QRN77103,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfnsyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvgaewprdhkyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1147,NaN,NaN,QRN77102,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssytmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycargprgyydfwsgyeneyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1148,NaN,NaN,QRN77101,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgytftsywigwvrqmpgkglewmgfiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarpvtydwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1149,NaN,NaN,QRN77100,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqklqgrvtittdeststaymelsslrsedtavyycarytyyydrsgyyrpdyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1150,NaN,NaN,QRN77099,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsisnyywswirqppgkglewigyiytsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargpprllwfgespptywyfnlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1151,NaN,NaN,QRN77098,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfstynmnwvrqapgkglewvssitssssyiyyadsvkgrftisrdnaenslylqmnslraedtavyycardrnrydfwsgyyrlvgfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1152,NaN,NaN,QRN77097,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsiigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycargsysnyvgymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1153,NaN,NaN,QRN77096,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsitsssyywgwirqppgkglewigtiyyggstyynpslksrvtisvdtsknqislklssvtaadtavyycaslrgayydfwsgprdggwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1154,NaN,NaN,QRN77095,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftayymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycarpprdyydssgyqirddhfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1155,NaN,NaN,QRN77094,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttddpgsyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1156,NaN,NaN,QRN77093,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarycsggschppgqwlsdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1157,NaN,NaN,QRN77092,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycardlpprrfdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1158,NaN,NaN,QRN77091,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgysmhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlgsddtavyycardleycsstscytsttfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1159,NaN,NaN,QRN77090,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpgrslrlscaasgftfddyamhwvrqapgkglewvsgtswnsgtigyadsvkgrftisrdnaknslylqmnrlraedtalyhcakdigskrstsenygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1160,NaN,NaN,QRN77089,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgttwnsgtigyadsvkgrftisrdnaknslylqmnslraedmalyycakdqtkdgggaysyglggmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1161,NaN,NaN,QRN77088,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaregagpyyydssgyytlfddwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1162,NaN,NaN,QRN77087,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakrggycsstscytryyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1163,NaN,NaN,QRN77086,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadkststaymelsslrsedtavcycarvgyyydrsgfprtedyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1164,NaN,NaN,QRN77085,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfssycigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisvdksistaylqwsslkasdtamyycarqwrgyydrsgyyhfdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1165,NaN,NaN,QRN77084,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscmasgytltayyihwvrqapgqgleslgwinprtggttilqkfqgwvtmtrdtsintvylelprvtladtavyycvrggtwnyvggevwgqgtavtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1166,NaN,NaN,QRN77083,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarggryydssgyngtyefdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1167,NaN,NaN,QRN77082,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpiggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycaraplyyydssgyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1168,NaN,NaN,QRN77081,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaelkkpgasvkvsckasgytfnsygiswvrqapgqglewmggisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarrvedngddggdyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1169,NaN,NaN,QRN77080,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfstydmswarqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycardtipfwsgyytspdyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1170,NaN,NaN,QRN77079,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaknqnsygylsyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1171,NaN,NaN,QRN77078,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkhyadsvkgrftisrdnskntlylqmnslraedtavyycakdpwelrqgnyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1172,NaN,NaN,QRN77077,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqperslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsksytswgyyhmdvw,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1173,NaN,NaN,QRN77076,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfrrygihwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakasgeycgggscyrgvfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1174,NaN,NaN,QRN77075,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscatsgftfssyglhwvrqapgkglewvalisydgsdkyyadsvkgrftisrdtskntlflqmnslraedtavyycakvmgpycsggscysgyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1175,NaN,NaN,QRN77074,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakaggpycsggscyssyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1176,NaN,NaN,QRN77073,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsrygmhwvrqapgkglewvavmsydgsskyyadsvkgrftisrdnskntlclqmnslraedtavyycakqagpycsggscysapfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1177,NaN,NaN,QRN77072,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpisggtnsaqkfqgrvtmtrdtsittaymelsslrsddtavyhcakspyyydssgylggfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1178,NaN,NaN,QRN77071,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggsttyaqkfqgrvtmtrdtststvymelsslrsedtavyycarvgcggdncyfwrplgngmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1179,NaN,NaN,QRN77070,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgrinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycakdggarqllpddyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1180,NaN,NaN,QRN77069,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfttyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelnslrsedtavyycarggssrycsstscysfgvdnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1181,NaN,NaN,QRN77068,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqpagkglewigriytsgstkynpslksrvtmsvdtsknqfslklssvtaadtavyycarappgdfydssgyfsafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1182,NaN,NaN,QRN77067,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggsttyaqkfqgrvtmtrdtststvymelsslrsedtavyycardraetegsetyyydssgyyllgywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1183,NaN,NaN,QRN77066,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasrftfsnyamswvrqapgkglewvstisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdraaahwatdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1184,NaN,NaN,QRN77065,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydgfdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1185,NaN,NaN,QRN77064,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakvdgsyyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1186,NaN,NaN,QRN77063,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyahsvkgrftisrdnaknslylhmnslraedtalyycakdmlgnyyyyamvvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1187,NaN,NaN,QRN77062,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlsctpsgftfgdyamswfrqapgkglewvgfirskayggtteyaasvkgrftisrddsksiaylqmnslktedtavyyctraprcsggscylvdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1188,NaN,NaN,QRN77061,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavtsydgtnkyyadsvkgrftisrdnskntlylqmnslraedtavyfcaknvgtgynvmyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1189,NaN,NaN,QRN77060,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfttyylhwvrqapgqglewmgiidpsggstsyaqkfqgrvtmtkdtststvymelsslrsedtavyycarvgrgfsygyfdywgqgalvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1190,NaN,NaN,QRN77059,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyfcakqlyyygsgsyvfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1191,NaN,NaN,QRN77058,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakaqysygyvvyyfdywgqgalvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1192,NaN,NaN,QRN77057,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakggysygyslyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1193,NaN,NaN,QRN77056,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfnnygmhwvrqapgkglewvavisydgnnkyyadsvkdrftisrdnskntlylqmnnlraedtamyycaragwellriryyfdfwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1194,NaN,NaN,QRN77055,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycargdsgsylgvwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1195,NaN,NaN,QRN77054,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypdsvkgrftisrenaknslylqmnslragdtavyycardrgssgwygwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1196,NaN,NaN,QRN77053,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssnaiswvrqapgqglewmggitpifgtvnyaqkfqgrvtitadeststaymelsslrsedtavyycaseweifgfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1197,NaN,NaN,QRN77052,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvgygyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1198,NaN,NaN,QRN77051,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsisayywswirqpagkglewigriytsgstiynpslksrvtmsvdtsknqfslklssvtaadtavyycardngyvwgsyrpdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1199,NaN,NaN,QRN77050,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdlgycsstncyyyywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1200,NaN,NaN,QRN77049,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggdlvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskstlylqmnslraedtavyycakdlrsttfyvyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1201,NaN,NaN,QRN77048,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycardglsghfphnwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1202,NaN,NaN,QRN77047,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarehtptdivvvnveywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1203,NaN,NaN,QRN77046,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaksggrhyydssgyyrlplddafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1204,NaN,NaN,QRN77045,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaitdsgdgtfyadsvkgrftisrdnskntlylqmnslraedtavyycaseedysnyvgwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1205,NaN,NaN,QRN77044,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfnsyamswvrqapgkglewvsgisgsgdstyyadsvkgrftisrdnskntvylqmnslraedtavyycakdggrqwlvelldywghgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1206,NaN,NaN,QRN77043,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslesrvtisvdtsknqfslklssvtaadtavyycasgelsafgelfphdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1207,NaN,NaN,QRN77042,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscvasgftfssywmhwvrqvpgkgpvwvshinsegsstnyadsvrgrftisrdnakdtlylqmnnlraedtavyycarptavaaagnyfyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1208,NaN,NaN,QRN77041,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysgystyyvdsvkgrftisrdnskntlylqmnslraedtavyycarvggahsgydgsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1209,NaN,NaN,QRN77040,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssdaiswvrqapgqglewmggimpifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycardlrycsggrclwwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1210,NaN,NaN,QRN77039,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtitrdtsistaymelsslrsedtavyycarggrycsdvscysgtgfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1211,NaN,NaN,QRN77038,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsgdstyfadsvkgrftisrdnskntlylhmnslraedtavyycakvvgsgtppdyyyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1212,NaN,NaN,QRN77037,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcavsggsvssgnyywnwirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklnsvtaadtavyhcaretyyydssgyyisdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1213,NaN,NaN,QRN77036,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmhwvrqapgkglvwvsrinsdgssttyadsvkgrftisrdnakntlylqmnslraedtavyycardkgivgatifdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1214,NaN,NaN,QRN77035,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftnywinwvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycarlntdlrsrfgelyyyfdywgqgtl,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1215,NaN,NaN,QRN77034,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfmfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardglnwnvphygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1216,NaN,NaN,QRN77033,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyyihwvrqapgqglewmgiinpsdggtsyaqkfqgrvtmtrdtststvymelsslrsedtavyscaraststtnwndalslgcwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1217,NaN,NaN,QRN77032,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpgtslrlscaasgftfssyamswvrqapgkglewvsaisssggstyyadsvkgrftisrdnskntlylhmnslraedtavyycateriavagtrmynwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1218,NaN,NaN,QRN77031,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardsedcsstscyldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1219,NaN,NaN,QRN77030,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfrtyamhwvrqapgkglewvavilsdgnnkyyadsvkgrftisrdnskntlylqmnslraedtaifycareqeanyydisgyyhwgeslgywgqgtlvtvps,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1220,NaN,NaN,QRN77029,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvatikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycargdydfwsgyydywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1221,NaN,NaN,QRN77028,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardgavvrflewptvgyyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1222,NaN,NaN,QRN77027,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmywvrqapgkglewvavisydgsnkyyadsvkgrftisrgnskntlylqmnslraedtavyycardcgpaqpplveaddyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1223,NaN,NaN,QRN77026,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgstftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgwvtmtrdtsistaymelsrlrsddtavyycarekvatmfalppygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1224,NaN,NaN,QRN77025,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycastgyyiltgyefgamdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1225,NaN,NaN,QRN77024,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistvymelsrlrsddtavyycardlgfsrlqflfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1226,NaN,NaN,QRN77023,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarssvtgtppfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1227,NaN,NaN,QRN77022,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckasgytftgyyihwvrqapgqglewmgwinpmsggtnytqkfqgwvtmtrdtsintaymelsrlrsddtavyycardfamgtvtgtfvywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1228,NaN,NaN,QRN77021,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsiitaymelsrlrsddtavyycarappfydfwsgidywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1229,NaN,NaN,QRN77020,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyyihwvrqapgqglewmgwinpnsggtkyaqkfqgwvtmtrdtsittvymelsrlrsddtavyycargteynwnsahfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1230,NaN,NaN,QRN77019,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggrnytqkfqgrvtmtrdtsistaymelsrlrsddtavyycardlgysyvqgyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1231,NaN,NaN,QRN77018,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsgisgsgtstyyadsvkgrftisrdnskntlyvqmnslraedtavyycakdlglygapywyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1232,NaN,NaN,QRN77017,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsgydihwvrqapgkglewvavisydgsskfyadsvkgrftisrdnskntlylqmnslraedtavyycakdlgsslyydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1233,NaN,NaN,QRN77016,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstryaqkfqgrvtmtrdtststvymelsslrsedtavyycaregvggtsyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1234,NaN,NaN,QRN77015,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglikpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttgvivvvvaapddafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1235,NaN,NaN,QRN77014,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarsydssglsynwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1236,NaN,NaN,QRN77013,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardsaysgydffeaprdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1237,NaN,NaN,QRN77012,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvqpggslrlscaasgftfttysmnwvrqapgkglewvsyinsgssniyyadsvkgrftisrdnaknslylqmnslrdedtavyycargdctssscysldywgqgalvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1238,NaN,NaN,QRN77011,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftftryamnwvrqapgkglewisyinigstnieygdsvkgrftisrdnaknsvylqmnslreedtavyycsrgdctssscysidfwgqgslvivss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1239,NaN,NaN,QRN77010,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvlpggslrlscaasgftftryamnwvrqapgkglewisyinigsanieygdsvkgrftisrdnpknsvylqmnslreedtavyycwrgdctsssrysmelggqgsmvivss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1240,NaN,NaN,QRN77009,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdtpggddiltgwglygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1241,NaN,NaN,QRN77008,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfifssydmhwvrqatgkglewvstigtagdtyypdsvkgrftisrenaknslylqmnslragdtavyycargdyniltgyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1242,NaN,NaN,QRN77007,NaN,SARS-CoV-2,Homo sapiens (human),evqlvetgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaraisesprygvywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1243,NaN,NaN,QRN77006,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfidyymswirqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycargrtwelvdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1244,NaN,NaN,QRN77005,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsskyyadsvkgrftisrdnskntlylqmnslraedtavyycardhdygeivdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1245,NaN,NaN,QRN77004,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycartmyyydssgsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1246,NaN,NaN,QRN77003,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrltsddtavyycarggqdeltgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1247,NaN,NaN,QRN77002,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslrdedtavyycarasglrsyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1248,NaN,NaN,QRN77001,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftftnynmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslrdedtavyycarvvgsgsyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1249,NaN,NaN,QRN77000,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymtwvrqapgkglewvsliysggstfyadsvkgrftisrdsskntlylqmnslraedtavyycargygdyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1250,NaN,NaN,QRN76999,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslragdtavyycardygdfyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1251,NaN,NaN,QRN76998,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardygdfyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1252,NaN,NaN,QRN76997,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardwgddyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1253,NaN,NaN,QRN76996,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardygdfyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1254,NaN,NaN,QRN76995,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardwgdyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1255,NaN,NaN,QRN76994,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardygdyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1256,NaN,NaN,QRN76993,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtretsistvymelsrlrsddtavyycardlgwsrlhgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1257,NaN,NaN,QRN76992,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvkgrftisrdnaknslhlhmrslraedtalyycakdgrsgdqwpelyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1258,NaN,NaN,QRN76991,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgiigyadsvmgrftisrdnaknslylqmnslraedtalyycakdggsgtteyeayyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1259,NaN,NaN,QRN76990,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaregsgwnseafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1260,NaN,NaN,QRN76989,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarmvtsgtyyydnsgysssgpfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1261,NaN,NaN,QRN76988,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqlpgkglewmgridpsdyytnyspsfqghvtisgdksistaylqwsslkasdtamyycarplipglwdaldiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1262,NaN,NaN,QRN76987,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsiiysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresprgydywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1263,NaN,NaN,QRN76986,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlsctasgftfgdyamnwfrqapgkglewvgfirskayggtteyaasvrgrftisrddsesiaylqmnslktedtavyyctrdlsyyydssgrgshlfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1264,NaN,NaN,QRN76985,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgdsmssyfwtwirqppgkglecigyfypsgstnynpslksrvtisidtsknqfslklssvtaadtavyycarlkqqlvgfgwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1265,NaN,NaN,QRN76984,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygihwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardgtsitlitegdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1266,NaN,NaN,QRN76983,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmhwvrqapgkglvwvsrinsdgsstsyadsvkgrftisrdnakntlylqmnslraedtavyycarawamrqttltpewidywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1267,NaN,NaN,QRN76982,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardlryydfspfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1268,NaN,NaN,QRN76981,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvkpggslrlscaasgfifsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycyrfcsdgscyrhfdywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1269,NaN,NaN,QRN76980,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftvrsysmnwvrqapgkglewvscmtssgsylyyadsvkgrftisrdnaknslylqmnslrdedtavyycakeeyygmdvwgqgatvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1270,NaN,NaN,QRN76979,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsdawmswvrqapgkglewvgrlksktdggttdyaapvkgrftisrddskntlslqmnslktedtavyycttdqiygdylrmpvpfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1271,NaN,NaN,QRN76978,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycargnrllycsstscyldavrqgyyyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1272,NaN,NaN,QRN76977,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyycardgravagtnwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1273,NaN,NaN,QRN76976,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfstytmnwvrqapgkglewvssissvssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarecsdesfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1274,NaN,NaN,QRN76975,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavirydgsnkyyadsvkgrftisrdnsknklylqmnslraedtavyycaredyydssgsldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1275,NaN,NaN,QRN76974,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssyimnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycareaeweafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1276,NaN,NaN,QRN76973,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfivssnymswvrqapgkglewvsdiysggsthyadsvkgrftisrdnskntlylqmnslraedtavyycarttphrggevwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1277,NaN,NaN,QRN76972,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgitwnsgsiayadsvkgrftisrdnaknslylqmnslraedtalyycakgssssyhnwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1278,NaN,NaN,QRN76971,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrvscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlslqmnslraedtavyycardlgergmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1279,NaN,NaN,QRN76970,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardlsvfgmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1280,NaN,NaN,QRN76969,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftfsrdnskntlylqmnslraedtavyycardlmaygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1281,NaN,NaN,QRN76968,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardrviygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1282,NaN,NaN,QRN76967,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgvivssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardgghygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1283,NaN,NaN,QRN76966,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssissstsyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarerygdnwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1284,NaN,NaN,QRN76965,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsgisdsgvstynadsvkgrftisrdnskntlylqmnslraedtavyycakvwsisldafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1285,NaN,NaN,QRN76964,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydiswvrqapgqglewmgwinayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarpsssltsyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1286,NaN,NaN,QRN76963,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdttyspsfqgqvtisadksvttaylqwsslkasdtamyycarlpqeekrflewlppanvrkqipyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1287,NaN,NaN,QRN76962,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisydgsnkyfadsvkgrftisrdnskntlylqmnslraedtavyycaratcsggsclfgqnafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1288,NaN,NaN,QRN76961,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslraedtavyycardsggdivvipavngfdywgqgtlvt,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1289,NaN,NaN,QRN76960,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgsrlvkpsqtlsltcavsggsissggyswswirqppgkglqwigyiyhsgstyynpslksrvtisvdrsknqfslklssvtaadtavyycarftnpnyydssgyygfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1290,NaN,NaN,QRN76959,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfstysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarvvanwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1291,NaN,NaN,QRN76958,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssycmhwvrqapgkglewvaviwydgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarekdivatdfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1292,NaN,NaN,QRN76957,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycasgighnwnyvstpngmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1293,NaN,NaN,QRN76956,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygihwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycareyfydssdyyfeyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1294,NaN,NaN,QRN76955,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvaviwydgsnkhyadsvkgrftisrdnskntlylqmnslraedtaeyycardmgtlvthfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1295,NaN,NaN,QRN76954,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfttycigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarhwyygdygnysyyyldvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1296,NaN,NaN,QRN76953,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqpagkglewigriytsgstnynpslesrvtmsvdtsknqfslklssvtaadtavyycarvvgyssrganyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1297,NaN,NaN,QRN76952,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvaviwydgsnkhyadsvkgrftisrdnskntlylqmnslraedtamyycardegsltttfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1298,NaN,NaN,QRN76951,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymnwvrqapgkglewvsviysggstyyadsvkgrftisrdnskntvylqmnsvraedtavyycareaygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1299,NaN,NaN,QRN76950,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsviysggstyyadsvrgrftisrdnsentlylqmnslraedtavyycarvgdwyfswgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1300,NaN,NaN,QRN76949,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycareaarrydfwsglnwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1301,NaN,NaN,QRN76948,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftnygiswvrqapgqglewmgwnsayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycartdgtpaeyfqywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1302,NaN,NaN,QRN76947,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarevkrvvaapeyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1303,NaN,NaN,QRN76946,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsgdityyadsvkgrftisrdnskntlylqmnslraedtavyycakdsgtamveifdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1304,NaN,NaN,QRN76945,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakddssgyhyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1305,NaN,NaN,QRN76944,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarqrsiaaregippgwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1306,NaN,NaN,QRN76943,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarygmgelltlrseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1307,NaN,NaN,QRN76942,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltcavsgdsirsggyywswvrqhpgrglewigyiyfsgttyynpslksrvtisvdtsekqfslkltsvtdadtavyfcarvkgwlrgyfdywgqgapvtvsa,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1308,NaN,NaN,QRN76941,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgtswnsgtigyadsvkgrftisrdnaknslylqmnslraedtalyycakgrvvyaidpdsvspfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1309,NaN,NaN,QRN76940,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgvtwnsgsigyadsvkgrfiisrdnaknslylqmnslraedtalyycakggegfrnwndgldyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1310,NaN,NaN,QRN76939,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarreaygprdyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1311,NaN,NaN,QRN76938,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsfssggyywhwirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarvatdygdsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1312,NaN,NaN,QRN76937,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgttnhaqkfqgrvtitadeststaymelsslrsedtavyyctsgqgagvnrgvvittlgywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1313,NaN,NaN,QRN76936,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycaryydiltgyyvdyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1314,NaN,NaN,QRN76935,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardrkyssgwsvvnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1315,NaN,NaN,QRN76934,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggttyyadsvkgrftisrdnskntlylqmnslraedtavyycakvpihycsngvcyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1316,NaN,NaN,QRN76933,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmnwvrqapgkglewigriksnsdggttdyaapvqgrftilrddskntlylqmtslrtedtavyfcttgpqyddngysytvdywgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1317,NaN,NaN,QRN76932,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgfifsdyymswirqapgkglewvsyisssastiyyadsvkgrftisrdnaknslylqmnslraedtavyycarglvytpyrfgywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1318,NaN,NaN,QRN76931,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgspyynpslksrvtisidtsknqfslklssvtaadtavyycarvhvvrgvanypyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1319,NaN,NaN,QRN76930,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycarvsglfdpwgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1320,NaN,NaN,QRN76929,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqasgkglewvsaigtsgdtyypgsvkgrftisrenaknslylqmnslragdtavyycargtffygsgsynwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1321,NaN,NaN,QRN76928,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsvsidyadsvkgrftisrdnaknslylqmnslraedtalyycakdgagtenwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1322,NaN,NaN,QRN76927,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftftsygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardmmirgvawyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1323,NaN,NaN,QRN76926,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardhslgvrgdgygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1324,NaN,NaN,QRN76925,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycarvgydssgysgwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1325,NaN,NaN,QRN76924,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavilydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardqgmattyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1326,NaN,NaN,QRN76923,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyvmnwvrqapgkglawvavisfdgsnkyyadsvkgrftvsrdnskntlylqmnslraedtalyycargpgwqwpeldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1327,NaN,NaN,QRN76922,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvkgrftisrdnaknslylqmnslraedtafyycakagvrgiaaagpdlnfdhwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1328,NaN,NaN,QRN76921,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvtvisydgrnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarefgdpewyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1329,NaN,NaN,QRN76920,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisydgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdpfplavagtgyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1330,NaN,NaN,QRN76919,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvalisydgsnkhyadsvkgrftisrdnskntlylqmnslraedtavyycaragttnsdyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1331,NaN,NaN,QRN76918,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiytsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarhswlrgmadywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1332,NaN,NaN,QRN76917,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycarvaafldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1333,NaN,NaN,QRN76916,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckvsgytftnywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksiitaylqwsslkasdtamyycarvpsssdygdyggfeywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1334,NaN,NaN,QRN76915,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarvpregtpgfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1335,NaN,NaN,QRN76914,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssntaawnwirqspsrglewlgrtyyrskwyndyavsvisriiinpdtsknqfslqlksvtpedtavyycardilrdtswphdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1336,NaN,NaN,QRN76913,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkysadsvkgrftisrdnskntlylqmnslraedtavyycardcggdcypttdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1337,NaN,NaN,QRN76912,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtissyaiswvrqapgqglewmggiipifgttnyaqkfqgrvtitadeststaymelsslrsedtalyycarddgqqlwsyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1338,NaN,NaN,QRN76911,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyflhwvrqapgqglewvgwispisggtnyalkfqgrvtmtrdtssttaymdlsrlrsddtavyycarealgygdfphdgfdlwgkgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1339,NaN,NaN,QRN76910,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftryhmqwvgqapgqglewmgiinpsggstsyaqkfqgrvtmardtstssvymelsslryedtavyycagryyydssgptggmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1340,NaN,NaN,QRN76909,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftvsrdnskntlylqmnslraedtalyycvnpftifgvvpdwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1341,NaN,NaN,QRN76908,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvqgrfiisrdnaknslylqmnslraedtalyycakdmgrddssgsllfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1342,NaN,NaN,QRN76907,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakprkrgdyygsgsydywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1343,NaN,NaN,QRN76906,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftyyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarpllpgetgslnrldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1344,NaN,NaN,QRN76905,NaN,SARS-CoV-2,Homo sapiens (human),evqlvetgggliqpggslrlscaaseftvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarvlpfgdyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1345,NaN,NaN,QRN76904,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaraavagiirdywgqgtlv,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1346,NaN,NaN,QRN76903,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsvissgggtfyadsvkgrftisrdnskntlylqmnslraedtavyycarslwlrgsfqhwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1347,NaN,NaN,QRN76902,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgttnynpslksrvtisvdksknqfslklssvtaadtavyycartwiqphnwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1348,NaN,NaN,QRN76901,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardlrgyssswydwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1349,NaN,NaN,QRN76900,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraeetavyycaslrwlqgdfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1350,NaN,NaN,QRN76899,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasrftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycatapwlrggfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1351,NaN,NaN,QRN76898,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvtnikldgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarlrwlradfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1352,NaN,NaN,QRN76897,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgltfsfyaihwvrqapgkglewvayisyegsdkyyadsvkgrftisranskstlylqmnslraedtavyycyalfergnwndaeywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1353,NaN,NaN,QRN76896,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqvpgkglewvsgiswnsasigyadsvkgrftisrdnaknslylqmnslrpedmafyycakgsssgwtrpldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1354,NaN,NaN,QRN76895,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqvpgkglewvsgiswnsasigyadsvkgrftisrdnaknslylqmnslrpedmafyycakgsssgwtrpldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1355,NaN,NaN,QRN76894,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesvkgrftisrdnaknslylqmnslivedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1356,NaN,NaN,QRN76893,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesmkgrftisrdnaknslylqmnslrvedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1357,NaN,NaN,QRN76892,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgyrftnywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksittaylqwsslkasdtamyycarlsdrwyspfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1358,NaN,NaN,QRN76891,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgyrftnywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksittaylqwsslkasdtamyycarlsdrwyspfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1359,NaN,NaN,QRN76890,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsiitgymelsrlrsddtavyycaikpptyyydssgyylsyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1360,NaN,NaN,QRN76889,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlksddtavyycaikpptyyydssgyylsyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1361,NaN,NaN,QRN76888,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllrpsetlsltcavyggsfsgsywtwirqppgkrlewigeishsgstnynpslksrftisidtsknqfslkltsvtaadtavyycvrglpmnavvwfdpwgqgtqvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1362,NaN,NaN,QRN76887,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllrpsetlsltcavyggsfsgsywtwirqppgkrlewigeishsgssnynpslksrftisidtsknqfslkltsvtaadtavyycvkglpmnavvwfdpwgqgtqvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1363,NaN,NaN,QRN76886,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarpnsphtattyyyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1364,NaN,NaN,QRN76885,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarpnsphtattyyyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1365,NaN,NaN,QRN76884,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgwvtmtrdtsistaymelsrlrsddtavyycarasewgyyydsgayytpdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1366,NaN,NaN,QRN76883,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgwvtmtrdtsistaymelsrlrsddtavyycarasewgyyydsgayytpdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1367,NaN,NaN,QRN76882,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscktsgyiftdysmhwvrqapgqglewmgwvnpnsggtnyaqkfqgwvtmardtsittvymelsrlrsddtavyycargplphrlvydfwsgfhdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1368,NaN,NaN,QRN76881,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftdysmhwvrqapgqglewigwvnpnsggtnyaqkfqgwvtmardtsittvymelsrlksddtavyfcargplfhrlvydfwsgyhdgfdmwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1369,NaN,NaN,QRN76880,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymdlrslrsddtavyycarvpasygdddyyyyygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1370,NaN,NaN,QRN76879,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvpasygdddyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1371,NaN,NaN,QRN76878,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfsnyamswvrqapgkglewvsaisgsggntyyadsvkgrftisrdnskntlylqmnslraedtavyycakavhyggnsdrrfsepsapfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1372,NaN,NaN,QRN76877,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggdlvqpggslrlscaasgftfsnyamswvrqapgkglewvsaisgsggntyyadsvkgrftisrdnskntlylqmnslraedtavyycakavhyggnsdrrfsepsapfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1373,NaN,NaN,QRN76876,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytvtgyyihwvrqapgqglewmgwispnsggtnyaqkfqgwvtmtrdmsittaymelsrlrsddtavyycareryfdlggmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1374,NaN,NaN,QRN76875,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytvtgyyihwvrqapgqglewmgwispnsggtnyaqkfqgwvtmtrdmsittaymelsrlrsddtavyycarepyfdlggmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1375,NaN,NaN,QRN76874,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiytsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarnthmysayspppdfwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1376,NaN,NaN,QRN76873,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyihtsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarnthmysgyspppdfwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1377,NaN,NaN,QRN76872,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvqpggslrlscsasgftfssyamhwvrqapgkgleyvsvisntggdtyyadsvkgrftisrdnskntlylqvsslrpedtavyycvkdqggrgwpsyyyyhymdvwgkgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1378,NaN,NaN,QRN76871,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvqpggslrlscsasgftfssyamhwvrqapgkgleyvsvisntggdtyyadsvkgrftisrdnskntlylqvsslrpedtavyycvkdqggrgwpsyyyyhymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1379,NaN,NaN,QRN76870,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaaagftfssygmhwvrqapgkglewvavisydgsnksyadsvkgrftisrdnskntlslqmnslrvedtavyycakaalrgyydrsgyyyenyngmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1380,NaN,NaN,QRN76869,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaaagftfssygmhwvrqapgkglewvavisydgsnksyadsvkgrftisrdnskntlslqmnslrvedtavyycakaalrgyydrsgyyyenyngmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1381,NaN,NaN,QRN76868,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakasgiycsggncysyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1382,NaN,NaN,QRN76867,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakasgiycsggdcysyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1383,NaN,NaN,QRN76866,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisssnyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslkvssvtaadtavyycarhaaayydrsgyyfieyfqhwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1384,NaN,NaN,QRN76865,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsvtctvsggsisssryywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarhaaayydrsgyyfieyfqhwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1385,NaN,NaN,QRN76864,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvavisydgsnkyfadsvkgrftisrdnskntlylqmnslrpedtavyycakvgmeyssgwygeeidfwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1386,NaN,NaN,QRN76863,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlsctasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakvglgyssgwygeeidywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1387,NaN,NaN,QRN76862,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgrdkyyvdsvkgrfiisrdnskntlylqmnslrgedtavyycaktysgygyyyygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1388,NaN,NaN,QRN76861,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgrdkyyvdsvkgrfiisrdnskntlylqmnslrgedtavyycaktysgygyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1389,NaN,NaN,QRN76860,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgynftsygiswvrqapgqglewmgwisgyngntnygqkfqggvtmttdtststaymelrslrsddtavyycardrgghnfwsgygyyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1390,NaN,NaN,QRN76859,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavfycardrgghdfwsgygfyyyygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1391,NaN,NaN,QRN76858,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgwvtmtrdtsistaymelsrlrsddtavyycareshggvwsapgyyygmdvwgqgt,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1392,NaN,NaN,QRN76857,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgwvtmtrdtsistaymelsrlrsddtavyycareshggvwsapgyyygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1393,NaN,NaN,QRN76856,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycathlrlgelrgvdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1394,NaN,NaN,QRN76855,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycathlrlgelrgvdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1395,NaN,NaN,QRN76854,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapakglewvavilydgsgkyyadsvkgrftisrdnskntlylqmnslraedtavyycardgivdtalvtwfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1396,NaN,NaN,QRN76853,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftysgyamhwvrqapgkglewvavilddgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardgivdtamvtwfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1397,NaN,NaN,QRN76852,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvscmasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycardspfsalgasndywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1398,NaN,NaN,QRN76851,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycardspfsglgasndywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1399,NaN,NaN,QRN76850,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfisyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycaranegaavsfdywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1400,NaN,NaN,QRN76849,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycaranegaavsfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1401,NaN,NaN,QRN76848,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywnwirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycardpgdpnlhdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1402,NaN,NaN,QRN76847,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywnwirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycardpgdpnlhdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1403,NaN,NaN,QRN76846,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyychrgsystfsyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1404,NaN,NaN,QRN76845,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyychrgsystfsyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1405,NaN,NaN,QRN76844,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfivssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardygdfyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1406,NaN,NaN,QRN76843,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyycardygdfyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1407,NaN,NaN,QRN76842,NaN,SARS-CoV-2,Homo sapiens (human),evqllesgggleqpggslrlscaasgftfstyamswvrqapgkglewvsaisgsgagtfyadsvkgrftisrdnskntlylqmnslraedtavyycaresdcgstscyqvgwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1408,NaN,NaN,QRN76841,NaN,SARS-CoV-2,Homo sapiens (human),evqllesgggleqpggslrlscaasgftfstyamswvrqapgkglewvsaisgsgagtfyadsvkgrftisrdnskntlylqmnslraedtavyycaresdcgstscyqvgwfdpwgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1409,NaN,NaN,QRN76840,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsatsdsggttyysdsvkgrftisrdnskntlylqmnslraedtaiyycarrgnsgsypdpdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1410,NaN,NaN,QRN76839,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsatsdsggttyyadsvkgrftisrdnskntlylqmnslraedtaiyycarrgnsgsypdpdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1411,NaN,NaN,QRN76838,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakepigqpllwwdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1412,NaN,NaN,QRN76837,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakepigqpllwwdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1413,NaN,NaN,QRN76836,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavyggsfsgyywswirqspgkglewigeindsgstnynpslksrvtisvdtsknqfslrlssvtaadtavyycarghtqekwelregyyfdywdqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1414,NaN,NaN,QRN76835,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavyggsfsgyywswirqspgkglewigeindsgstnynpslksrvtisvdtsknqfslrlssvtaadtavyycarghtqekwelregyyfdywdqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1415,NaN,NaN,QRN76834,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltctvssdsvssyywnwirqttgkgmewigridtggrtnynpslssrvamsmatsknqfslklssvtaadtavyfcarglsyyplygshinyidywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1416,NaN,NaN,QRN76833,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltctvssdsvssyywnwirqttgkgmewigridtggrtnynpslssrvamsmatsknqfslklssvtaadtavyfcarglsyyplygshinyidywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1417,NaN,NaN,QRN76832,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmnwvrqapgkglewvgrikdksdggtidyaapvqgrftisrddskntlylqmnslktedtavyycttgphyddsgysytvdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1418,NaN,NaN,QRN76831,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggdlvkpggslrlscaasgftfnnawmswvrqapgkglewvgrikdksdgettdyaapvqgrftvsrddskntlylqmnslktedtavyycttgphydssgysytvdswgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1419,NaN,NaN,QRN76830,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarvqvgargwvdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1420,NaN,NaN,QRN76829,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvsfissrssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarvqvgargwvdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1421,NaN,NaN,QRN76828,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydvnwvrqatgqglewmgwmnpnsgsagyaqkfqgrvtmtrntsistaymelsslrsedtavyycargfsltwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1422,NaN,NaN,QRN76827,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkksgasvkvsckasgytftsydinwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtmtrntsistaymdlsslrsedtavyycargfsltwyfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1423,NaN,NaN,QRN76826,NaN,SARS-CoV-2,Homo sapiens (human),evqlvetgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslrvedtavyycargpycggdcdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1424,NaN,NaN,QRN76825,NaN,SARS-CoV-2,Homo sapiens (human),evqlvetgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslrvedtavyycargpycggdcdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1425,NaN,NaN,QRN76824,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycvkgveyssssnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1426,NaN,NaN,QRN76823,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsdsigyadsvkgrftisrdnaknslylqmnsltaedtalyycakgveyssssnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1427,NaN,NaN,QRN76822,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycvkgveyssssnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1428,NaN,NaN,QRN76821,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdycmswirqapgkglewlsyisnsgttryyadsvkgrftisrdngrnslylqmnslsaedtavyycarrgdgsssiyyynymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1429,NaN,NaN,QRN76820,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdycmswirqapgkglewlsyisnsgttryyadsvkgrftisrdngrnslylqmnslsaedtavyycarrgdgsssiyyynymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1430,NaN,NaN,QRN76819,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgfifsdycmswirrapgkglewlsyisnsgttryyadsvkgrftisrdngrnslylqmdslsaedtavyycarrgdgsssiyyynymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1431,NaN,NaN,QRN76818,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwlnpisggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycaspasrgysgydhgyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1432,NaN,NaN,QRN76817,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpisggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycaspasrgysgydhgyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1433,NaN,NaN,QRN76816,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpisggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycaspasrgysgydhgyyyymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1434,NaN,NaN,QRN76815,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyycardlrdqdgysygafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1435,NaN,NaN,QRN76814,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyycardlrdqdgysygafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1436,NaN,NaN,QRN76813,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggsayyadsvkgrftisrdnskntlylqmnslraedtavyycardlrdqdgysygafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1437,NaN,NaN,QRN76812,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavyggsfsgyywtwirqppgeglewigeinhsgstnynpslksrvtisvdtsknqfslrlssvtaadtavyycargpirahlysqttvryfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1438,NaN,NaN,QRN76811,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavyggsfsgyywtwirqppgeglewigeinhsgstnynpslksrvtisvdtsknqfslrlssvtaadtavyycargpirahlysqttvryfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1439,NaN,NaN,QRN76810,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavyggsfsgyywtwirqppgeglewigeinhsgstnynpslksrvtisvdtsknqfslrlssvtaadtavyycargpirahlysqttvryfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1440,NaN,NaN,QRN76809,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavyggsfsgyywtwirqppgeglewigeinhsgstnynpslksrvtisvdtsknqfslrlssvtaadtavyycargpirahlysqttvryfdlwgrgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1441,NaN,NaN,QRN76808,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardtfgrggdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1442,NaN,NaN,QRN76807,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardtlgrggdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1443,NaN,NaN,QRN76806,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsliysggttyyadsvkgrftisrdnskntlylqmnslraedtavyycaretlgrggdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1444,NaN,NaN,QRN76805,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlylqmntlraedtavyycardtlgrggdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1445,NaN,NaN,QRN76804,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviyrggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarggwyydssgyysgrtdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1446,NaN,NaN,QRN76803,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvsnymswvrqapgkglewvsliysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarggwyydssgyysgrtdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1447,NaN,NaN,QRN76802,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggttyyadsvkgrftisrdnskntlylqmnslraedtavyycarggwyydssgyysgrtnafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1448,NaN,NaN,QRN76801,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviyrggntyyadsvkgrftisrdnskntlylqmnslraedtavyycarggwyydssgyysgrtdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1449,NaN,NaN,QRN76800,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviyrggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarggwyydssgyysgrtdafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1450,NaN,NaN,QRN76799,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesvkgrftisrdnaknslylqmnslivedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1451,NaN,NaN,QRN76798,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesvkgrftisrdnaknslylqmnslivedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1452,NaN,NaN,QRN76797,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesmkgrftisrdnaknslylqmnslrvedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1453,NaN,NaN,QRN76796,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesvkgrftisrdnaknslylqmnslivedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1454,NaN,NaN,QRN76795,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesvkgrftisrdnaknslylqmnslivedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1455,NaN,NaN,QRN76794,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisrdskyiyyaesvkgrftisrdnaknslylqmnslivedtavyycarddgiaaasdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1456,NaN,NaN,QRN76793,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstkymtwvrqapgkglewvsalysggsdyyadsvkgrftisrdnskntlylqmsslrvedtgvyycardssevrdhpghpgrsvgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1457,NaN,NaN,QRN76792,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstkymtwvrqapgkglewvsvlysggsdyyadsvkgrftisrdnsknalylqmnslrvedtgvyycardssevrdhpghpgrsvgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1458,NaN,NaN,QRN76791,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstkymtwvrqapgkglewvsvlysggsdyyadsvkgrftisrdnsknalylqmsslrvedtgiyycardssevrdhpghpgrsvgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1459,NaN,NaN,QRN76790,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstkymtwvrqapgkglewvsvlysggsdyyadsvkgrftisrdnsknalylqmsslrvedtgiyycardssevrdhpghpgrsvgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1460,NaN,NaN,QRN76789,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstkymtwvrqapgkglewvsvlysggsdyyadsvkgrftisrdnsknalylqmnslrvedtgvyycardssevrdhpghpgrsvgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1461,NaN,NaN,QRN76788,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstkymtwvrqapgkglewvsvlysggsdyyadsvkgrftisrdnsknalylqmnslrvedtgvyycardssevrdhpghpgrsvgafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1462,NaN,NaN,QRN76787,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycaryqlapgsgsyynwggypreseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1463,NaN,NaN,QRN76786,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycaryqlapgsgsyynwggypreseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1464,NaN,NaN,QRN76785,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycaryqlapgsgsyynwggypreseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1465,NaN,NaN,QRN76784,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycaryqlapgsgsyynwggypreseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1466,NaN,NaN,QRN76783,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycaryqlapgsgsyynwggypreseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1467,NaN,NaN,QRN76782,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycaryqlapgsgsyynwggypreseyyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1468,NaN,NaN,QRN76781,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssnsaawnwirqspsrglewlgrtyyrskwyndyavsvksritinpdtsknqfslqlnsvtpedtavyycardpsshfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1469,NaN,NaN,QRN76780,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssnsaawnwirqspsrglewlgrtyyrskwyndyavsvksritinpdtsknqfslqlnsvtpedtavyycardpsshfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1470,NaN,NaN,QRN76779,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssnsaawnwirqspsrglewlgrtyyrskwyndyavsvksritinpdtsknqfslqlnsvtpedtavyycardpsshfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1471,NaN,NaN,QRN76778,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssnsaawnwirqspsrglewlgrtyyrskwyndyavsvksritinpdtsknqfslqlnsvtpedtavyycardpsshfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1472,NaN,NaN,QRN76777,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssnsaawnwirqspsrglewlgrtyyrskwyndyavsvksritinpdtsknqfslqlnsvtpedtavyycardpsshfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1473,NaN,NaN,QRN76776,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltcaisgdsvssnsaawnwirqspsrglewlgrtyyrskwyndyavsvksritinpdtsknqfslqlnsvtpedtavyycardpsshfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1474,NaN,NaN,QRN76775,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarergyyggktppflggqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1475,NaN,NaN,QRN76774,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarergyyggktppflggqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1476,NaN,NaN,QRN76773,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssynmnwvrqapgkglewvscisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarergydggktppflggqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1477,NaN,NaN,QRN76772,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarergyyggktppflggqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1478,NaN,NaN,QRN76771,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarergyyggktppflggqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1479,NaN,NaN,QRN76770,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssynmnwvrqapgkglewvssissssshiyyadsvkgrftisrdnaknslylqmnslraedtavyycarergyhggktspflggqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1480,NaN,NaN,QRN76769,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrsdyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsknqfslklgsvtaadtavyycarqartdastyghnfdswgqgtlvt,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1481,NaN,NaN,QRN76768,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrsdyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsknqfslklgsvtaadtavyycarqartdgstyghnfdywgqgtlvt,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1482,NaN,NaN,QRN76767,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrsdfywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsknqfslkldsvtaadtavyycarqartdgstyghnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1483,NaN,NaN,QRN76766,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrsdyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsknqfslklgsvtaadtavyycarqartdgstyghnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1484,NaN,NaN,QRN76765,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrsdyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsknqfslklgsvtaadtavyycarqartdastyghnfdswgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1485,NaN,NaN,QRN76764,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisrsdyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtsknqfslklgsvtaadtavyycarqartdgstyghnfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1486,NaN,NaN,QRN76763,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1487,NaN,NaN,QRN76762,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1488,NaN,NaN,QRN76761,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1489,NaN,NaN,QRN76760,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1490,NaN,NaN,QRN76759,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscldafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1491,NaN,NaN,QRN76758,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1492,NaN,NaN,QRN76757,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1493,NaN,NaN,QRN76756,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcsggscydafdiwgqgtmvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1494,NaN,NaN,QRN76755,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslraedtavyycarianymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1495,NaN,NaN,QRN76754,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslrpedtavyycarianymdvwgkgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1496,NaN,NaN,QRN76753,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslrpedtavyycarianymdvwgkgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1497,NaN,NaN,QRN76752,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslrpedtavyycarianymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1498,NaN,NaN,QRN76751,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslrpedtavyycarianymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1499,NaN,NaN,QRN76750,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslrpedtavyycarianymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1500,NaN,NaN,QRN76749,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslraedtavyycarianymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1501,NaN,NaN,QRN76748,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggsqrlscaasgftvssnymswirqapgkglewvsviysggsayyvdsvkgrftisrdnskntlylqmnslrpedtavyycarianymdvwgkgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1502,NaN,NaN,QRN76747,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfsvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaregevegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1503,NaN,NaN,QRN76746,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvrnnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaregevegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1504,NaN,NaN,QRN76745,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaregdvegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1505,NaN,NaN,QRN76744,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaregdvegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1506,NaN,NaN,QRN76743,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstcyadsvkgrftisrdnskntlylqmnslraedtavyycaregdvegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1507,NaN,NaN,QRN76742,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvsnnymswvrqapgkglewvsviysggstyyadslkgrftisrdnskntlylqmnslraedtavyycaregevegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1508,NaN,NaN,QRN76741,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgfsvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaregevegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1509,NaN,NaN,QRN76740,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvsnnymswvrqapgkglewvsviysggstyyadsvkgrftisrdkskntlylqmnrlraedtavyycaregevegyndfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1510,NaN,NaN,QRN76739,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaregdvegyydfwsgysrdryyfdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1511,NaN,NaN,QRN76738,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskstlylqmnslraddtavyycakvgeycggdcyrgldywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1512,NaN,NaN,QRN76737,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskstlylqmnslraddtavyycakvgeycggdcyrgldywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1513,NaN,NaN,QRN76736,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycggdcyrgldywgqgt,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1514,NaN,NaN,QRN76735,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskstlylqmnslraddtavyycakvgeycggdcyrgldywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1515,NaN,NaN,QRN76734,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskstlylqmnslgaddtavyycakvgeycggdcyrgldywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1516,NaN,NaN,QRN76733,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskstlylqmnslraddtavyycakvgeycggdcyrgldywgqgtlvtspq,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1517,NaN,NaN,QRN76732,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfstyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycggdcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1518,NaN,NaN,QRN76731,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfsnyamswvrqapgkglewvsgisnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycgddcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1519,NaN,NaN,QRN76730,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycggdcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1520,NaN,NaN,QRN76729,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskstlylqmnslraddtavyycakvgeycggdcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1521,NaN,NaN,QRN76728,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycggdcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1522,NaN,NaN,QRN76727,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsavsnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycggdcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1523,NaN,NaN,QRN76726,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisnsggstyyedsvkgrftisrdnskntlylqmnslraedtavyycakvgeycggdcyrgldywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1524,NaN,NaN,QRN76725,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1525,NaN,NaN,QRN76724,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1526,NaN,NaN,QRN76723,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1527,NaN,NaN,QRN76722,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1528,NaN,NaN,QRN76721,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1529,NaN,NaN,QRN76720,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1530,NaN,NaN,QRN76719,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1531,NaN,NaN,QRN76718,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfpfsiygmhwvrqapgkglewvavisydggnkyyadsvkgrftisrdiskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1532,NaN,NaN,QRN76717,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1533,NaN,NaN,QRN76716,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1534,NaN,NaN,QRN76715,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1535,NaN,NaN,QRN76714,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1536,NaN,NaN,QRN76713,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakegrpsdivvvvafdywgqgtlvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1537,NaN,NaN,QRN76712,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1538,NaN,NaN,QRN76711,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvsrnymnwvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1539,NaN,NaN,QRN76710,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymtwvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaretygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1540,NaN,NaN,QRN76709,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1541,NaN,NaN,QRN76708,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1542,NaN,NaN,QRN76707,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1543,NaN,NaN,QRN76706,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1544,NaN,NaN,QRN76705,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1545,NaN,NaN,QRN76704,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1546,NaN,NaN,QRN76703,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1547,NaN,NaN,QRN76702,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtsp,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1548,NaN,NaN,QRN76701,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1549,NaN,NaN,QRN76700,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1550,NaN,NaN,QRN76699,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1551,NaN,NaN,QRN76698,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1552,NaN,NaN,QRN76697,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1553,NaN,NaN,QRN76696,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1554,NaN,NaN,QRN76695,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1555,NaN,NaN,QRN76694,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1556,NaN,NaN,QRN76693,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsvmysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycaresygmdvwgqgttvtvss,NaN,"Wang,Z. et al.; Enhanced SARS-CoV-2 Neutralization by Secretory IgA; Unpublished; 2021.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1557,NaN,NaN,QRJ89103,NaN,SARS-CoV-2,Unknown.,evqlvesggglvqpggslrlscaasgftfddyamswvrqapgkglewigrmynngrtsynpslkslvtisrdnskntlylqmnslraedtatyycardnlgyrpsenlygmdvwgqgttvtvss,NaN,"Dimitrov,D.S. et al.; Molecules that bind to SARS-CoV-2; US10822379-B1 96 03-NOV-2020 University of Pittsburgh-of the Commonwealth System of Higher Education; Pittsburgh, PA; 2021.",Sequence 96 from patent US 10822379,NaN,2022-03-14,NaN,NaN
1558,NaN,NaN,QRJ89017,NaN,SARS-CoV-2,Unknown.,evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrhnskntlylqmnslraedtavyycargygdyyfdywgqgtlvtvssastkgpsvfplapsskstsggtaalgclvkdyfpepvtvswnsgaltsgvhtfpavlqssglyslssvvtvpssslgtqtyicnvnhkpsntkvdkkvepksc,NaN,"Dimitrov,D.S. et al.; Molecules that bind to SARS-CoV-2; US10822379-B1 8 03-NOV-2020 University of Pittsburgh-of the Commonwealth System of Higher Education; Pittsburgh, PA; 2021.",Sequence 8 from patent US 10822379,NaN,2022-03-14,NaN,NaN
1559,NaN,NaN,QQO74752,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsnyvmswvrqapgkglewvsgisgsggstyyadsmkgrftisrdnskntlylqmnslraedtavyycakdltrdyydssgyqtgafdiwgqgtmvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1560,NaN,NaN,QQO74751,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfsnyvmswvrqapgkglewvsgiggsgdstyyadsvkgrftisrdnskntlylqinslraedtavyycakgaapyyyyyygmdvwgqgttvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1561,NaN,NaN,QQO74750,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvrsnymswvrqapgkglewvsliysggstyyadsvkgrfiisrdnskntlylqmnslraedtavyycardlavygmdvwgqgttvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1562,NaN,NaN,QQO74749,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgwvtmtrdtsistaymelsrlrsddtavyycargwatyydiltgyslfdywgqgtlvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1563,NaN,NaN,QQO74748,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamnwvrqapgkglewvsvisgsggrtyyadsvkgrftisrdnskntlylqmnslraedtavyycakdldivvvitgdafdiwgqgtmvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1564,NaN,NaN,QQO74747,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftnyfihwvrqapgqglewmgminpsvgsttyaqnfqgrvtmtrdtststvymelsslrsedtaiyycarthvaqlweiwyfdiwgrgtlvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1565,NaN,NaN,QQO74746,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctlsggairsgsyywgwirqtpgkglewigsifhignafynpslksrvtisadkaknqislnvrsvtaadtavyycvrpnnehggfffdywgqgilvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1566,NaN,NaN,QQO74745,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlfcaasgftfssfamswvrqapgkglewvstisgsggrtyyadsvkgrftifrdnskntlylqmnslraedtalyycakdmdivvvitgdafdiwgqgtmvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1567,NaN,NaN,QQO74744,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgpevkkpgasvkvsckasgytftsysinwvrqapgqglewmgwistyngntnyaqrlqgrvtmttdtstgtahmelrslrsddtaiyycareeplycsggscyefqhwgqgtlvtvss,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1568,NaN,NaN,QNT09656,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqseaevkepgasvevsckasgynftnfaiswvrqapgqglewmgwisgyngdtnsaqkflgrvtmttdtstttaymelrslrsddtavyycagsdnygfpyngmdvwgqgttvtvss,NaN,"Kreye,J. et al.; A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model; Cell (2020) In press; 2020.","anti SARS-CoV-2 immunoglobulin heavy chain, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1569,NaN,NaN,QNS17514,NaN,SARS-CoV-2,Lama glama (llama),dvqlqesgggsveaggslrlscaasgvtldyyaigwfrqapgkeregvscisssdgstyyadsvkgrfttsrdnakntvylqmnslkpedtadyycaavpstyysgtyyynchpgamhywgkgtqvtvss,NaN,"Esparza,T.J. et al.; Direct Submission; Submitted (08-SEP-2020) National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10 5C100, Bethesda, MD 20892, USA; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Lama glama]",NaN,2022-03-14,NaN,NaN
1570,VHAB8,NaN,QNN25877,NaN,SARS-CoV-2,synthetic construct,evqlvesggglvqpggslrlscaasgftfddyamswvrqapgkglewigrmynngrtsynpslkslvtisrdnskntlylqmnslraedtatyycardnlgyrpsenlygmdvwgqgttvtvss,NaN,"Li,W. et al.; High potency of a bivalent human VH domain in SARS-CoV-2 animal models; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region VHab8, partial [synthetic construct]",NaN,2022-03-14,NaN,NaN
1571,RBD-SPECIFIC,NaN,QLR06781,NaN,"SARS-CoV-2, Spike protein RBD",Vicugna pacos (alpaca),qvqlvetggglvqpggslrlscaasgftfssvymnwvrqapgkgpewvsrispnsgnigytdsvkgrftisrdnakntlylqmnnlkpedtalyycaiglnlssssvrgqgtqvtvss,NaN,"Hanke,L. et al.; An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction; Nat Commun 11 (1) (2020) In press; 2020.","SARS-CoV-2 RBD-specific neutralizing immunoglobulin heavy chain, partial [Vicugna pacos]",NaN,2022-03-14,NaN,NaN
1572,NaN,NaN,QMI58173,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgltfssyvmhwvrqapgkgldwvgviwydgskkyyadsvkgrftisrdnskntlylqmnslraedtavyycardprdyydfwsgydyyygldvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1573,NaN,NaN,QMI58172,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkhyadsvkgrftisrdnskntlylqmnslraedtavyycakdsgynygyswfdpwgqgtlvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1574,NaN,NaN,QMI58171,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssytmhwvrqapgkglewvaaisydgnnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsilygggmdvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1575,NaN,NaN,QMI58170,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyyctragwelrldafdiwgqgtmvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1576,NaN,NaN,QMI58169,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evhlvesggglvqpggslrlscaasgftfsdhymdwvrqapgkglewvgrtrnkansytteyaasvkgrftisrddaknslylqmnslktedtavyycarvhrwaycingvcfgaysdywgqgtlvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1577,NaN,NaN,QMI58168,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardlfyygmdvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1578,NaN,NaN,QMI58167,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywdddkryspslksrltitkdtsknqvvltmtnmdpvdtatyycahhkierifdywgqgtlvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1579,NaN,NaN,QMI58166,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvsssnyywswirqppgkglewigymyysgstkynpslksrvtisvdtsknqfslklssvtaadtavyycarevyyydrsgyyasdgfdiwgqgtmvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1580,NaN,NaN,QMI58165,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsisnyywswirqspgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarsakhwlappgdyyyymdvwgkgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1581,NaN,NaN,QMI58164,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytlielsmhwvrqapgkglewmggfdpedvetiyaqqfqgrvtmtedtstdtaymelsslrsedtavyycatgwaykstwyfgywgqgtlvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1582,NaN,NaN,QMI58163,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytlielsmhwvrqapgkglewmggfdpedaetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatgiavigpppstyyyygmdvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1583,NaN,NaN,QMI58162,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytlielsmhwvrqapgkglewmggfdpedaetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatgwavagssdvwyyyygmdvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1584,NaN,NaN,QMI58161,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqllqsgaevkkpgasvkvsckasgysftsyymhwvrqapgqglewmgiinpsgggttyaqkfqgrvtmtrdtststvymelsslrsedtavyycarpgggsyqefdywgqgtlvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1585,NaN,NaN,QMI58160,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgvinpsggstsyaekfrgrvtmtrdtststvymelsslrsedtavyycardrephsdssgywdslkyyyyyaldvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1586,NaN,NaN,QMI58159,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnytqmfqgrvtmtrdtsistaymevsrlrsddtavyycardrswavvyyymdvwgkgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1587,NaN,NaN,QMI58158,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckasgytftgyymhwvrqapgqglewmgwinpisdgtnyaqkfqgwvtmtrdtsistvymelsrlrsddtavyycarggsrcsggncygwaydafdiwgqgtmitvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1588,NaN,NaN,QMI58157,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsittaymelrrlrsddtavyycarglgvgcsggncyldyyymdvwgkgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1589,NaN,NaN,QMI58156,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggnipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycargvgyrgviplnwfdpwgqgtvvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1590,NaN,NaN,QMI58155,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkagssvkvsckasggtfsshtitwvrqapgqglewmgriipilgianyaqkfqgrvtitadkststaymelsslrsedtavyycaslqtvdtaiekyygmdvwgqgttvtvss,NaN,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1591,NaN,NaN,NaN,QMI58192,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssdlawyqhkpgqaprlliygastratgipvrfsgsgsgteftltisslqsedfavyycqqynnwppftfgggtkveik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1592,NaN,NaN,NaN,QMI58191,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapkllisaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsyntlqvtfgggtkveik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1593,NaN,NaN,NaN,QMI58190,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsadalakqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqstdnsgtypnwvfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1594,NaN,NaN,NaN,QMI58189,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrssyaswyqqkpgqapilviydknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgilfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1595,NaN,NaN,NaN,QMI58188,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqkpgqspvlviyqdnkrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstavfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1596,NaN,NaN,NaN,QMI58187,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspstfgqgtkleik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1597,NaN,NaN,NaN,QMI58186,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgilslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssgaltfgggtkveik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1598,NaN,NaN,NaN,QMI58185,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspqtfgqgtkveik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1599,NaN,NaN,NaN,QMI58184,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,aiqltqspsslsasvgdrvtitcrasqgissylawyqqkpgqapklliyaastlqsgvpsrfsgsgsgtdftltisslqpedfatyycqqlnsypltfgggtkveik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1600,NaN,NaN,NaN,QMI58183,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsypcfgpgtkvdik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1601,NaN,NaN,NaN,QMI58182,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsyltfgggtkveik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1602,NaN,NaN,NaN,QMI58181,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,aiqltqspsslsasvgdrvtitcrasqgissylawyqqkpgkapelliyaastlqsgvpsrfsgsgsgtdftltisslqpedfatyycqqlntypftfgpgtkvdik,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1603,NaN,NaN,NaN,QMI58180,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsasgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiyevskrpsgvpdrfsgsksgntasltvsglqaedeadyycssyagsrmgfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1604,NaN,NaN,NaN,QMI58179,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsasgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiyevskrpsgvpdrfsgsksgntasltvsglqaedeadyycssyagsnnlvfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1605,NaN,NaN,NaN,QMI58178,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsalaqpasvsgspgqsitisctgtssdvgaynyvswyqqhpgkapklmiydvskrpsgvsnrfsgsksgntasltisglqaedeadyycssyttsstvfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1606,NaN,NaN,NaN,QMI58177,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvskrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstyvfgtgtkvtvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1607,NaN,NaN,NaN,QMI58176,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsvsgspgqsvtisctgtssdvgsynrvswyqqppgtapklmiyevsnrpsgvpdrfsgsksgntasltisglqaedeadyycssytssstyvfgtgtkvtvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1608,NaN,NaN,NaN,QMI58175,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynfvswyqqhpgkapklmiydvskrpsgvsnrfsgsksgntasltisglqaedeadcycssytssstfvfgtgtkvtvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1609,NaN,NaN,NaN,QMI58174,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvskrpsgvsnrfsgsksgntasltisglqaedegdyycssytssstwvfgggtkltvl,"Liu,L. et al.; Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike; Nature (2020) In press; 2020.",NaN,"immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1610,NaN,NaN,QLI62517,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsssaiswvrqapgqglewmggiipilditnyaqkfqgrvtitadkststafmelsslrsedtavyycalrnqwdllvywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1611,NaN,NaN,QLI62516,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsiafagsvkgrftisrdnaknslylqmnslraedtalyycakdqgysygnyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1612,NaN,NaN,QLI62515,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvscmasgytftsyymhwvrqapgqglewmgiispsgggtsyaqkfqgrvtltrdtststvymelsslrsedtavyycarwydstgsidywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1613,NaN,NaN,QLI62514,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsiyaitwvrqapgqglewmggiipiigtanyaqkfqgrvtitadkststaymelsslrsedtavyycardfrycsstrcyfwfdpwgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1614,NaN,NaN,QLI62513,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytfatyalnwvrqapgqglewmgwvntntgsptyaqgftgrfvfsfdtsvstaylqirtlkaedtavyycavyyydsgspgwfdpwgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1615,NaN,NaN,QLI62512,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfsnyamtwvrqapgkglewvsaissgsgstyyadsvkgrftisrdnskntvylqmnslraedtaiyycakankysssefdfwgqgtlvtiss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1616,NaN,NaN,QLI62511,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfigyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistvymelsrlrsddtavyycarempaamgyyyygmdvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1617,NaN,NaN,QLI62510,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtvsadksistaylqwsslkasdtamyycarvnyydssgypsfhfdywgqgtlvtvs,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1618,NaN,NaN,QLI62509,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsgdstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdryyefwsgysnwfdpwgqgtlvtiss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1619,NaN,NaN,QLI62508,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscsasgftfsiygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdrtgnyyygmdvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1620,NaN,NaN,QLI62507,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarqgdcsttscaydywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1621,NaN,NaN,QLI62506,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsihwvrqapgkglewmggfdpedaetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatgfaqnmvlltpywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1622,NaN,NaN,QLI62505,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymdlsslrsedtavyycatafsifgvvppdywgqgtlvtvs,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1623,NaN,NaN,QLI62504,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmsslrgedtavyycakdqayydiltgylnppknyyyygmdvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1624,NaN,NaN,QLI62503,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakgsgsgsypnyyyyygmdvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1625,NaN,NaN,QLI62502,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarlhcggdcyldywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1626,NaN,NaN,QLI62501,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfrnygmhwvrqapgkglegvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakssgsyyyyyygmdvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1627,NaN,NaN,QLI62500,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaliwydgsnknyadsvkgrftisrdnskntldlqmnslraedtavyycardpfpgavagtgylqywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1628,NaN,NaN,QLI62499,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfstyemnwvrqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmsslraedtaiyycardrrrryctngvcyrpeeidywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1629,NaN,NaN,QLI62498,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfnyysmnwvrqapgkglewissistsssfvyyadsvkgrftisrdnaktslylqmnslraedtavyfcarggycsdgscyvqdrliyyysgldvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1630,NaN,NaN,QLI62497,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardpygyssiwdgqgghwgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1631,NaN,NaN,QLI62496,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiysgyymhwvrqapgqglewmgwispdsggtnyaqrfqgrvtmtrdtstttaymelsrlrsddtavyycargprysgtyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1632,NaN,NaN,QLI62495,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyifsgyythwvrqapgqglewmgwispdsggtnyaqkfqgrvtmtrdtsittayvelsglrsddtavyycargprysgtyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1633,NaN,NaN,QLI62494,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiysgyfmhwvrqapgqglewmgwispdsgganyaqtfqgrvtmtrdtstttahmelsrlrsddtavyycargprysgthfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1634,NaN,NaN,QLI62493,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgyifsgyymhwvrqapgqglewmgwispdsggtnyaqnfqgrvtmtrdtsistgymelsrlrsddtamyycargprysgtyfdywgqgvlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1635,NaN,NaN,QLI62492,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyifsgyythwvrqapgqglewmgwispdsggtnyaqkfqgrvtmtrdtsittayvelsglrsddtavyycargprysgtyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1636,NaN,NaN,QLI62491,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvtcktsgyifsgyymhwvrqvpgqglewmgwispdsgatnyaqkfqgrvtmtrdtsittsyveltwlksddtavyycargprysgtyfdfwgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1637,NaN,NaN,QLI62490,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyifsgyymhwvrqapgqglewmgwispdsggtnyaqkfqgrvtmtrdtsittgymelsglrsddtavyycargprysgtyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1638,NaN,NaN,QLI62489,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgyiysgyymhwvrqapgqglewmgwispdsggtnyaqrfqgrvtmtrdtstttaymelsrlrsddtamyycargprysgtyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1639,NaN,NaN,QLI62488,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwispnsggtnyaqkfqgwvtmtrdtsvstaymelsrlrfddtavyycateswvygsgsyssgafdiwgqgtmvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1640,NaN,NaN,QLI62487,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskstlylqmnslrvedtavyycardfgdfyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1641,NaN,NaN,QLI62486,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsvfysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardygdlyfdywgqgtlvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1642,NaN,NaN,QLI62485,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgltvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardldvygldvwgqgttvtvss,NaN,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1643,NaN,NaN,NaN,QLI62550,SARS-CoV-2,Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhygsslwtfgqgtkleik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1644,NaN,NaN,NaN,QLI62549,SARS-CoV-2,Homo sapiens (human),NaN,qlvltqppsvsvapgktaritcggnnigsksvywyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhpyvfgsgtkvtvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1645,NaN,NaN,NaN,QLI62548,SARS-CoV-2,Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqgirndlgwyqqkpgkapkrliyaasslqsgvpsrfsgsgsgteftltisslqpedfatyyclqhnsypiltfgggtkleik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1646,NaN,NaN,NaN,QLI62547,SARS-CoV-2,Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqnissylnwyqqeagkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystprtfgqgtkvdik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1647,NaN,NaN,NaN,QLI62546,SARS-CoV-2,Homo sapiens (human),NaN,diqltqspsslsasvgdrvtitcrasqtassylnwyqqkpgkapnlliyaasslqsgvpsrfsgsgsvtdftltisslqpedfatyycqqsystpptfgqgtkvdik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1648,NaN,NaN,NaN,QLI62545,SARS-CoV-2,Homo sapiens (human),NaN,qsaltqppsasgtpgqrvtiscsgsssnigsnyvywyqqlpgaapklliyrndqrpsgvpdrfsgsksgtsvslaisglrsedeadyycaawddslsgwvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1649,NaN,NaN,NaN,QLI62544,SARS-CoV-2,Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyycysyagsstfvfvfgtgtkvivl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1650,NaN,NaN,NaN,QLI62543,SARS-CoV-2,Homo sapiens (human),NaN,qtvvtqepsltvspggtvtltcvsstgavtsgyypnwfqqkpgqapraliystskkhswtparfsgsllggkaaltlsgvqpedeaeyycllyyggaqrwvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1651,NaN,NaN,NaN,QLI62542,SARS-CoV-2,Homo sapiens (human),NaN,qsaltqppsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapkvlvysndqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslngpvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1652,NaN,NaN,NaN,QLI62541,SARS-CoV-2,Homo sapiens (human),NaN,diqltqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasnlqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpwtfgqgtkveik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1653,NaN,NaN,NaN,QLI62540,SARS-CoV-2,Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttatltisgvqaedeadyycqsadssgtylvvfgggtklavl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1654,NaN,NaN,NaN,QLI62539,SARS-CoV-2,Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwppitfgqgtrleik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1655,NaN,NaN,NaN,QLI62538,SARS-CoV-2,Homo sapiens (human),NaN,qavvtqppsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslngpvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1656,NaN,NaN,NaN,QLI62537,SARS-CoV-2,Homo sapiens (human),NaN,qsvltqppsasstpgqrvtiscsgsssnigsnyvywyqqlpgtapklliytnnqrpsgvpdrfsgsksgtsaslaisglrsedeadyycaawddslsgrvvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1657,NaN,NaN,NaN,QLI62536,SARS-CoV-2,Homo sapiens (human),NaN,syeltqspsvsvapgqtaritcggnnigsksvhwyqrkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdnnsdhlvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1658,NaN,NaN,NaN,QLI62535,SARS-CoV-2,Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctrssgsiannyvkwyqqrpgsspttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydssnheeiwvfgggtklivl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1659,NaN,NaN,NaN,QLI62534,SARS-CoV-2,Homo sapiens (human),NaN,syeltqppsvsvapgktaritcggnnigsksvhwyqqkpgqapvlvvyddtdrpsgiperfsgsssgntatltisrveagdeadyycqvwdsssdhpvvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1660,NaN,NaN,NaN,QLI62533,SARS-CoV-2,Homo sapiens (human),NaN,syeltqppsvsvapgqtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdpwvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1661,NaN,NaN,NaN,QLI62532,SARS-CoV-2,Homo sapiens (human),NaN,qavltqppsvsgapgqrvtisctgsssnieagydvhwyqqlpgtapklliyvnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgvvfgggtklivl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1662,NaN,NaN,NaN,QLI62531,SARS-CoV-2,Homo sapiens (human),NaN,dvvmtqsplslpvtlgqpasiscrssqslvysdgntylnwfqqrpgqsprrliykvsnrdsgvpdrfsgsgsgtdftlkisrveaedvgvfycmqgthwpptfgqgtkvdik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1663,NaN,NaN,NaN,QLI62530,SARS-CoV-2,Homo sapiens (human),NaN,dvvmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnfatgvpsrfsgtgsgtdftftisslqpediatyycqqydnlpitfgqgtrleik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1664,NaN,NaN,NaN,QLI62529,SARS-CoV-2,Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpdkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsgstqvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1665,NaN,NaN,NaN,QLI62528,SARS-CoV-2,Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkvpklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsssaqlfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1666,NaN,NaN,NaN,QLI62527,SARS-CoV-2,Homo sapiens (human),NaN,qsaltqpasvsgspgqsltisctgtssdvggynyvswyqqhpdkapklmiydvnnrpsgvsnrfsgsksgstasltisglqaedeadyycssyagsstqvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1667,NaN,NaN,NaN,QLI62526,SARS-CoV-2,Homo sapiens (human),NaN,qsvltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkvpklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsssaqvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1668,NaN,NaN,NaN,QLI62525,SARS-CoV-2,Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynhvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsssaqlfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1669,NaN,NaN,NaN,QLI62524,SARS-CoV-2,Homo sapiens (human),NaN,qpvltqpasvsgspgqsltisctgtssdiggfnyvswyqqhpgkapklmifdvskrpsgvpnrfsgsksgntasltisglqaedegdyycssytissaqvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1670,NaN,NaN,NaN,QLI62523,SARS-CoV-2,Homo sapiens (human),NaN,qsaltqptsvsgspgqsitisctgtssdvggynyvswyqqhpgkapkliiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytvsstqvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1671,NaN,NaN,NaN,QLI62522,SARS-CoV-2,Homo sapiens (human),NaN,qtvvtqpasvsgspgqsitisctgtssdvggynyvswyqqhpdkapkliiydvsnrpsgvsnrfsgsksgntasltisglqaedeaayycssytssstqvfgggtkltvl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1672,NaN,NaN,NaN,QLI62521,SARS-CoV-2,Homo sapiens (human),NaN,qsvltqppsasgspgqsvtisctgtssdvggydyvswyqqhpgkapklmiyevskrpsgvpdrfsgsksgntasltvpglqaedeadyyctsyagsnnfvfgggtklivl,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1673,NaN,NaN,NaN,QLI62520,SARS-CoV-2,Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssprtfgqgtkleik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1674,NaN,NaN,NaN,QLI62519,SARS-CoV-2,Homo sapiens (human),NaN,eivmtqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygvssratgipdrfsgsgsetdftltisrlepeefavyycqqygssprtfgqgtkleik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1675,NaN,NaN,NaN,QLI62518,SARS-CoV-2,Homo sapiens (human),NaN,divmtqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsyppkftfgpgtkveik,"Rogers,T.F. et al.; Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model; Science (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1676,NaN,NaN,QLI33947,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfmssavqwvrqargqrlewigwivigsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycssiscndgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; Nat. Med. (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1677,NaN,NaN,QLI33945,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpgggsttyaqkfqgrvtmtsdtststvymelsslrsedtamyycargaippnsraeidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; Nat. Med. (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1678,NaN,NaN,NaN,QLI33948,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhygssrgwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; Nat. Med. (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1679,NaN,NaN,NaN,QLI33946,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgervtlscrasqsvssnlawcqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqyynwpltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; Nat. Med. (2020) In press; 2020.",NaN,"anti-SARS-CoV-2 immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
1680,NaN,NaN,QKY76702,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntdyaqkfqervtitrdvststaymelsslrsedtavyycaaprcsggscydgfdiwgqgtmvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1681,NaN,NaN,QKY76701,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvkisckasgyifinyamnwvrqapgqglewmgwintntgnptyaqdftgrfvfsldtslstaylqissleaedtavyycakigsrnslgvwgqgtlvtvsa,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1682,NaN,NaN,QKY76700,NaN,SARS-CoV-2,Homo sapiens (human),qlqvqesgpglvkpsetlsltctvsgasissnhyfwgwirqppgkglawigsmhysgstyynpslksrvtisvdtsknqlslklssvtaadtavyycargvnyydrngyyrndgfdirgqgtmvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1683,NaN,NaN,QKY76699,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgghlvqpgrslrlscaasgftfddyamhwvrqvpgkglewvsgiswnggilgyadsvkgrftisrdnaknslylqmrslrtddtalyycakdlrrqdyyadwyfdlwgrgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1684,NaN,NaN,QKY76698,NaN,SARS-CoV-2,Homo sapiens (human),qlqvqesgpglvkpsetlsltctvsgasissnhyfwgwirqppgkglawigsmhysgstyynpslksrvtisvdtsknqlslklssvtaadtavyycargvnyydrngyyrndgfdirgqgtmvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1685,NaN,NaN,QKY76697,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgghlvqpgrslrlscaasgftfddyamhwvrqvpgkglewvsgiswnggildyadsvkgrftisrdnaknslylhmrslrtddtalyycakdlrrqdyyadwyfdlwgrgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1686,NaN,NaN,QKY76696,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssntryytdsvmgrftisrdnaknslflqmnslraedtavyycasskgfcsggscsdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1687,NaN,NaN,QKY76695,NaN,SARS-CoV-2,Homo sapiens (human),qlqvqesgpglvkpsetlsltctvsgasissnhyfwgwirqppgkglawigsmhysgstyynpslksrvtisvdtsknqlslklssvtaadtavyycargvnyydrngyyrndgfdirgqgtmvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1688,NaN,NaN,QKY76694,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfsrytiiwvrqapgqglewmgriipildianyaqkfqgrvtitadkststaymelsslrsedtavyycareggldyfgsrnsgwtytwfdpwgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1689,NaN,NaN,QKY76693,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycatgarfgespfdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1690,NaN,NaN,QKY76692,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgrglewvsviysggstfyadsvkgrftisrdnskntlylqmnslrpedtavyycatgarfgespfdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1691,NaN,NaN,QKY76691,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgftfrnyamtwvrqapgkglewvsgisdsgdrtynadsvkgrfsisrdnskntlhlqmnslraedtavyycalasgsyfgganywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1692,NaN,NaN,QKY76690,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtglyycakdinydsggyhknyfdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1693,NaN,NaN,QKY76689,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfsssavqwvrqargqrlewigwivvgsgntnyaqkfqgrvtitrdmstrtaymelsslrsedtamyycaapycsstrcydafdiwgqgtmvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1694,NaN,NaN,QKY76688,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgfivssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardygdyffdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1695,NaN,NaN,QKY76687,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardfgdfffdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1696,NaN,NaN,QKY76686,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaatgftfrrygmhwvrqapgkglewvagilfdgsnkyyvdsvkgrftisrdssrntlylqlnslrredtavyycakggdyewelleswgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1697,NaN,NaN,QKY76685,NaN,SARS-CoV-2,Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcssticydgfdiwgqgtmvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1698,NaN,NaN,QKY76684,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgrnkyyvdsvkgrftisrdnskntlylqisslraedtavyycaraarrpvvtdtmayymdvwgkgttvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1699,NaN,NaN,QKY76683,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytflrfamnwlrqapgqglewmgwidtntgtptyaqgftgrfvfsldtsvstaylqisslkaedtavyycarslrganlvpwgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1700,NaN,NaN,QKY76682,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytflrfamnwlrqapgqglewmgwidtntgtptyaqgftgrfvfsldtsvstaylqisslkaedtavyycarslrganlvpwgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1701,NaN,NaN,QKY76681,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtmtrntsistaymelsslrsedtavyycarattdcsstscwsldfwsgyytggrekifdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1702,NaN,NaN,QKY76680,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgyiftnyyihwvrqapgqglewvgwihslsggtsyaqkfqgrvtltrdapirtaymelsglgsddtavyycarasvatitdfdywgqgtlvavss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1703,NaN,NaN,QKY76679,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevknpgasvkvsckasgyiftnyyihwvrqapgqglewvgwihslsggtsyaqkfqgrvtltrdasirtaymelsrlgsddtalyycarasvstitdfdywgqgtlvavss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1704,NaN,NaN,QKY76678,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlsctasgftfgdyamswfrqapgkglewvgfirskayggtteyaasvkgrftisrddsksivylqmnslktedtavyyctrvrrlwfgsyyygmdvwgqgttvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1705,NaN,NaN,QKY76677,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlsctasgftfgdyamswfrqapgkglewvgfirskayggtteyaasvkgrftisrddsksiaylqmnslktedtavyyctrvrrlwfgsyyygmdvwgqgttvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1706,NaN,NaN,QKY76676,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardgellgwfdpwgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1707,NaN,NaN,QKY76675,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadkststaymelsslrsedtavyycarvsgydssgywgdywgqgtlvtvss,NaN,"Kreer,C. et al.; Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients; Cell (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1708,NaN,NaN,QKY76674,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvagisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaradtmvrgtyfeywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1709,NaN,NaN,QKY76673,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscvasgftfsfywmswvrqapgkglewvanikqdggekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarlsgsswdfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1710,NaN,NaN,QKY76672,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgaanyaqnfqgrvtitadeststgymqlsslrfedtavyycartshydssgsyfeywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1711,NaN,NaN,QKY76671,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgaanyaqnfqgrvtitadeststgymqlsslrfedtavyycartshydssgsyfeywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1712,NaN,NaN,QKY76670,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyalfwvrqapgkglewvavisydgnnkyyadsvrgrftisrdnskntlylqmnslrpedtavyycarpytgsyksymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1713,NaN,NaN,QKY76669,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiiwvrqapgqglewmggiipifgttnyaqkfqgrvtitadeststayvelsslrsedtavyycarighfdssgyyldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1714,NaN,NaN,QKY76668,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtamyycakdgsiaaadywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1715,NaN,NaN,QKY76667,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiiwvrqapgqglewmggiipifgttnyaqkfqgrvtitadeststayvelsslrsedtavyycarighfdssgyyldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1716,NaN,NaN,QKY76666,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarstsgsyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1717,NaN,NaN,QKY76665,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfstywmtwvrqapgkglewvanikqdgsekyyvdsvkyrftisrdnaknslylqmnslraedtavyycarvgssswyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1718,NaN,NaN,QKY76664,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarstsgsyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1719,NaN,NaN,QKY76663,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgskkdyadsvkgrftisrdnskntlylqmnslraedtavyycardqsqgayiltgyrgygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1720,NaN,NaN,QKY76662,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydmnwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtmtrntsistaymelsslrsedtavyycarggiyylvrgfiigyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1721,NaN,NaN,QKY76661,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscvasgftfsfywmswvrqapgkglewvanikqdggekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarlsgsswdfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1722,NaN,NaN,QKY76660,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvagisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaradtmvrgtyfeywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1723,NaN,NaN,QKY76659,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgskkdyadsvkgrftisrdnskntlylqmnslraedtavyycardqsqgayiltgyrgygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1724,NaN,NaN,QKY76658,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsdnigyadsvkgrftisrdiaknslylqmnslraedtalyycakgiyydifmplldwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1725,NaN,NaN,QKY76657,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsyypmhwlwvrqapgkglewvavtsydgtnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarggatnfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1726,NaN,NaN,QKY76656,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycaityyydssgywwddwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1727,NaN,NaN,QKY76655,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqvvqsgaevkkpgasvkvsckasgytfknygiswvrqapgqglewmgwisaytgntnyaqkfqgrmtmttdtstgtgymelrslrsddtavyycarvqrrrldywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1728,NaN,NaN,QKY76654,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgaanyaqnfqgrvtitadeststgymqlsslrfedtavyycartshydssgsyfeywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1729,NaN,NaN,QKY76653,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftfnnyamswvrqapgkglewvsaiggsggstyyadsvkgrftvsrdnsentlylqmsslraedtavyycarvegdwllggpyyhyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1730,NaN,NaN,QKY76652,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscatsgftfssfalhwvrqapgkglewvtvisddgnnkyyvdsvkgrftisrdnskntlflqmnslrvedtaiyycarasynsnwsigeyfrdwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1731,NaN,NaN,QKY76651,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvtvisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaksyngnyydafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1732,NaN,NaN,QKY76650,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgsyywswirqpagkglewigrvyiyssgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargaasfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1733,NaN,NaN,QKY76649,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsgdsissgsyywswirqpagkglewigriytsgsttynpslksrvtisvntsknqfslnlssvtaadtavyycarvggispyyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1734,NaN,NaN,QKY76648,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfssydinwvrqatgqglewmgwvnpnsghtgyaqkfqgrvtmtrntsvstaymelsslrsedtavfycargrvgyvgsgsrgyyyyydmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1735,NaN,NaN,QKY76647,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcvvsggsisssnwgwvrqppgkglewigeiylsgttnynpsltsrvtisvdksknqfslklnsvtaadtaiyycarptagaggafdiwgqgtvvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1736,NaN,NaN,QKY76646,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfgsyviswvrqapgqglqwmggiipifgkpnyaqkfqgrvtitadeststaymelsslrsedtavyycargwfgellkgtywfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1737,NaN,NaN,QKY76645,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgssyyspslksrvtisadtsknqfslnlrsvtaadtavyycasgppymatfsyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1738,NaN,NaN,QKY76644,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitfkesgptlvkptetltltctfsgfsvstsgegvgwirqppgkalewlaviywdddkryspslksrltitrdtsknqvvltmtnmdpvdtatyycahrlwfrdafdiwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1739,NaN,NaN,QKY76643,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggdlvqpggslrltcaasgftfsshwmtwvrqapgkglewvanikedgrekyyvdsvkgrltisrdnaknslylqmnslraedtavyycarvvvevatnkgihgvdyyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1740,NaN,NaN,QKY76642,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgynkyyadsvkgrftisrdnskntlylqmnslraedtavyycaraqggnyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1741,NaN,NaN,QKY76641,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiiwvrqapgqglewmggiipifgttnyaqkfqgrvtitadeststayvelsslrsedtavyycarighfdssgyyldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1742,NaN,NaN,QKY76640,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscadsaftfssfwmswvrqapgkglewvanikqdgsekfyldsvkgrftisrdnaknslylqmnslraedtavyycarlgrsswnfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1743,NaN,NaN,QKY76639,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfifstyamhwvrqapgkglewvavisydgdnkyyadsvkgrftisrdnskntlylemnslraedtavyycarprggsyqtcfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1744,NaN,NaN,QKY76638,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvtlisydggnkyyadsvkgrftisrdnskntlylqmnslraedaavyfcarghtgnyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1745,NaN,NaN,QKY76637,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqleesgpglvkpsetlsltctvsggsisshywswirqppgkglewigyiqdsgstnynpslksrvtisvdtsknqfslrlssvttadtavyycvrgamawfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1746,NaN,NaN,QKY76636,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgfsfrnygmhwvrqapgkglewvavisgdennkfyansvkgrftisrdnskntlslqmnslrpedtaryycakggdssgwawdgdnpptdywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1747,NaN,NaN,QKY76635,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgsyywswirqpagkglewigriftsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarggllwfggagnymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1748,NaN,NaN,QKY76634,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtamyycakdgsiaaadywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1749,NaN,NaN,QKY76633,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgfivssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarestqwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1750,NaN,NaN,QKY76632,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydginkyyadavkgrftisrdnskntlylqmnslraedtavyycarprsgsyyayfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1751,NaN,NaN,QKY76631,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssfamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtaayycarelmsvgwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1752,NaN,NaN,QKY76630,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygmhwvrqapgqrlewmgwinvgngntkysqrfqgrvtitrdtsastaymelsslrsedtavyycamgpsafswldpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1753,NaN,NaN,QKY76629,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmtwvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslslqmnslrvedtavyycvrlgvsswyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1754,NaN,NaN,QKY76628,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisndefnkfyansvkgrftisrdnskntvylqlnslrtedtaryycakggdgsgwawdgdnpptdywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1755,NaN,NaN,QKY76627,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltcavsgasissgsyywswirqpagkglewigriytsgntnynpslksrvtisvdtsknqfslklssvtaadtavyycatgyigtyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1756,NaN,NaN,QKY76626,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcvvsggsisssnwgwvrqppgkglewigeiyhsgttnynpslrsrvtisvdksknqlslklnsvtaadtaiyycarptagaggafdtwgqgtmvtvsa,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1757,NaN,NaN,QKY76625,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitfkesgptlvkptetltltctfsgfsvstsgegvgwirqppgkalewlaviywdddkryspslksrltitrdtsknqvvltmtnmdpvdtatyycahrlwfrdafdiwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1758,NaN,NaN,QKY76624,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscvasgftfsfywmswvrqapgkglewvanikqdggekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarlsgsswdfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1759,NaN,NaN,QKY76623,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevrkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipvfgtanyaqkfqgrvtitadkststafmelnslrsedtavyycarigsypeyfqhwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1760,NaN,NaN,QKY76622,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgfilsdhymdwvrqapgkglewvgrtrnkansytteyaasvkgrftisrddsknslylqmnslktedtavyycasvitfggvivrsywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1761,NaN,NaN,QKY76621,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnpkntlylqmnslraedtavyycardtatyvllwsgdfnldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1762,NaN,NaN,QKY76620,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsrhamhwvrqapgkglewvavisydgsnkyyadsvkgrfaisrdnskntlylqmnslrpedtavyycardpsplvlitsidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1763,NaN,NaN,QKY76619,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsiywmswvrqapgkglqwvanikqdasekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarlggsswhfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1764,NaN,NaN,QKY76618,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsyyailwfrqapgkglewvaiisydgsnkyyadsvkgrftisrdnskntlylqmnslrpedtavyycarpqsggyyapldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1765,NaN,NaN,QKY76617,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqvvqsgaevkkpgasvkvsckasgytfknygiswvrqapgqglewmgwisaytgntnyaqkfqgrmtmttdtstgtgymelrslrsddtavyycarvqrrrldywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1766,NaN,NaN,QKY76616,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikedgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycardvggysgydlgfdyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1767,NaN,NaN,QKY76615,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvelvesgggvvqpgrslrlscaasgfifssyamhwvrqapgkglewvavisydggnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaraqggnyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1768,NaN,NaN,QKY76614,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglawvalisydgynkyyadsvrgrftisrinskntlslqmnslraedtavyycargsagnyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1769,NaN,NaN,QKY76613,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamywvrqapgkglewvavisydginkyyadsvkgrftisrdnskntlylqmnslraedtavyycarvnsgsyysyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1770,NaN,NaN,QKY76612,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgsalkkpgasvkvsckasgytftsyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvstaylqisslkaedtavyycargrsyglslgywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1771,NaN,NaN,QKY76611,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytfttyamnwvrqapgqglewmgwintntgnptyaqdftgrfvfsldtsvstaylqisslkaedtavyycarglvgridpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1772,NaN,NaN,QKY76610,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitfkesgptlvkptetltltctfsgfsvstsgegvgwirqppgkalewlaviywdddkryspslksrltitrdtsknqvvltmtnmdpvdtatyycahrlwfrdafdiwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1773,NaN,NaN,QKY76609,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigtiyysgstyynpslksrvtisvdtskkqfslklssvtaadtavyycageevrgvklyyyyamdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1774,NaN,NaN,QKY76608,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarstsgsyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1775,NaN,NaN,QKY76607,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipvfgttnyaqklqgrvtisadeststaymevsslrsedtavyycarvsgygdygaysdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1776,NaN,NaN,QKY76606,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisgdennkfyansvkgrftisrdnskntlslqmnslrpedtaryycakggdssgwawdgdnpptdywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1777,NaN,NaN,QKY76605,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmsslraedtavfycargdgdvynfllvrnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1778,NaN,NaN,QKY76604,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevrkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipvfgtanyaqkfqgrvtitadkststafmelnslrsedtavyycarigsypeyfqhwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1779,NaN,NaN,QKY76603,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsfisgtgdstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdqarvqdyiwgsyrsygmdvwglgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1780,NaN,NaN,QKY76602,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsyypmhwlwvrqapgkglewvavtsydgtnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarggatnfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1781,NaN,NaN,QKY76601,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnyamhwvrqapgkgldwvavisydgsnryyaasvkgrftisrdnskntlylqmnslrtedtavyfcargdgyrsqfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1782,NaN,NaN,QKY76600,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfttygiswvrqapgqglewmgwisayngnsnygkkfqgrvtmtadtststaymelrslrsddtavyycardlpikvvvpaadynwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1783,NaN,NaN,QKY76599,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyalfwvrqapgkglewvavisydgnnkyyadsvrgrftisrdnskntlylqmnslrpedtavyycarpytgsyksymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1784,NaN,NaN,QKY76598,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),eaqlvesggglvqpgrslrlscaasgftfddsamhwvrqapgkglewvsgiswnsgnvgyadsvkgrftisrdnaknslylqmnslraedtalyyctkasrycssticywnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1785,NaN,NaN,QKY76597,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),eaqlvesggglvqpgrslrlscaasgftfddsamhwvrqapgkglewvsgiswnsgnvgyadsvkgrftisrdnaknslylqmnslraedtalyyctkasrycssticywnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1786,NaN,NaN,QKY76596,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytftsyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvntaylqisslkaedtavyycararllgycsstscytigwgafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1787,NaN,NaN,QKY76595,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglawvalisydgynkyyadsvrgrftisrinskntlslqmnslraedtavyycargsagnyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1788,NaN,NaN,QKY76594,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisgdennkfyansvkgrftisrdnskntlslqmnslrpedtaryycakggdssgwawdgdnpptdywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1789,NaN,NaN,QKY76593,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyfvdsvkgrftisrdnaknslylqmnslraedaavyycarlvttvttanglyyysyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1790,NaN,NaN,QKY76592,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgfivssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarestqwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1791,NaN,NaN,QKY76591,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfafsnyaihwvrqapgkglewvavisydgnnkdyadsvkgrftisrdnskntlylqmnslraedtavyycarvpvmvrgvyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1792,NaN,NaN,QKY76590,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdltivvipaapnfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1793,NaN,NaN,QKY76589,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlsctasgfifgdyamgwvrqapgkglewvgfirgkaydgtteyaasvkgrftisrddskyiahlqmnslktedtavyycirdydfwggyyyhplrafdiwgrgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1794,NaN,NaN,QKY76588,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavissdgsnkyyagsvkgrftisrdnskntlylqmnslraedtavyycakdmveplfshyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1795,NaN,NaN,QKY76587,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgtyywswirqpagkglewigrfytsgstnynpslksrvtisvdasknqfslklssvtaadtavyycararpdyyyyyamdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1796,NaN,NaN,QKY76586,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvqvsceasgytfttyymhwvrqapgqglewmgiinpsggsttyaqkfqgrvtmtrdtststvymdlsslrsedtavyycardrlgdgsylgggyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1797,NaN,NaN,QKY76585,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarpdyssgwfsywyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1798,NaN,NaN,QKY76584,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggavqpgrslrlscaasgftfstyamywvrqapgkglewvavisydgsnryyadsvkgrftisrdnskntlylqmnslrpedtavyycardrsgnyrdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1799,NaN,NaN,QKY76583,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsvyyigstyynpslksrvtmsvdtsknqfslklssvtaadtavyycarapfqlldkyyffyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1800,NaN,NaN,QKY76582,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftshwigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycasalrergvqlwsvwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1801,NaN,NaN,QKY76581,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydeinkyyadsvkgrftisrdnskttldlqmnslraedtavyycaragggsyrgpfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1802,NaN,NaN,QKY76580,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisydgtnkyyadsvkgrftisrdnskntlylqmnslraddtavyycakgrgnyltffdswgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1803,NaN,NaN,QKY76579,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsfyaihwvrqapgqglewaaaissdgtykyyadsvkgrftisrdnskntsylqmnslraedtavyycaralnkgfdpwgqgtlltvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1804,NaN,NaN,QKY76578,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgyywswirqppgkglewigeinhsgstnynpslksrvtisvdtsknhfslkmnsvtaadtavyycarcrqmgnfyyyymdvwgkgttvtvsp,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1805,NaN,NaN,QKY76577,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitfkesgptlvkptetltltctfsgfsvstsgegvgwirqppgkalewlaviywdddkryspslksrltitrdtsknqvvltmtnmdpvdtatyycahrlwfrdafdiwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1806,NaN,NaN,QKY76576,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggrlvlpggslrlscaasgftfsvyemnwvrqapgkglewlsyigtsgspiyyadsvkgrftvsrdnaknslylqmnslrvedtalyycardrgwnygldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1807,NaN,NaN,QKY76575,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywidwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadkststaylqwsslkasdtamyycarrgeaagiwyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1808,NaN,NaN,QKY76574,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarpdyssgwfsywyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1809,NaN,NaN,QKY76573,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftnswigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtaiyycathrcsggfcylaywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1810,NaN,NaN,QKY76572,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvsgnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnspraedtavyycardpsayydiltgysgdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1811,NaN,NaN,QKY76571,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysagstyyadsvkgrfsisrdkskntlylqmnslraedtavyycakeggsgslryyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1812,NaN,NaN,QKY76570,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftshwigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycasalrergvqlwsvwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1813,NaN,NaN,QKY76569,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgpplvepkqtltltctfsgfslttsgeavgwirqppgkalewlaliywdddkhyspslrnrltitrdtsknqvvltltnvdpadtgtyycahravilnfdhwgqgflvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1814,NaN,NaN,QKY76568,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrvscaasgftfsshgmhwvrqapgkglewvsviwydgsnkyyadsvkgrftisrdnskntlslqmnslraedtavyycaresadissrldywgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1815,NaN,NaN,QKY76567,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfifssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsppasyynpstgyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1816,NaN,NaN,QKY76566,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytftrhamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvstaylqisslkaedtavyycvreygsghplpiwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1817,NaN,NaN,QKY76565,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfsdywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarltfggsgsyyfyyngmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1818,NaN,NaN,QKY76564,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyviswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardqgptyyygsgsphygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1819,NaN,NaN,QKY76563,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnaknslylqmnslraedtavyycargsagnyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1820,NaN,NaN,QKY76562,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgrnkyyadsvkgrftisrdnskntlylqmsslraedtavyycakegewelrgnaldiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1821,NaN,NaN,QKY76561,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctvsgfslstsgvgvgcirqppgkalewlaliywdddkryspslksrltitrdtsknqvvltmtnmdpvdtgtyfcvhrhvsgafdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1822,NaN,NaN,QKY76560,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfifstygmhwvrqapgkglewvavisydgsnkynadsvkgrftisrdnskntlylqmnslrvedtavyycaiygyyyygldvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1823,NaN,NaN,QKY76559,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgyywswirqppgkglewigeinhsgstnynpslksrvtisvdtsknhfslkmnsvtaadtavyycarcrqmgnfyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1824,NaN,NaN,QKY76558,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qgqlvqsggdvvqpgkslrlscaasgftftnyamhwvrqapgkglewvavisndgsnekyvdsvkgrfslsrdnskntvyldmhslrpedtaiyycardrsnlerlvmtfggiiagafdiwgqgarvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1825,NaN,NaN,QKY76557,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitfkesgptlvkptetltltctfsgfsvstsgegvgwirqppgkalewlaviywdddkryspslksrltitrdtsknqvvltmtnmdpvdtatyycahrlwfrdafdiwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1826,NaN,NaN,QKY76556,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytfsdyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvstaylqisslkaedtavyycarglislfrgaifhyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1827,NaN,NaN,QKY76555,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgrikgktdggttdyaapvkgrftiskddskntlylqmsslntedtavywcttltyyydssaylndafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1828,NaN,NaN,QKY76554,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsisssnyywgwirqppgkglewigtihysgisyynpslksrvtisvdtsnnkfslelssvtaadtavyfcarrtyydlwsaysstayycmdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1829,NaN,NaN,QKY76553,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisndgrnkyyadsvkgrltisrdnskntlylqmnslraedtavyycarpsnwyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1830,NaN,NaN,QKY76552,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstkynpslksrvtisvdtsknqfslklssvtaadtavyycardggnayssgwyryyyhmdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1831,NaN,NaN,QKY76551,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfhnyaiswvrqapgqglewmggfipilgttnyaqkfqgrvtitadeststaymelsslrsedtavyycarvegegvdsyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1832,NaN,NaN,QKY76550,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqiqqwgagvlkpsetlsltcavyggsfsghywswirqppgkglewigeinhsgstkynpslksrvtisvdtsknqfslklssvtaadtavyycargppvttffvfsllfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1833,NaN,NaN,QKY76549,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgkslrlscaasgftfssygmhwvrqapgkglewvaviwydgnnkfyvdsvkgrftisrdnskntlymemnslraedtavyycarkgplwrfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1834,NaN,NaN,QKY76548,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapdkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaregqwpnqafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1835,NaN,NaN,QKY76547,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywidwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadkststaylqwsslkasdtamyycarrgeaagiwyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1836,NaN,NaN,QKY76546,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckaseytftsyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvstaylqisslkaedtavyycarpgkaaafdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1837,NaN,NaN,QKY76545,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaregqgtyldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1838,NaN,NaN,QKY76544,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavvsydgsnkyytdsvkgrftisrdnskntlflqmiglreedtavyycaqgrggyyspfddwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1839,NaN,NaN,QKY76543,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslntngvavgwirqppgkalewlaliywdddkryspslksrltitkdtsknqvvltmtnmdpvdtatyycahrrgiltedafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1840,NaN,NaN,QKY76542,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvaviwydgnkkycadsvkgrctisrdnskntlylqmnslraedtavyycaregpfgdreasgafdvwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1841,NaN,NaN,QKY76541,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvssnymswvrqapgkglewvsviysggstyyadsvkgrftisgdnskntlylqmnslrvddtavyycardpgsrysggwydyyyamdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1842,NaN,NaN,QKY76540,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssnywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycardprvvvtarmynwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1843,NaN,NaN,QKY76539,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwtwvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycasrwgdyfdssgaydswgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1844,NaN,NaN,QKY76538,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssylmhwvrqapgkglewvaviwangnryyadsvkgrftisrdiskntlylqmnslraedtamyycardycngvtcnsnywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1845,NaN,NaN,QKY76537,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsglcvswirqppgkalewlaridwdddkyyntslrtrltiskdtsknqvvltmtnmdpvdtatyycarattffygmdvwgqgttatvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1846,NaN,NaN,QKY76536,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvavisfdgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdgsgsyygwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1847,NaN,NaN,QKY76535,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlacaasgftfssygmhwvrqapgkglewvavisydgnnkyyadslkgrftisrddskntlylqmnslraedtavyycakdrtavflffglgdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1848,NaN,NaN,QKY76534,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwfdgsnkhyadsvkgrftisrdnskntlylqmnslraedtavyycaregdfwsgyytgwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1849,NaN,NaN,QKY76533,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvavisydggnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaknlgpycsggtcyslvgdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1850,NaN,NaN,QKY76532,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftnswigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtaiyycathrcsggfcylaywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1851,NaN,NaN,QKY76531,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfssytinwvrqapgqglewmgriipilgipnyaqkfqgrvtitadkststafmelsslrsedtavyycargrgysnygasyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1852,NaN,NaN,QKY76530,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycaradpyqllgqhyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1853,NaN,NaN,QKY76529,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtmtrntsistaymelsslrsedtalyycarearyfdwifegsdyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1854,NaN,NaN,QKY76528,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgftfddygmswvrqapgkglewvsainwnggstgyadsvkgrftisrdnaknslylqmnslraedtalyhcarrrsssryssgwymyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1855,NaN,NaN,QKY76527,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklnsvtaadtavyycasrwgdyfdssgaydswgqgtlltvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1856,NaN,NaN,QKY76526,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvadisydgsekyyadsvkgrftiyrdnskntlylqmnslraedtavyycakdfggdntamveyffdfwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1857,NaN,NaN,QKY76525,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgftfddygmswvrqapgkglewvsainwnggstgyadsvkgrftisrdnaknslylqmnslraedtalyhcarrrsssryssgwymyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1858,NaN,NaN,QKY76524,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsiayadsvkgrftisrdnaknslylqmnslraedtalyfcakvgwelsidafdlwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1859,NaN,NaN,QKY76523,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvaviyydgsnkyyadsvkgrftisrdnskntlylqihslraedtavyycaregqmaattgidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1860,NaN,NaN,QKY76522,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvhlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavisndefnkfyansvkgrftisrdnskntvylqlnslrtedtaryycakggdgsgwawdgdnpptdywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1861,NaN,NaN,QKY76521,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evalvesggglvkpggslrlscaasgfifsnawmtwvrqapgkglewvgrikskseggtpeyaapvkgrfiisrddstnslhlqmnylriedtavyycttggyssyaasdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1862,NaN,NaN,QKY76520,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarstsgsyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1863,NaN,NaN,QKY76519,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgftfddygmswvrqapgkglewvsainwnggstgyadsvkgrftisrdnaknslylqmnslraedtalyhcarrrsssryssgwymyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1864,NaN,NaN,QKY76518,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywdddkryspslksrltitkdtsknqvvltmtnmdpvdtatyycahnrfqycssttcytllpfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1865,NaN,NaN,QKY76517,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycvrdlalfevviqqgvwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1866,NaN,NaN,QKY76516,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfttywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarrrggigieygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1867,NaN,NaN,QKY76515,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscavsgftfssywmhwvrqapgkglvwvsrinsdgsstsyadsvkgrftisrdnakntlylqmnslraedtavyycareveqlahmvdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1868,NaN,NaN,QKY76514,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftshymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtgdtststvymelsslrsedtavyycardlagvpaalgcwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1869,NaN,NaN,QKY76513,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissttyywgwirqppgkglewiasiyysgstyynpslksrltvsvdtsknqfslklssvtaadtavyycarqwkwfgeawyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1870,NaN,NaN,QKY76512,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysfptywigwvrqmpgkglewmgiiypgdsdtrygpsfqgqvtisadksistaylqwsslkasdtamyycarrdtdfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1871,NaN,NaN,QKY76511,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evrllesggglvqpggslrlscaasgftfsdyamnwvrqapgkglewvsaisatggstfyadsvkgrfsisrdnsknslvlqmnslraedtavyycakpygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1872,NaN,NaN,QKY76510,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygihwvrqapgqglewvagiwydgsnkyyvdsvkgrftisrdnskntlylqmnslraedtavyycagssgegglyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1873,NaN,NaN,QKY76509,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfdsygvhwvrqapgkglewvavisydgsnkhyadsvkgrftisrdnskntlyvqmnslrtedtavyycardsggnygdsyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1874,NaN,NaN,QKY76508,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytfttyamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvntaflhigslkaedtavyycardqdsgyptyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1875,NaN,NaN,QKY76507,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftftsyamswvrqapgkglewvsgisisggstyyaasvkgrftisrdnskntlylqmnslraedtavyycakdsrsgiagvdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1876,NaN,NaN,QKY76506,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdmsknqfslklrsvtaadtavyycaraprerlqwgeyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1877,NaN,NaN,QKY76505,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmiglraedtavyycardwaptyydmpsafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1878,NaN,NaN,QKY76504,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlkesgpvlvkptetltltcavsgfslsnakmgvswirqppgkalewlahifsndekaystslktrltiskdtsksqvvltvtnmdpvdtatyycarivlgasgtypspgfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1879,NaN,NaN,QKY76503,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgstnynpslksrvtisvdksknqfslklssvtaadtavyycargwyfdywgqgtlvtvsa,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1880,NaN,NaN,QKY76502,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggslssyywswirqppgkglewigyiydsggasrstnynpslksrvtisvdtsrnqlslklssvtaadtavyycardqrqfqllgrfgwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1881,NaN,NaN,QKY76501,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgyywswirqppgkglewigeinhsgssnynpslksrvtisvdtsknqfslklssvtaadtavyycargwgwgavagraeyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1882,NaN,NaN,QKY76500,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslrvedtavyycardqewfrelflfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1883,NaN,NaN,QKY76499,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslkltsvtaadtavyycareandsgsfyngpfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1884,NaN,NaN,QKY76498,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsihwvrqapgkglewmggfdpedaetiyaqqfqgrvtmtedtstdtaymelsslksedtalyycatgfavfgraavpywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1885,NaN,NaN,QKY76497,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evrllesggglvqpggslrlscaasgftftsyamswvrqapgkglqwvstisvsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdpasgivgpthfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1886,NaN,NaN,QKY76496,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaavkkpgssvkvsckasggtfssyaiswvrqapgqglewmggivpifgtanyaqkfqgrvtitadestttaymelnslrsedtavyycaredyygsgslvdpyyyyrmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1887,NaN,NaN,QKY76495,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmnwvrqapgkglewvaninqdggekyyvdsvrgrftisrdnaknslylqmnslraedtavyycardpydlygdyggtfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1888,NaN,NaN,QKY76494,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisnsnsfiyyadsmkgrftisrdnaknslylqmnslraedtavyycarvngnsnwnfgsyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1889,NaN,NaN,QKY76493,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissgtyycgwirqppgkglewigstyyggstlynpslrgrvtisvdtsknqfslklssvtaadtavyycarrgnyydsknwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1890,NaN,NaN,QKY76492,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyemnwvrqapgkglewvsyisssgsaiyyadsvkgrftisrdnaknslylqmnslrvedtavyycarearsryfdwlpsyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1891,NaN,NaN,QKY76491,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftftsyamnwvrqapgkglewvsaisvsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdfgsgivgatgfdfwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1892,NaN,NaN,QKY76490,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftftsygmswvrqapgkglewvsaisisggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakllgsgitldndafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1893,NaN,NaN,QKY76489,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsfyysgstyynpslksrvtisvdtsknqfslnlssvtaadtavyscaslwfgdlysfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1894,NaN,NaN,QKY76488,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsgysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarwlqlrsdyyyfgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1895,NaN,NaN,QKY76487,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlkesgpvlvkptetltltctvsgfslsnarmgvswirqppgkalewlahifsgdeksystslksrltiskdtsksqvvltmtnmdpldtatyycarttwgtwiqawyfdiwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1896,NaN,NaN,QKY76486,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsghywswirqppgkglewigeinhsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarppqaarihyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1897,NaN,NaN,QKY76485,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggpisssryywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklnsvtaadtavyycarhdgsgemdtitwgpiyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1898,NaN,NaN,QKY76484,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlsctasgftfssyamhwvrqapgkglewvalisydgnnkyyadsakgrftisrdnskntlylqmnslrsedtavyycardlgrgldpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1899,NaN,NaN,QKY76483,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsirsssyywgwirqppgkglewiasiyysgstyynsslksrvtisvdtsknqfslkvnsmtaadtavyycailwrgsswadrhyyyysmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1900,NaN,NaN,QKY76482,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllqsggglvqpggslrlscaasgftfrnyamswvrqapgkglewvsaisgsggttyyadsvkgrftisrdnskntlylqmnslraedtavyycakneritmlvvvtlfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1901,NaN,NaN,QKY76481,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlsceasgftfssseinwvrqapgkglewvshisssgsiiyyadsvkgrftisrdnaknslylqmnslraedtavyycarrsyrsswyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1902,NaN,NaN,QKY76480,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvhpggslrlscaasgftfssyalswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnrlraedtavyycaqmgplgstssaadywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1903,NaN,NaN,QKY76479,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsgdsinsgnyywswirqpagkglewigrmftsgstnynpsltsrvtmsidtsknqfslnlnsvtaadtamyycarghvaawescyywgqgilvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1904,NaN,NaN,QKY76478,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlkesgpvlvkptetltltcavsgfslsnakmgvswirqppgkalewlahifsndekaystslktrltiskdtsksqvvltvtnmdpvdtatyycarivlgasgtypspgfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1905,NaN,NaN,QKY76477,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsghywswirqppgkglewigeinhsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarppqaarihyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1906,NaN,NaN,QKY76476,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdmsknqfslklrsvtaadtavyycaraprerlqwgeyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1907,NaN,NaN,QKY76475,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsgysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarwlqlrsdyyyfgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1908,NaN,NaN,QKY76474,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisnsnsfiyyadsmkgrftisrdnaknslylqmnslraedtavyycarvngnsnwnfgsyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1909,NaN,NaN,QKY76473,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslrvedtavyycardqewfrelflfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1910,NaN,NaN,QKY76472,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsihwvrqapgkglewmggfdpedaetiyaqqfqgrvtmtedtstdtaymelsslksedtalyycatgfavfgraavpywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1911,NaN,NaN,QKY76471,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyemnwvrqapgkglewvsyisssgsaiyyadsvkgrftisrdnaknslylqmnslrvedtavyycarearsryfdwlpsyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1912,NaN,NaN,QKY76470,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmiglraedtavyycardwaptyydmpsafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1913,NaN,NaN,QKY76469,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlsceasgftfssseinwvrqapgkglewvshisssgsiiyyadsvkgrftisrdnaknslylqmnslraedtavyycarrsyrsswyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1914,NaN,NaN,QKY76468,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsihwvrqapgkglewmggfdpedgetvyaqkfqgrvtmtedtssdtaymelsslrsedtavyycatsfpirgdpsyyyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1915,NaN,NaN,QKY76467,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytlielsihwvrqapgkglewmggfdpedvetiyaqkfqgrvtmtedtstdtaymelssltsedravyycatqpaaiggtppyywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1916,NaN,NaN,QKY76466,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsihwvrqapgkglewmggfdpedaetiyaqnfqgrvtmtedtstdtaymelsslrsedtalyycaaapavmtagwfdpwgqgtlvsvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1917,NaN,NaN,QKY76465,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyfwswirqhpgkglewigsiyysgstyynpslrsritisvdtsknqfslklssvtaadtavyycarggsgsyslfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1918,NaN,NaN,QKY76464,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamnwvrqppgkglewvsgiswnsdsigyadsvkgrftisrdnaknslylqmnslraedtamyycakgrgagytsymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1919,NaN,NaN,QKY76463,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgnglewigsiyysgstyynpslkgrvsisvdtsknqfslklssvtaadtavyycarilviftlnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1920,NaN,NaN,QKY76462,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvawirqppgkalewlaliywdddkryspslksrltitkdtsknqvvltmtnmdpvdtatyycahrlptpqllpsfenwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1921,NaN,NaN,QKY76461,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgseltkpgasvkvsckasgytftsyamnwvrqapgqglewmgwintdtgnptyaqgftgrfvfsldtsvstaylqisslkaedtavyycardpsycsstrcytvgwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1922,NaN,NaN,QKY76460,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslntsgvgvgwirqppgkalewlaliywdddkrynpslksrltitkdtsknqvvltmtnmdpvdtatyycahrppsyhgwcyfdywgqgnlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1923,NaN,NaN,QKY76459,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfstygmhwvrqapgkglewvavilydgsnryyadsvkgrftisrdnskntlylqmnslraedtavyycakqgglycsgtncwggyldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1924,NaN,NaN,QKY76458,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsrygmhwvrqapgkglewvgiisydasdktyaesvkgrftisrdnskntlylqmnslraedtavyycakvsatyyyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1925,NaN,NaN,QKY76457,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywvgwvrqmpgkglewmgiiypgdsdtrdspsfqgqvtisadksistaylqwsslkasdtamyycarlgseskidyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1926,NaN,NaN,QKY76456,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglecvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycardpirdgvwglnendywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1927,NaN,NaN,QKY76455,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftshymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtsdtststvymelsslrsedtamyycardvfwvpaassfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1928,NaN,NaN,QKY76454,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstkrvgvgwirqppgkalewlaliywdddqryspslksrltitkdtsknqvvltmtnmdpvdtatyycahsgppdlspvlsqgwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1929,NaN,NaN,QKY76453,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssgitiyyadsvkgrftisrdnaknslylqmnslraedtavyyctgvvaapaeyfqhwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1930,NaN,NaN,QKY76452,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyfwswirqhpgkglewigsiyysgstyynpslrsritisvdtsknqfslklssvtaadtavyycarggsgsyslfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1931,NaN,NaN,QKY76451,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavyggsfsgyywnwlrqppgkglewigeinhsgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarvggyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1932,NaN,NaN,QKY76450,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevktpgasvkvsckasgytftsydinwvrqatgqgpewmgwmnpnsgntgyahkfqgrvtmtrntsistaymelsslrsedtavyycargpsiltgfynpldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1933,NaN,NaN,QKY76449,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgfifddydmtwvrqapgkglewvsginwnggstgyadsvkgrftisrdnaknslylqmnslraedtalyhcavimspiprysgydwagdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1934,NaN,NaN,QKY76448,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytftsydinwvrqatgqglewmgwmnpnsghtgyaqkfqgrvtmtrntsistaymelsslryedtavyycargygltyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1935,NaN,NaN,QKY76447,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfrrygmywvrqapgkglewvavisydgtdkyytdsvkgrftisrdnskntlylqmnslraedtavyycakkggpycgggncyagyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1936,NaN,NaN,QKY76446,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgdtfssyylhwvrqapgqglqwmgisnpsggsttyaqkfqgrvtmtgdtststvymelsslrsedtavyycargglvpaarnafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1937,NaN,NaN,QKY76445,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiqpgdsdtryspsfqgqvtmsadkststaylqwsslkasdtamyycardliiestiaarpgyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1938,NaN,NaN,QKY76444,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvstigtagdtyypdsvkgrftisrenaknslflqmnslragdtavyycarvdfdiltgyysnwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1939,NaN,NaN,QKY76443,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvrlvqsgaevkkpgssvkvsckasggtfsdyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeftitaymelsslrsedtavyycarlsgsgwlgyamdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1940,NaN,NaN,QKY76442,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgfifddydmtwvrqapgkglewvsgiswnggntgyadsvkgrftisrdnaknslylqmnslraedtalyhcavimspiprysgydwaggafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1941,NaN,NaN,QKY76441,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsryamywvrqapgkglewvalisydgrneyyadsvkgrftisrdnskntlylqmnslragdsavyycardlayhpyrdygdddyyyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1942,NaN,NaN,QKY76440,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpggslrlscaasgftfddyamhwvrqapgkglewvslisgdggntyyadsvkgrftisrdnsknslylqmnslrtedtalyycakdemayppshhyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1943,NaN,NaN,QKY76439,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsykyfadsvkgrftisrdnskntlylqmnslraedtavyycardqgtvvthfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1944,NaN,NaN,QKY76438,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhggstdynpslksrvtisvdksknqfslkltsvtaadtavyycarvdhvnvrdywgpgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1945,NaN,NaN,QKY76437,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscvasgftfssygmhwvrqapgkglewvavisfdgsnkyyadsvkgrftisrdnskntlylqmnslraedtavfycakdlppyasgwyeggfdywgrgtqvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1946,NaN,NaN,QKY76436,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsdyamhwvrqapgkglewvadisfdgsnkyyadsvkgrftisrdssentlylqmdslraddtavyycardlsttwylemwgpdafdiwgqgtvvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1947,NaN,NaN,QKY76435,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavmsydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaknlgpycsggtcyslvgdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1948,NaN,NaN,QKY76434,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavsggsfsayywswirqppgkglewigeinhsgstnynpslrsrvtisvdtsknqfslklssvtaadtavyycarvgysqgyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1949,NaN,NaN,QKY76433,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),eaqlvesggglvqpggslrlsceasgfifssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarvndgrpnpleyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1950,NaN,NaN,QKY76432,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqsggslrlscaasgftfstygmhwvrqapgkglewvaiisydginkyyadsvkgrftisrdnskntvylqmnslrtedtamyycakgdgsylmdyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1951,NaN,NaN,QKY76431,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycargltgssaykdeiyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1952,NaN,NaN,QKY76430,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesggglvqpggslrlscaasgftfnnyamswvrqapgkglewvsaiggsggstyyadsvkgrftvsrdnsentlylqmsslraedtavyycarvegdwllggpyyhyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1953,NaN,NaN,QKY76429,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlkesgpvlvkptetltltctvsgfslsnarmgvswirqppgkalewlahifwndensystslktrltiskdtsksqvvlnmtnmdpvdtatyycartewllsdnwfdswgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1954,NaN,NaN,QKY76428,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfrrygmywvrqapgkglewvavisydgtdkyytdsvkgrftisrdnskntlylqmnslraedtavyycakkggpycgggncyagyfdywgqgilvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1955,NaN,NaN,QKY76427,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypdsvkgrftisrenaknslylqmnslragdtavyycarggdsgydlgawyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1956,NaN,NaN,QKY76426,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamnwvrqppgkglewvsgiswnsdsigyadsvkgrftisrdnaknslylqmnslraedtamyycakgrgagytsymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1957,NaN,NaN,QKY76425,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgnglewigsiyysgstyynpslkgrvsisvdtsknqfslklssvtaadtavyycarilviftlnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1958,NaN,NaN,QKY76424,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfrsydmhwvrqvtgkglewvstigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycarvfetkvirggryyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1959,NaN,NaN,QKY76423,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftnyymhwvrqapgqglewmgilnpgagstsyaqkfqgrvtmtsdtstntvymqlsslksedtavyycardqqivphadgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1960,NaN,NaN,QKY76422,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamnwvrqppgkglewvsgiswnsdsigyadsvkgrftisrdnaknslylqmnslraedtamyycakgrgagytsymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1961,NaN,NaN,QKY76421,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakvssitsllgyyfdswgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1962,NaN,NaN,QKY76420,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavmsydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaknlgpycsggtcyslvgdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1963,NaN,NaN,QKY76419,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsssdlhwvrqatgkglewvsaigtagdtyylgsvkgrftisrengknslylqmnslragdtavyycarvlydssgfynwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1964,NaN,NaN,QKY76418,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvqpggslrlscaasgftfddyamhwvrqapgkglewvslisgdggntyyadsvkgrftisrdnsknslylqmnslrtedtalyycakdemayppshhyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1965,NaN,NaN,QKY76417,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyylhwvrqapgqglewmgiinpsggsttyaqkfqgrvtmtrdtstsavymelrslrsedtavyycarendygdyveprdyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1966,NaN,NaN,QKY76416,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgftfmssavqwvrqargqrlewigwivigsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycssiscndgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1967,NaN,NaN,QKY76415,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyisysgstyynpslksrltisvdtsknqfslklssvtaadtavyycardlgdgynlrvpayfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1968,NaN,NaN,QKY76414,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsrhwmtwvrqapgkglewvanikqdgsekyyvdsvkgrltisrdnaknslylqmnslraedtavyycarlgfyyggadywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1969,NaN,NaN,QKY76413,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggdlvkpgrslrlscsasgftfgdytmswfrqapgkglewvafirskayggtteyaasvigrftisrddsksiaylqmnslksedtavyycsrvrgsfygsvgknygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1970,NaN,NaN,QKY76412,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfsfssyvmnwvrqapgkglewvavisydgsskyyadsvkgrftisrdnskntlylqmnslraedtavyycardidsgydptpvfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1971,NaN,NaN,QKY76411,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktaggtsssyaiswvrqapgqglewmgriipilgvaiyaqkfqgrvtitadkststaymelnslrsedtavyyctttqggdygdnlyyldywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1972,NaN,NaN,QKY76410,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssgsyywswirqppgkglecigyiyysgssnynpslksrvtisvdtsknqfslkmssvtaadtavyycagspvpptivgasywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1973,NaN,NaN,QKY76409,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgdtfttyyihwvrqapgqglewmgiinpsggsrsyaqkfqgrismtsdtststvymelsslrsedtavyycargygfvpnvlyyfdywgqgilvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1974,NaN,NaN,QKY76408,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydlhwvrqgtgkrlewvsaigtagdtyylgsvkgrftisrenaknslylqmnslragdtavyycarvlydssgfynwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1975,NaN,NaN,QKY76407,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqvvesggglvqpgrslrlscaasgftfedyamhwvrqapgkglewvsgvswnsgiigyadsvkgrftisrdnaknslylqmnslraedtalyycakldvggydfvsghyyafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1976,NaN,NaN,QKY76406,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsnygmhwvrqapgkglewvavmsydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaknlgpycsggtcyslvgdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1977,NaN,NaN,QKY76405,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsdyamhwvrqapgkglewvadisfdgsnkyyadsvkgrftisrdssentlylqmdslraddtavyycardlsttwylemwgpdafdiwgqgtvvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1978,NaN,NaN,QKY76404,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmhwvrqvpgkglvwvsrinsdgsstsyadsvkgrftisrdnakntlylemnslraqdtavyycagspwlrgdidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1979,NaN,NaN,QKY76403,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvhlvqsgaevkkpgasvklsckasgytftnyllhwvrqapgqglewmgnvnpsrgtatypqklddrvtmtsdksastiymelsglrsedtaiyycarersgtyffdywgqgtlltvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1980,NaN,NaN,QKY76402,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkrpgasmnisckasgynfnnnyiywvrqapgqglewmgvvnptgggtayaqgfqdrvtitsdtprntvylgvtglhsedtavyfcarggewrivpggrdyfdywgqgtlvtvsa,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1981,NaN,NaN,QKY76401,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpgggsttyaqkfqgrvtmtsdtststvymelsslrsedtamyycargaippnsraeidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1982,NaN,NaN,QKY76400,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydlhwvrqgtgkrlewvsaigtagdtyylgsvkgrftisrenaknslylqmnslragdtavyycarvlydssgfynwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1983,NaN,NaN,QKY76399,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckapgytfttyyihwvrqapgqglewmgiinpsagsttyaqkfqgrvtmtrdtststvymelsslrsedtavyycargfhvpaalrnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1984,NaN,NaN,QKY76398,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgvtvssnymswvrqapgkglewvsliysggstfyadsvkgrftisrhnskntlylqmnslrpedtavyycargpepdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1985,NaN,NaN,QKY76397,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvscktsgftftssaiqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcnrtscydafdlwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1986,NaN,NaN,QKY76396,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfsfssyvmnwvrqapgkglewvavisydgsskyyadsvkgrftisrdnskntlylqmnslraedtavyycardidsgydptpvfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1987,NaN,NaN,QKY76395,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissrsstikyadsvkgrftisrdnaknslylqmnslrdedtavyycarvdyygsgsvywyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1988,NaN,NaN,QKY76394,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfmssavqwvrqargqrlewigwivigsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycssiscndgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1989,NaN,NaN,QKY76393,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyaesvkgrftisrdnskntlylqmnslraedtavyycardlhqdwvvvvaanvygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1990,NaN,NaN,QKY76392,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvkgrfiisrdnaknslylqmnslrpedtalyycakdiirqgedgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1991,NaN,NaN,QKY76391,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsagstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycargtlipahrgafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1992,NaN,NaN,QKY76390,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrsltlscaasgftfddytmhwvrqapgkglewvsgidwnggtigyadsvkgrftisrdnaknslylqmnslraedtalyycakagyyayvwgsyrfeyfdnwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1993,NaN,NaN,QKY76389,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsrgtnyaqkfqgrvtmtrdtsistvymelsrltsddtavyycarvvvlgygrpnnyydgrnvwdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1994,NaN,NaN,QKY76388,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsglcvswirqppgkalewlaridwdddkyyntslrtrltiskdtsknqvvltmtnmdpvdtatyycarattffygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1995,NaN,NaN,QKY76387,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqvvesggglvqpgrslrlscvssgfifddyvmhwvrqrpgkglewvagitynggilgygdsvkgrfiiardnvrgflslqmgdlrtedtalyycardycssttcpaetyyymdvwgkgtavtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1996,NaN,NaN,QKY76386,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggdliqpggslrlscaasgltvssnymswvrqapgkglewvsiiysggstyyadsvkgrfsisrdnsnntlylqmnslraedtavyfcarhipawgykwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1997,NaN,NaN,QKY76385,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarddnspqgsgwyfyyyyamdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1998,NaN,NaN,QKY76384,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqvvqsgpglvkpsetlsltctvsgdpvintnyywgwirqppgkglewigtlsysggthynpslssrvtiavdsskkrfsltlrsvtaadtaiyycarhpvdgynygysdlwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
1999,NaN,NaN,QKY76383,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssgsyywswirqppgkglecigyiyysgssnynpslksrvtisvdtsknqfslkmssvtaadtavyycagspvpptivgasywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2000,NaN,NaN,QKY76382,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvrsnymtwvrqtpgkglewvsviysggstfyadsvkgrftisrdnskntvylqmnslraedtavyycardlvtygldvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2001,NaN,NaN,QKY76381,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsvssgsyywswirqppgkglecigyiyysgssnynpslksrvtisvdtsknqfslkmssvtaadtavyycagspvpptivgasywgqgtlvtdss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2002,NaN,NaN,QKY76380,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqagaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycargaavpaagefdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2003,NaN,NaN,QKY76379,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytftgyvvhwvrqapgqdlewmgwintgygntkysqkfqgrvtiswdtsattaymelsnlksedkavyycasmtrmseqtyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2004,NaN,NaN,QKY76378,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviypggsafyadsvkgrftisrhnsnntlclqmnslrtedtavyycarsydiltgyrdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2005,NaN,NaN,QKY76377,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfmssavqwvrqargqrlewigwivigsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycssiscndgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2006,NaN,NaN,QKY76376,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsgdsissgryywswirqhpgkglewigfvyysgstyynpslksrvtisvdtsknqfslrlssvtaadtavyycaretysayemppyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2007,NaN,NaN,QKY76375,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgdtfttyyihwvrqapgqglewmgiinpsggsrsyaqkfqgrismtsdtststvymelsslrsedtavyycargygfvpnvlyyfdywgqgtlvtvst,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2008,NaN,NaN,QKY76374,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkrpgssvkvsckasggtfssytiswvrqapgqglewmgriipilavanyaqkfqgrvtitadkststaymelsslrsedtavyycardhsgyydstslmspffdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2009,NaN,NaN,QKY76373,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlpltctvsggsissssyywgwirqppgkglqwigniyysgstyynsslksrvtisvdtsknqfslklssvtaadtavyycarqsrgysyawsfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2010,NaN,NaN,QKY76372,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvkgrfiisrdnaknslylqmnslrpedtalyycakdiirqgedgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2011,NaN,NaN,QKY76371,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmspnsgntgyaqkfqgrvtmtrdtsistaymelnslrsedtavyycarmrsgwpthgrpddhwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2012,NaN,NaN,QKY76370,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgeslrlscaasgitvssnymswvrqapgkglewvsviysggstfyadsvkgrfiisrhnskntlylqmnslraedtavyycardlnehgldvwgqgttvsvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2013,NaN,NaN,QKY76369,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltcsvsggsirsyfwnwvrqppgkglewigyiyysgstnykpsfksrvtisldtsknqislklssvtaadtavyycaratwlrdafgiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2014,NaN,NaN,QKY76368,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscvaseftfssywmswfrqapgkglewvsginwnggstgyadsvkgrftisrdnaknslylqmnslktedtavyycasvitfggvivrsywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2015,NaN,NaN,QKY76367,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgdyywswirqppgkglewigyiyysgstyynpslksrvtisvdtsknqvslklssvtaadtavyycarfrrsygsgsyynisfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2016,NaN,NaN,QKY76366,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvrsnymtwvrqtpgkglewvsviysggstfyadsvkgrftisrdnskntvylqmnslraedtavyycardlvtygldvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2017,NaN,NaN,QKY76365,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgityynpslksrvtisvdtsknqfslklssvtaadtavyycarhqrycsssschvwdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2018,NaN,NaN,QKY76364,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvscqasgytftsydinwvrqatgqglewmgwmksnsgntgyaqkfqgrvtmtrntsistaymeltslrsedtavyycarmrsgwpthgrpddlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2019,NaN,NaN,QKY76363,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssysitwvrqapgqglewmgriipvlgianyaqkfqdrvtitadkststaymelsslrsedtavyycarvgvsgfksgsnwyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2020,NaN,NaN,QKY76362,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmcvswirqppgkalewlaridwdddkyystsletrltiskdtsknqvvltmtnmdpvdtatyycariqyqlngmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2021,NaN,NaN,QKY76361,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfssytinwvrqapgqglewmgriipilgipnyaqkfqgrvtitadkststafmelsslrsedtavyycargrgysnygasyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2022,NaN,NaN,QKY76360,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvkgrfiisrdnaknslylqmnslrpedtalyycakdiirqgedgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2023,NaN,NaN,QKY76359,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),eaqllesggalvqpggslrlscaasgftfsccamgwvrqapgrglewvssihddgvgtfyavsvkgrfsisrdnskntvylqmnglraedtgvyycakwagpivmkyylqywgqgalvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2024,NaN,NaN,QKY76358,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgfsvstnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardyrdwiwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2025,NaN,NaN,QKY76357,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycasaklvatisyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2026,NaN,NaN,QKY76356,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpnsgnagygqkfqgrvtmtrntsistaymelsslrsedtavyycarmrsgwpthgrpddywgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2027,NaN,NaN,QKY76355,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakvgytisrqwlvgefdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2028,NaN,NaN,QKY76354,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftnywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycartptlynwfhpwgqgtpvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2029,NaN,NaN,QKY76353,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtlsltctfsgfslgtsgmcvswirqppgkalewlaridwdddkyystslktrltiskdtsknqvvltmtnmdpvdtatyycargvvtydywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2030,NaN,NaN,QKY76352,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvrvsckapgytfttyyihwvrqapgqglewmgiinpsagsttyaqkfqgrvtmtrdtststvymelsslrsedtavyycargfhvpaalrnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2031,NaN,NaN,QKY76351,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgtigyadsvkgrfiisrdnaknslylqmnslrpedtalyycakdiirqgedgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2032,NaN,NaN,QKY76350,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvscktsgftftssaiqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcnrtscydafdlwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2033,NaN,NaN,QKY76349,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaqsgaevkkpgasvkvsckaagytftsydinwvrqatgqglewmgwmnsnsgnagyaqkfqgrvtmtrdtststaymelssltsddtavyycarmrtgwpthgrpddfwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2034,NaN,NaN,QKY76348,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaqsgaevkkpgasvkvsckaagytftsydinwvrqatgqglewmgwmnpnsgnagyaqkfqgrvtmtrdtsistaymelsslrsedtavyycarmrsgwpthgrpddfwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2035,NaN,NaN,QKY76347,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpgggsttyaqkfqgrvtmtsdtststvymelsslrsedtamyycargaippnsraeidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2036,NaN,NaN,QKY76346,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviypggsafyadsvkgrftisrhnsnntlclqmnslrtedtavyycarsydiltgyrdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2037,NaN,NaN,QKY76345,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfgsfdinwvrqatgqglewmgrmnsnsgntayaqkfqgrvtmtrdtstntaymelsslrsedtamyycarmrsgwpthgrpddfwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2038,NaN,NaN,QKY76344,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgselkkpgasvkvsckasgytftshtmnwvrqapgqglewmgwintntgnpmyaqgftgrfvfsldtsgstaylqisslkaedtavyycarwgpdygdyasndywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2039,NaN,NaN,QKY76343,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsrgtnyaqkfqgrvtmtrdtsistvymelsrltsddtavyycarvvvlgygrpnnyydgrnvwdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2040,NaN,NaN,QKY76342,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvalissdggnkfyadsvkgrftisrdnskntlylqmnslraedtavyycardvpttvtaftvftywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2041,NaN,NaN,QKY76341,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqatgkglewvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycararggynwnfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2042,NaN,NaN,QKY76340,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtlsltctfsgfslgtsgmcvswirqppgkalewlaridwdddkyystslktrltiskdtsknqvvltmtnmdpvdtatyycargvvtydywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2043,NaN,NaN,QKY76339,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdttynpsfqgqvtisadkslttaflhwsslkasdtaiyycarrfygpssfdywgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2044,NaN,NaN,QKY76338,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfsfssyvmnwvrqapgkglewvavisydgsskyyadsvkgrftisrdnskntlylqmnslraedtavyycardidsgydptpvfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2045,NaN,NaN,QKY76337,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssysitwvrqapgqglewmgriipvlgianyaqkfqdrvtitadkststaymelsslrsedtavyycarvgvsgfksgsnwyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2046,NaN,NaN,QKY76336,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvscisssssfiyyadsvkgrftisrdnaknslylqmnslraedtavyycardpvwvdgellsggipfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2047,NaN,NaN,QKY76335,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasgdtfssytinwvrqapgqglewmgriipilgipnyaqkfqgrvtitadkststafmelsslrsedtavyycargrgysnygasyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2048,NaN,NaN,QKY76334,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),nvqlvesggglvqpggslrlscaasgftfhhyamhwvrqapgkglewvsgisgssdyrayadslkgrftisrdyaknslwlqmnsltsedtafyycakgvdyggklayfdswgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2049,NaN,NaN,QKY76333,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlresgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavfycarmsrgynyaytfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2050,NaN,NaN,QKY76332,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasevtvssnymswvrqapgkglewvsliysggttyyadsvkgrftisrdnskntlylqmnslraedtavyycardflrwhdlwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2051,NaN,NaN,QKY76331,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsltcavsggsfsayywswirqppgkglewigeinhsgstnynpslrsrvtisvdtsknqfslklssvtaadtavyycarvgysqgyyyyymdvwgkgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2052,NaN,NaN,QKY76330,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviypggsafyadsvkgrftisrhnsnntlclqmnslrtedtavyycarsydiltgyrdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2053,NaN,NaN,QKY76329,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsiaytdsvkgrftisrdnaknslylqmnslraedtalyycakahstghqyyygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2054,NaN,NaN,QKY76328,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftfmssavqwvrqargqrlewigwivigsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycssiscndgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2055,NaN,NaN,QKY76327,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydlhwvrqgtgkrlewvsaigtagdtyylgsvkgrftisrenaknslylqmnslragdtavyycarvlydssgfynwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2056,NaN,NaN,QKY76326,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissttyywgwirqppgkglewiasiyysgstyynpslksrltvsvdtsknqfslklssvtaadtavyycarqwkwfgeawyfdlwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2057,NaN,NaN,QKY76325,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyainwvrqapgqglewmggiipifgtanyaqkfqgrvtftadeststaymevsslrsedtavyycarscgdcysadldfwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2058,NaN,NaN,QKY76324,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgaevkkpgeslkisckgfgynftnywigwvrqmpgkglewmgiiypgdsetrnspsfqgqvtisadksmstaylqwsslkasdtamyycarlgvskycsggrclsggsnwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2059,NaN,NaN,QKY76323,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfrdysmnwvrqapgkglewvssissggsyiyyadsvkgrftisrdnaknslylqmnslraedtavyycarggsilwwlidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2060,NaN,NaN,QKY76322,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsrhwmtwvrqapgkglewvanikqdgsekyyvdsvkgrltisrdnaknslylqmnslraedtavyycarlgfyyggadywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2061,NaN,NaN,QKY76321,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsmyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarllwlrghfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2062,NaN,NaN,QKY76320,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evhlvgsgggliqpggslrlscaasgftvssnfmswvrqapgkglewvsiihnggdsyytdsvkgrftisrdnskntlylqmnnlraedtavyycassswlrgafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2063,NaN,NaN,QKY76319,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslstsgmclswirqppgkalewlaridwdddkyystsletrltiskdtsknqvvltmtnmdpvdtgtyycartmatinafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2064,NaN,NaN,QKY76318,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewighiyytgssyynpslksrvtisldtsknqfslklnsvtaadtavyycarlrwlrggidfwgqgtlvivss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2065,NaN,NaN,QKY76317,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasevtvssnymswvrqapgkglewvsliysggttyyadsvkgrftisrdnskntlylqmnslraedtavyycardflrwhdlwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2066,NaN,NaN,QKY76316,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggliqpggslrlscaasgftfsnyamswvrqapgkglewvsgiistsggatynadsvrgrfttsrdnsknilylqmnslrgedtavyycvkglfdwfplwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2067,NaN,NaN,QKY76315,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgitvssnymswvrqapgkglewvsviyaggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardalyyngpgrdgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2068,NaN,NaN,QKY76314,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgftlddyglswvrhapgkglewvsginwnggrtayadsvkgrftisrdnaknslylqmnslraedtalyhcarargpseqyydlltgyydafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2069,NaN,NaN,QKY76313,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvtlresgpalvkptqtltltctfsgfslttsgmcvswirqppgkalewlaridwdddkyystslqtrltiskdtsknqvvltmtnmdpvdtatyycaretpvtaidywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2070,NaN,NaN,QKY76312,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslrtedtalyycamgpfgellpyyfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2071,NaN,NaN,QKY76311,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasgitvssnymswvrqapgkglewvsviyaggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardalyyngpgrdgmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2072,NaN,NaN,QKY76310,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviypggsafyadsvkgrftisrhnsnntlclqmnslrtedtavyycarsydiltgyrdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2073,NaN,NaN,QKY76309,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqqwgagllkpsetlsrtcavygasfsnyywswirqppgkglewigeinhsentnynpslksrvtisvdtsknqfslrlssvtaadtavyycarlrysssgghifdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2074,NaN,NaN,QKY76308,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqllesgggliqpggslrlscaasgftfsnyamswvrqapgkglewvsgiisssggatynadsvrgrfttsrdnsknilylqmnslrgedtavyycvkglfdwfplwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2075,NaN,NaN,QKY76307,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qitlkesgptlvkptqtltltctfsgfslstsgvgvgwirqppgkalewlaliywdddkryspslksrlsitkdtsknqvvltmtnmdpvdtgtyycarhqivvlfdmwgqgtrvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2076,NaN,NaN,QKY76306,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgvtvssnymswvrqapgkglewvsliysggstfyadsvkgrftisrhnskntlylqmnslrpedtavyycargpepdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2077,NaN,NaN,QKY76305,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggliqpggslrlscaasevtvssnymswvrqapgkglewvsliysggttyyadsvkgrftisrdnskntlylqmnslraedtavyycardflrwhdlwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2078,NaN,NaN,QKY76304,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaqsgaevkkpgasvkvsckaagytftsydinwvrqatgqglewmgwmnsnsgnagyaqkfqgrvtmtrdtststaymelssltsddtavyycarmrtgwpthgrpddfwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2079,NaN,NaN,QKY76303,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvrsnymtwvrqtpgkglewvsviysggstfyadsvkgrftisrdnskntvylqmnslraedtavyycardlvtygldvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2080,NaN,NaN,QKY76302,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlaqsgaevkkpgasvkvsckaggytftsydinwvrqatgqglewmgwmnsnsgnagyaqkfqgrvtmtrdtsistaymelsslrsedtavyycarmrtgwpthgrpddfwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2081,NaN,NaN,QKY76301,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgfifddydmtwvrqapgkglewvsgiswnggntgyadsvkgrftisrdnaknslylqmnslraedtalyhcavimspiprysgydwaggafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2082,NaN,NaN,QKY76300,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvgsnymnwvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqlnslraedtavyycarevvgyfdcwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2083,NaN,NaN,QKY76299,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesgggvvrpggslrlscaasgfifddydmtwvrqapgkglewvsginwnggstgyadsvkgrftisrdnaknslylqmnslraedtalyhcavimspiprysgydwagdafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2084,NaN,NaN,QKY76298,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfvtsgihwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakggpnkevlyfgelldygmdvwgqgttvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2085,NaN,NaN,QKY76297,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsgdsissagyywswirqhpgkglewigyiyysgrtyynpslksrvtmsvdtsknqfslrlrsvtaadtavyycarvvptrgpvawfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2086,NaN,NaN,QKY76296,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfrdvwmswvrqapgkglewvgrikskidggttdyaapvkgrftisrddskntlylqmnslktedtavyycttagsyyydtvgpglpegkfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2087,NaN,NaN,QKY76295,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftdyymhwvrqapgqglewmgwinpnsrgtnyaqkfqgrvtmtrdtsistvymelsrltsddtavyycarvvvlgygrpnnyydgrnvwdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2088,NaN,NaN,QKY76294,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvesggglvqpggslrlscaasgltvssnymswvrqapgkglecvsviyaggntyyadsvkgrftisrdnskntlylqmnslraedtavyycargdggyyspfdywgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2089,NaN,NaN,QKY76293,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfgsfdinwvrqatgqglewmgrmnsnsgntayaqkfqgrvtmtrdtstntaymelsslrsedtamyycarmrsgwpthgrpddfwgrgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2090,NaN,NaN,QKY76292,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qvqlvqsgaevkkpgssvkvscktsgdtsssytvgwvrqapgqglewmgriipilgiaysaqkfqgrltitadkststsymelsslrsedtavyycargvvaatpgwfdpwgqgtlvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2091,NaN,NaN,QKY76291,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvsckasgftftssavqwvrqargqrlewigwiavgsgntnyaqkfqervsitrdmststaymelsslrsedtavyycaapycsrtschdafdiwgqgtkvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2092,NaN,NaN,QKY76290,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),evqlvqsgpevkkpgtsvkvsckasgftfmssavqwvrqargqrlewigwivigsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaapycssiscndgfdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2093,NaN,NaN,QKY76289,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsvssrsyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarhtvdcggdcfpndafdiwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2094,NaN,NaN,QKY76288,NaN,"SARS-CoV-2, Spike protein",Homo sapiens (human),qmqlvqsgpevkkpgtsvkvscktsgftftssaiqwvrqargqrlewigwivvgsgntnyaqkfqervtitrdmststaymelsslrsedtavyycaaphcnrtscydafdlwgqgtmvtvss,NaN,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.","anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2095,NaN,NaN,NaN,QKY76287,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyccssytssravlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2096,NaN,NaN,NaN,QKY76286,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqrpgqspvlviyqdskrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstgvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2097,NaN,NaN,NaN,QKY76285,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltissldpedfavyychkrsnwppsltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2098,NaN,NaN,NaN,QKY76284,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltissldpedfavyychkrsnwppsltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2099,NaN,NaN,NaN,QKY76283,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknslawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyysiswtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2100,NaN,NaN,NaN,QKY76282,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssflawyqqkpgqaprlliydasnrptgiparftgsgsgtdftltisslepedfavyycqhrtnwpplftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2101,NaN,NaN,NaN,QKY76281,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlhssnnkdslvwyqqkpgqppklliywassresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystpwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2102,NaN,NaN,NaN,QKY76280,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssflawyqqkpgqaprlliydasnrptgiparftgsgsgtdftltisslepedfavyycqhrtnwpplftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2103,NaN,NaN,NaN,QKY76279,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgdynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeaeyycssytssstllyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2104,NaN,NaN,NaN,QKY76278,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqkpgqspvvviyqdskrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstavfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2105,NaN,NaN,NaN,QKY76277,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgdynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeaeyycssytssstllyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2106,NaN,NaN,NaN,QKY76276,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynyldwylqkpgqspqfliylgsnrasgvpdrfsgsgsgtdfilkisrveaedvgvyycmqalqtpftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2107,NaN,NaN,NaN,QKY76275,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystpltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2108,NaN,NaN,NaN,QKY76274,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqrpgqspvlviyqdskrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstgvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2109,NaN,NaN,NaN,QKY76273,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyccssytssravlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2110,NaN,NaN,NaN,QKY76272,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynyldwylqkpgqspqfliylgsnrasgvpdrfsgsgsgtdfilkisrveaedvgvyycmqalqtpftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2111,NaN,NaN,NaN,QKY76271,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsstflawyqqkpgqaprllifgassratgipdrfsgsgsgtdftltisrlepedfavyychqygtspytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2112,NaN,NaN,NaN,QKY76270,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktanitcggnnigrksvhwyqqksgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhpewvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2113,NaN,NaN,NaN,QKY76269,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssflawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwppsytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2114,NaN,NaN,NaN,QKY76268,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divvtqtplslsvtpgqpasisckssetllhsdgktylswylqkpgqppqlliyevsnrfsgvpdrfsgsgsgtdftlkigrveaedvglyycmqsiqlafgqgtrleie,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2115,NaN,NaN,NaN,QKY76267,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltissldpedfavyychkrsnwppsltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2116,NaN,NaN,NaN,QKY76266,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsnyvywyqqlpgtapkllisrnnqrpsgvpdrfsgsksgtsaslaisglqsedeanyyclvwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2117,NaN,NaN,NaN,QKY76265,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsllytsnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyysppwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2118,NaN,NaN,NaN,QKY76264,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscragqtvsssylawyqhkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2119,NaN,NaN,NaN,QKY76263,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsdgytyldwylqkpgqspqlliylgskrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqalqtpltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2120,NaN,NaN,NaN,QKY76262,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapkllmyaastlqsgvpsrfsgsgsgteftltintlqpedfatyycqqlnsypitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2121,NaN,NaN,NaN,QKY76261,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkprqapvliisgnnnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnhlrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2122,NaN,NaN,NaN,QKY76260,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgtpgqrvtiscsgsnskigsysvnwyqqlpgtapklliyrnnqrpsgvpdrffgsksgtsaslaisglqsedeadyycsvwddslngplfgggtkltfv,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2123,NaN,NaN,NaN,QKY76259,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystpgfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2124,NaN,NaN,NaN,QKY76258,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswfqhhpdkaprlmiydvskrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstpfvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2125,NaN,NaN,NaN,QKY76257,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrarqsisnylnwyqqkpgkapklliyaasslhsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystptfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2126,NaN,NaN,NaN,QKY76256,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqapvvviygknnrpsgipdrfsgsssgnkasltitgaqagdeadyycnsrdnsgnlnwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2127,NaN,NaN,NaN,QKY76255,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigtkgvhwyqqkpgqapvlvvyddsdrpsgipgrfsgsnsgntatltisrveagdeadyfcqvwdsssdhhvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2128,NaN,NaN,NaN,QKY76254,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssflawyqqkpgqaprlliydasnrptgiparftgsgsgtdftltisslepedfavyycqhrtnwpplftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2129,NaN,NaN,NaN,QKY76253,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkfvcwyqqkpgqspvlviyqdnkrpsgiperfsgsnsgntatltisgtqaldeadyycqawdsstgvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2130,NaN,NaN,NaN,QKY76252,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwpgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2131,NaN,NaN,NaN,QKY76251,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,itcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfggsasgtdftltisslqpedfatyycqqsystftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2132,NaN,NaN,NaN,QKY76250,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagynvhwyqqlpgtapklliygnnnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsfdsslsgsdvfgtgtkvsvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2133,NaN,NaN,NaN,QKY76249,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdflavslgeratinckssqsvlhtpknknylawykqkpgqppkvliywastresgvperfsgsgsgtdftliisslqaedaavyycqqyytapltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2134,NaN,NaN,NaN,QKY76248,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystppytfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2135,NaN,NaN,NaN,QKY76247,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlhssnnkdslvwyqqkpgqppklliywassresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystpwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2136,NaN,NaN,NaN,QKY76246,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrashsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqyntysqtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2137,NaN,NaN,NaN,QKY76245,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqgisnylawfqqkpgkapksliyaasslqsgvpskfsgsgsgtdftltisslqpedvatyycqqynshpptfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2138,NaN,NaN,NaN,QKY76244,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigarydvhwyqqlpgtapkllmygnnnrpsgvpdrfsgsksgtsvslaitglqaedeadyycqsydsslsgwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2139,NaN,NaN,NaN,QKY76243,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqhlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgwsvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2140,NaN,NaN,NaN,QKY76242,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqkpgqspvlviyqdtkrpsgiperfsgsnsgntatltisgtqamdeadyycqawgssrgvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2141,NaN,NaN,NaN,QKY76241,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdflavslgeratisckssqsvlytpknknylawykqkpgqppkvliywastresgvpdrfsgsgsgtdftliisslqaedaavyycqqyytapltfgggtrveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2142,NaN,NaN,NaN,QKY76240,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsistylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyhcqqsystltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2143,NaN,NaN,NaN,QKY76239,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnskigsysvnwyqqlpgtapklliyrnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycsvwddslngplfgggtkltfl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2144,NaN,NaN,NaN,QKY76238,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrarqsisnylnwyqqkpgkapklliyaasslhsgvpsrfsgsgsgtdftltisslqpedfatyycqqtystfwtfgqgtnveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2145,NaN,NaN,NaN,QKY76237,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqrpgqspvlviyqdskrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstgvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2146,NaN,NaN,NaN,QKY76236,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssflawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyychyrsnwppvltfgggtkveie,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2147,NaN,NaN,NaN,QKY76235,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqyygsspfgfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2148,NaN,NaN,NaN,QKY76234,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtsgdvgaynyvswyqqhpvkapklmiydvskrpsgvsnrfsgsksgntasltisglqtedeadyycssytssstlwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2149,NaN,NaN,NaN,QKY76233,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalprqytywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadtigtywvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2150,NaN,NaN,NaN,QKY76232,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkysswyqqkpgqspvlviyedtkrpsgiperfsgsnsgntatltisgtqamdeadyycqawssstavfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2151,NaN,NaN,NaN,QKY76231,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2152,NaN,NaN,NaN,QKY76230,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divvtqtplslsvtpgqpasisckssetllhsdgktylswylqkpgqppqlliyevsnrfsgvpdrfsgsgsgtdftlkigrveaedvglyycmqsiqlafgqgtrleie,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2153,NaN,NaN,NaN,QKY76229,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyanwyqqkpgqapvvvifgknnrpsgipdrfsgsnsgntasltitgaqaedeadyycnsrdssgyiwgwmfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2154,NaN,NaN,NaN,QKY76228,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsknvhwyqqkpgqapvkvvyhdgdrpsgiperfsgsnsgntatltinrveagdeadyscqvwdsssdhhvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2155,NaN,NaN,NaN,QKY76227,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqtitnylnwyqlksgrapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2156,NaN,NaN,NaN,QKY76226,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystpltfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2157,NaN,NaN,NaN,QKY76225,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliyaasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnllqftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2158,NaN,NaN,NaN,QKY76224,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnslswyqqkpgkapklliydasnlktgvpsrfsgsgsgtdftftisslqpediatyycqqydnlllftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2159,NaN,NaN,NaN,QKY76223,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrarqsisnylnwyqqkpgkapklliyaasslhsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpgtfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2160,NaN,NaN,NaN,QKY76222,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdiggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsistwvfgggtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2161,NaN,NaN,NaN,QKY76221,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgdynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeaeyycssytssstllyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2162,NaN,NaN,NaN,QKY76220,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvsrflawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwpprltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2163,NaN,NaN,NaN,QKY76219,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdflavslgeratinckssqsvlhtpknknylawykqkpgqppkvliywastresgvperfsgsgsgtdftliisslqaedaavyycqqyytapltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2164,NaN,NaN,NaN,QKY76218,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvgnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2165,NaN,NaN,NaN,QKY76217,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssflawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyychyrsnwppvltfgggtkveie,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2166,NaN,NaN,NaN,QKY76216,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynyldwylqkpgqsphlliylgsnrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqalqtprtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2167,NaN,NaN,NaN,QKY76215,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktanitcggnnigrksvhwyqqksgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdhpewvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2168,NaN,NaN,NaN,QKY76214,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2169,NaN,NaN,NaN,QKY76213,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpptfgggtkvqik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2170,NaN,NaN,NaN,QKY76212,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknslawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyysiswtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2171,NaN,NaN,NaN,QKY76211,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliygasslqtgvpsrfsgsgsgtdftltirslqpedfasyycqqsystptfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2172,NaN,NaN,NaN,QKY76210,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliygasslqtgvpsrfsgsgsgtdftltirslqpedfasyycqqsystptfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2173,NaN,NaN,NaN,QKY76209,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasldiskylnwyqhkpgkapnlliydafnlergvpsrfsgsgsgtdftftisslqpediatyycqqydnlppgvsttfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2174,NaN,NaN,NaN,QKY76208,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqtitnylnwyqlksgrapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2175,NaN,NaN,NaN,QKY76207,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdflavslgeratinckssqsvlhtpknknylawykqkpgqppkvliywastresgvperfsgsgsgtdftliisslqaedaavyycqqyytapltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2176,NaN,NaN,NaN,QKY76206,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapklliygntnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsyasslsahvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2177,NaN,NaN,NaN,QKY76205,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrashsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqyntysqtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2178,NaN,NaN,NaN,QKY76204,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvvgynyvswyqqhpgkapklmiydvrnrpsgvsnrfsgsksgntasltisglqaedeadyfcisytssrtlvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2179,NaN,NaN,NaN,QKY76203,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsrsgntasltisglqaedeadyycssytssstpvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2180,NaN,NaN,NaN,QKY76202,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqprsvsgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiydvtkrpsgvperfsgsksgntasltisglqaedeadysccsyagsytyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2181,NaN,NaN,NaN,QKY76201,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaisglqaedeadyscqsydsslsgyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2182,NaN,NaN,NaN,QKY76200,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisnwlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsystwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2183,NaN,NaN,NaN,QKY76199,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkrgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssprltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2184,NaN,NaN,NaN,QKY76198,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvssnflawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygrspitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2185,NaN,NaN,NaN,QKY76197,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnenylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyyssytfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2186,NaN,NaN,NaN,QKY76196,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwppgvtfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2187,NaN,NaN,NaN,QKY76195,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapkllifinsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslgalfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2188,NaN,NaN,NaN,QKY76194,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqprsvsgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiydvskrpsgvpdrfsgsksgntasltvsglqaedeaeyycsayagsnnlvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2189,NaN,NaN,NaN,QKY76193,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwpgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2190,NaN,NaN,NaN,QKY76192,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyysspytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2191,NaN,NaN,NaN,QKY76191,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgvpgqrvtvsctgsssnigagfdvywyqqflgtapklliygnnnrpsgvpdrfsasksgtsaslaitglqaedeadyycqsfdigrggwifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2192,NaN,NaN,NaN,QKY76190,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvsageratlscrasqsissnlawyhqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynsysltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2193,NaN,NaN,NaN,QKY76189,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqpssvsvspgqtaritcsgdalpkryaywyrqksgqapvlvihedskrpsgiperfsgstsgtmatltitgaqledeadyycfsmdssgdlrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2194,NaN,NaN,NaN,QKY76188,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvltqppsasaslgasvtltctlssgysnykvdwyqqrpgkgprfvmrvgtggivgskgdgipdrfsvlgsglnryltikniqeedesdyhcgadhgsgsnfeyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2195,NaN,NaN,NaN,QKY76187,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvssnflawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygrspitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2196,NaN,NaN,NaN,QKY76186,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvltqppsasaslgasvtltctlssgysnykvdwyqqrpgkgprfvmrvgtggivgskgdgipdrfsvlgsglnryltikniqeedesdyhcgadhgsgsnfvfvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2197,NaN,NaN,NaN,QKY76185,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsinswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqysiyswtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2198,NaN,NaN,NaN,QKY76184,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvvtqppsasgtpgqrvtiscsgsssnigynivnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgtsaslsisglqsedeadyycaawddslngyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2199,NaN,NaN,NaN,QKY76183,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapkllifinsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslgalfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2200,NaN,NaN,NaN,QKY76182,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,fyeltqppsvsvspgqtagitcsgdklghkyaywyqqkpgqspilliyqddkrpsgiperfsgsnsgtiatltisgtqpvdeadyycqawdndagvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2201,NaN,NaN,NaN,QKY76181,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalptkyaywyqqksgqapvlviyddskrpsgiperfsgsssgtmatltisgaqvedeadyycystdssgnvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2202,NaN,NaN,NaN,QKY76180,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatfycqqsystpmhtfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2203,NaN,NaN,NaN,QKY76179,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsadalskqyaywyqqkpgqapvvviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssshwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2204,NaN,NaN,NaN,QKY76178,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygrssgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2205,NaN,NaN,NaN,QKY76177,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmaqtplslpvtpgepasiscrssqslldsddgntyfdwylqkpgqspqlliytlsyrasgvpdrfsgsgsgtdftlkinrveaedvgvyycmqriefpwtfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2206,NaN,NaN,NaN,QKY76176,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedyatyycqqsystpgtfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2207,NaN,NaN,NaN,QKY76175,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsadalpkhyaywyqqrpgqapvlviykdierpsgiperfsgsssgttvtltitgaqaedeadyycqsvdgsgssvvfgggtklavl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2208,NaN,NaN,NaN,QKY76174,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgetyvswyqqkpgqspvlviyedskrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstggvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2209,NaN,NaN,NaN,QKY76173,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssgtyfwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2210,NaN,NaN,NaN,QKY76172,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvassylawyqqkpgqaprlliygasgratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspprytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2211,NaN,NaN,NaN,QKY76171,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspgtlsvspgeratlscrasqslsshlawyqqkpgqaprlliygvstratgiparfsgsgsgteftlaisslqsedsavyycqqyhvwppitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2212,NaN,NaN,NaN,QKY76170,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrarqsisnylnwyqqkpgkapklliyaasslhsgvpsrfsgsgsgtdftltisslqpedfatyycqqtystfwtfgqgtnveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2213,NaN,NaN,NaN,QKY76169,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqprsvsgspgqsvtisctgtssdvggytyvswyqqhpgkapklmiydvnkrpsgvpdrfsgsksgitasltisglqaedeadyyccsyagrytwvfgggttltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2214,NaN,NaN,NaN,QKY76168,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkkyaywyqqksgqapvlvisedskrpsgiperfsgsssgtvatltisgaqvedeadyycystdssgnhrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2215,NaN,NaN,NaN,QKY76167,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsypltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2216,NaN,NaN,NaN,QKY76166,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyevskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyasssivvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2217,NaN,NaN,NaN,QKY76165,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratviparfsgsgsgteftltisslqsedfavyycqqynnwpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2218,NaN,NaN,NaN,QKY76164,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsadalpkqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqstdssgsyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2219,NaN,NaN,NaN,QKY76163,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsnyvywyqqlpgtapklliyssnqrpsgvpdrfsgsksgtsaslaisglrsedeadyycaawdaslsgwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2220,NaN,NaN,NaN,QKY76162,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqipgtapkllfygnnnrpsgvpdrfsdsksgtsaslaitglqaedeadyycqsydsslsawvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2221,NaN,NaN,NaN,QKY76161,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdklgdkyacwyqqkpgqspvlvihqdsqrpsgiperfsgsnsgntatltisgtqamdeadyycqawdssthvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2222,NaN,NaN,NaN,QKY76160,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvltqppsasaslgasvtltctlssgysnykvdwyqqrpgkgprfvmrvgtggivgskgdgipdrfsvlgsglnryltikniqeedesdyhcgadhgsgsnfeyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2223,NaN,NaN,NaN,QKY76159,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynfldwylqkpgqspqlliylgsnrasgvpdrfsgsgsgtdftlkisrvqaedvgvyycmqalqtpwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2224,NaN,NaN,NaN,QKY76158,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkkyahwyqqksgqapvlviyedskrpsgiperfsgsssgtmatltisgaqvedeadyyccstdssgnqrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2225,NaN,NaN,NaN,QKY76157,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspgtlsvspgeratlscrasqtlssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyhcqqynnwplafgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2226,NaN,NaN,NaN,QKY76156,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqrpgkapklliyaasslqsgvpsrfsgsgygtdftltisslqpedfatyycqqsyntprtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2227,NaN,NaN,NaN,QKY76155,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkkytywyqqksgqapvvviyedskrpsgiperfsgsssgtmatltisgaqvedeadyycystdssgkgvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2228,NaN,NaN,NaN,QKY76154,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssppytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2229,NaN,NaN,NaN,QKY76153,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspgtlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgvparfsgsgsgteftltisslqsedfavyycqqynnwppmytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2230,NaN,NaN,NaN,QKY76152,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspssvsasvgdrvtitcrasqgisswlawyqqkpgkapklliyaasslqrgvpsrfsgsgsgtdftltisslqpedfatyycqqanslpltfgggtkvevk,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2231,NaN,NaN,NaN,QKY76151,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dfvmtqspgslavslgeratincrssqsvldnssnknhlawhqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyysshwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2232,NaN,NaN,NaN,QKY76150,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcstdalpneyiywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsvdssgtyrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2233,NaN,NaN,NaN,QKY76149,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspdfqsvtpkekvtitcrasqnigsslhwyqqkpdqspkviikyasqsfsgvpsrfsgsgsgtdftltinsleaedaatyychqssslpptfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2234,NaN,NaN,NaN,QKY76148,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsksvhwyqqkpgqapvvvvyddsdrpsglperfsgsnsgntatltisrveagdeadyycqvwdsssdhwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2235,NaN,NaN,NaN,QKY76147,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwprtfgqgnrvein,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2236,NaN,NaN,NaN,QKY76146,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgvpgqrvtvsctgsssnigagfdvywyqqflgtapklliygnnnrpsgvpdrfsasksgtsaslaitglqaedeadyycqsydsslsgyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2237,NaN,NaN,NaN,QKY76145,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvltqppsasaslgasvtltctlssgysnykvdwyqqrpgkgprfvmrvgtggivgskgdgipdrfsvlgsglnryltikniqeedesdyhcgadhgsgsnfvfvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2238,NaN,NaN,NaN,QKY76144,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdinhylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftitslqpedvatyycqqsdnlpmytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2239,NaN,NaN,NaN,QKY76143,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygssplitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2240,NaN,NaN,NaN,QKY76142,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsvsgspgqsvtisctgtssdvgsynrvswyqqppgtapklmiyevsnrpsgvpdrfsgsksgntasltisglqaedeadyycssytssslrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2241,NaN,NaN,NaN,QKY76141,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsvstwlawyqqkpgkapnlliyeasslesgvpsrfsgsgsgteftltisslqpddfatyycqqyntysgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2242,NaN,NaN,NaN,QKY76140,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspssvsasvgdrvtitcrasqgisswlawyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltitslqpedfatyycqqgnsfpltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2243,NaN,NaN,NaN,QKY76139,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsysptfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2244,NaN,NaN,NaN,QKY76138,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsvstwlawyqqkpgkapnlliyeasslesgvpsrfsgsgsgteftltisslqpddfatyycqqyntysgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2245,NaN,NaN,NaN,QKY76137,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylgwyhqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhygssrstfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2246,NaN,NaN,NaN,QKY76136,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvsprqtaritcsgdalpkkyaywyqqksgqapvlviyedskrpsgiperfsgsssgtmatltisgaqvedeadyycystdtsgnhwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2247,NaN,NaN,NaN,QKY76135,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdflavslgeratisckssqsvlytpknknylawykqkpgqppkvliywastresgvpdrfsgsgsgtdftliisslqaedaavyycqqyytapltfgggtrveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2248,NaN,NaN,NaN,QKY76134,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqlitifcngsisdvggwnyvswyqqhpdkapkmmiydvrhrpsgvssrfsgsksgntasltisglqaedegdyycssftsrgalvlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2249,NaN,NaN,NaN,QKY76133,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgdynyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeaeyycssytssstllyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2250,NaN,NaN,NaN,QKY76132,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsvstwlawyqqkpgkapnlliyeasslesgvpsrfsgsgsgteftltisslqpddfatyycqqyntysgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2251,NaN,NaN,NaN,QKY76131,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvrdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsypftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2252,NaN,NaN,NaN,QKY76130,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkkyaywyqqksgqapvlviyedskrpsgiperfsgsssgtmatltisgaqvedeadyycystdssgnhwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2253,NaN,NaN,NaN,QKY76129,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sneltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdterpsgiperfsgsssgttvtltisgvqaedeadyycqstassgtyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2254,NaN,NaN,NaN,QKY76128,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpnqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssgtswvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2255,NaN,NaN,NaN,QKY76127,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydaykrdtgiparfsgsgsgtdftltisslepedfavyycqqrsnwpliftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2256,NaN,NaN,NaN,QKY76126,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvvtqspsasaslgasvkltctldsghrsyaiawhqqrpekgprflmrittdgrhtkgdgipdrfsgsgsgteryltisslqsedeadyycqtwgtfgggtrltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2257,NaN,NaN,NaN,QKY76125,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvltqppsasaslgasvtltctlssgysnykvdwfqqrpgkgprfvmrvgtggivgskgdgipdrfsvlgsglnryltikniqeedesdyhcgadhgsgsnfvyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2258,NaN,NaN,NaN,QKY76124,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynfvswhqqhpgkapknmiydvskrpsgvsnrfsgsksgntasltisglhtedeadyycssytststpwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2259,NaN,NaN,NaN,QKY76123,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqttritcsgdalpkqygywyqqkagqapilviykdserpsgiperfsgsssgttvtltisgvqaedeahyycqsgdssgtyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2260,NaN,NaN,NaN,QKY76122,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalskqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsvdrsgtyfnwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2261,NaN,NaN,NaN,QKY76121,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqtplslsvtpgqpasisckssqsllhsdgktylywylqkpgqspqlliyevsnrfsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqsiqppltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2262,NaN,NaN,NaN,QKY76120,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgrtaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgskfgntatliisrveagdeadyscqvwdsgsdhvvfgggtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2263,NaN,NaN,NaN,QKY76119,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhagkapklmiyevikrpsgvsnrfsgsksgntasltisglqaedeadyyccsyavsttyvifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2264,NaN,NaN,NaN,QKY76118,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnignkgvhwyqqkpgqapvlvvdddsdrpsgiperfsgsnsgntatliissvevgdeadfycqvwdsssdhpgvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2265,NaN,NaN,NaN,QKY76117,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qtvvtqepsltvspggtvtltcassagavtsgyypnwfqqkpgqapraliystankhswtparfsgsllggkaaltlsgvqpedeaeyycllyyggawvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2266,NaN,NaN,NaN,QKY76116,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyevskrpsgvsnrfsgsksgntasltisglqaedeadyycysyagsstwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2267,NaN,NaN,NaN,QKY76115,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwprtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2268,NaN,NaN,NaN,QKY76114,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyevskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstwgfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2269,NaN,NaN,NaN,QKY76113,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspssvsasvgdrvtitcrasqgisswlawyqqkpgkapklliydasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqansfpptfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2270,NaN,NaN,NaN,QKY76112,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppklliywastresgvpdrfsgsgsgtdftltisslqaedvavyycqqyystrtfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2271,NaN,NaN,NaN,QKY76111,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcfgdklgdkyacwfqqkpgqspvliiyqgakrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2272,NaN,NaN,NaN,QKY76110,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qlvltqspsasaslgasvkltctlssghttyaiawhqqqpekgprylmklnsdgshtrgdgipdrfsgsssgaeryltisslqsedeadyycqswdtgigvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2273,NaN,NaN,NaN,QKY76109,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgtdftltisslqsedfalyycqqynnwwrtfgqgtkvein,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2274,NaN,NaN,NaN,QKY76108,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsisswlawyqqkprkapklliykastlesgvpsrfsgsgsgteftltisslqpddfatyycqqynsysltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2275,NaN,NaN,NaN,QKY76107,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspailslspgeratlscrasqsvssylawyqqkpgqaprlliydtsnratgiparfsgsgsgtdftltisslepedfafyycqqrgnwwtfaqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2276,NaN,NaN,NaN,QKY76106,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatvsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsasgsgteftltisslqsedfavyycqqynnwppmytfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2277,NaN,NaN,NaN,QKY76105,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdiggynyvswyqqhpgkapklliydvsnrpsgvstrfsgsksgntasltisglqaedeadyycssytsssthvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2278,NaN,NaN,NaN,QKY76104,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpnqyaywyqqkpgqapvlvmckdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssgtyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2279,NaN,NaN,NaN,QKY76103,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaatslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqtystplytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2280,NaN,NaN,NaN,QKY76102,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtftcrasqgisnylawyqqkpgkvpklliyaastlqsgvpsrfsgigsgtdftltisslqpedvatyycqkynsapwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2281,NaN,NaN,NaN,QKY76101,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvsnnlawyqhkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyfcqqcynwppwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2282,NaN,NaN,NaN,QKY76100,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdigsynlvswyqqypgkapklmiyevskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyaggntfvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2283,NaN,NaN,NaN,QKY76099,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynywppltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2284,NaN,NaN,NaN,QKY76098,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiyyvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytsstlnvlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2285,NaN,NaN,NaN,QKY76097,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqspsvsvspgqtasitcsgdklgdkyacwyqqrpgqspvlviyqdsqrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstavfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2286,NaN,NaN,NaN,QKY76096,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgstsnigsntvnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgpsaslaisglqsvdeadyycaawddslngwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2287,NaN,NaN,NaN,QKY76095,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsaapgqkvtiscsgsssnignnyiswyqqlpgtapklliydnnkrpsgipdrfsgsksgtsatlgitglqtgdeadyycgtwdsslsavvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2288,NaN,NaN,NaN,QKY76094,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsypvtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2289,NaN,NaN,NaN,QKY76093,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcsgdkmgdkyacwyqqkpgqspvvviyednkrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsslvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2290,NaN,NaN,NaN,QKY76092,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nivmtqsplslpvtpgepasiscrssqsllnsngltyldwylqkpgqspqlliyfvsnrasgvsdrfsgsgsgadftltisrveaedvgvyycmqalqtpqtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2291,NaN,NaN,NaN,QKY76091,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qtvvtqepsltvspggtvtltcassagavtsgyypnwfqqkpgqapraliystankhswtlarfsgsllggkaaltlsgvqpedeaeyycllyyggawvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2292,NaN,NaN,NaN,QKY76090,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynywppltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2293,NaN,NaN,NaN,QKY76089,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhagkapklmiyevikrpsgvsnrfsgsksgntasltisglqaedeadyyccsyavsttyvifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2294,NaN,NaN,NaN,QKY76088,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvsnnlawyqhkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyfcqqcynwppwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2295,NaN,NaN,NaN,QKY76087,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspailslspgeratlscrasqsvssylawyqqkpgqaprlliydtsnratgiparfsgsgsgtdftltisslepedfafyycqqrgnwwtfaqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2296,NaN,NaN,NaN,QKY76086,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspssvsasvgdrvtitcrasqgisswlawyqqkpgkapklliydasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqansfpptfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2297,NaN,NaN,NaN,QKY76085,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtasitcfgdklgdkyacwfqqkpgqspvliiyqgakrpsgiperfsgsnsgntatltisgtqamdeadyycqawdsstvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2298,NaN,NaN,NaN,QKY76084,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdiggynyvswyqqhpgkapklliydvsnrpsgvstrfsgsksgntasltisglqaedeadyycssytsssthvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2299,NaN,NaN,NaN,QKY76083,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnignkgvhwyqqkpgqapvlvvdddsdrpsgiperfsgsnsgntatliissvevgdeadfycqvwdsssdhpgvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2300,NaN,NaN,NaN,QKY76082,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsypvtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2301,NaN,NaN,NaN,QKY76081,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqgitnylawfqqkpgkapksliyavsslqsgvpskfsgsgsgtdftltisslqpedfatyycqqynsypwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2302,NaN,NaN,NaN,QKY76080,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsnyvywyqqlpgtapklliyrnnqrpsgvpdrfsgsksgtsaslaisglrsedeadyycaawdaslsghvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2303,NaN,NaN,NaN,QKY76079,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggyhyvswyqhhpgkapkliiydvikrpsgvsnrfsgsksgntasltisglqaedeayyycssytssttwvfgggtrltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2304,NaN,NaN,NaN,QKY76078,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqditnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpedfatyycqqydnlysvhfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2305,NaN,NaN,NaN,QKY76077,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcegnnigsksvhwyqqkpgqapvlvvyddsgrpsgiperfsgsnsgntatltisrveagdeadyfcqvwdsssdhhvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2306,NaN,NaN,NaN,QKY76076,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydsgnpifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2307,NaN,NaN,NaN,QKY76075,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvseaprqrvtiscsggssnignnavnwyqqlpgkapklliyyddllpsgvsdrfsgsksgtsaslaisglqsedeadyycaswddsligpvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2308,NaN,NaN,NaN,QKY76074,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsknvhwyqqkpgqapvvvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdpvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2309,NaN,NaN,NaN,QKY76073,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisiylnwyqqkpgkapklliyaastlqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsysthmstfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2310,NaN,NaN,NaN,QKY76072,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylhwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqyhnlppitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2311,NaN,NaN,NaN,QKY76071,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdistylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnllftfgpgtkvdvk,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2312,NaN,NaN,NaN,QKY76070,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrpsqsittylnwyqqkpgkaprlliyavsslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpptfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2313,NaN,NaN,NaN,QKY76069,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qpvltqsssasaslgssvkltctlssghssyiiawhqqqpgkaprylmklegsgsynkgsgvpdrfsgsssgadcyltisnlqsedeadyycetwdsntrvfaggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2314,NaN,NaN,NaN,QKY76068,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsylgtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2315,NaN,NaN,NaN,QKY76067,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviyrdserpsgiperfsgstsgttvtltisgvqaedeadyycqsadstgwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2316,NaN,NaN,NaN,QKY76066,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsksvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdpfyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2317,NaN,NaN,NaN,QKY76065,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqditnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpedfatyycqqydnlysvhfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2318,NaN,NaN,NaN,QKY76064,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsitsylnwyqqrpgkapklliyaasslqsgvpsrfsgsgsgtdftlsisslqpedfatyycqqsyttlltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2319,NaN,NaN,NaN,QKY76063,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsiisylnwyhqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2320,NaN,NaN,NaN,QKY76062,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqvpilviydknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnavvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2321,NaN,NaN,NaN,QKY76061,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcggnnigsknvhwyqqkpgqapvlvvyddsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdssyyhpvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2322,NaN,NaN,NaN,QKY76060,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasigdrvtitcrasqnirsylnwyqhkpgkapklliyaastlqsgvpsrfsgsesgtdftltisslqpedfatyycqqsssspitfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2323,NaN,NaN,NaN,QKY76059,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsyswtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2324,NaN,NaN,NaN,QKY76058,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdafpkqygywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadsrgavfgsgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2325,NaN,NaN,NaN,QKY76057,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dfqmtqspsslsasvgdrvtitcrasqsistylnwyqqkpgkapnllifaasslhsgvpsrfsgsgsgtdftlsisslqpedfatyycqqsyssewtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2326,NaN,NaN,NaN,QKY76056,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynfvswyqqhpgkapkliiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyyctsytssstlnvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2327,NaN,NaN,NaN,QKY76055,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqvpilviydknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnavvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2328,NaN,NaN,NaN,QKY76054,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcfgdalpkqyaywyqqkpgqgpvlviykdserpsgiperfsgstsgttvtltisgvqaedeadyycqsadssgtyrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2329,NaN,NaN,NaN,QKY76053,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcstdalpneyiywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsvdssgtyphvifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2330,NaN,NaN,NaN,QKY76052,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslstsvgdrvtitcrasqsirsylnwyqqkpgkapklliyvasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystppwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2331,NaN,NaN,NaN,QKY76051,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvggynyvswyqqhpgkapklmiydvskrpsgvsnrfsgsksgntasltisglqaedeadyycssytsssipyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2332,NaN,NaN,NaN,QKY76050,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qtvvtqepsltvspggtvtltcasstgavtsgyfpnwfqqkpgqapralifstnnrhswtparfsgsllgdkaaltlsgvqpedeaeyycllyyggpwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2333,NaN,NaN,NaN,QKY76049,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasigdrvtitcrasqsisswlawyqqipgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsypytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2334,NaN,NaN,NaN,QKY76048,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqyanlpftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2335,NaN,NaN,NaN,QKY76047,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisnylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdfsltisslqpedfatyscqqsyttlltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2336,NaN,NaN,NaN,QKY76046,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyhqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssgtsvlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2337,NaN,NaN,NaN,QKY76045,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvsnnlawyqqkpgqaprlliygastratgipvrfsgsgsgteftltisslqsedfavyycqqyddwppevtfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2338,NaN,NaN,NaN,QKY76044,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdterpsgiperfsgsssgttvtltisgvqaedeadyycqsadssgsrfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2339,NaN,NaN,NaN,QKY76043,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsnyvywyqqlpgtapkllisrnnqrpsgvpdrfsgsksgtsaslaisglrsedeadyycaawddslsswvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2340,NaN,NaN,NaN,QKY76042,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdawpnqyaywyqqkpgqapvlviykdterpsgiperfsgsssgttvtltisgvqaedeadyfcqssdssgvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2341,NaN,NaN,NaN,QKY76041,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyqqkagkapklliydasnletgvpsrfsgsgsgtdftftisslqpddiatyycqqydnlplafgpgtkvdvk,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2342,NaN,NaN,NaN,QKY76040,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsvsiylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltvsslqpedfatyycqqsysmppitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2343,NaN,NaN,NaN,QKY76039,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcegnnigsksvhwyqqkpgqapvlvvyddsgrpsgiperfsgsnsgntatltisrveagdeadyfcqvwdsssdhhvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2344,NaN,NaN,NaN,QKY76038,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydsgnpifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2345,NaN,NaN,NaN,QKY76037,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsysnpsytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2346,NaN,NaN,NaN,QKY76036,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwpprtwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2347,NaN,NaN,NaN,QKY76035,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktaritcegnnigsksvhwyqqkpgqapvlvvyddsgrpsgiperfsgsnsgntatltisrveagdeadyfcqvwdsssdhhvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2348,NaN,NaN,NaN,QKY76034,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqhrsnwpprltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2349,NaN,NaN,NaN,QKY76033,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqyanlpftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2350,NaN,NaN,NaN,QKY76032,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslksgvpsrfggsgsgtdftltisslqpedfatyycqqsyemppwtfgqgtkveie,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2351,NaN,NaN,NaN,QKY76031,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcstdalpneyiywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsvdssgtyphvifgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2352,NaN,NaN,NaN,QKY76030,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpkqyaywyqqkpgqapvlviykdserpsgiperfsgsssgttvtltisgvqaedeadyycqsadssaayvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2353,NaN,NaN,NaN,QKY76029,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpddiatyycqqydnlplafgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2354,NaN,NaN,NaN,QKY76028,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqppsvsvspgqtaritcsgdalpnqyaywyhqkpgqapvvviykdserpsgipqrfsgsssgttvtltisgvqaedeadyycqsadssgyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2355,NaN,NaN,NaN,QKY76027,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttvisednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydginrawvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2356,NaN,NaN,NaN,QKY76026,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhsngynyldwylqkpgqspqlliylgstrasgvpdrfsgsgsgtdftlkisrveaedvgvyycmqalqtplytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2357,NaN,NaN,NaN,QKY76025,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsacvgdrvtitcrasqsissylnwyqqkpgkgpklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsysslsitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2358,NaN,NaN,NaN,QKY76024,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syvltqppsvsvapgktasitcegnnigsksvhwyqqkpgqapvlviyydsdrpsgiperfsgsnsgntatltisrveagdeadyycqvwdsssdrlyvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2359,NaN,NaN,NaN,QKY76023,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtfsctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydginrwlvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2360,NaN,NaN,NaN,QKY76022,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctrssgsiassyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydssdvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2361,NaN,NaN,NaN,QKY76021,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslesgvpsrfsgsgsgtdftltisslqpedfatyycqqsyeippwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2362,NaN,NaN,NaN,QKY76020,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dvvmtqsplslpvtlgqpasiscrssqslvysdgntylnwfqqrpgqsprrliykvssrdsgvpdrfsgsgsgtaftlkisrveaedvgvyycmqgthwpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2363,NaN,NaN,NaN,QKY76019,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdisnylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqyanlpftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2364,NaN,NaN,NaN,QKY76018,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasigdrvtitcrasqsisswlawyqqipgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsypytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2365,NaN,NaN,NaN,QKY76017,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglmtedeadyycqsydgsnhavvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2366,NaN,NaN,NaN,QKY76016,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqsvtiscsgsssnignnkvnwyqqlpgtapkvliynsnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycavwddslhsyvfgtetkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2367,NaN,NaN,NaN,QKY76015,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,dmevtqfpsslsasigdrvtitcratqsistylnwyqqkpgkapnlliysashlqrgvparfsgsgsgteftltittlqpedvgtyychqsygvpitfgggtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2368,NaN,NaN,NaN,QKY76014,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgervtlscrasqsvssnlawcqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqyynwpltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2369,NaN,NaN,NaN,QKY76013,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslesgvpsrfsgsgsgtdftltisslqpedfatyycqqsyeippwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2370,NaN,NaN,NaN,QKY76012,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapklliynnnqrpsgvpdrlsgsksgtsaslaisglqsedeadyycatwddslngpvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2371,NaN,NaN,NaN,QKY76011,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsysnpsytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2372,NaN,NaN,NaN,QKY76010,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylgwyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2373,NaN,NaN,NaN,QKY76009,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsacvgdrvtitcrasqsissylnwyqqkpgkgpklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsysslsitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2374,NaN,NaN,NaN,QKY76008,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqprsvsgspgqsvtisctgtssdvggynyvswyqqhpgkapklmiydvskrpsgvpdrfsgsksgntasltisglqaedeadyyccsyagiwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2375,NaN,NaN,NaN,QKY76007,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhygssrgwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2376,NaN,NaN,NaN,QKY76006,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrryyaswyqqkpgqapvlviygknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnprwfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2377,NaN,NaN,NaN,QKY76005,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqvpilviydknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnavvfgggtkltva,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2378,NaN,NaN,NaN,QKY76004,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssflawyqqkpgqaprlliygasnratgipdrfsgsgsgtdftltisrlepedfavyycqqygnspqfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2379,NaN,NaN,NaN,QKY76003,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklllyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystppwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2380,NaN,NaN,NaN,QKY76002,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqekpgqaprllmysassratgipdrfsgsgsatdftltinrlepedfavyycqqyveppftfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2381,NaN,NaN,NaN,QKY76001,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsrynigsnyvywyqqlpgtaprlliysnnqrpsgvpdrfsgsksgtsaslaisglrsedeadyycaawddslsglifgggtkltvq,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2382,NaN,NaN,NaN,QKY76000,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syelaqppsvsvapgetatifcratyigrknvqwyqqkpgqapvlvvyddsdrpsgipgrfsgsnsgdtatltisrieagdeaayycqvwdgindrvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2383,NaN,NaN,NaN,QKY75999,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdirnylnwyqqkpgkapelliydasnletgvpsrfsgsgsgtdfiftisslqpediatyychqydylpytfgqgtkldik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2384,NaN,NaN,NaN,QKY75998,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsaapgqkvtiscsgsssnignnyvswyqqlpgtapklliydnnerpsgipdrfsgsksgtsatlgitglqtgdeadyycgtwdsslsayvfgtgtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2385,NaN,NaN,NaN,QKY75997,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlalsvgeratlscvasqrvssdyiawyqkkpglaprllvyhgsawatgssarfsgsgsgtaftltisslepedfavyycqqygnspftfgpgtkvefk,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2386,NaN,NaN,NaN,QKY75996,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtfsctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydginrwlvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2387,NaN,NaN,NaN,QKY75995,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgisnylawyqqkpgtapnlliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqllnshpltfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2388,NaN,NaN,NaN,QKY75994,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtfsctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydginrwlvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2389,NaN,NaN,NaN,QKY75993,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspstlsasvgdrvtitcrasqsisswlawyqqkpgkapklliykasslesgvpsrfsgsgsgteftltisslqpddfatyycqqynsysytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2390,NaN,NaN,NaN,QKY75992,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisnylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdfsltisslqpedfatyscqqsyttlltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2391,NaN,NaN,NaN,QKY75991,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigsgsdvhwyqqlpgtapklliygntnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsrlsgfvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2392,NaN,NaN,NaN,QKY75990,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspprytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2393,NaN,NaN,NaN,QKY75989,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyarsstrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2394,NaN,NaN,NaN,QKY75988,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgitasltisglqaedeadyyccsyagsstwlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2395,NaN,NaN,NaN,QKY75987,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpgtapkllifgntnrpsgvpdrfsgsksgtstslaitglqaedeadyycqsydsslngdvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2396,NaN,NaN,NaN,QKY75986,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgshgqsitisctgtssdvgsynlvswyqqhpgkapklmiyevskrpsgvsnrfsgstsgntasltisglqaedeadyyccsyagivlfgggtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2397,NaN,NaN,NaN,QKY75985,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqniasylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpeefatyycqqsystpwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2398,NaN,NaN,NaN,QKY75984,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnsnigsytvnwyqqlpgtapkllifgnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycvawddsrnglvfgggakltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2399,NaN,NaN,NaN,QKY75983,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspssvsasvgdrvtitcrasqgisswlawyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqtnsfptfgqgtrleir,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2400,NaN,NaN,NaN,QKY75982,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgnsgsiasnyvqwyqqrpgsapttviyedsqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsfdsgnvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2401,NaN,NaN,NaN,QKY75981,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgtsaslaisglqsedennyycavwddslngvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2402,NaN,NaN,NaN,QKY75980,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyevskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyvgsstyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2403,NaN,NaN,NaN,QKY75979,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgisnylawyqqkpgtapnlliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqllnshpltfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2404,NaN,NaN,NaN,QKY75978,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklmiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsstwlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2405,NaN,NaN,NaN,QKY75977,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnsnigsytvnwyqqlpgtapklliydnnqrtsgvpdrlsgsksgtsaslaisglqsedeanyycavwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2406,NaN,NaN,NaN,QKY75976,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtlsctgsnsnigagydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsdsvfgggtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2407,NaN,NaN,NaN,QKY75975,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslhsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2408,NaN,NaN,NaN,QKY75974,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpetapklliyansnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgsvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2409,NaN,NaN,NaN,QKY75973,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqniasylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpeefatyychqsyftpqtfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2410,NaN,NaN,NaN,QKY75972,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qslltqppsvsgapgqrvtlscagatsnigagsdvhwyqqlpgtapklliyyntnrpsgvpdrfsgsksatsaslvitglqtedeadyycqsydislggwvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2411,NaN,NaN,NaN,QKY75971,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdiskylnwyqqkpgkapklliydasnlergvpsrfsgsgsgtdftftisslqaediatyycqqyhnlprtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2412,NaN,NaN,NaN,QKY75970,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvseaprqrvtiscsgsssnignnavnwyqqlpgkapklliyyddllpsgvsdrfsgsksgtsaslaisglqsedeadyycaawddslngvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2413,NaN,NaN,NaN,QKY75969,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtfscsgsnsnigsytvnwyqqlpgtapklliydnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycavwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2414,NaN,NaN,NaN,QKY75968,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqppsasgspgqsvtisctgtssdvgtynyvswyqqhpgkapklmiyevskrpsgvpdrfsgsksgntasltvsglqaedeaeyycsayagsnnlvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2415,NaN,NaN,NaN,QKY75967,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsnslnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslngswvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2416,NaN,NaN,NaN,QKY75966,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsiagylnwyqqkpgkapklliygttslqsgvpvrfsgsgsgtdftltisslqpedfatyycqqsystpgtfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2417,NaN,NaN,NaN,QKY75965,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssnigsntvnwyqqlpgtapklliynnnqrpsgvpdrlsgsksgtsaslaisglqsedeadyycvawddsrnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2418,NaN,NaN,NaN,QKY75964,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqniasylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpeefatyycqqsystpwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2419,NaN,NaN,NaN,QKY75963,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylgwyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlesedfalyycqqynnwwrtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2420,NaN,NaN,NaN,QKY75962,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnsnigsytvnwyqqfpgtapklliydnnqrtsgvpdrfsgsksgtsaslaisglqsedeanyyclvwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2421,NaN,NaN,NaN,QKY75961,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnsnigsytvnwyqqfpgtapklliydnnqrtsgvpdrfsgsksgtsaslaisglqsedeanyyclvwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2422,NaN,NaN,NaN,QKY75960,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgervtlscrasqsvssnlawcqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqyynwpltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2423,NaN,NaN,NaN,QKY75959,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpetapklliyansnrpsgvpdrfsgsksgtsaslaisglqseaeadyycvawddsrnglvfgggakltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2424,NaN,NaN,NaN,QKY75958,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqapsasgtpgqrvtiscsgsnsnigsytinwyqqlpgtapklliygndqrtsgvpdrfsgskfgtsaslaisglqsedennyycavwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2425,NaN,NaN,NaN,QKY75957,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,syeltqpssvsvspgqtaritcsgdvlaknyarwfqqkpgqapvlviykdserpsgipkrfsgsssgttvtltisgaqvedeadyycysaadnnrvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2426,NaN,NaN,NaN,QKY75956,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrviiscsgsssnigsntvkwyhqlpgtapkllicsnnqrpsgvpdrfsgsksdtsaslaisglqsedeadyycaawddslnalvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2427,NaN,NaN,NaN,QKY75955,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsistylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedyatyycqqsystpgltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2428,NaN,NaN,NaN,QKY75954,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliydasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystppitfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2429,NaN,NaN,NaN,QKY75953,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsiagylnwyqqkpgkapklliygttslqsgvpvrfsgsgsgtdftltisslqpedfatyycqqsystpgtfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2430,NaN,NaN,NaN,QKY75952,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvtitcqgdslrshyaswykvkpgqapllviygrnnrpsgipdrfsgsrsgntasltitgaqvddeadyycssgdsstdhhvvfaggtklavv,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2431,NaN,NaN,NaN,QKY75951,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsacvgdrvtitcrasqsissylnwyqqkpgkgpklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2432,NaN,NaN,NaN,QKY75950,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtlsctgsnsnigagydvhwyqqlpgtapklliygnsnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsdsvfgggtkvtvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2433,NaN,NaN,NaN,QKY75949,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsssniesnsvnwyqqlpgtapklliysnnqrpsgvpdrfsgsksgtsaslaisglqsedeadyycaawddslngvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2434,NaN,NaN,NaN,QKY75948,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigagydvhwyqqlpetapklliyansnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsslsgsvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2435,NaN,NaN,NaN,QKY75947,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqsplslpvtpgepasiscrssqsllhslgynslswylqkpgqsphlliylgsnrasgvpdrfsgsgsatdftlkisrleaedvgvyycmqalqtpltfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2436,NaN,NaN,NaN,QKY75946,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtssdvgsynlvswyqqhpgkapklkiyegskrpsgvsnrfsgsksgntasltisglqaedeadyyccsyagsvlfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2437,NaN,NaN,NaN,QKY75945,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdinnylnwyqqkpgkapklliydasnletgvplrfsgsgsgtdftftisslqpediatyycqqydnlppvfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2438,NaN,NaN,NaN,QKY75944,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisnylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdfsltisslqpedfatyscqqsyttlltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2439,NaN,NaN,NaN,QKY75943,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigsgsdvhwyqqlpgtapklliygntnrpsgvpdrfsgsksgtsaslaitglqaedeadyycvawddsrnglvfgggakltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2440,NaN,NaN,NaN,QKY75942,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissflnwyqqkpgkapklliyaafnlqsgvpsrfsgsgsgtdftltisslqsedfatyycqqsyntpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2441,NaN,NaN,NaN,QKY75941,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,etvltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhygssrgwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2442,NaN,NaN,NaN,QKY75940,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslesgvpsrfsgsgsgtdftltisslqpedfatyycqqsyeippwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2443,NaN,NaN,NaN,QKY75939,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeraslscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspftfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2444,NaN,NaN,NaN,QKY75938,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsissflawyqqkpgqaprlliydasnratgiparfsgsgsgtdftltisslepedfavyycqrrsnwppftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2445,NaN,NaN,NaN,QKY75937,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgeratlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgsgsgteftltisslqsedfavyycqqynnwppmytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2446,NaN,NaN,NaN,QKY75936,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydstsrvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2447,NaN,NaN,NaN,QKY75935,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttvisednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydginrawvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2448,NaN,NaN,NaN,QKY75934,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydssnywvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2449,NaN,NaN,NaN,QKY75933,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nfmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydsskyvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2450,NaN,NaN,NaN,QKY75932,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasagdrvtitcrasqsiryylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfaayycqqsfstprtfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2451,NaN,NaN,NaN,QKY75931,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,nlmltqphsvsespgktvtisctgssgsiasnyvqwyqqrpgsapttviyednqrpsgvpdrfsgsidsssnsasltisglktedeadyycqsydsnnqvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2452,NaN,NaN,NaN,QKY75930,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdinnylnwyqqkpgkapklliydasnletgvplrfsgsgsgtdfiftisslqpediatyycqqydnlppvfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2453,NaN,NaN,NaN,QKY75929,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspatlsvspgerailscrasqsvrsnlawyqqkpgqaprllisgastrataiparfsgsgsgteftltitslqsedcavyychqynnwpqtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2454,NaN,NaN,NaN,QKY75928,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,viqmtqspsslsasvgdrvtitcqasqdinkylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqyanlpftfgpgtkvdik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2455,NaN,NaN,NaN,QKY75927,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscgasqsisssylawyqqkpgqaprlliygassraagipdrfsgsgsgtdftltisrlepedfavyfcqqyggsltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2456,NaN,NaN,NaN,QKY75926,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsisrylnwyqqkpgkapklliytasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystprtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2457,NaN,NaN,NaN,QKY75925,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspatlslspgeratlscrasqsvssylawyqqkpgqaprlliydtsnratgiparfsgsgsgtdftltisslepedfavyycqqrsnwppytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2458,NaN,NaN,NaN,QKY75924,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,viqmtqspsslsasvgdrvtitcqasqdinkylnwyqqkpgkapklliydasnletgvpsrfsgsgsgtdftftisslqpediatyycqqydnlprtfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2459,NaN,NaN,NaN,QKY75923,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsvsgapgqrvtisctgsssnigsgsdvhwyqqlpgtapklliygntnrpsgvpdrfsgsksgtsaslaitglqaedeadyycqsydsrlsgfvvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2460,NaN,NaN,NaN,QKY75922,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdinnylnwyqqksgkapklliydasnletgvpsrfsgsgsgtdftftinslqpediatyycqqydnlpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2461,NaN,NaN,NaN,QKY75921,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspatlsvspgerailscrasqsvrsnlawyqqkpgqaprllisgastrataiparfsgsgsgteftltitslqsedcavyychqynnwpqtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2462,NaN,NaN,NaN,QKY75920,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsaltqpasvsgspgqsitisctgtgsdvggsnyvswyqqhpgkapklmiydvsnrpsgvsnrfsgsksgntasltisglqaedeadyycssytssstlvlfgggtklsvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2463,NaN,NaN,NaN,QKY75919,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgissylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsysfetfgpgtkvaik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2464,NaN,NaN,NaN,QKY75918,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcqasqdinnylnwyqqkpgkapklliydasnletgvplrfsgsgsgtdftftisslqpediatyycqqydnlppvfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2465,NaN,NaN,NaN,QKY75917,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnsnigsytvnwyqqfpgtapklliydnnqrtsgvpdrfsgsksgtsaslaisglqsedeanyyclvwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2466,NaN,NaN,NaN,QKY75916,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgisnylawyqqkpgtapnlliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqllnshpltfgqgtrleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2467,NaN,NaN,NaN,QKY75915,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrvtiscsgsnsnigsytvnwyqqfpgtapklliydnnqrtsgvpdrfsgsksgtsaslaisglqsedeasyyclawddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2468,NaN,NaN,NaN,QKY75914,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqvpilviydknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnavvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2469,NaN,NaN,NaN,QKY75913,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqltqspsflsasvgdrvtitcrasqgistylawyqqkpgkapklliyaastlqsgvpsrfsgsgsgteftltisslqpedfatyycqqlnsypgytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2470,NaN,NaN,NaN,QKY75912,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqvpilviydknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnavvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2471,NaN,NaN,NaN,QKY75911,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqtplslsvtpgqpasfsckssqsllhsdgktylywylqkpgqspqlliyavsnrfsgvpdrfsgsgsgtdftlkisrveaedvgvyycmqsiqlpytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2472,NaN,NaN,NaN,QKY75910,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqrpgkapklliyaasslqsgvpsrfsgsgsgtdftltistlqpedfatyycqqsystllytfgqgtkleik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2473,NaN,NaN,NaN,QKY75909,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,divmtqspdslavslgeratinckssqsvlyssnnknylawyqqkpgqppkllmywastresgvpdrfsgsgsgaeftltisslqaedvaiyycqqyystltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2474,NaN,NaN,NaN,QKY75908,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqppsasgtpgqrviiscsgsssnigsntvkwyhqlpgtapkllicsnnqrpsgvpdrfsgsksdtsaslaisglqsedeadyycaawddslnalvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2475,NaN,NaN,NaN,QKY75907,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,diqmtqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapkvliyaastmqsgvpsrfrgsgsgtdftltisslqledfatyycqqsystpqtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2476,NaN,NaN,NaN,QKY75906,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,qsvltqapsasgtpgqrvtiscsgsnsnigsytinwyqqlpgtapklliygndqrtsgvpdrfsgskfgtsaslaisglqsedennyycavwddslnglvfgggtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2477,NaN,NaN,NaN,QKY75905,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivmtqspatlsvspgervtlscrasqsvssnlawyqqkpgqaprlliygastratgiparfsgggsgteftltisslqsedfavyycqqynnfltfgggtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2478,NaN,NaN,NaN,QKY75904,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,evvltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyhcqhfgsssqwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2479,NaN,NaN,NaN,QKY75903,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylawyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqhygssrgwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2480,NaN,NaN,NaN,QKY75902,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,sseltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqapllviygknnrpsgipdrfsgsssgntpsltitgaqaedeadyycnfrdssghhpvfgegtkltvl,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2481,NaN,NaN,NaN,QKY75901,"SARS-CoV-2, Spike protein",Homo sapiens (human),NaN,eivltqspgtlslspgeratlscrasqsvsssylgwyqqkpgqaprlliygassratgipdrfsgsgsgtdftltisrlepedfavyycqqygsspwtfgqgtkveik,"Zost,S.J. et al.; Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein; bioRxiv (2020); 2020.",NaN,"anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2482,NaN,NaN,QKQ15231,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesraemkkpgeslkisckgsgytftnhwiawvrqmpgkglewmgiiypgdsdtryspsfegqvtisadksistaylqwsslkasdtamyycarrgytygadfygldvwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2483,NaN,NaN,QKQ15230,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakmgpdpahdygrkndafdiwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2484,NaN,NaN,QKQ15229,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslrlscaasgfiftnywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycarerylttdgwfdpwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2485,NaN,NaN,QKQ15228,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdnaknslylqmnslraedtalyycakaepevggydyymdvwgkgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2486,NaN,NaN,QKQ15227,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesraevkkpgssvkvsckasggtfssyaiswvrqapgqglewmgriipilgitnyaqkfqgrvtitadkststaymelsslrsedtavyycardapdyydssgptyfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2487,NaN,NaN,QKQ15226,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycataysvdtamvrgvgywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2488,NaN,NaN,QKQ15225,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarvgsvkstagydfwsgdpfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2489,NaN,NaN,QKQ15224,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyamswvrqapgkglewvstisgsggntyyadsvkgrftisrdnskntlylqmnslraedtavyycakeiavagcfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2490,NaN,NaN,QKQ15223,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycardweeqwlvafdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2491,NaN,NaN,QKQ15222,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargpaatyyyymdvwgkgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2492,NaN,NaN,QKQ15221,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpgrslrlscaasgftfddyamhwvrqapgkglewvsgiswnsgsigyadsvkgrftisrdsaknslylqmnslraedtalyycakvatyyydrsgyyyggaldywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2493,NaN,NaN,QKQ15220,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctasggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarhpsglyqllnwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2494,NaN,NaN,QKQ15219,NaN,SARS-CoV-2,Homo sapiens (human),evqllesgaevkkpgasvkisckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycargdgdyydssgyyrptlynwldpwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2495,NaN,NaN,QKQ15218,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsykyyadsvkgrftisrdnskntlylqmnsltaedtavyycaregsrqwlviyfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2496,NaN,NaN,QKQ15217,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqpgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngdtnyaqklqgrvtmttdtststaymelrslksddtavyycarfdygypysswsvlsidywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2497,NaN,NaN,QKQ15216,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsqtlsltctvsgasitsggyywtwirqhpgkglewigyiyysgssfynpslmsrvsisvdtskkqfslklrsvtaadtavyycakegsgggsqnwfdlwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2498,NaN,NaN,QKQ15215,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscsasgftfsnynmdwvrqapgkglewvssisssssyiyladsvkgrftisrdnaknslylqmnslraedtavyycarvqkdivvvpvaladyyyygmdvwgqgttvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2499,NaN,NaN,QKQ15214,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsgtlsltcavsggsisssnwwswvrqppgkglewigeiyhsgssnynpslksrvtisvdksknqfslklnsvtaadtavyycagrycsggrcgwfdpwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2500,NaN,NaN,QKQ15213,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvetgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviytggttyyadsvkgrftisrdnskntlylqmnslraedtavyycarahvdtamvesgafdiwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2501,NaN,NaN,QKQ15212,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqsgpglvkpsetlpltctvsggsissssyywgwirqppgkglewigsvfysgstyynpslksrvtisvdtsknqlslklssvtaadtavyycarqvrqwleddafdiwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2502,NaN,NaN,QKQ15211,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgasvkvsckvsgytlpelsmhwvrqapgkgldwmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatspavmsvgwvdpwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2503,NaN,NaN,QKQ15210,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywidwvrqmpgkglewmgifypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarhnpdyydssgpldywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2504,NaN,NaN,QKQ15209,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgggvvqpgrslrlscaasgftfsiygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnsknmvylqmnslraddtavyycardgsnescsggfcsdswgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2505,NaN,NaN,QKQ15208,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsasgsyygafdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2506,NaN,NaN,QKQ15207,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgeslrisckgsgysftshwiswvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycarlkvitifgvvrddygmdvwgqgttvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2507,NaN,NaN,QKQ15206,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgratittdeststaymelsslgsedtavyycarthsydnsgqyfdywgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2508,NaN,NaN,QKQ15205,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgvevkkpgasvkvsckafgytftgqdmhwvrqapgqglewmgwinpssagtnyaqkfqgrvtmtrdtsistaymelsrlrsddtsvyycrkmltifgkvnqtmlliswgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2509,NaN,NaN,QKQ15204,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpglvkpsqtlsltctvsggsissgdyywswirqppgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycargvedpvvpaaipwcwfdpwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2510,NaN,NaN,QKQ15203,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssytmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaslpvvpaaigplpafdiwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2511,NaN,NaN,QKQ15202,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmdslraedtamyycakdkappcssgwyyfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2512,NaN,NaN,QKQ15201,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgytftsydinwvrqatgqglewmgwmnpnsgntgyaqkfqgrvtmtrntsistaymelsslrsedtavyycarvvgsswypvdafdiwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2513,NaN,NaN,QKQ15200,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdrgdsygyyycmdvwgkgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2514,NaN,NaN,QKQ15199,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgasvkvsckvsgytlpelsmhwvrqtpgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatgptiaaaatnwfdpggqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2515,NaN,NaN,QKQ15198,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslrisckgsgysftsywiswvrqmpgkglewmgridpsdsytnyspsfqghvtisadksistaylqwsslkasdtamyycarpnpaggydssgwvdafdiwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2516,NaN,NaN,QKQ15197,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtittdeststaymelsslrsedtavyycargprycsstscyagvyfdywgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2517,NaN,NaN,QKQ15196,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpglvkpsetlsltctvsggsissyywswirqpagkglewigriytsgstnynpslksrvtmsvdtsknqfslklssvtaadtavyycarwkyndrfdywgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2518,NaN,NaN,QKQ15195,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslipssvtaadtavyycarggelphynwfdpwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2519,NaN,NaN,QKQ15194,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycaspllltppdyyyymdvwgkgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2520,NaN,NaN,QKQ15193,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsysiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycasvvggriaaagclgywgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2521,NaN,NaN,QKQ15192,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgttnyaqkfqgrvtittdeststaymelsslrsedtavyycarvysydssgyyleywgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2522,NaN,NaN,QKQ15191,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgaevkkpgssvkvsckasggtfssyginwvrqapgqglewmggiipifgtanyaqkfqgrvtittdeststaymelsslrsedtavyycasfgddsgdegvrwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2523,NaN,NaN,QKQ15190,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgatvkisckvsgytftdyymhwvqqapgkglewmglvdpedgetiyaekfqgrvtitadtstdtaymelsslrsedtavyycassdssgfvgsrgfdywgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2524,NaN,NaN,QKQ15189,NaN,SARS-CoV-2,Homo sapiens (human),qvqllesggglvqpggslrlscaasgftfssyamswvrqapgkglewasaisgsggstyyadsvegrftisrdnskntlylqmnslraedtavyycakdtgycgddcyiklirggpdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2525,NaN,NaN,QKQ15188,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssyaiiwvrqapgqglewmggiipifgtanyaqkfqgrvtittdeststaymelsslrsedtavyycarvryydssgyyedywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2526,NaN,NaN,QKQ15187,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvetgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardldtmggmdvwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2527,NaN,NaN,QKQ15186,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfgsysmswvrqapgkglewvssisrsssyiynadsvrgrltisrdnaknslylqmnslrvedtavyycardqplpdiltgyytgpldywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2528,NaN,NaN,QKQ15185,NaN,SARS-CoV-2,Homo sapiens (human),vqtggilgaevkkpgpsvkvscqagrapsssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtittdeststaymelsslrsedtavyycargprgcsstscygsyfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2529,NaN,NaN,QKQ15184,NaN,SARS-CoV-2,Homo sapiens (human),evqllesggglvqpggslklscaasgftfssyamswvrqapgkglewvsaisgsgsntyyadsvkgrftisrdnskntlylqmnslraedtavyycakglrgqqlvipteyfqhwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2530,NaN,NaN,QKQ15183,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqqwgagllkpsetlsltcavsggsfsnyywtwirqppgkglewigeidhsgstnynpslksrvtisvdtsknqfslwlssvtaadtavyycargrnyvlqfsewphprahfdnwgqgtlvtiss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2531,NaN,NaN,QKQ15182,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfsryamywvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarviggnyfgafdiwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2532,NaN,NaN,QKQ15181,NaN,SARS-CoV-2,Homo sapiens (human),evqlvetgggliqpggslrlscaasgltvssnymnwvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycareaygmdvwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2533,NaN,NaN,QKQ15180,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlpltctvsggsissfywswirqppgkglewigyihnngntnynpslksrvtmsidtsknqfslklssvtaadaavyycarggwsldswgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2534,NaN,NaN,QKQ15179,NaN,SARS-CoV-2,Homo sapiens (human),evqllesgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarhmrpsiaarpgyqyymdvwgkgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2535,NaN,NaN,QKQ15178,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvetgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnskntlylqmnslraedtavyycardleraggmdvwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2536,NaN,NaN,QKQ15177,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssysmnwvrqapgkglewvsyissssstiyyadsvkgrftisrdnaknslylqmnslraedtavyycareansdfwsgylgyfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2537,NaN,NaN,QKQ15176,NaN,SARS-CoV-2,Homo sapiens (human),vqlqqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarrstsrwgyyymdvwgkgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2538,NaN,NaN,QKQ15175,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssydmhwvrqttgkglqwvsaigtagdtyypgsvkgrftisrenaknslylqmnslragdtavyycarggdrypvgyfdlwgrgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2539,NaN,NaN,QKQ15174,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgytftsyamhwvrqapgqrlewmgwinagngntkysqkfqgrvtitrdtsastaymelsslrsedtpvyycarhnraeewepgfdiwgqgttvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2540,NaN,NaN,QKQ15173,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsqtlsltctvsggsissggyywswirqlpgkglewigyiyysgstyynpslksrvtisvdtsknqfslnlssvtaadtavyycarqqldyydssgcfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2541,NaN,NaN,QKQ15172,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgpglvkpsetlsltctvsggsisstsyywgwirqppgkglecigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarlnydfwsgyysyalyymdvwgkgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2542,NaN,NaN,QKQ15171,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgeslkisckgsgyrfttywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwssltasdtaiyycaryyydsrgytsidfwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2543,NaN,NaN,QKQ15170,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardpppddssgwtmgyfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2544,NaN,NaN,QKQ15169,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngytnsaqklqgrvtmttdtststaymelrslrsddtavyycardlvdtamvqtlddygmdvwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2545,NaN,NaN,QKQ15168,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdntkntlylqmnslraedtavyycardseyydiltgylapthyyyyymdvwgkgttvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2546,NaN,NaN,QKQ15167,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrddaknslflqmnslraedtavyycagdqnlycsgdscyyhyygmdvwgqgtvvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2547,NaN,NaN,QKQ15166,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssfiyyadsvkgrftisrdnaknslylqmnslraedtavyycarwksdyydssgyypaafdiwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2548,NaN,NaN,QKQ15165,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarvewaaagtfywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2549,NaN,NaN,QKQ15164,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyyihwvrqapgqglewmgwinpnsgttnyaqrfqgrvtmtrdtsistaymelsrlrsddtavyycareavaarpgnfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2550,NaN,NaN,QKQ15163,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinssggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycarpprnyydrsgyyqraeyfqhwgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2551,NaN,NaN,QKQ15162,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssnamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntmylqmnslraedtavyycarprggnylagfdpwgqgtrvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2552,NaN,NaN,QKQ15161,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsggsmnlyywiwirqppgkglewigyvyytgstnynpslksrvtmsvdtsksqfslkmsavtaadtavyycarrgevngyrgafdiwgqgarvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2553,NaN,NaN,QKQ15160,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnrlraedtavyycaretptstyssgwynyyyymdvwgkgttvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2554,NaN,NaN,QKQ15159,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgtevkkpgasvkvsckasgytfpgyyihwvrqapgqglewmgwinpnsgvaksaqkfqgrvtmtrdssistvyldvtsddtavyycardlvwatvsgtmdvwgqgttvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2555,NaN,NaN,QKQ15158,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsasgsyygafgywgqrtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2556,NaN,NaN,QKQ15157,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvtstymtwvrrapgkglewvsiiynddttyyadsvkdrvtvsrddskntlylqmnslraedtaiyycarggyyydpsgyysrsfsfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2557,NaN,NaN,QKQ15156,NaN,SARS-CoV-2,Homo sapiens (human),qlqlvesgpglvkpsetlsltctvsggsissyfwswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycarhsqgwlqqavafdiwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2558,NaN,NaN,QKQ15155,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpggslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaredyydssgsfdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2559,NaN,NaN,QKQ15154,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgaevkkpgssvkvsckasggtlssyaitwvrqapgqglewvggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycarvgaydssgysndywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2560,NaN,NaN,QKQ15153,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsggglvqpgrslrlscaasgftfgeyamhwvrqapgkglewvsgiswnsgsidyadsvkgrftisrdnaknslylqmnslraedtalyycakdmgeavagthygmdvwgqgtmvtass,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2561,NaN,NaN,QKQ15152,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatsrvrgvsnwfdpwgqgtpitiss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2562,NaN,NaN,QKQ15151,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycaripgydssgyyrgdywgqgtlvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2563,NaN,NaN,QKQ15150,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdgqyydfwsgylgartnphyyyymdvwgkgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2564,NaN,NaN,QKQ15149,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsiyamhwvrqapgkglewvavisydgsnqyyadsvrgrftisrgnskntlylqmnslrpedtavyycararggsyndafdiwgqgtmvtvss,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2565,NaN,NaN,QKQ15148,NaN,SARS-CoV-2,Homo sapiens (human),hqhqveqgpggveqsetlfltccvsggftisscykrggirqpprkgeewavssyyssstyytpslksrvtisvdksknqfslkmssvtaadtavyycarvssgyyftpfdywgqgtrghrlf,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","anti-SARS-CoV-2 monoclonal antibody heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2566,NaN,NaN,QJU69682,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstfyadsvkgrftisrdnsmntlflqmnslraedtavyycarvlpmygdyldywgqgtlvtvssastkgpsvfplapsskstsggtaalgclvkdyfpepvtvswnsgaltsgvhtfpavlqssglyslssvvtvpssslgtqtyicnvnhkpsntkvdkrvepkscdkthtcppcpapellggpsvflfppkpkdtlmisrtpevtcvvvdvshedpevkfnwyvdgvevhnaktkpreeqynstyrvvsvltvlhqdwlngkeykckvsnkalpapiektiskakgqprepqvytlppsrdeltknqvsltclvkgfypsdiavewesngqpennykttppvldsdgsfflyskltvdksrwqqgnvfscsvmhealhnhytqkslslspgk,NaN,"Shi,R. et al.; A potent human neutralizing monoclonal antibody targeting the receptor binding site of SARS-CoV-2 virus; Unpublished; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2567,NaN,NaN,QJU69680,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycaregycsggscysgyyyyygmdvwgqgttvtvssastkgpsvfplapsskstsggtaalgclvkdyfpepvtvswnsgaltsgvhtfpavlqssglyslssvvtvpssslgtqtyicnvnhkpsntkvdkrvepkscdkthtcppcpapellggpsvflfppkpkdtlmisrtpevtcvvvdvshedpevkfnwyvdgvevhnaktkpreeqynstyrvvsvltvlhqdwlngkeykckvsnkalpapiektiskakgqprepqvytlppsrdeltknqvsltclvkgfypsdiavewesngqpennykttppvldsdgsfflyskltvdksrwqqgnvfscsvmhealhnhytqkslslspgk,NaN,"Shi,R. et al.; A potent human neutralizing monoclonal antibody targeting the receptor binding site of SARS-CoV-2 virus; Unpublished; 2020.","anti-SARS-CoV-2 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2568,NaN,NaN,QJU69735,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssygmhwvrqapgkglewvaviwydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardimfgddwlqkqpdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2569,NaN,NaN,QJU69734,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgssvkvsckasggtfssytinwvrqapgqglewmgriipilgiadyaqkfqgrvtitadkststaymelsslrsedtavyycardlvedtamvtgaaagtwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2570,NaN,NaN,QJU69733,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisaysgntnyaqklqgrvtmttdtststaymevrslrsddtavyycarvglwwlghpdvfdiwgqgtmvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2571,NaN,NaN,QJU69732,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfnlsnyamhwvrqasgkglewvslisydgsikyytdsvkgrftvsgdnskntlflqmnslrpddsalyycvrggvsgpnsfdmwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2572,NaN,NaN,QJU69731,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvtveaifgvvilplknwfdpwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2573,NaN,NaN,QJU69730,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyymhwvrqapgqglewmgiinpsggstsyaqkfqgrvtmtrdtststvymelsslrsedtavyycardltstssspysyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2574,NaN,NaN,QJU69729,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarvtvvhfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2575,NaN,NaN,QJU69728,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqkvqgrvtmttdtststaymelrslrsddtavyycardrgyaatfgvfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2576,NaN,NaN,QJU69727,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycartkggsyfapfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2577,NaN,NaN,QJU69726,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfssygiswvrqdpgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvglwwlghpdafdiwgqgtmvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2578,NaN,NaN,QJU69725,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrsmrlscaasgfnlssyamhwvrqasgkglewvslisydgsikyyadsvkgrftvsgdnskntlflqmsslraddsalyycvrggvsgpnafdiwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2579,NaN,NaN,QJU69724,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycaraqtahysssfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2580,NaN,NaN,QJU69723,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycararvaydyiwgsyrykafdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2581,NaN,NaN,QJU69722,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyvqkfqgrvtmtrdtsistaymelnrlrsddtavyfcardltttagtdyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2582,NaN,NaN,QJU69721,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgysissgyywgwirqppgkglewigsiyhsgstyynpslksrvtisvdtsknqfslklssvtaadtavyycartplslrlrynwyfdlwgrgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2583,NaN,NaN,QJU69720,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsyggsyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2584,NaN,NaN,QJU69719,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsydiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycardsvagiyyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2585,NaN,NaN,QJU69718,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsdvtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycareardyygsgsldywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2586,NaN,NaN,QJU69717,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatappysppsswfdpwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2587,NaN,NaN,QJU69716,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesgggliqpggslrlscaasgvivssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycardldvsggmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2588,NaN,NaN,QJU69713,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvalisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsfggsyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2589,NaN,NaN,QJU69712,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardeayydiltgyinapknyyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2590,NaN,NaN,QJU69711,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissgdyywswirqppgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycardhhydfwsgyssyyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2591,NaN,NaN,QJU69710,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatappysppsswfdpwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2592,NaN,NaN,QJU69709,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsyamhwvrqapgqrlewmgwinagngntkysqkfqgrvtitrdtsastaymelsslrsedtavyycarvwgycsggscyvdafdiwgqgtmvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2593,NaN,NaN,QJU69708,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfssysmnwvrqapgkglewvssisssssyiyyadsvkgrftisrdnaknslylqmnslraedtavyycardresydiltgysmegcfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2594,NaN,NaN,QJU69707,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsnawmswvrqapgkglewvgriksktdggttdyaapvkgrftisrddskntlylqmnslktedtavyycttdrvydyiwgsyryldywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2595,NaN,NaN,QJU69706,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycareyyydssvypyyyyamdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2596,NaN,NaN,QJU69705,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycattspivgaitwfdpwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2597,NaN,NaN,QJU69704,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftgyymhwvrqapgqglewmgwinpnsggtnyaqkfqgrvtmtrdtsistaymelsrlrsddtavyycarvdygsgsygwgwfdpwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2598,NaN,NaN,QJU69703,NaN,SARS-CoV-2,Homo sapiens (human),evqlvqsgaevkkpgeslkisckgsgysftsywigwvrqmpgkglewmgiiypgdsdtryspsfqgqvtisadksistaylqwsslkasdtamyycarqssfyssgwysygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2599,NaN,NaN,QJU69702,NaN,SARS-CoV-2,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssywmswvrqapgkglewvanikqdgsekyyvdsvkgrftisrdnaknslylqmnslraedtavyycardfnsyqllwyyyygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2600,NaN,NaN,QJU69701,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvklscqasgysftnhamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvsttylhisslkaedtavyycarasarpgvatnldfwgqgtlvvvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2601,NaN,NaN,QJU69700,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgfnlsnyamhwvrqasgkglewvslisydgsvkyytdsvkgrftvsgdnskntlflqmnslrpddsalyycvrggvsgpnsfdmwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2602,NaN,NaN,QJU69699,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsqtlsltctvsggsissggyywswirqhpgkglewigyiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycarettghfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2603,NaN,NaN,QJU69698,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltcnvsggsissyywswirqppgkglewigyiyysgstnynpslksrvtisvdtsknqfslklssvtaadtavyycargfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2604,NaN,NaN,QJU69697,NaN,SARS-CoV-2,Homo sapiens (human),qlqlqesgpglvkpsetlsltctvsggsissssyywgwirqppgkglewigsiyysgstyynpslksrvtisvdtsknqfslklssvtaadtavyycathivvvtatpnwyfdlwgrgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2605,NaN,NaN,QJU69696,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarlvptwasyydfwsgypggygmdvwgqgttvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2606,NaN,NaN,QJU69695,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsisgsylgafdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2607,NaN,NaN,QJU69694,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckvsgytltelsmhwvrqapgkglewmggfdpedgetiyaqkfqgrvtmtedtstdtaymelsslrsedtavyycatgppycsstscehwfdpwgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2608,NaN,NaN,QJU69693,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgaevkkpgasvkvtckasgytftsyylhwvrqapgqglewmgiinpsggttsyaqkfqgrvtmtrdtststvymelsslrsedtavyycaragrrysssddgafdiwgqgtmvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2609,NaN,NaN,QJU69692,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarsisgsylgafdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2610,NaN,NaN,QJU69691,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvqsgselkkpgasvklscqasgysftnhamnwvrqapgqglewmgwintntgnptyaqgftgrfvfsldtsvsttylhisslkaedtavyycarasarpgvatnldfwgqgtlvvvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2611,NaN,NaN,QJU69690,NaN,SARS-CoV-2,Homo sapiens (human),qvqlvesgggvvqpgrslrlscaasgftfssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycarvrgsyylfdywgqgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2612,NaN,NaN,QJU69689,NaN,SARS-CoV-2,Homo sapiens (human),qvqlqesgpglvkpsetlsltctvsgysissgyywgwirqppgkglewigsiyhsgstyynpslksrvtisvdtsknqfslklssvtaadtavyycartplslrlrynwyfdlwgrgtlvtvss,NaN,"Seydoux,E. et al.; Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual; bioRxivorg (2020) In press; 2020.","anti-SARS-CoV-2 immunoglobulin gamma heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2613,NaN,NaN,QJG66105,NaN,SARS-CoV,Lama glama (llama),qvqlqesggglvqaggslrlscaasgrtfseyamgwfrqapgkerefvatiswsggstyytdsvkgrftisrdnakntvylqmnslkpddtavyycaaaglgtvvsewdydydywgqgtqvtvss,NaN,"Wrapp,D. et al.; Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies; Cell (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Lama glama]",NaN,2022-03-14,NaN,NaN
2614,NaN,NaN,QJG66104,NaN,SARS-CoV,Lama glama (llama),qvqlqesgggsvqaggslrlscvasgsifsinamdwyrqapgkqrelvagitsggstnygdfvkgrftisrdnakntvylqmdslkpedtavyycaaevggwgpprpdywghgtqvtvss,NaN,"Wrapp,D. et al.; Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies; Cell (2020) In press; 2020.","immunoglobulin heavy chain variable region, partial [Lama glama]",NaN,2022-03-14,NaN,NaN
2615,NaN,NaN,QIQ28229,NaN,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),qqlkesggrlvtpgtpltltctasgfslssyyvswvrqapgkglewigiipgtgptycaswakgrftisktsttvdlkitspttedtatyfcarvyagfstwlyfdlwgpgtlvtvss,NaN,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.","anti-SARS-CoV-2 RBD antibody immunoglobulin heavy chain variable region, partial [Oryctolagus cuniculus]",NaN,2022-03-14,NaN,NaN
2616,NaN,NaN,QIQ28228,NaN,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),qsvkesggrlvtpgtpltltctvsgfslssyamswvrqapgkglewigiisksgstyyaswakgrftisktsttvdlkitspttedtatyfcarddilytsssgyyygmdlwgpgtlvtvss,NaN,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.","anti-SARS-CoV-2 RBD antibody immunoglobulin heavy chain variable region, partial [Oryctolagus cuniculus]",NaN,2022-03-14,NaN,NaN
2617,NaN,NaN,QIQ28227,NaN,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),qsvkesggrlvtpgtpltltctvsgfslssydmiwvrqapgeglewigiidtaggayyaswakgrftisrtsttvdlkitspttedtatyfcarafygsgwgftrldlwgqgtlvtvss,NaN,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.","anti-SARS-CoV-2 RBD antibody immunoglobulin heavy chain variable region, partial [Oryctolagus cuniculus]",NaN,2022-03-14,NaN,NaN
2618,NaN,NaN,QIQ28226,NaN,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),eqlkesggrlvtpgtpltltctvsgfdlsscsmgwvrqapgkgleyigiisssgstyyaswpkgrftisktsttvdlkitspttedtatyfcargfwyfnlwgqgtlvtvss,NaN,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.","anti-SARS-CoV-2 RBD antibody immunoglobulin heavy chain variable region, partial [Oryctolagus cuniculus]",NaN,2022-03-14,NaN,NaN
2619,NaN,NaN,QIQ28225,NaN,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),qsvkesggrlvtpgtpltltctasgfslssyymswvrqapgkglewigiiyassstnyaswatgrftisktsttvdlkitspttedtatyfcarvyssgwgdafdlwgpgtlvtvss,NaN,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.","anti-SARS-CoV-2 RBD antibody immunoglobulin heavy chain variable region, partial [Oryctolagus cuniculus]",NaN,2022-03-14,NaN,NaN
2620,NaN,NaN,QIQ28224,NaN,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),qsvkesggrlvtpgtpltltctvsgfslssywmswvrqapgkglewigiiftggstyyaswakgrftisktsttvdlkitspttedtatyfcartsyydvsgwgvgrldlwgqgtlvtvss,NaN,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.","anti-SARS-CoV-2 RBD antibody immunoglobulin heavy chain variable region, partial [Oryctolagus cuniculus]",NaN,2022-03-14,NaN,NaN
2621,NaN,NaN,NaN,QIQ28235,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),NaN,dpmltqtaspvsaavggtvtincqasqsisssnwlswyqqkpgqppklliykastlasgvpsrfkgsgsgtqftltisgvqcddaatyyclgyysftsadnafgggtevvvk,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.",NaN,"anti-SARS-CoV-2 RBD antibody immunoglobulin light chain variable region, partial [Oryctolagus cuniculus]",2022-03-14,NaN,NaN
2622,NaN,NaN,NaN,QIQ28234,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),NaN,alvmtqtpasvsaavggtvtincqasediysnlawyqqkpgqppklliygastlasgvpsrfkgsgsgteytltisgvqcddaatyycqctydsssytfgggteleik,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.",NaN,"anti-SARS-CoV-2 RBD antibody immunoglobulin light chain variable region, partial [Oryctolagus cuniculus]",2022-03-14,NaN,NaN
2623,NaN,NaN,NaN,QIQ28233,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),NaN,dpvltqtpssasepvggtvnikcqasqsigtrlawyqqkpgqppklliyyastlasgvpsrfkgsgsgteytltisgvqcddaatyyclgehsyssgdgrtafgggtevvvk,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.",NaN,"anti-SARS-CoV-2 RBD antibody immunoglobulin light chain variable region, partial [Oryctolagus cuniculus]",2022-03-14,NaN,NaN
2624,NaN,NaN,NaN,QIQ28232,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),NaN,alvmtqtpssvsepvggtvtincqasediysnlawyqqkpgqppklliydasnlasgvpsrfsgsgsgteytltisgvqcadaatyycqtyystvtrafgagtkveik,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.",NaN,"anti-SARS-CoV-2 RBD antibody immunoglobulin light chain variable region, partial [Oryctolagus cuniculus]",2022-03-14,NaN,NaN
2625,NaN,NaN,NaN,QIQ28231,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),NaN,apvltqtpspvsaavggtvtincqaseniysflawyqqkpgqppklliytasklasgvpsrfkgsgsgtqftltisdvqcddaatyycqqtdtysnvdnafgggtevvve,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.",NaN,"anti-SARS-CoV-2 RBD antibody immunoglobulin light chain variable region, partial [Oryctolagus cuniculus]",2022-03-14,NaN,NaN
2626,NaN,NaN,NaN,QIQ28230,"SARS-CoV-2, Spike protein RBD",Oryctolagus cuniculus (rabbit),NaN,dpmltqtassvsaavggtvtiscqssqsvydnnwlgwyqqkpgqppklliysastlasgvpsrfkgsgsgtqftltisdlecddaatyycaggysgnifafgggteleil,"Hong,J. et al.; Generation and characterization of rabbit neutralizing monoclonal antibodies against SARS-CoV-2; Unpublished; 2020.",NaN,"anti-SARS-CoV-2 RBD antibody immunoglobulin light chain variable region, partial [Oryctolagus cuniculus]",2022-03-14,NaN,NaN
2627,NaN,NaN,ABS86623,NaN,SARS-CoV,synthetic construct,qvqlvqsgaevkkpgssvkvsckasggtfssyaiswvrqapgqglewmggiipifgtanyaqkfqgrvtitadeststaymelsslrsedtavyycargywgsgyhyygmdvwgqgttvtvss,NaN,"Zhao,A. et al.; Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV; Microbes Infect. 9 (8), 1026-1033 (2007); 2007.","SARS-CoV nucleocapsid protein antibody heavy chain, partial [synthetic construct]",NaN,2022-03-14,NaN,NaN
2628,H12,NaN,AAX19356,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgaevkkpgssvkvsckasggtfsshavnwvrqvpgqglewmgrvipilgtvknaqkfqgrvtitadeatstaymelnslrsedtavyycarggwctgdcdartfvwfepwgqgttvtvss,NaN,"Yan,X. et al.; A SARS antibody; Unpublished; 2005.","SARS antibody H12 immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2629,NaN,NaN,AAT73721,NaN,SARS-CoV,Mus musculus (house mouse),qvqlqqpgaelvkpgasvkvsckasgytftnywihwvkqrpgqglewigeinpgngrtnyngnfmnkatltvdkssntaymqlssltsedsavyhcarldywgqgttltvssakttppsv,NaN,"Gubbins,M.J. et al.; Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus; Mol. Immunol. 42 (1), 125-136 (2005); 2004.","immunoglobulin gamma heavy chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2630,NaN,NaN,AAT73720,NaN,SARS-CoV,Mus musculus (house mouse),evqleesgpglvapsqslsitctvsgfsltnydiswirqppgkglewlgiiwtgggtsynsafmsrlsiskdnsksqvflkmnslqtddtaiyycvrdrvyyfpmdywgqgtsvtvssakttapsvypla,NaN,"Gubbins,M.J. et al.; Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus; Mol. Immunol. 42 (1), 125-136 (2005); 2004.","immunoglobulin gamma heavy chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2631,NaN,NaN,AAT73718,NaN,SARS-CoV,Mus musculus (house mouse),lvqleesgtvlprpgasvkmsckasgytftsywmhwvkqrpgqglewigaiypgnsdtnynqkfkgratltavtststasmelssltnedsavyyctrdgygslyyyamdfwgqgtsvtvssakttapsvkg,NaN,"Gubbins,M.J. et al.; Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus; Mol. Immunol. 42 (1), 125-136 (2005); 2004.","immunoglobulin gamma heavy chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2632,NaN,NaN,AAT73717,NaN,SARS-CoV,Mus musculus (house mouse),evqleesgtvlarpgasvkmsckasgysftsywmhwvkqrpgqgldwigaiypensdtsynqkfkgkakltavtsastaymehssltnedsavyyctrsvyygygyfdvwgagttvtvssakttapsvyplapvcgdttgssvtlgclvkgyfpepvtltwnsgslssgvhtfpavlqsdlytlsssvtvtsstwpsqsitcnvahpasstkvdkkieprvptsqn,NaN,"Gubbins,M.J. et al.; Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus; Mol. Immunol. 42 (1), 125-136 (2005); 2004.","immunoglobulin gamma heavy chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2633,NaN,NaN,AAT73715,NaN,SARS-CoV,Mus musculus (house mouse),vellesgtvlarpgasvkmsceasgytfttywmhwikqrpgqglewigaiypgnsdttynqkfkgkakltavtststaymelssltnedsavyyctregipqllrtmdywgqgtsvtvssakttppsv,NaN,"Gubbins,M.J. et al.; Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus; Mol. Immunol. 42 (1), 125-136 (2005); 2004.","immunoglobulin gamma heavy chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2634,NaN,NaN,AAT73714,NaN,SARS-CoV,Mus musculus (house mouse),mewswvflfllsgtagvlsevrlqqsgpelvkpgasvkiscktsgytfteytmhwvkqshgknlewigginpnnggttynqkfkgkatltvdkssntaymelrsltsedsavyycsrgdygtsygyfdvwgagttvtvssakttapsvypla,NaN,"Gubbins,M.J. et al.; Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus; Mol. Immunol. 42 (1), 125-136 (2005); 2004.","immunoglobulin gamma heavy chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2635,NaN,NaN,AAT51717,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfssyamswvrqapgkglewvsaisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakfnpftsfdywgqgtlvtvss,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2636,NaN,NaN,AAT51716,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvrpggslrlscaasgftfddygmswvrqapgkglewvsginwnggstgyadsvkgrftisrdnaknslylqmnslraedtavyycarglslrpwgqgtlvtvsr,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2637,NaN,NaN,AAT51715,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsdhymdwvrqapgkglewvgrtrnkansytteyaasvkgrftisrddsknslylqmnslktedtavyycargispfyfdywgqgtlvtvss,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2638,NaN,NaN,AAT51714,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsdhymdwvrqapgkglewvgrtrnkansytteyaasvkgrftisrddsknslylqmnslktedtavyycakgltplyfdywgqgtlvtvss,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2639,NaN,NaN,AAT51713,NaN,SARS-CoV,Homo sapiens (human),evqlvesgggvvqpgrslrlscaasgftfsdypmnwvrqapgkglewvssisgsggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakglfmvttyafdywgqgtlvtvle,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2640,NaN,NaN,AAT51712,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvqpggslrlscaasgftfsgypmhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycakdgsprtpsfdywgqgtlvtvle,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2641,NaN,NaN,AAT51711,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsgysmswvrqapgkglewvgrtrnkansytteyaasvkgrftisrddsknslylqmnslktedtavyycaryysrslkafdywgqgtlvtvle,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2642,NaN,NaN,AAT51710,NaN,SARS-CoV,Homo sapiens (human),evqlvesggglvkpggslrlscaasgftfsgysmnwvrqapgkglewvssisggstyyadsrkgrftisrdnskntlylqmnnlraedtavyycarhrfrhvfdywgqgtlvtvle,NaN,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.","anti-SARS-CoV immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2643,NaN,NaN,NaN,AAT51720,SARS-CoV,Homo sapiens (human),NaN,seltqdpavsvalgqtvritcqgdslrsyyaswyqqkpgqapvlviygknnrpsgipdrfsgsssgntasltitgaqaedeadyycnsrdssgnhvvfgggtkltvl,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.",NaN,"anti-SARS-CoV immunoglobulin lambda light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2644,NaN,NaN,NaN,AAT51719,SARS-CoV,Homo sapiens (human),NaN,diqmtqsphslsasvgdrvtitcrasqgisnylawyqqkpgkvpklliyaastlqsgvpsrfsgsgsgtdftltisslqpedvgvyycqqrfrtpvtfgqgtkleik,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.",NaN,"anti-SARS-CoV immunoglobulin kappa light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2645,NaN,NaN,NaN,AAT51718,SARS-CoV,Homo sapiens (human),NaN,eltqspsslsasvgdrvtitcrasqsissylnwyqqkpgkapklliyaasslqsgvpsrfsgsgsgtdftltisslqpedfatyycqqsystpptfgqgtkveik,"van den Brink,E.N. et al.; Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus; J. Virol. 79 (3), 1635-1644 (2005); 2005.",NaN,"anti-SARS-CoV immunoglobulin kappa light chain variable region, partial [Homo sapiens]",2022-03-14,NaN,NaN
2646,NaN,NaN,AAC53258,NaN,SARS-CoV,Mus musculus (house mouse),mkcswvifflmavviginsevqlqqsgaelvrsgasvklsctasgfnikdyymhwvkqrpeqglewigwidpengyteyapkfqgkatvtadtssntaylqlssltsedtavyycnafyyrydafdywgqgttltvss,NaN,"Castilla,J. et al.; Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies; J. Virol. 71 (7), 5251-5258 (1997); 1997.","monoclonal antibody gamma one chain variable region, partial [Mus musculus]",NaN,2022-03-14,NaN,NaN
2647,NaN,NaN,AAS19427,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytfttygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarddlsdygewlgpdywgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2648,NaN,NaN,AAS19426,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsggglvqpggslrlscaasgftfssswmswvrqapgkglewvayikqdgsekyyvdsvkgrftisrdnaknslylqmdslraedtavyycardqgwgwdgteyysdywgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2649,NaN,NaN,AAS19425,NaN,SARS-CoV,Homo sapiens (human),evqlvqsgggvvqpgkslrlscaasgfafssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardrsyyldywgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2650,NaN,NaN,AAS19424,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarnfgedfdywgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2651,NaN,NaN,AAS19423,NaN,SARS-CoV,Homo sapiens (human),qvqlqesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycarerwlqigedafdiwgqgttvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2652,NaN,NaN,AAS19422,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgaevkkpgasvkvsckasgytftsygiswvrqapgqglewmgwisayngntnyaqklqgrvtmttdtststaymelrslrsddtavyycarvgyygdyawgyyyygmdvwgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2653,NaN,NaN,AAS19421,NaN,SARS-CoV,Homo sapiens (human),evqlvqsggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtgvyycardwgysfgdwgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2654,NaN,NaN,AAS19420,NaN,SARS-CoV,Homo sapiens (human),qvqlvqsgggvvqpgrslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdygegfdywgqgtlvtvss,NaN,"Sui,J. et al.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association; Proc. Natl. Acad. Sci. U.S.A. 101 (8), 2536-2541 (2004); 2004.","anti-SARS S protein immunoglobulin heavy chain variable region, partial [Homo sapiens]",NaN,2022-03-14,NaN,NaN
2655,NaN,NaN,ADS07413,NaN,SARS-CoV,Unknown.,qvqlvqsggglvqpggslrlscaasgftfssswmswvrqapgkglewvayikqdgsekyyvdsvkgrftisrdnaknslylqmdslraedtavyycardqgwgwdgteyysdywgqgtlvtvss,NaN,"Marasco,W. et al.; Antibodies against SARS-CoV and methods of use thereof; US7750123-B2 13 06-JUL-2010 Dana Farber Cancer Institute, Inc.; Boston, MA; US;; 2010.",Sequence 13 from patent US 7750123,NaN,2022-03-14,NaN,NaN
2656,NaN,NaN,ADS07412,NaN,SARS-CoV,Unknown.,evqlvqsgggvvqpgkslrlscaasgfafssyamhwvrqapgkglewvavisydgsnkyyadsvkgrftisrdnskntlylqmnslraedtavyycardrsyyldywgqgtlvtvss,NaN,"Marasco,W. et al.; Antibodies against SARS-CoV and methods of use thereof; US7750123-B2 12 06-JUL-2010 Dana Farber Cancer Institute, Inc.; Boston, MA; US;; 2010.",Sequence 12 from patent US 7750123,NaN,2022-03-14,NaN,NaN
2657,NaN,NaN,ADS07411,NaN,SARS-CoV,Unknown.,qvqlvqsgggliqpggslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycarnfgedfdywgqgtlvtvss,NaN,"Marasco,W. et al.; Antibodies against SARS-CoV and methods of use thereof; US7750123-B2 11 06-JUL-2010 Dana Farber Cancer Institute, Inc.; Boston, MA; US;; 2010.",Sequence 11 from patent US 7750123,NaN,2022-03-14,NaN,NaN
2658,NaN,NaN,ADS07410,NaN,SARS-CoV,Unknown.,qvqlqesggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtavyycarerwlqigedafdiwgqgttvtvss,NaN,"Marasco,W. et al.; Antibodies against SARS-CoV and methods of use thereof; US7750123-B2 10 06-JUL-2010 Dana Farber Cancer Institute, Inc.; Boston, MA; US;; 2010.",Sequence 10 from patent US 7750123,NaN,2022-03-14,NaN,NaN
2659,NaN,NaN,ADS07408,NaN,SARS-CoV,Unknown.,evqlvqsggglvkpggslrlscaasgftfsdyymswirqapgkglewvsyisssgstiyyadsvkgrftisrdnaknslylqmnslraedtgvyycardwgysfgdwgqgtlvtvss,NaN,"Marasco,W. et al.; Antibodies against SARS-CoV and methods of use thereof; US7750123-B2 8 06-JUL-2010 Dana Farber Cancer Institute, Inc.; Boston, MA; US;; 2010.",Sequence 8 from patent US 7750123,NaN,2022-03-14,NaN,NaN
2660,NaN,NaN,ADS07407,NaN,SARS-CoV,Unknown.,qvqlvqsgggvvqpgrslrlscaasgftvssnymswvrqapgkglewvsviysggstyyadsvkgrftisrdnskntlylqmnslraedtavyycakdygegfdywgqgtlvtvss,NaN,"Marasco,W. et al.; Antibodies against SARS-CoV and methods of use thereof; US7750123-B2 7 06-JUL-2010 Dana Farber Cancer Institute, Inc.; Boston, MA; US;; 2010.",Sequence 7 from patent US 7750123,NaN,2022-03-14,NaN,NaN
2661,NaN,NaN,ADA40860,NaN,SARS-CoV,Unknown.,evqleesgpglvapsqslsitctvsgfsltnydiswirqppgkglewlgiiwtgggtsynsafmsrlsiskdnsksqvflkmnslqtddtaiyycvrdrvyyfpmdywgqgtsvtvssakttapsvypla,NaN,"Berry,J. et al.; Anti-SARS monoclonal antibodies; US7622112-A 7 24-NOV-2009; 2009.",Sequence 7 from patent US 7622112,NaN,2022-03-14,NaN,NaN
2662,NaN,NaN,ADA40857,NaN,SARS-CoV,Unknown.,evqleesgtvlarpgasvkmsckasgysftsywmhwvkqrpgqgldwigaiypensdtsynqkfkgkakltavtsastaymehssltnedsavyyctrsvyygygyfdvwgagttvtvssakttapsvyplapvcgdttgssvtlgclvkgyfpepvtltwnsgslssgvhtfpavlqsdlytlsssvtvtsstwpsqsitcnvahpasstkvdkkieprvptsqn,NaN,"Berry,J. et al.; Anti-SARS monoclonal antibodies; US7622112-A 4 24-NOV-2009; 2009.",Sequence 4 from patent US 7622112,NaN,2022-03-14,NaN,NaN
2663,NaN,NaN,ADA40855,NaN,SARS-CoV,Unknown.,vellesgtvlarpgasvkmsceasgytfttywmhwikqrpgqglewigaiypgnsdttynqkfkgkakltavtststaymelssltnedsavyyctregipqllrtmdywgqgtsvtvssakttppsv,NaN,"Berry,J. et al.; Anti-SARS monoclonal antibodies; US7622112-A 2 24-NOV-2009; 2009.",Sequence 2 from patent US 7622112,NaN,2022-03-14,NaN,NaN
